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Summary 
This thesis is about the process and practice of diagnosis and the implications of new 
diagnostic technologies in low resource settings. As a setting and a disease which has seen 
significant investment in diagnostics, Lassa fever in Sierra Leone has been selected as a case 
study to examine these themes. In this thesis, 'new diagnostic technologies’ refers to 
laboratory-based diagnostics which are fast, reliable, accurate and can be used in low income 
settings. The starting point of this thesis is a narrative surrounding such technologies which 
suggests that they will revolutionise low income healthcare settings by allowing accurate 
scientific diagnosis in places where it was not possible before. Various perspectives on 
diagnosis are examined and some limitations are identified in relation to their accounts of 
diagnostic process, context, practice and technology. To explore the case, aspects of science 
and technology studies, the sociology of scientific knowledge and medical anthropology are 
combined. A multi-sited ethnography of Lassa fever diagnosis was conducted in three 
settings: a rural village, a laboratory and the wards of a hospital. Documents were reviewed 
and interviews conducted with key actors and ex-Lassa fever patients. Analysis focused on 
framings (partial and subjective interpretations), narratives (persuasive storylines which 
make use of particular framings) and practice in relation to Lassa fever and the development 
of technology for its diagnosis. Assumptions about the disease, diagnostics and the process of 
diagnosis are identified and the conclusion considers how they compare with practice in each 
setting. This thesis argues that diagnosis is a complex negotiated process and that new 
diagnostics represent only one aspect of that process. Thus, they are not a ‘silver bullet’ to 
transform low resource healthcare contexts. In particular, ‘improved’ diagnostics do not 
always have the expected impacts, sometimes even introducing complexity and uncertainty. 
In challenging narratives about diagnostics, this thesis provides an alternative, practice-based, 
approach to thinking about diagnostics and innovations in health systems; this approach 
acknowledges the importance, and complexity, of the diverse contexts which shape 
innovations and technology use.     
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1 Introduction 
A story doing the rounds after the then Sierra Leonean president, Ernest Bai Koroma, visited 
the Kenema Government Hospital (KGH) in 2010 claimed that, as he was being shown the 
hospital’s general laboratory, he noted a closed door and asked what was behind it. The reply: 
“the Lassa Lab”. On hearing this, the president indicated to his aides that they should make a 
swift exit. He was apparently eager to get away from anything to do with Lassa fever, a 
notoriously gruesome, and often fatal, viral haemorrhagic fever that is one of Sierra Leone’s 
peculiar claims to fame. Another story relates to a second unenviable reason for notoriety: the 
decade long civil war which made the country famous for child soldiers, so-called ‘blood 
diamonds’ and amputations.1 During the war, when some of the Lassa fever research and 
treatment activities were still carried out at Nixon Memorial Hospital in Segbwema - a town in 
Sierra Leone’s Eastern region where the conflict took a heavy toll - the rebels had sacked the 
hospital but had left all buildings associated with Lassa fever untouched. These building were 
avoided, it was said, because the rebels were afraid of the disease. I had trouble verifying both 
these tales and consequently I am not sure they are true. Their retelling, however, is 
representative of the symbolic power Lassa fever commands in Sierra Leone - and further 
afield - much of which is the subject of this thesis. Concern about the threat of infection from 
the virus, which includes its potential use as an agent of bioterrorism, means that a dedicated 
laboratory has been set up to research and diagnose it and an isolation ward is used to treat it 
at KGH.  
 
The ‘Lassa lab’ and the ‘Lassa ward’ are important settings in this thesis as they are the places 
where cases of Lassa fever should be confirmed and dealt with. But the pathway a patient 
takes in being diagnosed with Lassa fever, a process which is at the centre of the upcoming 
chapters, is not usually straightforward. A ‘typical’ story is hard to decipher but Adama’s 
                                               
1 The civil war lasted between 1991 and 2002. In 1991, after 23 years of rule by the All People’s 
Congress (APC) party, the Revolutionary United Front (RUF) began an armed struggle from near the 
Liberian border. A coup from within the Sierra Leonean Army (SLA) followed in 1992. A decade of 
further coups, new governments and broken peace agreements ensued. The RUF was assisted by 
Charles Taylor, the ex-president of Liberia. Taylor and a number of senior RUF commanders were 
convicted of war crimes by the Special Court for Sierra Leone in 2012. See Richards (1996) for an 
account of the conditions leading up to the war.  
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account is illustrative2: in June 2009, at six months pregnant and living only a few streets from 
KGH, Adama began to experience a mild fever. She tried paracetamol from a pharmacy but 
when symptoms persisted she tried a nearby unofficial health clinic. After that, still suffering 
from fever, she tried a Chinese doctor whom she knew. Between these two informal providers 
of healthcare she was given antibiotics and drips, paying in total about 70,000 Leones 
(approximately £12.60 at 2009 exchange rates3). Thinking it was malaria she continued to 
take medicines bought from traders and pharmacists. Ultimately, about ten days after the 
onset of her illness, she went with her husband to KGH. By that point her eyes were red, a 
classic sign of Lassa fever. The doctor ordered a laboratory test for Lassa fever straight away; 
it was positive. She was admitted straight to the isolation ward and put on Ribavirin, the only 
known treatment for Lassa fever. Adama survived, but her baby died. After four days on the 
ward Adama suffered a miscarriage, she told me in Krio4: “mi belleh poil” (my belly spoilt).  
 
As a pregnant woman Adama was lucky to survive. Among those infected with Lassa fever, 
pregnant women are particularly high risk and it is common for both the woman and their 
foetus to die (Price et al., 1988). Adama and her husband explained their choice of healthcare 
as being to do with the severity of symptoms: it was not expense that made them go to 
informal providers, in fact they paid about as much as they would have for admission and 
similar treatment at the government hospital, it was because hospitals were only for “serious 
sicks”. They had thought Adama “only” had malaria. Adama’s journey to the Lassa ward took a 
roundabout route despite KGH’s proximity to her home but, once there, she was swiftly 
diagnosed with Lassa fever. Her story provides a glimpse into a landscape of multiple health 
providers and some specific ideas about categorising disease within that landscape. Yet while 
Adama’s journey was delayed, it was relatively easy compared to that of others whose stories 
I heard. As I will describe, for many people a journey to hospital involves not only greater 
distances but higher human and financial costs too. Furthermore, simply getting to a formal 
                                               
2 Interview ‘Lassa history 7’, Kenema, 10/04/2010. Chapter three explains how interviews are 
referenced in this thesis. Appendix 1 contains details of each interview, including interviewee 
categories, places and any relevant pseudonyms.  
3 I have used a 2009 exchange rate here as that is when Adama fell ill. Elsewhere I use a 2010 exchange 
rate (1 Leone to 0.00018 GBP) as that is when I did most of my fieldwork. To put this money into 
context, in 2007 the average annual income (GDP per capita) in Sierra Leone was $679 USD and 
between 2000-2007 76% of the population were living on less than $2USD a day (UNDP, 2009).  
4 Krio is an English-based creole. Originally spoken by descendants of freed American and West Indian 
slaves who settled in the Freetown peninsular area, it is now widely spoken throughout Sierra Leone. In 
this thesis I use English, Krio and Mende (an indigenous language spoken in Eastern Sierra Leone. As 
Krio and English can be similar any Krio terms and phrases will be italicised in the text to distinguish 
them. Mende words will be in bold.   
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health provider does not ensure that a swift diagnosis of Lassa fever, or anything else, will 
follow. Nor is a laboratory test result necessarily a closed case. Diagnostic pathways, as in the 
various routes and turns which a patient takes, are varied even within the hospital grounds.   
   
This thesis is about diagnostic technology and diagnostic processes in low resource and 
complex health care systems. It is about how both disease and diagnosis are framed, meaning 
how they are defined, interpreted and represented (Jasanoff, 2005, Schon and Rein, 1994), 
and how that relates to diagnostic practices. A number of factors shaped this research. First, 
my interest was sparked by growing excitement about developments in biotechnology which 
have the potential to “revolutionise” (MacArthur, 2009 p23) the management of disease by 
making laboratory approaches5 to diagnosis available in resource poor settings where 
previously it could not be imagined. Second, I had become aware of efforts to improve 
diagnostics for Lassa fever in Sierra Leone which presented a suitable case study. As 
developments in diagnostics for Lassa fever unfold it is timely to examine how they are being 
achieved, and to ask whether narratives of revolution like those above are justified. 
Accordingly, the question driving this research is: how are developments in laboratory-based 
diagnostic technologies incorporated into the process and practice of Lassa fever diagnosis in 
Sierra Leone?  
 
To understand diagnostic process and practice, I combine the sociology of diagnosis with 
aspects of medical anthropology and selected works in science and technology studies. I use 
literature on framing and narratives to challenge some of the assumptions about diagnostic 
technology and their revolutionary potential: how are Lassa fever and diagnosis framed in 
these narratives? On what basis are improvements in diagnostics made? What are the 
implications for people living and working in resource poor settings such as those in Eastern 
Sierra Leone where Lassa is prevalent? 
1.1 Why diagnostics?  
In 2002 a panel of scientific experts considered the ‘Top ten biotechnologies for improving 
health in developing countries’ and concluded that “Modified molecular technologies for 
affordable, simple diagnosis of infectious diseases” was the area of biotechnology which 
would bring the most improvement in the next five to ten years (Daar et al., 2002 p230). They 
                                               
5 For example diagnosis based on analysis of immune responses or genetic information 
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noted how many existing diagnostic technologies were not suitable for use in limited resource 
settings but that innovations in molecular testing systems meant that reliable diagnostics 
could increasingly be provided in contexts with minimal infrastructure.  
 
Laboratories have been described as the ‘Achilles heel’ of health services (Berkelman et al., 
2006). For a long time overshadowed by efforts to produce drugs and vaccines (MacArthur, 
2009), currently laboratory and diagnostic services in sub-Saharan Africa suffer from 
inadequate funding and a range of related capacity and infrastructure problems: staff and skill 
shortages, poor training, a limited range of tests on offer, lack of consumables and equipment 
to do them (e.g. reagents6, refrigerators), limited support services (e.g. for the transport of 
samples), lack of basic facilities (i.e. clean water, electricity) and lack of regulation, standards 
and protocols (Bates and Maitland, 2006, Peeling and Mabey, 2010, Petti et al., 2006).  
 
The potential benefit of appropriate diagnostics has now been extensively outlined (Global 
Health Diagnostics Forum, 2006, Mabey et al., 2004, Peeling and Nwaka, 2011). ‘Lab on chip’ 
point-of-care (POC) and rapid diagnostics tests (RDT) is a field of rapid development but 
commentators also predict a ‘coming of age’ of laboratory medicine in Africa (Bates and 
Maitland, 2006). Laboratory services and systems are increasingly high up on the policy 
agenda. In 2008 the World Health Organization (WHO) convened a conference in Mozambique 
to focus on laboratory challenges (Olmsted et al., 2010). Integrated laboratory systems are 
argued to underpin health system strengthening (Nkengasong et al., 2010) and to be key to 
meeting health targets such as those in the MDGs (Birx et al., 2009).  
 
Diagnosis now finds itself the target of international attention and investment. The 
Foundation for Innovative Diagnostics (FIND) was set up in 2003 with sponsorship by the Bill 
and Melinda Gates Foundation to support innovation in diagnostics7 (FIND, 2012). From 2004 
to 2006 the Bill and Melinda Gates Foundation also convened8 the Global Diagnostics Forum 
to assess the impact of new diagnostics (Burgess et al., 2006). The African Network for Drugs 
and Diagnostics Innovation (ANDI) was launched in 2008 to encourage African-led innovation 
                                               
6 A reagent is a substance used in diagnostic procedures which tests for a reaction 
7 Focus was initially on diagnostic solutions for tuberculosis, malaria and African Trypanosomiasis, it 
has since expanded. 
8 Along with the Rand Corporation 
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in those areas9 (ANDI, 2010). Developments in genomic and molecular research mean that 
diagnostics have become increasingly attractive to the biotechnology industry (Poste, 2001), 
although for diseases which afflict developing countries the perceived lack of market can still 
be a barrier to investment (Mabey et al., 2004). It has also been claimed that an increasing 
concern for biodefense within some governments has raised investment which will converge 
with research and development for diagnostics more generally (Mabey et al., 2004, Peeling 
and Mabey, 2010).  
 
In this thesis I examine how increased interest and investment in diagnostics translates into 
research, practice and impact. The final point above about biodefense is especially relevant 
because Lassa virus has been classified as a ‘Category A’ priority pathogen by the US National 
Institutes of Allergy and Infectious Diseases (NIAID) on account of its potential threat to 
public health and security (NIAID, 2012). Moreover, it has been designated a potential 
bioterrorist weapon by the Centers for Disease Control and Prevention (CDC) (CDC, 2012a). 
So, in this case, to what extent do biodefense and infectious disease control agendas converge? 
 
The experts in the ‘Top Ten biotechnologies’ study confidently conclude “Infectious disease 
can be controlled by molecular diagnostics (rated first) and recombinant vaccines (second)” 
(Daar et al., 2002, p230). In questioning whether such technologically optimistic assertions 
and the ‘narratives of revolution’ noted above are valid, this thesis considers what they might 
overlook. Pang and Peeling (2007) note that when developing diagnostic tests for developing 
country settings context needs to be taken into account. Yet consideration of ‘context’ has 
been limited. Moreover as the next chapter shall demonstrate, what evidence there is suggests 
that ‘improved’ diagnostics do not always have the impact they are expected to have 
(Chandler et al., 2008a, Chandler et al., 2012, Polage et al., 2006). What these studies show is 
that ‘new’ diagnostics do not act on a blank slate; rather, they come to interact with older 
established processes calling claims of ‘revolution’ into question.  
1.2 Why Lassa fever in Sierra Leone? 
Sierra Leone is one of the world’s poorest countries. In 2009, at the start of this research, it 
was ranked 180 out of 182 in the Human Development Index (UNDP, 2009) having moved 
from the bottom in 2007 (UNDP, 2007). The Ministry of Health and Sanitation (MOHS) 
                                               
9 ANDI has been supported by the WHO’s Special Programme for Research and Training in Tropical 
Diseases (TDR) and the United Nations Economic Commission for Africa (UNECA) 
17 
 
struggles with underinvestment, a high disease burden and a health system weakened during 
the civil war (MOHS, 2009, SSL and ICF Macro, 2009). Basic infrastructure, such as roads and 
electricity, is severely limited even in the capital Freetown let alone more rural areas. Such 
conditions make the kind of high-tech diagnostics available in richer countries, which need 
reliable electricity and expensive equipment, a challenge. As such, Sierra Leone is precisely 
the kind of country where improved diagnostics are expected to have the most impact.  
 
Looking at Sierra Leone’s long list of health problems, Lassa fever stands out. Lassa fever was 
first identified in Nigeria in 1969 (Frame et al., 1970). In the following few years, large 
outbreaks were recorded in Sierra Leone (Monath et al., 1974) and decades later Lassa fever 
still continues to afflict communities there. As a rodent-borne virus it cross-cuts issues of land 
use, stigma and poverty. A much cited paper has estimated there to be between 100,000-
300,000 infections a year across West Africa with as many as 5,000 deaths (McCormick et al., 
1987b). Others put that figure higher with as many as 3 million new infections a year and 
67,000 deaths (Richmond and Baglole, 2003). Although it is not Sierra Leone’s biggest killer10 
a number of factors make it a worthy case study.  
 
First, as the above figures make clear, there is considerable uncertainty about prevalence 
which has implications for diagnosis and framing. Diagnosis presents a number of problems. 
In some instances symptoms appears to be so mild that they can go unreported (Khan et al., 
2008, McCormick et al., 1987a). Or as Adama’s story above makes clear, when symptoms are 
evident they are mostly non-specific, such as fever, which means infection can be mistaken for 
other common diseases. The combination of non-specific symptoms followed by rapid decline 
into severe disease and frequently death means that reliable fast diagnostics are of great 
value. 
 
Second, the dangers associated with Lassa virus mean it is subject to the highest biosafety 
regulations: it is a Biosafety level 4 (BSL-4) pathogen. As such, producing laboratory 
diagnostics for Lassa fever is both expensive and difficult, meaning they have been largely 
unavailable in Sierra Leone (Khan et al., 2008). Investment for a disease which primarily 
                                               
10 Data for cause-specific mortality rates are not reliable but diseases estimated to cause the greatest 
mortality and morbidity in Sierra Leone are malaria, malnutrition, pneumonia, anaemia, tuberculosis, 
diarrheal diseases and respiratory infections, with HIV/AIDS also being a potential problem (MOHS, 
2009, SSL and ICF Macro, 2009) 
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affects poor populations in West Africa had not been forthcoming. Until recently that is, as 
Lassa fever is now the focus of international collaboration to improve diagnostics and 
surveillance (Khan et al., 2008). These efforts grew out of mounting concern with regional and 
international disease outbreaks and, in an important example of framing, the Lassa virus’ 
classification as a potential bioterrorist agent. The result is the ‘Lassa lab’, an island of 
relatively high investment and technology in an extremely resource poor region in Eastern 
Sierra Leone. Such contextual issues make Lassa fever diagnosis in Sierra Leone an 
interesting, if extreme, case through which to explore the opportunities and challenges 
presented by innovations in diagnostics.  
 
A third reason for studying Lassa fever is that the work to enhance diagnostics intersects in a 
fundamental way with diverse framings of the virus.  Lassa fever is primarily associated with 
Sierra Leone, Liberia, Guinea and Nigeria where it is routinely and historically reported. 
However, estimates of disease burden and geographical spread across West Africa are 
increasingly contested. As the figures quoted earlier make clear there is huge variation in 
estimates. In the time since I began this research Lassa fever has been detected in areas where 
it was not previously thought to occur (Sogoba et al., 2012). Recently an article in Nature 
asked if the observed expansion represented real changes in prevalence or just improved 
diagnosis (Gire et al., 2012). Another article comments “It is possible that the illness may be 
one of the infections responsible for mysterious deaths in many parts of Nigeria and other 
African countries (Ogbu et al., 2007 p4). Clearly there are some fundamental questions about 
how to frame Lassa fever: is the disease old or emerging? Is it stable or on the move? Is it 
endemic to all of West Africa or just Sierra Leone, Guinea, Liberia and Nigeria? As this thesis 
will show, such framing debates are not simply distant scientific musings, they are central to 
the practice and process of diagnosis. Furthermore, with developments in diagnostics and 
epidemiology, many of the most well-established principles relating to Lassa fever are being 
challenged.  
 
A fourth and final reason for studying Lassa fever is that there has been no extensive 
qualitative research into the disease. Thus, there is an urgent need to illuminate the 
perspectives of those who live and work with Lassa fever on a daily basis, including 
healthcare workers. How do inhabitants of a large and potentially increasing area of West 
Africa understand Lassa fever, or fever more generally? How do they interpret and deal with 
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the risks that accompany Lassa fever? The narratives of revolution might be justified in the 
long term, but in the short term new biotechnologies need to be put in context.  
1.3 Outline of chapters 
In the following chapter, I begin by outlining the importance of framings and narratives in this 
thesis. Central to this research is the notion that there can be multiple positioned and partial 
views of Lassa fever and of diagnosis, and that combinations of these get pieced together into 
distinct policy narratives which emphasise particular dynamics, responses and outcomes. 
After that I explore the literature on diagnosis. There have been recent attempts to carve out a 
‘sociology of diagnosis’ which aim to address a perceived neglect of the issue (Jutel, 2009). 
Despite some compelling observations, I suggest that there are some oversights which limit 
this literature’s capacity to answer my research questions. In order to understand the 
significance and use of new diagnostic technology I highlight that process, technology, 
practice and context have been overlooked. I turn to aspects of science and technology 
studies, the sociology of scientific knowledge and medical anthropology to fill these gaps. A 
conceptual framework is described where the diagnosis of Lassa fever is conceptualised as a 
system; and the processes and practice within that system are characterised according to 
Andrew Pickering’s ‘mangle of practice’ (Pickering, 1995). 
 
In chapter three, I set out the non-positivist methodological underpinnings of my research 
strategy. Arguing that in-depth qualitative data collection is needed to assess diagnostic 
practice across a variety of settings involved in diagnosis, I explain why and how I conducted a 
multi-sited ethnographic study of the diagnostic system. Using a combination of observations 
and interviews, supplemented by documentary and literature reviews, I collected data in 
three sites: a remote rural village, the ‘Lassa lab’ and the wards at Kenema Government 
Hospital. Data collection is described for each site.  
 
Chapter four provides some more detail on Lassa fever and healthcare in Sierra Leone. It 
describes three narratives which emphasise different aspects of Lassa fever’s emergence and 
control: Lassa as a global threat, as an endemic disease contained in West Africa and as a 
neglected disease in need of a scientific fix. After that, I set out the official version of the 
diagnostic system, as described in formal surveillance documents. I then suggest two areas of 
research which focus on aspects of Lassa fever which are less well represented in these 
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narratives and surveillance policy documents. These are the longer term dynamics of Lassa 
fever and Lassa fever in practice. In order to see how new diagnostic technologies fit into 
existing diagnostic processes, and how that differs from policy descriptions of these 
processes, this thesis seeks to contribute to the latter area of research.   
 
In the first of my ethnographic chapters, chapter five, I describe the therapeutic practices and 
landscape of a rural community in Eastern Sierra Leone. As well as identifying the health and 
healing providers used by villagers, I explore the categories, techniques, tools and patterns 
with which people navigate the ‘therapeutic landscape’ (Leach et al., 2008). Perspectives on, 
and experience with, Lassa fever are woven in to this. I find that, in this village, Lassa fever has 
a ‘big name’ but in practice it blends into existing understandings and approaches to illness, 
particularly fevers. 
   
The focus of chapter six is practices within the ‘Lassa Lab’. I show how narratives identified in 
chapter four are adapted by researchers and technicians and then drive activity in the 
laboratory. The global threat becomes a commercial research opportunity while the lack of 
research highlighted in the neglected disease narrative leaves gaps in knowledge which the 
researchers argue need to be addressed, starting with improved diagnostics. I use Karin Knorr 
Cetina’s term ‘laboritization’ (Knorr Cetina, 1999, p26) to characterise the reconfiguration of 
natural orders which takes place in the laboratory. Claims to superiority (compared with old 
tests) are made on the basis of innovations, or manipulations, in the ingredients, technique 
and interpretation of the diagnostic test. I describe each of these, and then suggest that there 
are some limits to the laboritization processes.  
 
The last of the empirical chapters, chapter seven, takes the wards of Kenema Government 
Hospital as its subject. A contrast is drawn between the view of Lassa fever and diagnostic 
pathways described in case management and surveillance forms and the messier reality of 
diagnosis in this setting. There, under significantly constrained conditions, the diagnosis of 
Lassa fever is an uncertain, non-linear and variable affair. The laboratory test results form 
part of this landscape but they intersect with some well-established practical and experience-
based categories of the disease, and appropriate ways to deal with it in the circumstances. The 
diagnostic profile of Lassa fever in this context proves to be more multi-dimensional than the 
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reductionist definitions of ‘positive’ ‘negative’ or ‘indeterminate’ which are made in the 
laboratory. 
 
With chapter eight, I conclude this thesis by drawing together key observations from the three 
settings and relating them to the ‘mangle of practice’. The implications of this perspective on 
diagnosis are discussed. It is apparent that the process of diagnosis cannot be said to be pre-
determined by an underlying cause and it is not straightforward even when there is an 
identifiable virus. Diagnostic pathways are not singular, even when there are clear treatment 
protocols set out. Diagnosis is the result of many hands, tools and negotiations and as such, it 
is unpredictable. On the narratives of technological optimism, there is evidence to suggest that 
a revolution will not take place based on technology alone. Indeed, I suggest that ‘improved’ 
diagnostics can introduce uncertainty and complexity. Ultimately, efforts to improve 
diagnosis, or disease control more generally, need to be broadened and should consider the 
diverse social settings of their application. Lastly, the extent of the ‘convergence’ of interests 
in delivering health interventions and biodefense is questioned as a way of delivering wide-
ranging benefits in global health.        
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2 Understanding diagnosis, diagnostics and disease 
As the expansion of diagnostic capacity gathers excitement it is timely to explore diagnosis 
and its practice. By unpicking various aspects of diagnosis I establish a conceptual basis from 
which to view the implications of new technologies. I review a loose but increasingly self-
defined collection of studies which fall under the umbrella of ‘sociology of diagnosis’. To this I 
add concepts from medical anthropology and science and technology studies (STS), taking a 
particular interest in politics of knowledge and ‘science as practice’ arguments.  
 
Before discussing diagnosis, I introduce the concepts of framing and narratives. By framing, I 
mean an awareness of partial and differential interpretations of the world (Jasanoff, 2005, 
Schon and Rein, 1994). By narratives I mean the piecing together of certain framings into 
persuasive stories (Roe, 1994, Wald, 2008), which then find traction in particular institutions 
or communities. I deal with framing and narratives first because they run throughout what 
follows. This can be illustrated by simply asking, what is diagnosis? In some accounts 
diagnosis is presented as a scientific endeavour: the ‘modern scientific physician’ applies 
‘modern statistical theory’ in the pursuit of a ‘scientific diagnosis’ (Miettinen, 2001). In 
contrast, others emphasise the importance of tacit knowledge (Braude, 2009, Henry, 2006) 
and pattern recognition in the ‘art of diagnosis’ (Eddy and Clanton, 1982). The art or science 
question frames diagnosis differently. It is portrayed either as a flash of intuitive brilliance on 
the part of a clinician or the methodical application of scientific logic. Elsewhere it is reasoned 
that diagnosis, like most clinical decision making, requires a blend of both interpretive and 
methodical elements (Malterud, 2001).  
 
In what should be considered my own framing of diagnosis, I argue that diagnosis is a 
complex and negotiated process. In fact, it entails many processes all playing out within what I 
call the ‘diagnostic system’. This system is full of multiplicity, assorted assemblages of people 
and things, diverse classifications and enactments of disease used by different actors at 
different times which frame disease in various, sometimes conflicting, ways. I use Andrew 
Pickering’s (1995) concept of a ‘mangle of practice’ to characterise the diagnostic system. The 
mangle suggests something which is twisted, contested, hard to disentangle and above all, not 
straightforward. As a metaphor it conveys the complexity of the diagnostic system without 
rendering it systematic. 
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This chapter consists of three main sections. In section - I discuss the significance of framings 
and narratives and their place in this thesis. Section 2.2 provides the core literature on 
diagnosis. The insights and oversights identified here provide the basis for my 
characterisation of the diagnostic system as a mangle of practice. Finally in section 2.3, I 
review the principles of Pickering’s mangle and discuss the implication of applying it to 
diagnosis. In the course of reviewing this literature the research question which I introduced 
in chapter one is supplemented by three sub-questions, shown below. 
  
How are developments in laboratory-based diagnostic technologies incorporated into the 
process and practice of Lassa fever diagnosis in Sierra Leone? 
 
- How is the diagnosis of Lassa fever framed and how do these framings relate to 
diverse narratives about the disease’s significance and control? 
- How is Lassa fever diagnosed in practice and how do different framings and practices 
intersect with each other? 
- How do new diagnostics influence the uncertainty surrounding diagnosis?  
2.1 Framings and Narratives 
Noting that perspectives can be situated and partial is not new (for example, see Haraway, 
1988). The diversity of explanatory cultural models and worldviews has long been noted in 
anthropology (Evans-Pritchard, 1976) especially in relation to explanations of disease, illness 
and healing (Janzen, 1978, Kleinman, 1980, Young, 1982). My reason for putting framing at 
the centre of my analysis is that it represents a way of examining the extent and impact of 
these different perspectives. Broadly, framing is used to describe an ‘assumptional basis’ 
through which issues are viewed, described and acted upon (Rein and Schön, 1996, p88). 
Framing analysis has been applied to disease in different ways: as a ‘recognition’ process by 
which a society comes to understand a disease over time (Aronowitz, 2008, Rosenberg, 1989, 
Rosenberg, 1992); and in the approach that I use here, by looking at how disease is 
understood and represented by different actors within society (Edstrom, 2010, Leach et al., 
2010b). This second use of framing builds on the tradition of applying framing to policy 
debates (Jasanoff, 2005, Schon and Rein, 1994). Although I follow this latter approach, Charles 
Rosenberg’s work is also relevant as I will set out shortly. 
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The second framing approach treats disease as a complex system whose emergence, re-
emergence or stasis is due to interlinked, non-linear, context specific social, technological and 
environmental processes (Leach et al., 2010b). Framing in this context is used to draw 
attention to the diverse ways in which the system’s dynamics can be interpreted. It means 
paying attention to “the many ways in which system boundaries, dynamics, functions and 
outcomes are open to multiple, particular, contextual, positioned and subjective assumptions, 
methods, forms of interpretation, values and goals” (Leach et al., 2010b, p371). Different 
actors value and make use of different forms of knowledge in their framings of systems. A 
particular actor’s response to disease is dependent on their framing of it and responses can 
then feedback in to shape the framed dynamics. This is particularly true when framings are 
institutionalised. In this way framings are more than just interpretations, they are also 
implicated in system dynamics. Epidemics provide a good example of framing. Epidemics can 
be understood as short shocks caused by recent triggers or as the result of longer term 
stresses and changes (Leach and Dry, 2010). A premise of this research is that both Lassa 
fever and its diagnosis involve interlocking social, technical, cultural, political, economic, 
ecological and biological dynamics which can be framed differently.  
 
Framings can become particularly influential when they become part of narratives. Narratives 
adopt particular framings to make a coherent story and to suggest and justify actions (Roe, 
1994, Wald, 2008). They are mobilised by particular people, institutions, networks or 
communities and are often embedded in institutional and political governance processes 
(Leach et al., 2010b). Narratives define response pathways and given their 
institutionalisation, they implicate politics at various levels. Some are more dominant than 
others. These more dominant narratives can conceal alternatives, thus marginalising groups 
who may experience the world through contrasting frames or narratives (Leach and Dry, 
2010).  
 
Ann Kelly and Uli Beisel (2011) demonstrate the importance of framing and narratives in 
their discussion of the various biological, socio-political and behavioural ‘guises’ of Malaria. 
They argue that the articulation of malaria as a grand challenge, backed up by stunningly high 
worldwide mortality statistics, obscures its multiplicity and paints it as a singular ‘Enemy 
Number One’. Over the years this enemy has been targeted for eradication many times. Mass 
spraying of Dichloro-Diphenyl-Trichlororethane (DDT) has given way to the power of public-
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private partnerships to generate bold innovations for better detection, treatment and other 
silver bullets. The authors suggest that current policy formulations of malaria “struggle(s) to 
come to grips with the malaria found in urban plots and tyre tracks” (p73). They highlight a 
“back alleys” malaria (p71), “a product of relations” (p84) whose management is an everyday 
affair of co-existence between man and mosquito. The complexity of the practice of disease 
and health interventions is highlighted in the authors’ alternative framing of malaria.  
 
In this thesis I identify framings and narratives associated with diagnosis and with Lassa 
fever. Some are familiar in international health policy discourses while others are rooted in 
practices and everyday concerns in Sierra Leone. Framings and discourses about Lassa fever 
which are articulated on the global stage, by international organisations such as the WHO or 
Northern governments, emphasise the risk of infection to Northern populations. In contrast, 
for people living and working with Lassa fever in Sierra Leone, it is an endemic disease which 
is both feared and normalised and as such, it occupies a quite different position in the health 
landscape. As I will show, framings and narratives on both levels have influenced approaches 
to disease control and diagnosis.  
2.1.1 A ‘scientization’ of diagnosis? 
This introduction to framing and narratives allows me to introduce a key theme in this thesis: 
namely, that heightened expectations surrounding diagnostics are related to particular 
framings of the process of diagnosis, healthcare systems and disease. The most visible 
contemporary narrative about diagnostics in low-resource healthcare settings is of 
technological optimism and implicit determinism: new diagnostics have made accurate 
scientific diagnosis possible in settings where previously it was not possible which, in turn, 
has generated an expectation the rational provision of healthcare will follow. The speculation 
is that this new generation of diagnostics will replace the misdiagnosis, ignorance and 
uncertainty which previously characterised medical care in these settings. 
 
As discussed in chapter one, expectations of molecular diagnostics are rooted in their 
potential to be rapid and mobile, as well as to achieve high levels of accuracy. As such they 
appear to be continuing a documented trend from symptom-based medicine to specific 
disease-based medicine, enabled by technology (Jutel, 2011c, Rosenberg, 2002). There is an 
underlying ‘scientization’ narrative at work wherein symptom based diagnoses have been 
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referred to as “pre-scientific” (Blaxter, 1978, p10). The capacity of science to reach new levels 
of specificity (Cambrosio and Keating, 1995) creates the potential for new levels of specificity 
in diagnosis: antibodies and virus proteins can be targeted making disease identification more 
scientific. This narrative is not new; indeed diagnosis has previously been framed as a moving 
from an art to a science (Zung, 1973). Yet the application of this narrative to low income 
settings is new. Is this narrative of an increasingly scientific process at play for Lassa fever in 
Sierra Leone? What about the implicit framings of disease and of health care systems that they 
entail, for example that disease and ‘underlying causes’ are out there waiting to be detected by 
the ‘right’ or ‘most accurate’ diagnostics? Or that ignorance is being replaced by science? In 
chapter four I will show how these narratives have been applied to Lassa fever. 
 
To answer these questions, biomedicine must be understood as a particular framing of 
disease. Similarly to Michel Foucault’s (1973) work on the ‘gaze’ of clinical medicine, 
Rosenberg (see 1989, 1992, 2002) reveals the terms on which modern medical framings of 
disease have emerged. He charts the advent of biomedicine by showing how increasingly 
specific conceptualisations of disease replaced the fluid, transient and individualised 
manifestations of symptom-based ‘humoral’ medicine. It was these developments, he argues, 
which propelled diagnosis to occupy such an influential place in modern medical practice. 
Diseases began to be identified by unique characteristics and treated in a specialised manner. 
New tools played a part as “instruments of precision” (Rosenberg, 2002, p243) boosted the 
“specificity revolution” (Rosenberg, 2002 p240). By the 21st century, disease was defined 
more by accounts produced by those precision instruments than the narrative of the patient; 
and disease was imagined as an entity independent of the patient. ‘Ideal-typical’ (Rosenberg, 
2002, p243) models of both diseases and bodies were developed. These models had 
characteristic mechanisms which could be objectively captured by technological 
investigations. A technology-enabled rise of diagnosis has also been noted by others who 
point out that it replaced prognosis as a central element of modern medical practice 
(Christakis, 1997). The underlying assumption, Rosenberg points out, is that stable and 
specific disease entities were the cause of illness. These ‘specific disease entities’ have since 
become a critical cog in medical practice and are the basis for healthcare systems, hospital 
administration and a range of associated bureaucratic institutions as well as a considerable 
amount of moral and social order. All of these developments also feedback to, and strengthen, 
the disease entities. In this sense they could be said to be ‘co-produced’ (Jasanoff, 2004). 
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Rosenberg himself describes the traction that ‘specific disease entities’ have in society as the 
‘tyranny of diagnosis’.  
 
Rosenberg points out a number of problems with the specific disease diagnostic model.  
Despite being effective and seemingly value free organisers of treatment and healthcare 
systems, it is unclear how to fit particular cases to the ‘ideal’ model (or framing), particularly 
when those cases are atypical. Much of this thesis provides empirical observations of precisely 
this problem. In practice, a number of disease framings are often used. A specific and 
mechanistic framing of disease tends to overlook the multi-dimensionality of disease, as do 
the bureaucratic institutions which are co-produced by those framings. Rosenberg reminds us 
that the mechanistic framing of disease is very good at dealing with aspects of disease 
pertaining to the immediate physiological causal mechanisms of a complaint but is less good 
at dealing with multi-causality and longer-term causal mechanisms. Diagnostic categories and 
the medical institutions co-produced by them only deal with a small segment of disease in 
society. Rosenberg gives the example of a homeless person who becomes visible when an 
ailment flares up but returns to invisibility once treated saying it is “almost as though the 
disease, not its victim, justifies treatment” (Rosenberg, 2002 p255). Rosenberg’s analysis 
takes a similar direction to that of Paul Farmer, who has emphasised how inequality, as a 
driver of infectious disease, is often overlooked (Farmer, 1999). Both I think would emphasise 
that the act of diagnosis is always political and blinkered. I do not mean political in the sense 
that there are controversies over whether the disease being diagnosed is real or not (a topic 
explored in section 2.2.1), but rather that it moderates which aspects of disease (and patients) 
are seen and which are ignored.  
 
Rosenberg’s work is extremely insightful. His account of the dominant biomedical framing of 
disease and its blind-spots is powerful. I have one concern relating to the ‘tyranny of 
diagnosis’ which he says pervades most aspects of life. On closer inspection how far does such 
tyranny prevail? In both high and low resource health care contexts other conceptualisations 
of wellbeing and disease (and the body) have long been noted (Janzen, 1978, Kleinman, 1980, 
Scheper-Hughes and Lock, 1987). There are limits, and resistances, to the reach of 
biomedicine (Williams and Calnan, 1996). Rosenberg himself acknowledges that the 
biomedical model is reductionist, but might the extent of contemporary agreement about this 
form of disease classification have been overstated? In Sierra Leone (constrained) biomedical 
health services compete with (well established) traditional healing practitioners. As a result 
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biomedical authority is not guaranteed. It follows that the disease-specific bureaucracies that 
Rosenberg describes may not be as omnipresent as in the well-resourced US/European 
insurance and welfare based healthcare systems which he describes.  
 
Applying Rosenberg’s ideas to a setting like Sierra Leone raises questions about the assumed 
trajectory of technological development and accompanying societal co-production. In his 
descriptions of the biomedical model and the way its influence extends into aspects of societal 
organisation he highlights the assumptions upon which expectations about new diagnostics 
are founded. He describes an idealised biomedical healthcare system model which is now 
being proposed for low resource settings like Sierra Leone with the expectation that they will 
follow the same trajectory as Europe and America. Health and surveillance systems based on 
‘specific disease entities’ are the gold standard and are viewed as universally applicable. But 
will the same social processes identified as having occurred historically in Europe and 
America also occur in Sierra Leone? By this I mean the medical, bureaucratic, social and moral 
order which Rosenberg describes as created, or made possible, by ‘specific’ framings of 
disease. It is these processes which are presumed will accompany rolled out diagnostics in 
low resource contexts. It would be reasonable to expect that the ‘tyranny of diagnosis’ may be 
less pervasive; and also, that the direction of technological and social change may be different.  
2.2 Theories of diagnosis  
In the years since I started this doctorate in autumn 2008 it seems that the calls for a 
‘sociology of diagnosis’ (Brown, 1995, Jutel, 2009) have been heard. Diagnosis has gone from 
being overlooked (Blaxter, 1978, Jutel, 2009) to emerging as a sub-discipline in the space of a 
few years. A special edition of Social Science and Medicine was devoted to diagnosis (see Jutel 
and Nettleton, 2011); and at least three books have been published on the topic: 
“Ethnographies of Diagnostic Work” (Büscher et al., 2010) was followed by the “Sociology of 
Diagnosis” (McGann and Hutson, 2011) and “Putting a Name to it: Diagnosis in Contemporary 
Society” (Jutel, 2011c). Although diagnosis was afforded considerable importance in much 
early medical sociology and anthropology it was often not the explicit focus of study. For 
instance diagnosis was important in Eliot Freidson’s (1970) work as a means of separating 
medical professionals (who could diagnose) from lay people (who could not diagnose); a 
distinction which he used to highlight the issue of medical authority and professional 
dominance. Similarly, for Talcott Parsons (1951) a diagnosis gave whoever was granted one a 
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sanctioned exemption from normal participation in society. Thus for Parsons, diagnosis was 
interesting because it performed a function in social systems. Consequently, diagnosis has 
been referred to as an “absent presence” in the sociology of health and illness11 (Jutel and 
Nettleton, 2011 p793). However recent efforts, spearheaded by Annemarie Jutel, have 
succeeded in bringing many of the relevant but disparate studies together, as well as 
generating a new body of focused research on the subject as I discuss in the following 
sections.   
2.2.1 Sociology of diagnosis and contesting disease 
The overarching concern in much of this literature, judging by both old and new reviews of 
diagnosis (Brown, 1990, Brown, 1995, Brown et al., 2011, Jutel, 2009, Jutel, 2011a, Jutel, 
2011b, Jutel and Nettleton, 2011, McGann and Hutson, 2011), has been to show how 
diagnostic categories, or ‘disease labels’, are as much social, moral and normative 
constructions as they are objective health conditions. The ‘sociology of diagnosis’ rejects the 
neutrality of diagnostic categories and the notion of scientifically identifying an ‘underlying 
cause’ and instead emphasises the social context of diagnosis. Scholars have examined how 
definitions of medical conditions shift over time or differ between people or cultures; some 
famous examples being homosexuality (Conrad and Angell, 2004), gulf war syndrome (Brown 
et al., 2001) and obesity (Jutel, 2006). Steeped in the sociological themes of social 
construction, medicalization, social control, identity and power, this growing body of work 
has shown the variety of ways disease labels can be used, for example: to legitimise or de-
legitimise patient’s illness experiences (Scott, 1990); to access or deny treatment and other 
resources, such as pensions (Trundle, 2011); to extend medical authority by repackaging 
previously non-medical feelings or experiences as medical ones (Jutel, 2010); to create, or 
authenticate, diseases and open up markets for pharmaceutical products (Barker, 2011, 
Ebeling, 2011, Jutel, 2010); to control, marginalise and stigmatise by turning deviance or 
abnormality into medical pathology (Conrad, 1980); or more positively, to empower patients, 
create positive identities, challenge authority and demand equity (Brown et al., 2004). In 
general, pharmaceutical companies, medical or psychiatric clinicians and their professional 
associations, large corporations and governments are frequently seen as playing the sinister 
roles of denying, refusing and inventing while patients and lay populations take on more 
positive roles such as campaigning, suffering, questioning or resisting. With such strong moral 
                                               
11 The contribution of medical anthropology on the subject of diagnosis is relevant and I discuss this in 
section 2.2.3. 
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foundations diagnostic categories are increasing conceptualised as ‘discursive resources’ 
(Willig, 2011); instead of having fixed meanings they are the vehicles through which tensions 
and contestations are revealed and enacted.  
 
Even though a key insight from these studies of diagnosis is that diseases can be deeply 
contested, there is a sense in which the sub-discipline gives up on the argument half-way in. 
Many of the examples in this literature are of particular kinds of contested conditions, often 
concerning mental health. This has led to criticism that it has been overly focused on diseases 
where ‘a biopathological mechanism is either unproven or unprovable’ (see also Aronowitz, 
2008, Rosenberg, 1992, pXV). I would add that overall the ‘sociology of diagnosis’ literature is 
concerned with a strikingly Western collection of diseases and struggles. Such details appear 
to have contributed to an over-representation of psychiatric and psychological disorders in 
the diagnosis literature. Indeed some of the newer reviews replicate this: in the recently 
published volume ‘Sociology of Diagnosis’ (McGann and Hutson, 2011) every single empirical 
chapter is about some aspect of mental health, for example Gender Identity Disorder, 
Attention Deficit Disorder, Addiction and Asperger’s, almost all of which are concerned with 
disease categories found in the American Psychiatric Association’s controversial Diagnostic 
and Statistical Manual (DSM).  For a book claiming to be about diagnosis in general this is 
somewhat surprising.  
 
The oversight is important because it seems to suggest that when diseases have identifiable 
pathogens, such as viruses, then diagnosis is easy. This obscures the complexity of diagnosis 
and disease, and it means that much of the existing sociological literature is of questionable 
power for understanding Lassa fever diagnosis. With an identifiable virus and acute 
symptoms, Lassa fever is not a conventionally contested or Western disease. The Lassa virus 
can be isolated and so it can be laboratory confirmed, supposedly, in no uncertain terms. In 
addition to the literature on framing disease described earlier, a considerable body of 
scholarship says that infectious diseases are as equally contested as many mental health 
disorders. For example, work on HIV where there are well documented struggles over its 
characterisation and links with AIDS (see Epstein, 1996). Paula Treichler (1999) has pointed 
to the layers of social and symbolic meaning involved in HIV/AIDS biomedicine and science, 
for example in the assumptions about homosexual men’s behaviour and risk factors for 
infection. Controversies have been intense around the causal link between the HIV virus and 
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AIDS (Fassin and Schneider, 2003) and its treatment (Cassidy and Leach, 2009), highlighting 
the interplay between power, politics and viruses. There were problems with the diagnostic 
profile of AIDS: thus the collection of opportunistic infections recognised as ‘AIDS defining 
illnesses’ was skewed towards problems observed in men, homosexuals and intravenous drug 
users and not those common in women more generally (Treichler, 1999). Melissa Parker and 
Ian Harper (2006) have pointed out the limitations of applying a ‘factorial’ model of disease 
which makes an implicit separation between science and culture. They argue that public 
health and biomedicine must also be subject to critical reflection. To avoid applying a factorial 
model of disease to diagnosis, a close up look at the intricacies of diagnostic practice is called 
for, whether the ‘disease’ is a virus or a mental health problem. Thus the next section will 
review literature on diagnostic processes and practices. 
2.2.2 Process of diagnosis: assemblages and enactments  
It has been a long time since Mildred Blaxter made the point that diagnosis is both a category 
and a process (Blaxter, 1978) but arguably the process of diagnosis has been overlooked until 
more recently. As the previous section demonstrated the dominant themes in the social 
literature on diagnosis have been diagnostic categories and labels. The need to address this 
imbalance and pay greater attention to diagnosis in action has been noted recently (Anspach, 
2011). 
 
It would be inaccurate to say that no studies take process or technology into account; the 
work of Annemarie Mol and Bernard Elsman (1996) and Blaxter (1978) are early examples 
and there are more appearing. Emerging themes have been experiences of cancer diagnosis 
(Olson, 2011, Schaepe, 2011, Willig, 2011), the impact of genomic based technologies on 
medical practice (Bourret et al., 2011, Hedgecoe, 2002) and the politics of risk, identity or 
reproduction that new predictive technologies bring (Rapp, 1999, Salter et al., 2011). These 
are important sociological themes but my questions are, in some senses, more practical: how 
do new technologies actually get used in healthcare systems? What difference do they make to 
diagnostic processes and pathways? These questions are important because recent work on 
innovations in diagnostics show that the expected changes do not always materialise. 
Healthcare workers often ignore the results of malaria rapid diagnostic tests (RDTs) because 
they attend to other care-giving concerns and are guided by broader conceptualisations of 
malaria than the evidence of parasites (Chandler et al., 2008a, Chandler et al., 2008b, Chandler 
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et al., 2012). Newly available laboratory services remain underutilised too (Barat et al., 1999). 
These last few studies draw attention to the importance of understanding the broad practices 
and processes which surround the use of diagnostics.  
 
How has the process of diagnosis been described? In the ‘scientific’ view (Miettinen, 2001) of 
diagnosis with which I opened the chapter, the process is linear: a clinician accumulates 
evidence about symptoms and systematically assesses (by rationally applying probability 
theory no less) the likelihood that those symptoms are caused by each of a differential set of 
diseases.12 Another linear view of diagnosis is that it is a process of organisation from 
disorder to order. Michael Balint talked of “unorganized” and “organized” states of illness pre 
and post diagnosis respectively (Balint, 2000 p18). Significantly, in his account it is the doctor 
who has the expertise to bring order to the situation. In contrast, studies which describe 
diagnostic activity in detail present rather different accounts. Both the ‘science’ of medicine 
and the linearity of the process are challenged by authors who bring a ‘science as practice’ 
(Pickering, 1992) perspective to diagnosis. A brief detour into this aspect of the science and 
technology literature (STS) is helpful here as it sets out the principles upon which the studies 
of medical practice and diagnosis which I am about to discuss are based.   
 
Building on studies which have emphasised the human and social shaping of scientific 
knowledge, the ‘science as practice’ perspective (Knorr Cetina, 1999, Latour and Woolgar, 
1979, Pickering, 1992) emphasised the fundamental role played by practice in ‘intervening’ in 
its research objects (Hacking, 1983) and ‘constituting’ (Berg, 1996) its findings. For example, 
for Alberto Cambrosio and Peter Keating (1995) there is no a priori separation between a fact 
and the technique which discovered that fact. The standardisation of apparatus and 
techniques to make knowledge and facts stable is a considerable project: “The apparent 
universality of science is tribute to the power of a collective rendered stable by the pre-
circulation of stable objects” (O'Connell, 1993 p165). Knowledge (scientific or otherwise) is 
shared through shared artefacts and practices (See Knorr Cetina, 1999, Latour and Woolgar, 
1979, Pickering, 1992, Star and Griesemer, 1989). Societies, then, are patterned by distinct 
knowledge communities which operate within knowledge production contexts and through 
‘machineries of knowing’ (Knorr Cetina, 1999). These can be very specialist or more general. 
A concept I use in chapter six, to describe diagnosis in the laboratory, is Knorr Cetina’s notion 
                                               
12 Often a number of possible diseases may be causing the observed symptoms. Differential diagnosis is 
the systematic exclusion of each possible disease until a positive diagnosis can be reached. 
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of ‘laboritization’ (Knorr Cetina, 1999, p26). She uses ‘laboritization’ to describe the 
transformations which objects undergo in a laboratory’s ‘machinery of knowing’. This 
highlights how the laboratory’s production of knowledge relies on its manipulation of natural 
orders and social orders as a result of particular practices. A theme explored in this thesis is 
the limits to laboritization.  
 
Diagnosis should be viewed as an exercise in (re)producing disease related knowledge but 
there are diverse ways of doing this within the diagnostic system, hence the limits to 
laboritization. The diagnosis of Lassa fever spans a number of knowledge production contexts 
each with various techniques, routines, and instrumentation. Whether the production context 
is a network of scientists publishing in peer-reviewed journals or a village that is hours from 
the nearest hospital, they will apply different practices and framings to the subject of Lassa 
fever. 
 
Ethnographic studies of diagnostic practice show that the process of diagnosis is not a 
singular linear process, but many non-linear ones, shaped by divergent interpretations, 
evaluations, and competing priorities (Büscher et al., 2010). To start with, the distinction 
between diagnosis and treatment, often assumed to be a fundamental feature of medical 
order, is fuzzier than it is often said to be. Detecting and treating disease are not necessarily 
distinct processes (Mol and Elsman, 1996) and treatment sometimes precedes diagnosis 
(Starbuck, 2006). In fact, treatment often takes the place of diagnosis, a pattern particularly 
noted in low resource settings (D'Acremont et al., 2009). In her ethnographic account 
neonatal care Jessica Mesman questions the received wisdom that diagnosis revolves around 
identifying an underlying cause and suggests diagnostic work is broader; and more 
particularly that it is a collaborative practice of moving forward, reading and processing the 
conduct of others and weighing up opportunities (Mesman, 2010). As such, diagnosis can be 
conceptualised as many interactive and overlapping processes, consisting of a wider set of 
priorities than just identifying the root cause of a particular patient’s problem.  
 
Scholars have pointed out that biomedicine is not a ‘seamless web’ and its practitioners do not 
present a unified professional front. Instead, there are differences and tensions at 
biomedicine’s core. Disease labels have a fluidity and multiplicity of meaning which vary 
across different stages in healthcare and between the many people involved in medical work 
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(Berg and Mol, 1998, Büscher et al., 2010). Clinical medicine encompasses different ways of 
seeing and interacting with patients or parts of them (Mol and Berg, 1998, p32). Mol coined 
the phrase ‘the body multiple’ (Mol, 2002) to make an ontological argument that different 
versions of the body and disease are made in medical practice. Multiple bodies and diseases 
are ‘assembled’ and ‘enacted’ by a range of people using different techniques: but the ‘body 
multiple’ is both singular and many. Mol and Elsman’s (1996) description of diagnosing 
diseased leg vessels illustrates the heterogeneity:  
 
“it draws together vessels, surgeons, research designs, hospital organisation, patients, apparatus, 
general practitioners, dye, buttons, interview questions, catheters, gel, blood, and many other 
elements. All of them interrelated. Yet each irreducible to the other” (p628).  
 
It is perhaps more fitting to talk of the processes of diagnosis. As Mol points out, these 
enactments are sometimes in opposition. Mol’s lens has been applied to the diagnosis of chest 
pain (Gardner et al., 2011) where it highlighted the negotiating techniques used by doctors to 
draw together or discount conflicting enactments into a coherent whole; doctors would 
question the reliability of tests and promote particular causes of symptoms over others.  
  
If diagnostic processes are made up of enactments of disease assemblages of people and 
technologies then they are also, by definition, embedded in classification systems. 
Classification systems are usually assumed to be made up of complete and mutually exclusive 
categories, with consistent organising principles. In contrast, Geoffrey Bowker and Susan 
Leigh Star (2000) argue that most modern day classification systems do not fit those 
specifications. Bowker and Star studied the International Classification of Diseases (ICD) and 
found it to be contradictory, messy, ill-defined and applied in many different ways, not always 
as intended. Bowker and Star highlight the importance of hidden practices in the upkeep and 
application of such a messy classification system. Within well established and formal 
structures there are informal and ad-hoc classificatory practices and ‘rules of thumb’ which 
work around or patch over inconsistency. This speaks to my notion of the diagnostic system. I 
conceptualise the system, and the process of diagnosis, as involving village healers as well as 
laboratory technicians. Therefore the diagnostic system is a combination of socio-technical 
elements, assemblages, enactments, and formal and informal classifications, all of which frame 
disease differently. The classification work within it is disjointed and not necessarily systemic. 
It is for these reasons, outlined fully in section 2.3, that I am drawn to the mangle of practice 
to characterise the system and the emergence of diagnoses within it. 
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Given this thesis’ focus on new diagnostics, I wish to highlight one further insight from 
Bowker and Star: classifications systems divide up the world, and in doing so, they promote 
some aspects of the world above others. Bowker and Star note that when classification tools 
change, different aspects of the world become more or less visible. These shifts can be subtle 
or obvious and unsettling. The question becomes how do new and old diagnostic technologies 
shift the established patterns and practices of classification? What aspects of Lassa fever come 
more or less into focus?  So far I have mostly discussed biomedicine and hospital settings. 
Now, I will outline some diagnostic practices and processes which become important once a 
broader perspective on diagnosis is taken 
2.2.3 Negotiating plural health systems 
The negotiation of disease framings and of particular diagnostic pathways begins, usually, at 
the onset of symptoms. Lay interpretations of symptoms are an important first step. Some 
symptoms, like those caused by autism, are unusual and so the need for specialist help is 
quickly noted (Daley, 2004). However, many illnesses begin with routine and ordinary 
symptoms and so cause little initial alarm. Such is the case for fevers (Kamat, 2006) where 
there are strong lay traditions of treating high temperatures and flu or cold like sicknesses. 
For a disease such as Lassa fever, which has non-specific symptoms but where early diagnosis 
is imperative, it is important to identify when, how, and by whose judgement symptoms of 
fever are perceived to shift to something out of the ordinary. Equally, the range of responses 
to such a shift should be established. Even once that shift has occurred, pathways to diagnosis 
and treatment are not straightforward; indeed Salome Bukachi et al. (2009) have illustrated 
the back and forth between providers and treatments, and the resulting delays, for patients in 
Kenya and Uganda for another hard to diagnose disease, African trypanosomiasis (or sleeping 
sickness). 
 
The interactions between multiple framings of disease, and their enactments in diverse 
healing practices, are central to the diagnostic process. Importantly, different framings do not 
always lead to different responses. Barry and Bonnie Hewlett have shown that despite 
radically different explanatory models for understanding an Ebola epidemic, the Ugandan 
Acholi’s response was broadly consistent with that of the visiting infection control personnel 
(Hewlett and Amola, 2003, Hewlett and Hewlett, 2008). Though it is sometimes assumed local 
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cultural practices exacerbate infection, the Acholi communities’ protocol (which is rooted in 
beliefs about bad spirits) for dealing with serious outbreaks matched the biomedical 
recommendations.  However, the authors warn that insensitive implementation of infection 
control, such as the use of opaque screens for isolation or burials without notice in body bags, 
fuelled long-held local ideas about Euro-American harvesting of African body parts. There 
were reports of resistance from local communities as a result. Ebola serves as an example that 
alternative understandings of disease are relevant to disease control and should not be 
ignored or assumed to be counter-productive to biomedical efforts. The importance and 
validity of local perspective has been increasingly acknowledged in Ebola outbreak control 
(Hewlett and Hewlett, 2008, Leach, 2008) and has been part of responses (Lamunu et al., 
2004). Despite differences to Lassa fever, the example of Ebola is especially relevant as at 
times they can both be subject to similar ‘outbreak’ panic, albeit to a lesser extent for Lassa 
fever. Equally, they both require isolation and are hard to diagnose. Yet, understanding of 
local knowledge and practices related to Lassa fever is currently limited. In exploring 
processes of diagnosis in Sierra Leone this thesis will go some way in addressing this 
limitation.   
  
Contrasting, interlocking and complimentary health systems have been the focus of much 
medical anthropology. The variation in approaches to therapy has been labelled medical 
pluralism, although this term has been used in a number of ways (Johannessen, 2006, 
Reynolds Whyte, 1982): it can describe one medical system with many medical traditions 
within it; or it can describe a situation where multiple medical systems co-exist; it can mean 
that a society has an orthodox ‘closed’ system but that therapeutic alternatives also thrive; or, 
alternatively, it can mean an ‘open’ system which incorporates many new traditions. The form 
of pluralism has also been attributed to the scale and scope of the medical system (Baer et al., 
2003). John Janzen (1981) and Susan Reynolds Whyte (1982) have emphasised the open and 
multiple nature of African medical systems and for this thesis, I favour these accounts. In such 
systems, patients may make use of apparently contrasting medical traditions even at the same 
time. Janzen points out that the shifting between medical domains is not random but that the 
plurality is based on multiple causation beliefs (e.g. natural, lack of respect, greed, 
environmental, misfortune, magic, and sorcery) which are not mutually exclusive. Distinctions 
are made between treating symptoms and treating causes, and there are hierarchies of 
medicines for different causes (Reynolds Whyte, 1982). Both authors maintain that these 
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plural systems are not closed; the incorporation of pharmaceuticals, famously injections, 
alongside existing alternatives in African medical systems is cited as an example of this.  
 
The argument is also made that Western medicine does not monopolise because Western 
medicine does not have all the answers. There are diseases which biomedicine fails to cure 
and established healers are able to operate on its ‘outer parameters’ (Janzen, 1981). Also, as I 
noted previously, the limited government provision of biomedical care means alternative 
approaches to therapy will always be attractive (MacCormack, 1984), particularly when 
providers are sensitive and more flexible about payments (Reynolds Whyte, 1992). Indeed, 
more important than the compatibility of underlying beliefs about sickness – or new medical 
traditions and devices - are the social relations which are involved in causing, diagnosing, 
managing and healing sickness (Janzen, 1978, Young, 1982). In relation to the mass treatment 
of neglected parasitic diseases, Parker et al. (2008) note that while local understandings of 
bilharzia may overlap with biomedical ones they, and the interventions to combat them, are 
experienced as part of wider local social and political discourses. Fear and resistance to 
treatment is shown to be a manifestation of inappropriate delivery and health promotion 
which does not consider the local contexts, as opposed to simple non-compliance on account 
of ignorance. 
 
Recent work on health systems in developing country contexts have argued that pervasive 
dichotomies such as those between ‘public’ and ‘private’, ‘formal’ and ‘informal’, or 
‘traditional’ and ‘biomedical’ are artificial (Cross and MacGregor, 2010, Leach et al., 2008, 
Standing and Bloom, 2002). Instead plural medical systems should be conceptualised as 
hybrid. In Guinea, Melissa Leach et al. (2008) found that categories such as ‘traditional’ and 
‘biomedical’ are less relevant when you look at what people actually do. Archaic and artificial 
boundaries are inadequate. Therapeutic practices are related not only to diverse framings of 
disease and treatments but also to wider social, historical, political and economic factors, 
including the health service and policy environment. Leach et al. use the notion of a 
‘therapeutic landscape’ to describe the practical, social and historical considerations in 
complex health systems. I too will employ this concept to explore health and Lassa fever 
diagnosis at the community level because the landscape of therapeutic options shapes the 
process of diagnosis fundamentally.  
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Diagnostic processes and pathways are rooted in various approaches to therapy and their 
social context; biomedical expertise is not the only relevant knowledge, alternative 
understandings and experiences of disease are important throughout healthcare and they do 
not always give way to ‘expert’ knowledge even when a patient decides to consult those 
experts. The use and availability of technology also shapes the process of diagnosis. 
Technology is central to my research question and its importance has been implied 
throughout the previous pages; it is the focus of the following section. 
2.2.4 Diagnostic technology  
Technological change has fundamentally altered medical practice. New technologies have 
brought about new ways of seeing, investigating and diagnosing the body (Anspach, 2011, 
Blaxter, 1978, Rosenberg, 2002). Not only have clinical activities been transformed, but 
arguably the clinicians themselves have been re-shaped as they have been required to possess 
different kinds of dexterities in order to optimise their new implements (Anspach, 2011, 
Knorr Cetina, 1999). Technology has a complex relationship with medicine and society; the 
literature covered in this section suggests that the answer to my main research question 
about how new diagnostic technology will be incorporated into the process of diagnosis will 
be multi-dimensional. I suggest that studies of diagnosis have not paid adequate attention to 
technology, what it is, how it is shaped and used, and so lack insight into some of the key 
processes which I seek to understand. Here I turn to some key strands of the innovation 
literature in order to shed light on these processes.  
 
Scholars of technology and innovation have emphasised the social construction of technology 
(Bijker, 1995, Pinch and Bijker, 1984). Technologies shape and are shaped by social dynamics, 
such as divisions of labour, hierarchies, configurations of power and knowledge (Blume, 
1992). In terms of laboratory diagnostics any developments need to be put in context; as 
Andrew Cunningham and Perry Williams (1992) have stressed the pre-eminence of 
laboratory medicine should not be taken for granted, as self-evident progress. It will be a 
story of group struggle, they say. The characteristics of particular technologies are not the 
result of pure ‘technological determinism’ nor ‘social essentialism’, instead they should be 
viewed as the result of negotiated practice between the two (Timmermans and Berg, 2003). 
The practice of technology is multi-dimensional: Michael Hopkins (2004, p9-10) synthesises 
the work of a number of authors to arrive at a deconstruction of technology as comprising of 
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artefact, technique, and regime (see also Hopkins, 2006). The ‘artefact’ is the tangible, visible 
element of technology; its material manifestation. ‘Technique’ encompasses routines, skills 
and habits; it is embodied in people and describes, broadly, the mode of human action used to 
operationalise an artefact (i.e. take a photo with a camera), or group of artefacts (process a 
film). Techniques have a degree of flexibility, different routines can produce the same effect, 
and the same routine can be performed with varying degrees of skill (Hopkins, 2004, p15-16). 
Artefacts are not essential components of technology, techniques can be technologies in 
themselves (e.g. classification of diseases); thus technology can exist independently of 
material form. The ‘regime’ includes rules, systems, organisational networks; it is the wider 
context which structures the deployment of techniques and artefacts. As regime is a concept 
taken from evolutionary theories of technical change (Dosi, 1982, Nelson and Winter, 1982) it 
brings with it an emphasis on cognitive processes of innovation as subject to bounded 
rationality and path-dependency.  
 
Technology then, is neither simply technical nor simply social; in important ways it is a 
combination of the two. Wiebe Bijker (1995) has referred to technology as a ‘sociotechnical 
ensemble’ to highlight the bricolage quality of socio-technical interactions which constitute a 
technology. Likewise, regimes can be characterised as ‘socio-technical’ (Berkhout et al., 2004, 
Geels, 2004). The science, technology and innovation (STI) literature emphasises that 
technology should always be understood in the context of broader social dynamics – including 
interests, networks, history, path-dependency, and material, political and embodied 
interactions. Importing technology also means importing techniques, systems and regimes, 
there are likely to be incumbent technologies, embedded in entrenched socio-technical 
systems and regimes. In Sierra Leone it would be naive to assume that because laboratory 
diagnostics were not ‘up to scratch’ that there are not alternative technologies and practices 
related to diagnosis and disease. The interactions between existing and new diagnostics are 
likely to be significant and complex.  
 
Finally, the ‘biotech revolution’ has been problematised by Paul Nightingale and Ben Martin 
(2004) and Hopkins et al. (2007). Predictions about the biotech revolution and its relationship 
to the scope and pace of technical change have been called into question. These papers stress 
that the path of technical change in the drug innovation process, and the impact of 
developments in biotechnology on that path, is one of slow, typical and incremental steps 
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rather than of ‘revolution’. This present research focuses on the broader innovation processes 
for diagnostics, looking at innovations in practice once new products are developed. It looks at 
their use and impact once they enter clinical practice. Hopkins et al.’s paper provides some 
insights: the fact that innovations do not always bring the expected benefit is not simply the 
arguments that ‘context matters’ or that some issues are not resolved by the new technology 
as in ‘silver bullet’ analogies (although both are equally true) but innovation surrounding new 
technologies often make matters more complicated. In terms of possible implications for 
health care systems like those in Sierra Leone it is important that this research captures 
broader implications of new technology.  
2.2.5 Challenging uncertainty narratives 
Implicit in the preceding discussion are challenges to an assumed relationship between 
uncertainty and diagnosis. I have noted how diagnosis is frequently seen as reducing 
uncertainty but, as I have also suggested, in some situations this is misguided. For example 
Cornelius Schubert says that instruments determine and resolve the cause of diagnostic 
uncertainty (Schubert, 2011). Underlying these ideas about uncertainty is the idea that 
technology makes diagnosis more precise and scientific. Indeed diagnostics are becoming 
increasingly mechanistic (as opposed to symptom based) as they achieve ‘exquisite specificity’ 
at the molecular level (Cambrosio and Keating, 1995). With such advances in science the 
implication is often that levels of uncertainty are reduced.  
 
In the technical literature on diagnostics a test’s performance is judged and reported by 
‘sensitivity’ and ‘specificity’ calculations. As well as a diagnostic test’s suitability for low 
resource settings the dominant theme in discussions about improvements to diagnostics are 
these two calculations. ‘Sensitivity’ is the proportion of true positives that are correctly 
identified by the test and ‘specificity’ is the proportion of true negatives that are correctly 
identified by the test (Altman and Bland, 1994a). A perfect test would be 100% sensitive and 
100% specific: such a test would never miss a person with the disease and would always 
exclude people without it. A test which was 100% sensitive and 0% specific would never miss 
a true positive but it would take every person to be positive regardless of whether they had 
disease or not (false positive). A test which was 0% sensitive and 100% specific would always 
show people without disease to be negative (true negative) but it would also report everyone 
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else as negative (false negative), even if they had disease. As the ‘perfect test’ is (usually) 
unattainable, clearly there needs to be some middle ground between the last two scenarios.  
 
A degree of error and uncertainty is tolerated and set against the potential for other benefits: 
the Global Health Diagnostics Forum modelled the impact (lives saved, harm done by 
misdiagnosis and treatment) of a range of sensitivity and specificity values for tests which 
could be used in settings with different levels of infrastructure (Girosi et al., 2006, Urdea et al., 
2006). The distinction between high, middle and low infrastructure was related to how 
accessible the test would be; for malaria for example, it was determined that a more accurate 
test which needed more infrastructure, such as Polymerase Chain Reaction (PCR) or 
microscopy, would save less lives than a less accurate one which was able to reach more 
people, such as the ‘lab on chip’ rapid diagnostic tests (Rafael et al., 2006). These calculations 
of uncertainty and access are central to the development and provision of diagnostics. The 
Global Health Diagnostics Forum used this analysis to support their call for improved 
diagnostics in a number of key diseases. As chapter six will describe, claims made about 
improvements in sensitivity and specificity play an important role in justifying the superiority 
of the new diagnostics for Lassa fever.  
 
However, as the following chapters will demonstrate, sensitivity and specificity only portray 
some aspects of the uncertainties, doubts and limitations to knowledge which pervade 
diagnosis and diagnostics. They represent an incomplete picture of the incertitude involved. 
On paper, sensitivity and specificity are straightforward and calculable. They represent the 
risk of classification error: is this a true positive or a false positive? Error has become the 
dominant understanding of uncertainty in diagnostics and indeed in laboratories in general 
(Plebani, 2006). Yet, there are deeper ambiguities. Who and what defines the ‘gold standard’? 
How should these values be interpreted for individual cases? As I explain below, applying the 
sensitivity and specificity calculations which are reported for a diagnostic test to a given 
result for a particular patient is conceptually difficult in practice (Miettinen, 2001); worse still, 
it is spurious to do so for a test which was ‘validated’ in one population but is used on another 
where prevalence rates are not known (Akobeng, 2007) as is often the case. 
 
Sensitivity and specificity are characteristics of the test, they do not tell the person using them 
how likely they are to give a correct result for the patient and disease at hand (Altman and 
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Bland, 1994b). For this the test results need to be put into context. From a statistical point of 
view this means calculating the proportion of correct and incorrect diagnoses which are made 
by a test.13 To do this you need to know the prevalence of the disease in the population on 
which you are using the test. As prevalence changes so do the probabilities of a test’s positive 
or negative result being true or false: “The predictive values of a test in clinical practice 
depend critically on the prevalence of the abnormality in the patients being tested; this may 
well differ from the prevalence in a published study assessing the usefulness of the test.” 
(Altman and Bland, 1994b). As we shall see with Lassa fever there are not even any published 
studies on this aspect of diagnosis to refer to. Even when sensitivity and specificity are high 
the implications of the test in two different populations can be dramatically different14. The 
test is of a fundamentally different value in different populations. And to know the value of a 
test you must first know the prevalence of the disease in the population. This is exactly what 
is not known in Sierra Leone. As chapter four will describe, there is much debate and a lot of 
uncertainty about the prevalence of Lassa fever in Sierra Leone and West Africa.   
 
But uncertainty extends further than the validity of probabilities. Paradoxically, a few studies 
even suggest that enhanced diagnostics can increase uncertainty and ambiguity (Miller et al., 
2005, Rosenstein, 2002) particularly where they disrupt existing classification regimes. The 
clinical implications of new methods of genetic testing, for example, have included increased 
ambiguity as differences open up between systems of classification: a person could have a 
genetic mutation but no symptoms, or they could have symptoms but no mutation. The issue 
is not of uncertainty about whether the test was right or not, rather that there is underlying 
ambiguity about the disease. How should it be defined? What does it do to the patient? How 
can it be passed on? New ways of diagnosing disease can present enormous difficulty because 
of the ambiguity over interpretation when there are conflicts with old ways of defining it. 
Caught in the middle of such doubts about classification are the patients. Where classification 
                                               
13 These values are the positive predictive value (PPV) and the negative predictive value (NPV). The 
PPV is the proportion of patients with the positive test who are correctly diagnosed. The NPV is the 
proportion of patients with negative test results who are correctly diagnosed.   
14 An example given by Ben Goldacre (2006) is helpful. Take a test which is 99.99% specific and 99.99% 
sensitive. In every 10,000 people tested the test will give, on average, 1 false positive. If you screen 
10,000 people in a population where the prevalence of the disease being tested for is 1 in 10,000 then 
you will get, on average, 2 positive results: one will be the true positive and the other will be the false 
positive you would expect from screening that number of people. If you are one of the people who 
receive a positive result, there is a 50% chance that it is wrong. Use the same test on 10,000 people in a 
population where the disease prevalence is 10 in 10,000 and you should expect to get 11 positive 
results: 10 are your true positives and 1 is the false positive. If you are one of the 11 people with a 
positive result the chances that your result is wrong is now approximately only 10%.      
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lines are drawn can have important practical implications. Treatment, insurance and 
counselling options may become open or closed. In later chapters I discuss how there are 
similar debates over how to classify Lassa fever; as diagnostics develop questions are asked 
about the relevance of virus or antibody in a blood sample. For patients these decisions are 
anything but irrelevant. This begs the question, is uncertainty reduced, and if so, how and for 
whom? 
 
Figure 1 shows the different dimensions of incertitude and incomplete knowledge. Risk 
should be used when probabilities and outcomes can be known and predicted. Uncertainty is 
where outcomes are familiar but probabilities for predicting them are unknown. Ambiguity 
relates to disagreements about the scope, scale, and nature of outcomes; differences in how 
issues are framed can cause ambiguity as it makes comparison difficult. Ignorance is when 
neither outcomes nor probabilities can be known. Andy Stirling (2007) and colleagues (Leach 
et al., 2010a) have argued that ambiguity, uncertainty and ignorance are often condensed into 
a discourse of risk concealing the extent of what is not known or is not controllable. An 
underlying theme in this thesis is whether the weight afforded to sensitivity and specificity in 
assessing the value of diagnostic technologies may also be part of a narrow risk discourse. To 
illustrate this, I have added to figure 1 (in red) some of the questions which can be asked in 
the process of diagnosing Lassa fever.  
 
Moving away from concerns over the introduction of new diagnostics, a more general 
comment is that uncertainty is deeply embedded in diagnostic and therapeutic work and not 
easily eliminated. I have already pointed out that medicine involves the negotiation of 
difference. Dawn Goodwin tells us that the practical implications of this diversity (of roles, 
perspectives, tools and places) means that at each stage practitioners have to piece together 
the clinical picture about a patient from ‘partial stories’ (Goodwin, 2010, p88). The potential 
for variation and diversity, therefore, is significant throughout the process and it should not 
be assumed that this diminishes once a patient reaches an official biomedical health care 
provider.  
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      Figure 1 Dimensions of incertitude (adapted from Stirling, 2007) 
  Knowledge about 
OUTCOMES 
  Not problematic  Problematic 
Not problematic 
 
 
 
 
 
 
 
Knowledge 
about 
PROBABILITIES 
 
 
 
 
 
 
 
Problematic 
RISK 
 Probabilities and outcomes 
are known (i.e. for a known 
epidemic) 
 Was the test performed 
correctly? 
 Is prevalence of disease 
known in the population 
being tested?  
 AMBIGUITY 
 Contested framings, questions, 
assumptions, methods  
 Does a positive result in a 
laboratory test mean that the 
symptoms are caused by Lassa 
fever?  
 What happens when symptoms 
and test results disagree?  
 Could symptoms be caused by a 
witch? 
 
 UNCERTAINTY 
 Complex, non-linear, open 
systems 
 Is this likely to be Lassa 
fever or malaria? 
 Which other diseases are 
there which might look like 
Lassa fever? 
 
 IGNORANCE 
 Unanticipated effects 
 Gaps, surprises, unknowns 
 Is Lassa fever spreading? 
 What is the prevalence in West 
Africa and within Sierra Leone? 
 
 
 
Yet, despite the acknowledgement of uncertainty and multiplicity in these up-close 
ethnographic studies of diagnostic work (Goodwin, 2010, Mesman, 2010, Mol, 2002), 
diagnosis is still treated as a fundamental organising principle and goal in medical practice. 
Diagnostic practice has been described elsewhere as a continuous process of ‘making sure’ 
(Schubert, 2011). Even in Mol’s work, where difference is centre stage, there is an implied 
‘coming together’. Alice Street has questioned this and pointed out that much of the literature 
presumes a kind of ‘hanging together’ (Street, 2011). She suggests that this stems from an 
assumption that closure is always a desired endpoint. Highlighting that this is an idea 
imported from science studies, she argues that it is not universally applicable to practice in 
biomedical health care settings. And I have already pointed out that most of these studies 
have been of biomedicine as practiced in the West in broadly similar and well equipped 
settings. Street shows that healthcare worker’s objectives and practice can be very differently 
motivated in more diverse settings. In her ethnographic observations of a hospital in Papua 
New Guinea, Street does not see a ‘hanging together’ of people and technology. She does not 
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see healthcare professionals strategically working towards ‘diagnostic closure’, but rather 
‘practices of not-knowing’ where the value of keeping options open is emphasised over 
narrowing down in regards to particular causes and pathways for action.  
 
Such practices might be considered subversive in traditional Western biomedicine but they 
highlight how in diverse contexts alternative strategies find their own rationales. The 
implication here is that healthcare strategies will have local contexts shaping them and 
diverse logics guiding them. Street’s case is supported by the work on malaria RDTs which I 
mentioned previously; in those studies the explanation for ignoring test results or clinical 
guidelines was because medical professionals were working to broader concerns and 
concepts of disease (Chandler et al., 2012). I develop these ideas in my empirical chapters. 
Universal ideals and standards, such as isolation procedures, do not always fit alongside the 
practical concerns of the West African Lassa fever context. This means they must be 
renegotiated on site. These negotiations run deeper than simply working out how to make do 
with scarce resources, they also concern differential ways of dealing with risk and uncertainty 
surrounding diagnoses.    
 
This brings the very essence of the diagnostic process into question: what is actually being 
achieved during the course of this spread out, multiple, non-linear, interactive cycle?  Is 
uncertainty reduced? Is order being created out of disorder? Or do those narratives conceal 
that the transition is not as smooth or complete as is hoped? Marc Berg (1996) has examined 
the use of a patient record and argued that it is a constructed artefact which artificially paints 
the diagnostic and treatment processes as linear and as a self-evident ‘natural’ progression, 
omitting from the record the uncertainty which was present throughout its creation. How is 
uncertainty dealt with during diagnosis? Might it be, as Berg describes, reminiscent of well 
know practices of consensus building and black-boxing (Latour and Woolgar, 1979)? Equally, 
what of the idea that closure may not be people’s primary objective? In her critique of the 
central role STS scholars have placed on stability and closure, Street’s argument contradicts 
that of Berg’s in an interesting way (Street, 2011). Stabilization appears not to be universal in 
medical practice and instead, in the Papua New Guinean context, dealing with uncertainty, 
rather than closing it down, is a prized skill. Street’s work may be especially germane because 
Sierra Leone, particularly the Mende areas where Lassa fever is endemic, is rich in the social 
cultivation of uncertainty; in the face of wide-ranging instability it has been argued that 
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strategies which maintain uncertainty are valued and can be used as a resource (Ferme, 2001, 
Murphy, 1990). This touches on another dimension, put forward by Murray Last (1981), that 
in some health care contexts not-knowing becomes institutionalised. Last characterises 
Nigerian traditional medicine as a ‘non-system’, on account of it being diverse and un-
organised, and attributes the ‘not- knowing’ or indifference to knowing which he frequently 
observes, as a reaction to the ambiguity presented by the non-systematic nature of traditional 
medicine. According to Last, people ‘switch off’ from what cannot be known. He argues that in 
his Nigerian setting communities have devised codes of secrecy, suspicion and scepticism to 
cover up for the inability to know. For instance, knowing too much about sicknesses can be 
dangerous and lead to accusations of witchcraft. 
 
Despite their differences, a lesson from Berg, Street’s and Last’s work is that the process of 
diagnosis is not simply about moving from uncertainty to certainty, or from disorder to order. 
While Berg points out that uncertainty is hidden, Street and Last point out that uncertainty 
can be valued and cultivated; either way how uncertainty is dealt with necessitates close 
attention. Uncertainty, risk, ambiguity, doubt and ignorance will be part of diagnostic journeys 
both for patients, their healers, and the people around them. The way this is viewed and dealt 
with may well be significant in shaping both the pathway and the patient’s experience of it. 
Overall, to explore disease and diagnosis fully their respective systems should be viewed as 
complex, non-linear, and fraught with uncertainty, ambiguity and ignorance. 
2.3 The diagnostic system: a mangle of practice?  
The preceding pages have called the relationship between uncertainty and diagnosis into 
question. They have also challenged assumptions about the process and practice of diagnosis. 
By highlighting the socio-technical assemblages and multiple enactments in medicine this 
chapter has presented an alternative view of diagnosis which is not neat, straightforward, or 
linear. However, notions of assemblages and enactments are themselves not entirely 
satisfactory explanations of diagnosis. Though they emphasise multiplicity they also presume 
convergence and eventually closure. If you take a broad view of the diagnostic system, and 
particularly if you look outside of high income settings which are dominated by biomedicine, 
this becomes less convincing. The notion of a ‘socio-technical system’ has been used to 
describe a combination of technological and social facets which perform functions in society 
(Geels, 2004). Here that could be diagnosis; in fact, in scientific and health policy literature 
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diagnostic and surveillance activity is often described in terms of systems (e.g. Nkengasong, 
2009, Olmsted et al., 2010, Saijo et al., 2006, WHO and CDC, 2010). Yet this notion of a system 
also raises questions about the presumed unity and functioning of the parts within it. 
Diagnostic processes span a number of different settings (or ‘production contexts’) as they 
negotiate various socio-technical assemblages and enactments of disease. How do framings 
and practices across these settings interact and shape diagnostic pathways in this context? 
How will new diagnostics influence these processes? How can the multi-dimensional nature of 
knowing (and not knowing) be accounted for in the process?  
 
In answer to the above questions I suggest the ‘mangle of practice’ Pickering (1993, 1995). 
The mangle of practice was intended as an explanation of scientific practice which was able to 
do justice to the richness of micro level practices.15 Pickering perceived that the actual 
performance of science had been overlooked by STS being overly focused on macro level 
processes such as scientific closure and the social shaping of knowledge thorough interests. 
Similarly I have argued that the process and practice of diagnosis have been ignored by the 
sociology of diagnosis’ focus on themes such as medicalization and labelling. I have also 
highlighted that understandings of diagnosis must account for the contested nature of viruses 
which do not follow simple constructivist or realist lines. The mangle offers a way of 
conceptualising the complexity of therapeutic practice through which a diagnosis emerges 
across multiple settings. 
 
Pickering tells us that ‘doing’ science involves a complex, reciprocal and inter-dependent 
pattern of behaviour. Human action, goals and theories are continually reconfigured through 
interactions with the material world they are attempting to understand or control. In 
Pickering’s mangle there are human and non-human agencies and these are “mutually and 
emergently productive of each other” (Pickering, 1995, p567). That is, they interact and 
respond to each other in a “dance of agency” (Pickering, 1995, p21). Science should be seen as 
the business of coping with material agency. An important concept in understanding the 
mangle is the idea of de-centred emergent becoming (Pickering, 2008). This is the idea that 
                                               
15
 Pickering (1995) makes a distinction between practice and practices: practice, in his usage, is the 
reproduction and extension of scientific culture and knowledge which involves skills and social 
relations, machines and material culture, and theories and concepts; practices, describes ways of doing 
things which are usually community or context specific. Practices can be articulated or non-articulated, 
material or social. Scientific practice can involve many practices. Thus, the practice of diagnosis 
involves many different practices.  
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theories, procedures, goals, problems, and functions emerge during the course of practice. 
There is no set pathway and the field of agency is diverse. An advantage of the mangle is that 
it is not hermetically sealed and it offers a theory of diagnosis which is neither socially 
constructed nor predetermined, in part, because material agency is taken seriously; a person’s 
diagnosis develops in conjunction with its surroundings and is shaped by many hands (and 
things) in the process. The field of material agency in this thesis could be the Lassa virus itself. 
It is evolutionarily programmed to behave in mysterious ways. Equally it could be seasonal 
rainfall and muddy roads. They can all be said to exert agency on human practice as they are 
all involved in a dynamic relationship with patterns of human sickness as well as attempts to 
identify and deal with them. 
 
Underlying all practice, Pickering tells us, is a pattern of resistance and accommodation 
between the human and material world. In these struggles, non-human agency is more 
restricted than human agency which can change its goals. Still, human practice must always 
contend with the resistance put up by material or non-human agency. Pickering’s summary is 
useful: 
 
“Scientists are human agents in a field of material agency which they struggle to capture in 
machines. Further, human and material agency are reciprocally and emergently intertwined in 
this struggle. Their contours emerge in the temporality of practice and are definitional of an 
sustain one another. Existing culture constitutes the surface of emergence for the international 
structure of scientific practice, and as such practice consists in the reciprocal tuning of human 
and material agency, tuning that can itself reconfigure human intentions. The upshot of this 
process is, on occasion, the reconfiguration and extension of scientific culture – the construction 
and interactive stabilization of new machines and the disciplined human performances and 
relations that accompany them.” (Pickering, 1995, p21) 
 
Pickering elaborates on the processes of resistance and accommodation by introducing the 
notions of goal orientated practice, modelling, tuning, and stabilisation. Pickering says that 
practice is goal-orientated, where goals are formulated and revised based on models of the 
world as that actor knows it. At some point, the interplay between human and material agency 
may become stabilised, for instance when a machine or an experiment works and can be 
repeated. This involves ‘disciplined human action’, such as is required when following a 
protocol (which provides an example of the influence material agency can have on human 
behaviour). Reaching stabilisation is a ‘tuning’ process whereby human conceptual 
frameworks can be applied to interpret the reasons for stabilisation (or non-stabilisation).  
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Politics are evident in people’s practices and relationships with aspects of health, science, 
medicine and technology (see Ong and Collier, 2005) yet politics do not feature heavily in 
Pickering’s presentations of the mangle. This is an area where the mangle could be usefully 
modified. This can be done by a consideration of framings within the mangle. Pickering does 
use the term ‘framing’ (Pickering, 1995, p83) though in a slightly different sense. For 
Pickering framing is about how the emergent agency of material objects is interpreted. I use it 
in a broader sense to acknowledge that the goals, models and practices of different actors in 
the diagnostic system will be framed differently, as will their interpretations of material 
agency. This structures what actors in the system intend to do and how they interpret 
diagnostic signs. In this sense human agency is path-dependent and frame specific. Politics is 
involved when people’s understandings, knowledge and motivations diverge. Indeed, 
framings can be seen as a possible source of resistance in the mangle. Partial and subjective 
views of the world can conflict and may need to be negotiated. 
 
The mangle of practice has been called a theory of everything (Pickering, 2008). So what is to 
be expected and gained by imagining the practice of diagnosis within Sierra Leone’s Lassa 
fever diagnostic system to adhere to the principles of the mangle? Quite simply, the mangle 
tells an open-ended story. Besides an endlessly repeated pattern of resistance and 
accommodation, it imposes very little on whatever subject matter it is applied to. This is more 
appropriate for addressing diagnosis in Sierra Leone where it would be premature to impose 
more prescriptive theories, particularly those developed in higher income settings. Therefore, 
the mangle provides a way of exploring how technologies are incorporated ‘into the thick’ of 
existing practice. Importantly it resists the determinism implied in some sociology of 
diagnosis and technology.  
 
The key aspects of the mangle are: first, the dance of agency; second, a dialectic of resistance 
and accommodation; third, goal orientated practice involving tuning and stabilisation; and 
fourth, de-centred emergent becoming.  With regards to the first, I provided some examples of 
non-human agency previously. In the mangle of diagnosis doctors, patients, diagnostics and 
pathogens will have to negotiate each other’s agencies and resistances. The inclusion of non-
human agency seems appropriate in settings where the environment, the virus and the tools 
used to detect it may not behave as they ‘should’. The mangle suggests that human attempts to 
define and identify Lassa will face some unruly resistance.  
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The implication of the second point, the interplay between resistance and accommodation, is 
fairly self-explanatory. Diagnostic pathways should involve trial and error and the 
modification of theories to interpret the case at hand. This pattern will occur in all settings. In 
a broad view of the diagnostic system, it would not be restricted to the application of scientific 
theories. As chapter five will demonstrate it can also include local classifications of fevers and 
how they are applied and revised over the disease course. By adding a concern for framing 
within the mangle a new dynamic between resistance and accommodation is revealed. 
Framings may become both a source of resistance and a tool of accommodation. Perceptions 
about Lassa fever determine how people deal with it, but as we have seen these are partial. 
Thus they can obscure significant details. For example throughout the empirical chapters I 
show how ingrained ideas about Lassa fever’s prevalence in particular regions, or its 
manifestation in some ‘classic’ symptoms, serve to inhibit the recognition of cases which do 
not fit those moulds. As such, restrictive and inflexible framings of Lassa fever become a 
source of resistance within the system.    
 
Concerning the third mangle characteristic, the goals, tuning and stabilisation will be context 
specific. This relates to the STS ideas explored earlier about the boundedness of ‘machineries 
of knowing’ and socio-technical regimes. Furthermore, within socio-technical regimes people 
have various framings which mean they enact disease and diagnosis differently. As later 
chapter show, in each setting attempts are made to create something stable and 
understandable. Even within specific sites such efforts come up against contingencies of 
agency and practice. However, being based on particular framings means that such 
stabilisations are always partial. A potential issue is that stability can be disrupted when 
divergent methods of making objects stable compete, both across and within sites. Stability in 
one setting may not equal stability in another setting. Even if particular technologies claim to 
be increasingly certain the potential for uncertainty remains across settings. 
 
This brings me to the fourth point about the mangle. This would imply that the process of 
diagnosis is decentred and heterogeneous. This relates to Mol’s work on difference in medical 
practice. I favour the mangle’s emphasis on unplanned and unpredictable emergence over 
Mol’s more problematic suggestion that multiple enactments somehow converge and hang 
together. However, I will continue to use her language of multiple enactments, assemblages or 
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amalgams as they convey the diversity of diagnosis clearly. However, returning to the theme 
of politics within the mangle, it is likely that some conceptualisations of Lassa fever will 
emerge more forcefully than others depending on differences in the agency, power and 
interests of those promoting them. 
2.4 Conclusion  
In summary, the focus of my research is on the process of diagnosis, with a particular interest 
in the use of diagnostic technologies during that process. A closer look at the process of 
diagnosis in this chapter has brought into view the full range of people, technologies, 
relationships, practices and perspectives involved in health care. I have discussed the 
importance of framings and narratives about disease and diagnosis and have pointed to a 
‘specific disease’ model of healthcare systems which is assumed to be universally applicable. It 
was suggested that the uncritical application of such models downplays the social, political 
and historical processes which shape approaches to disease and health in particular settings. 
This chapter has drawn together literature in medical anthropology and science and 
technology studies which have emphasised non-linear and informal aspects of diagnosis. I 
argued that diagnosis can be understood as a system, but that the system is composed of 
diverse elements within which there exist many ways to frame Lassa fever. Along diagnostic 
pathways various framings of Lassa fever can be enacted and assembled. The implications for 
uncertainty were discussed and the relationship between technology, increased specificity 
and uncertainty was questioned. Pickering’s mangle of practice has been combined with 
framings to provide a conceptual framework to explore the differential processes and 
practices of diagnosis. I have tried to evoke these differences by studying the processes of 
diagnosis in three different settings within the diagnostic system. The next chapter will 
provide details of how this was achieved.  
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3 Research Methods 
In the previous chapter I outlined the conceptual framework which I have used to explore 
diagnosis; it is based on a broad view of diagnosis, which is conceptualised as a system with 
diverse elements, where various processes and practices are mangled to shape diagnostic 
pathways. In this chapter I describe how in designing and carrying out my research, I applied 
this framework to answer the following questions: 
 
How are developments in laboratory-based diagnostic technologies incorporated into the 
process and practice of Lassa fever diagnosis Sierra Leone? 
 
- How is the diagnosis of Lassa fever framed and how do these framings relate to 
diverse narratives about the disease’s significance and control? 
- How is Lassa fever diagnosed in practice and how do different framings and practices 
intersect with each other? 
- How do new diagnostics influence the uncertainty surrounding diagnosis?  
 
My research strategy followed on from the fact that my questions ask how changes in 
diagnosis are occurring. As my aim is to understand the process and practice of such change, I 
chose an ethnographic method in order to capture the necessary descriptive detail. In the 
previous chapter I argued that to understand if, and how, new diagnostics make a significant 
impact on healthcare systems it is necessary to look at health and diagnostic processes as they 
occur in particular contexts, which requires a degree of depth and familiarity with the context. 
Assessing impact is often the domain of quantitative research and randomised controlled 
trials are a mainstay in the evidence base for diagnostics. Yet such methods are limited for 
understanding the change observed in particular settings (Cartwright, 2011a, Cartwright, 
2011b). As I have pointed to the importance of social, political and historical processes which 
shape approaches to disease and health in particular settings it follows that my aim is not to 
produce a generalizable explanation of how all diagnostics will be introduced in all settings 
for all diseases: contexts, diseases and diagnostics are far too varied for that. A more general 
aim of this research can be understood as establishing in what ways it is justified to challenge 
narratives about innovations in diagnostics and health systems.   
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I have advocated a broad view of diagnosis, informed by ideas of systems but characterised 
more loosely as a mangle of practice (and practices), which reach past the boundaries of a 
hospital or laboratory, to include less central, formal, or biomedical elements. Within this 
diagnostic system, the premise is that different actors have diverse perspectives and that their 
actions have agency but are embedded in social contexts and socio-technical regimes. I 
highlighted the importance of practices and framings as a way of accessing these diverse 
perspectives and diagnostic activities. Clearly, as I have outlined, a non-positivist, qualitative, 
line of enquiry is required. But in exploring the ways Lassa fever is framed, diagnosed and 
responded to, I took an ethnographic approach because such processes are fundamentally 
social, cultural and political and so could only be gauged by being observed as they ‘naturally’ 
occurred which is central to ethnography (Atkinson and Hammersley, 1994, Hammersley, 
1990). Without seeing how people behaved in those contexts, and without having some 
experience of them myself, I would be unable to answer my how questions. In doing so, I have 
been influenced by the insights of sociology of science and knowledge. They have shown how 
bodies of expert knowledge, including medicine, long held to be distinct on account of claims 
to scientific objectivity, are in fact, deeply cultural. Scientific and medical knowledge has been 
shown to flourish in just such a way within their expert communities, through shared beliefs, 
practice and artefacts (See Knorr Cetina, 1999, Latour and Woolgar, 1979, Pickering, 1992, 
Star and Griesemer, 1989).  
 
Given the above, an ethnographic approach is particularly fitting; more specifically a multi-
sited ethnography. In general, qualitative research can be good for probing values, 
perspectives and alternative social realties; it does not seek to establish causality in a 
measurable or generalizable way. Ethnography, literally translated as ’writing culture’, is the 
process of observing and interpreting ‘culture’ in its natural setting and producing a written 
account of it, as far as possible from the perspective of the peoples whose culture it is 
(Mitchell, 2007). Clifford Geertz’s famous phrase “thick description” gives an indication of why 
ethnography is appropriate for this study; ‘writing culture’ involves not just observing and 
describing but also interpreting. It is that last element which merits the term ‘thick 
description’ (Geertz, 1973). It should be noted that this is not a one way activity: an 
ethnography is co-constructed by the researcher and the people and communities they work 
with.   
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3.1 Multi-sited ethnography 
In using ethnography, my aim was not to understand some reified notion of ‘culture’ but to 
understand where, what, and how Lassa is diagnosed by different groups of people or 
individuals. I needed to see and understand the interactions between these contingent sets of 
framings and practices and so I took a multi-sited ethnographic approach because it 
renegotiates traditional ethnography’s focus on long-stays in one setting for the study of 
dynamic multi-sited cultural landscapes. It looks at the changing significances of cultural 
objects as they pass through multiple actors, levels and boundaries (Marcus, 1995). By 
following the intersections and connections between different contexts it builds up a picture 
of the world system these objects are part of. George Marcus describes the approach as: 
 
 “designed around  chains,  paths,  threads,  conjunctions,  or juxtapositions  of  locations  in  
which  the  ethnographer  establishes some  form  of  literal,  physical  presence, with an explicit,  
posited  logic  of association or  connection  among  sites  that  in  fact  defines the  argument  of  
the ethnography.” (Marcus, 1995, p105).  
 
A flexible approach is important when the object of study, and the influences on it, are not 
located in any single setting – as in the process of Lassa fever diagnosis - and so cannot be 
adequately characterised by collecting data from just one place as in traditional ethnography. 
 
In this thesis, the diagnostic system is the ethnographic case. Over the next few pages I 
describe how I defined my case and how I researched framings and practices within it. Briefly, 
I did this by carrying out fieldwork in, and following pathways between, three sites which I 
identified as settings where important activities in the diagnostic system occur or where 
important material or technological elements of the system are located. These were: a Sierra 
Leonean village, the Lassa Laboratory at Kenema Government Hospital; and the clinical wards 
at Kenema Government Hospital (KGH), including the Lassa ward, although this was 
supplemented by data collected in other clinical settings in Sierra Leone.  
 
To answer my overarching question about how diagnostics would be incorporated into 
practices of diagnosis I based my data collection and analysis around the three sub questions 
which overlapped somewhat in terms of the methods they called for. The ‘hook’ was practice: 
how is diagnosis practiced, how do framings and practices intersect? The separate questions 
on uncertainty and framings both tie back in to practice, for instance: how do the framings of 
the process of diagnosis or perceptions of uncertainty relate back to diagnosis as practiced in 
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Sierra Leone for Lassa fever?  The backbone of my research was participant observation, 
backed up by interviews and documentary analysis. Participant and non-participant 
observation involves the researcher directly participating in (or just observing) the activities, 
or setting, which they are studying. To observe practice, and to comprehend uncertainties in 
practice, there is no more appropriate research method. I will describe what I did, and how I 
selected each site in more detail in the coming pages. To summarise quickly, my methods 
were simple: I spent days in the laboratory with the technicians, I observed wards and clinical 
routines at KGH and I went to stay in a Mende village. I carried a small note book with me to 
make jottings as things happened. If it was not appropriate or possible to write at the time, I 
relied on memory. These jottings were written up into fuller field notes as soon as possible. 
Conversations about diagnosis and related topics were conducted in each setting as much as 
possible, with individuals or groups. These parts of my fieldwork were not pre-arranged and 
were not tape recorded. These periods of observation allowed me to see practice as it 
occurred, not as I was told it occurred. This was also where uncertainty emerged to be an 
important theme: time and again the broader dimensions of risk, uncertainty and ambiguity 
came up in discussions.  
 
To elicit framings and narratives I began, before I started fieldwork, with documentary 
analysis. I reviewed scientific journals articles, academic research applications, epidemic 
reports and notifications, and health policy documents from governments and international 
organisations. Funding, policy or academic documents can contain powerful narratives which 
are helpful for characterising dominant institutional framings of issues (Leach et al., 2010b). 
More often than not they contain idealised, normative, versions of events and subject matter: 
how things should work. I also searched for documents produced by different actors and 
institutions which would contain alternative framings or narratives: press reports, blogs, 
fiction and non-fiction books on Lassa and Lassa-like diseases, from the perspectives of non-
scientists, or other interested individuals.  
 
To gauge alternative framings, those which were not scientific, official, or sensationalist news 
reports of disembodied accounts separated from place and people, I again relied on 
participant observation and interviews. I explored these alternative framings by scrutinizing 
the practice of diagnosis in the three key settings which I describe below. In these settings I 
looked for how Lassa fever and diagnosis was being defined by people as they performed or 
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told me about their therapeutic activity: which disease categories or framings of diagnosis 
were being enacted? What boundaries were being drawn to define the disease and its 
significance? Documentary analysis also played a role here. Like policy documents, protocols 
and guidelines can also be seen as embodying institutional and formalised framings, but 
documents such as these which are integral to work routines have dual significance: they are 
based on particular framings, of entities and processes, but clinical records or guidelines do 
not simply record or instruct practice they also constitute it in a fundamental way (Berg, 
1996). Thus seeing how they are used, adapted, or ignored in practice allowed me to see the 
intersection between framings and practices. Because of this dynamic quality I looked for 
documents which were part of laboratory, surveillance or medical practice and gave them a 
good deal of attention in my analysis: symptoms checklists and case definitions, safety notices, 
standard operating procedure, assay protocols and result forms, to name a few.  
 
To probe framings and practices from another angle I conducted interviews with health 
workers, community members and Lassa patients, which concentrated on their experiences of 
Lassa fever: where it came from, how they thought other people got sick, how they thought 
they got sick, and of course, what happened when they did? Interviews can be used to assist in 
understanding experiences, events, and decisions (Rubin and Rubin, 2005) because they offer 
the researcher a window in to interviewee’s unique perspectives. Interviews were necessary 
because there is much about health and Lassa fever which cannot be easily observed and 
because I wanted to triangulate my observations with people’s accounts; and to compare the 
stories I collected in my research village to those of patients coming from elsewhere. I also 
conducted a limited range of interviews with health and government officials to triangulate 
with my initial documentary review of scientific and policy documents and with my 
observations of diagnosis in practice. I was interested to see if civil servants, WHO staff and 
scientists would relay different concerns about Lassa fever, or different dimensions of 
diagnosis, to what I had learned on the ground. Each of these interviews served different 
purposes. They were all semi-structured but they were conducted rather differently; some 
were more formal than others, in local community settings in particular it was sometimes 
hard to find privacy and what began as an individual interview turned into a group discussion. 
I describe how I conducted and sampled interviews in each setting in the relevant sections 
below. Although I organised all the interviews in advance, questions could not be sent 
beforehand because email/post are not widespread (except on a few occasions noted below). 
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Mostly interviews were conducted in English though a significant number of patient and 
community interviews were conducted in Krio (by myself) and a few in Mende with the help 
of a local translator. I recorded them all, with consent, except for the few occasions when I 
was asked not to. 
 
The quality of research is commonly assessed by triangulation which is a strategy of collecting 
and comparing data generated in different ways to add depth, breadth, and rigour to 
investigations. Comparisons can be made between (Denzin, 1970):  
 
- Data sources (e.g. different people, groups or communities) 
- Investigators (e.g. multiple versus single data collectors/observers/analysts) 
- Theories (e.g. different theoretical perspectives) 
- Methodologies (e.g. within and between method triangulation)  
 
Triangulation is often described as a technique of checking the validity of research data. The 
validity checking view has been challenged on the grounds that there is no single reality that 
can be objectively obtained from any collection of data sources. It has been suggested that 
because all methods are designed to investigate specific aspects of (subjective) reality they 
would not, and should not, produce concordant evidence (Ritchie, 2003). This thesis is 
designed around the principle of multiple perspectives and so it would not be appropriate to 
pursue a triangulation strategy that was concerned with checking if any one perspective was 
‘correct’. For this research I have triangulated a number of data sources in order to extend 
breadth and to provide as full an account of the diagnostic process as possible. I did this by 
collecting and comparing multiple perspectives of people (and institutions) involved in 
diagnosis in three very different sites. In my interviews, observations and reading of 
documents I sought to identify divergences. Where there was contradiction I asked further 
questions. In analysis I compared my data sources, for example in the laboratory I checked 
how my observations of practices fitted in with the written protocols. The same was done 
with ‘case notifications’ forms and observations on the hospital wards. I compared what I was 
told by different people and different communities; not just scientist’s opinions versus 
doctor’s, but from one village to the next. With some limitations discussed below, in all the 
sites that I chose I was able to access key actors and to ascertain degrees of coherence and 
divergence in perspectives between groups.   
58 
 
3.2 Research  process 
The basic stages of my research were as follows: first, I began a literature review which 
continued throughout; second, I carried out fieldwork which was an on-going process of 
‘scoping out’ the diagnostic system and exploring framings and practices in field sites; and 
finally, I proceeded to analysis, in which I explored the data from these settings and the 
connections between them. I will now describe each stage in more detail. 
3.2.1 Literature review 
I was interested in academic, policy, health reports and ‘grey literature’, including blogs, news 
websites, and disease outbreak information websites like ‘ProMED’. I used internet search 
engines such as in Web of Knowledge, Google, and Google scholar. I also followed article 
citations manually. I asked experts in the fields for reading lists and key papers or reports. To 
keep up to date I set up a ‘Google alert’ for Lassa fever so I remained informed of any scientific 
or other developments. This was very useful for obtaining reports on the 2011 and 2012 
‘outbreaks’ of Lassa fever in Sierra Leone and Nigeria respectively. I also searched the WHO 
and UN websites for ‘epidemiological records’ and reports on Lassa fever. In Sierra Leone I 
asked research participants, at KGH and in the Ministry of Health and Sanitation (MOHS) for 
relevant materials.  
3.2.2 Fieldwork 
I carried out a total of 9 months fieldwork between 2009 and 2011 which was spread across 
three trips: 
 
- 3 week scoping trip in April 2009, 
- 7 month stay from November 2009 until June 2010  
- 1 month return visit in April 2011.  
 
I was based in Kenema16, a town in the East of Sierra Leone where the country’s Lassa fever 
activities are the most concentrated.  Kenema and the approximate location of my village field 
site are shown in a map of Sierra Leone in figure 2. Before leaving for my fieldwork proper in 
November 2009 I made contact with Tulane University who coordinate, in partnership with 
                                               
16 Kenema is Sierra Leone’s third largest city. Census data recorded the population as 128,402 in 2004 
(SSL, 2006), however the city is likely to have grown considerably since then. 
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the WHO and Sierra Leone’s MOHS, the Lassa Fever Research Programme17, based out of 
Kenema Government Hospital (KGH). This research programme forms part of the Mano River 
Union Lassa Fever Network (MRU-LFN) which also involves the Governments of Liberia and 
Guinea. Tulane staff agreed to let me to stay at their guesthouse in Kenema, giving me an entry 
point into Lassa fever activities in and around KGH.  
 
Researcher positionality is a constant issue in qualitative research like this. My 
accommodation at the ‘Tulane’ house gave me unparalleled access to the developments taking 
place within the laboratory at KGH but this access, as in every site, was something that I had 
to negotiate. How close should I get to people? How should I manage - and avoid – conflicts 
that arise between research subjects? Living in the same house as the Tulane researchers, and 
in the same room as the children of the family who put me up in my research village, meant 
that these were daily concerns. How I was seen, and how I interacted with people in each 
setting, influenced the way I interacted with my research topic - and eventually of course it 
will have influenced what I concluded. It was not only the relationships I made within specific 
contexts that mattered but the associations they carried with them outside and between these 
contexts mattered too; for instance, I was sometimes assumed to be a ‘Tulane’ researcher. I 
will try to describe these negotiations as I go through each setting and stage of research.  
 
Running through all aspects of this research, including many of the questions above, is ethics. 
Although I had formal ethics approval (see section 3.3) this was not enough to prepare for the 
dilemmas which arose during the course of fieldwork and write up. I will discuss key issues in 
the following pages and conclude with some general comments at the end of this chapter.          
 
                                               
17 Sometimes referred to as the Mano River Union Lassa Fever Program (MRU-LFP) 
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          Figure 2 Map of Sierra Leone, with research site locations marked (UN, 2004) 
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3.2.3 Defining the system: selecting the case and sites 
Even though qualitative research does not aim for the same generalisability of quantitative 
research, sampling is still an important issue and data collection sources have to be matched 
to the research rationale and questions. My primary unit of analysis is the diagnostic system 
so for the purposes of this research that is my ethnographic case. The case was selected for its 
intrinsic interest and capacity to learn within it, rather than for external generalisability 
(Stake, 1994). I was not seeking to test a specific theory but instead to explore an empirical 
question by blending aspects of the existing literature into a suitable theoretical framework. 
Furthermore, when it comes to health and disease, a typical case is unlikely to be found. As I 
outlined in chapter one, the diagnosis of Lassa fever in Sierra Leone represents a rather 
extreme case that has a number of points of interest. It is hard to diagnose because of its non-
specific symptoms and for a long time real-time diagnosis was all but impossible because of 
inadequate technology and strict biosafety regulations. Yet since the virus has become a topic 
of international bio-political concern there has been dramatic and unprecedented investment 
in research. As such, there is a huge learning potential from Lassa fever diagnosis, both 
theoretical and empirical. 
 
To study Lassa fever, KGH was an obvious choice. Sierra Leone has a particularly high burden 
of disease and KGH has the only treatment and diagnostic facility in the country. In fact it is 
the only dedicated Lassa fever isolation ward in the world. KGH is also the site of the MRU-
LFN’s most substantial diagnostic efforts, with a research project carried out by consortium of 
research institutions administered by Tulane University and funded by the National Institutes 
for Health (NIH). At KGH there would be both patients and laboratory supported diagnosis at 
one hospital site. Thus KGH became the anchor for my ethnography. Government health care 
in Sierra Leone is tiered and organised into: Peripheral Health Units (PHUs) which includes 
Community Health Centres (CHCs), Community Health Posts (CHPs), and Maternal and Child 
Health Posts (MCHPs) making up the first line of primary health care; District Hospitals 
provide secondary care; and Regional/National Hospitals provide tertiary care.  In this 
system, KGH is a major regional hospital to which complicated cases are referred and after 
which the only option for unresolved cases is to be referred to a hospital in Freetown (if 
staying in Government provided healthcare). The situation is different for Lassa fever; all 
Lassa fever cases in Sierra Leone go to Kenema, it is the only officially sanctioned option. 
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To define the diagnostic system I was keen that the process of diagnosis took centre stage. I 
used Marcus’ strategies of following the ‘people’ (patients) and the ‘thing’ (blood samples)18 
as they are the transient elements in the diagnostic process. I concentrated on blood and 
people because there are times when they diverge. Although the base was KGH there were 
parts of the system to map which were further afield. For the first 2 months of my 7 month 
fieldwork trip I was predominately based at KGH. I spent as much time as possible in the 
laboratory and on the hospital wards in order to get familiar with Lassa fever and the wider 
hospital and health care context. Following the pathways of patients and blood samples, I 
noted the procedures, people and places involved in Lassa fever diagnosis around the 
hospital. To explore beyond KGH I accompanied the Lassa fever outreach team on their 
sensitization and ‘contact tracing’ trips which were usually between 1-3 days long; on these 
trips they often investigated old and new cases so our interests in ‘following people’ were 
aligned. By joining them on these trips I became familiar with a number of villages and 
chiefdoms in the ‘Lassa belt’. The ‘Lassa belt’ is an area in the Eastern region of Sierra Leone, 
also known as the ‘hyper-endemic’ zone, which is considered to be most heavily affected by 
Lassa fever. As the next chapter notes, the higher detection rates in this area may be a 
symptom of increased surveillance in them. During these trips I also visited some of the 
hospitals and PHUs which serve these ‘hyper-endemic’ communities and which refer cases on 
to KGH (described later); KGH is actually located outside of the ‘Lassa belt’. Returning to the 
literature, particularly surveillance policy and strategies, enabled me to contextualise the 
system ‘in practice’ with the system ‘as planned’.  
 
I settled on doing ethnographic work in three sites: the ‘Lassa Lab’ at KGH; a village located in 
a chiefdom (Dodo chiefdom), which has seen a relatively high number of recorded Lassa 
cases; and the KGH wards. At this point some clarification on what I mean by ‘sites’ is needed, 
as well as an explanation of their place in the diagnostic system which is my ethnographic 
case. The ‘sites’ represent settings where aspects, or framings, of Lassa fever are enacted in 
various diagnostic processes, along various diagnostic pathways. These multiple processes, 
pathways, framings and enactments make up the diagnostic system, along with the 
assemblages of people, pathogens and things which they entail. Crucially, the ‘sites’ should not 
                                               
18 Marcus identifies six methodological strategies: follow the people; follow the thing (i.e. a material 
object); follow the metaphor; follow the plot story or allegory; follow the life or biography; or follow the 
conflict. 
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be understood as the only places where diagnostic activity goes on; neither are they 
necessarily physically distinct locations. They are not in themselves parts of the system; they 
are locales where facets of the system interact. The diagnostic system, as I explain in the next 
chapter, is comprised of people, places, blood, technology, multiple healthcare providers, 
governments, universities and international organisations, to name a few; it also includes 
institutional cultures, policies, regulations and norms. Those elements are more aptly 
described as parts, facets, aspects, even components, of the system.  Within this assemblage of 
parts, there are some more formal aspects of the system (e.g. those centralised and 
converging at KGH) and some more informal aspects (e.g. the un-official health providers who 
do not have strong links with KGH). The distinction between formal and informal should not 
be taken too strongly however, as I will show there is much that is informal within the formal. 
Nevertheless, when discussing Lassa fever specifically there is some merit in using the term 
formal as the drug for Lassa fever is only available in at KGH.  
 
The selection of sites presented different challenges and opportunities. To various degrees 
they overlapped or diverged. Some, such as the laboratory, were more distinct; the Lassa Lab 
is the only laboratory diagnosing Lassa fever in Sierra Leone. The clinical and village settings 
however, were not unique; there are many villages and health posts which have experience of 
Lassa fever. To an extent, they also spill over into each other, with health providers being 
stationed in villages or health workers visiting rural areas. Each setting provides different 
opportunities for understanding linkages between parts of the diagnostic system. Being based 
at KGH, with the official Lassa fever laboratory and Lassa fever ward, my case was anchored in 
the institutionalised and formal aspects of the system. This was inevitable and deliberate 
because of my research interest in laboratory technology. However, I wanted to explore the 
unofficial aspects of the system as much as I could, to understand the way in which cases are 
missed, or slip out of the official KGH based system. I engaged with these aspects of the system 
in my ethnographic observations and interviews with local communities, particularly in my 
research village, to try to elucidate the range of health care options they used.  
 
Spreading an ethnography across multiple sites gives the research additional breadth but it 
can be at the expense of some of traditional ethnography’s depth (Marcus, 1995).  
As extended periods of fieldwork were not possible in each site I had to gather data efficiently. 
I split my time roughly evenly between the three sites. At first I tried to do this in separate 
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blocks in an attempt to immerse myself in each of the very different settings. However I learnt 
early on that it was not always possible to divide my time so neatly when my plans to spend a 
week on the Lassa fever ward were scuppered; it was to be my first experience of the famed 
isolation ward, and still wary of it, I had pre-arranged it with the ward’s head nurse. When the 
time came there were no patients at all, no referrals, no suspect cases and no admissions. 
When I was in Kenema I had to be flexible in the way that I split my time; there were times 
when the Lassa ward was particularly ‘hot’ and so I would maximise time there or vice versa if 
the laboratory was busy. By the time the faster laboratory tests were being introduced, from 
around January 2010, I had settled in to a routine which followed the rhythm of work in both 
places: I would accompany the doctor on ward rounds in the morning, go to the laboratory as 
the technicians started to run the tests (which the doctor had ordered on his rounds) and 
when the results were ready I would return to the wards, either the general wards or the 
Lassa fever ward, and stay there keeping up with general activities or a particular patient’s 
progress. The village level research was done in distinct blocks of time, described below, 
because it entailed being based in a remote settlement hours from Kenema.  
3.2.4 Laboratory 
Observing laboratory practices was relatively straightforward, understanding the framings 
and logics involved in them was less so. I would join the Sierra Leonean technicians, and the 
Tulane researchers, in the laboratory while they were preparing, running and analysing tests. 
There was only one ‘Lassa lab’ and so being at the centre of the action was not difficult, 
especially as routines were well established and timed. However, having stopped studying 
science at the age of 16, let alone having any kind of background in molecular biology, it was a 
steep learning curve. Though my ignorance may have been a blessing as my endless questions 
about what they were doing, which were all answered with incredible patience, enabled me to 
see the framings that were being operationalised. Why were they adding a solution to a 
sample at a particular time, at a particular temperature, or why were they using a particular 
machine to perform a certain task? If I had been familiar with what was happening I would 
have been blind to some of the underlying assumptions. Because of safety and quality control I 
did not participate in any of the assays or sample preparation. Occasionally I would help to 
clean up, set timers or oversee the plate washing machine. As well as the work inside the 
laboratory there was also activity outside of it: maintaining supplies, collecting samples from 
further afield such as the Liberian border, delivering results to other health units or to clinical 
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staff at KGH. There was also lots of waiting. Waiting for tests to run or waiting for samples to 
come in.  
 
I spent a lot of time with the Sierra Leonean technicians during which we explored aspects of 
their work and discussed specific cases. I did not do formal interviews with them as I already 
had so much contact with them, often in one on one almost interview like scenarios. A concern 
in ethnographic research is how open people are with the researcher and how the researcher 
is viewed by the research participants. At KGH, both the technicians and the hospital staff 
were more than used to students and researchers passing through on different research 
projects. What was unusual about me was that I was not attached to Tulane or on a medical 
elective, so I fell in to a strange category. I did not encounter suspicion from the laboratory 
staff; the technicians were always very welcoming to me and would actively involve me in 
their work, calling me when samples came in and asking if I wanted to come in to the 
laboratory. I think it helped that I was not there in any kind of capacity that may have been 
experienced as judging or assessing the quality of their work; I was not there to train them 
and I was not another laboratory scientist who needed to use them and the laboratory 
equipment to run samples for any associated project. I was sanctioned to be there by their 
bosses, Tulane and authorities at KGH, but I had no other guise other than being there to learn 
about a subject on which I was clearly an amateur. It helped that sometimes, when Tulane 
staff would bring a new protocol or piece of equipment, that we were learning together. I 
think I also earned some favour and acceptance among the Mende technicians by being one of 
few visitors, particularly from those associated with Tulane and the laboratory, to learn some 
Mende and spend time in villages.   
 
I initially considered including a site to represent the research and development (R&D) of the 
diagnostics, which would have included fieldwork in the US to supplement data on the field 
testing at KGH. However although R&D is vital for maintaining and improving the supply of 
diagnostics for Lassa fever, it was not strictly speaking a ‘site’ where negotiations over 
individual diagnoses took place.19 Nevertheless, it was still important to trace the way R&D 
processes influenced routine laboratory work; fortunately the steady flow of researchers in 
and out of Kenema allowed me to keep up with developments and, most importantly, to see 
how they were implemented into diagnostic practice at the KGH site. The visits from 
                                               
19 Results were debated but it was from an R&D perspective, the result was not of immediate clinical 
importance. However, some of these debates are relevant and are included in reports here. 
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researchers and field-testing of the new diagnostics gave me ample opportunity to gauge the 
on-going interaction between R&D and clinical diagnostics. This presents a limitation in this 
research, there were people and organisations involved in the development of the diagnostics 
who I did not meet. However as my research is on the use and implications for clinical 
practice this is less important. A perhaps more pressing difficulty was that not only was the 
research difficult to keep up with, but some of the uncertainties I saw may have been a 
product of the on-going research and as such will be short-lived. But another way of looking at 
this is that these are the uncertainties which get ironed out and forgotten, or ‘black boxed’; in 
that sense I am looking at ‘science in action’ (Latour, 1987) before its closure and presentation 
as a finished product.    
 
It was, therefore, important to spend time around the laboratory when Tulane researchers 
and students visited because each time they came they would bring new equipment and 
protocols with them. The core Tulane research team made three visits during my fieldwork 
period, each staying for different amounts of time, from a week or so to months. Their trips 
were always very busy, more than once depleting the energy supplied by the solar panels. 
Evenings were time for unwinding, reviewing the day and trying to unravel puzzles; by 
staying in the same house as the Tulane researchers I was able to participate in these 
discussions which could be very revealing about how the day’s events and data were being 
interpreted and how it fitted into their ideas about the bigger picture. Days in the laboratory 
could be extremely fast paced with a number of different procedures going on at the same 
time. Without these evening discussions I would have missed the broader significance of 
much of this work.  
 
As well as the scientific papers which presented particular perspectives on the diagnostics 
and the virus, the laboratory was full of the more practical documents I was so interested in. 
There were assay protocols, safety instructions and general laboratory standard operating 
procedures (SOPs), plus documents which formed part of the diagnostic process: results 
forms, graphs, spread sheets and the laboratory records book. The material culture of the 
laboratory was important too: the layout, the ELISA20 plates, the colour of the wells in the 
ELISA plates, all of which I photographed. In none of my other settings was the 
instrumentation of diagnostic enactments so clear; in the standardised equipment and the 
                                               
20 ELISA is shorthand for Enzyme Linked Immunosorbent Assay, the diagnostic technique of choice in 
the Lassa lab. The technique will be explained in detail in chapter six. 
67 
 
standardised instructions. Outside of the laboratory I sought other documents to compare and 
contextualise my observations and the evidence presented by other documents in the 
laboratory, for example textbooks which the researchers used and which set out the 
principles of ELISA testing procedures. Funding applications and project proposals which 
presented the rationale behind the research were instructive concerning the idealised and 
scientific framings of Lassa and diagnostics.  
 
I became interested in disjunctures. Between the built environment and the patterns of use 
within it, between the formal and codified knowledge and protocols and what people did in 
practice. Narratives and frames were more easily visible when oppositions emerged: for 
instance, when everyone in the laboratory would be dressed in barrier clothing including 
wellington boots, goggles, face masks, lab coats and gloves and the engineer would walk in 
wearing shorts and flip flops. Oppositions were not just between formal and informal or 
framings and practice, but between people, different members of the Tulane research team, or 
between Tulane researchers and Sierra Leonean laboratory technicians. These differences 
were all revealing of people’s perspectives and how they related to the various frames at 
work. It is not an underestimate to say that there were differences of opinion within the 
Tulane team about how to interpret the diagnostics. As time with the Tulane researchers was 
more limited, I conducted some interviews to get an overview of the project development and 
history, as well as, activities in the US. It was also a chance to compare perspectives and 
explore some of these disjunctures. I interviewed four Tulane ‘researchers’ (out of the nine 
Tulane-associated people whom I had contact with, some of whom were logistical staff or 
research assistants). My interviews were with: one doctoral student who was a laboratory 
scientist and heavily involved in the diagnostics project; another doctoral student researching 
disease and rodent ecology and helping out in the laboratory as well as using the diagnostics 
in their own work; and two medical doctors who were involved in the diagnostics project as 
well as other clinical research on Lassa fever, one replacing the other during my fieldwork 
period. They were all involved in different aspects of the diagnostic project and because of 
their different backgrounds they could reflect on a range of dimensions in diagnostics work. 
3.2.5 Clinic 
As I have previously outlined, this part of my research was based at KGH. To explore practices 
and framings in a clinical context I decided that it would be beneficial to have a main site 
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where I could get to know, and become trusted by, the health workers there. Again, because 
this was a setting and a world I was unfamiliar with concentrating efforts in one setting 
allowed me to get in-depth data quicker than if I had moved from site to site. Thus, KGH was 
the main observational setting for this ‘site’ as it was the location of the Lassa ward and 
laboratory so I was guaranteed to see more ‘confirmed’ diagnostic activity there. 
Nevertheless, I did visit other settings as I will describe.  
 
To ascertain the narratives and practices I focused on disjunctures, again looking at how what 
people did contrasted with what they or others reported, or what formal documents such as 
case definitions described. I reviewed published papers on the clinical aspects of Lassa fever 
and looked at MOHS policy documents. I also examined forms and documents used in clinical 
settings and on the Lassa fever ward including: case definitions, case notification forms, 
clinical data collection forms and ward logs and records. I looked at the kinds of data these 
forms tried to obtain and the ways they were supposed to be used, for instance as referrals. I 
did not use them to compile case histories because the data was frequently not sufficient, as I 
describe in chapter six. I did initially spend some time trying to follow cases through these 
documents, laboratory forms, referral forms and ward reports, but found it very difficult to 
track them down and the information on them limited. I came to realise that this is a feature of 
diagnosis in Sierra Leone. Documents which are filled out regularly have special status such as 
the ‘Lassa Bible’ a record of people tested or admitted to the Lassa ward with brief notes of 
symptoms, results and outcomes. A routine computerised database was being developed 
while I was there but most things are done in person and on paper.       
          
The doctor in charge of Lassa fever is also responsible for some general wards (see chapter 
four for an overview of the hospital) and I started by shadowing him on ward rounds to get 
familiar with the way the hospital worked. Later I did this with the obstetrician on the 
maternity ward, as Lassa in pregnant women poses particularly high risk both for the women 
and nursing staff so it was an important domain to observe practices. As I got to know the 
hospital better I moved about more independently, although ward rounds remained 
particularly interesting not only for the updates on patients’ conditions but also as a chance to 
see interactions between the doctors and nurses. The doctors were quite used to students 
following them round, from within Sierra Leone and abroad. Although my shadowing was not 
unusual I had the impression that when students, like me, were there the doctors took longer 
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to explain things. However, the longer I was there the more my presence on the rounds and 
wards seemed to make less difference; we moved past patients quickly and cases weren’t 
explained to me in so much detail, but rather questions and comments were directed at the 
ward’s nurses. I also sat in on this doctor’s outpatient consultations. I would watch from a 
chair in the corner of the cramped ‘container’ (as the transformed shipping container where 
outpatients were examined was known). There were usually others people coming in and out 
throughout patient’s consultations and my presence in the corner was of minimal disruption. 
The doctor would sometimes ask me to write the prescriptions he dictated or to check things 
in his medical textbooks.   
 
I had a huge amount of access to clinical routines and to patients, which initially felt too much. 
I was sometimes mistaken for a doctor and I was invited to examine patients (which I 
refused). I sat in on some very intimate, and harrowing, moments. It goes without saying that I 
would not have been allowed such access in the UK healthcare context. However, the same 
concepts of patient privacy do not exist in Sierra Leone and I had to determine what was 
acceptable for myself. Trying to limit my access on the grounds that it would be considered an 
invasion of privacy in the UK seemed odd, especially if other people, and students, were also 
walking in and out of these situations. I stuck to observation only; although I was happy to 
check textbooks and write prescriptions as instructed I did not think it appropriate that I 
should start examining patients, except perhaps when the doctor insisted I felt a fever on 
someone. It was not that I thought I would do any harm or upset patients, but invariably 
patients appeared unable to refuse and it was an unnecessary coercion that was not of much 
benefit to my work.  
 
On the Lassa fever ward I was aware that my presence during active care giving could be a 
risk not only to myself but also to the staff and patients who were already in a high pressure 
situation. Unless I was invited to observe specific procedures by nursing staff, for example 
washing and decontaminating a corpse, I refrained from straying beyond the point at which 
protective clothing needed to worn and only nurses should go. There was a red line painted 
on the floor across the ward’s reception area to make this point clear, although it was faded. 
This ‘do not cross’ line was the dividing line between the open parts of the ward and the 
supposedly isolated parts of it where only nurses or patients should be; in practice, as later 
chapters show, it was more porous than the line and warning signs would suggest. My 
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observation of this safety line was not as detrimental to my research as it may sound because 
most of the diagnostic deliberations and decision making happened outside of the ward, or at 
its entrance. Doctors and nurses did not want to spend endless hours ‘gowned up’ in the 
tropical heat. In fact, the doctor did not always go on the ward and many times the patients 
were often not behind that red line themselves. One doctor joked with me that he did not need 
to go on the ward because the patients were all running around anyway; it certainly was not 
an isolation ward in the way I imagined one.  
 
A limitation of this research was that I was based very much at the heart of the centralised 
diagnostic system and so lacked perspectives from PHUs and other clinical contexts.  
Accompanying the outreach team was a helpful way of reaching these settings and involving 
myself with wider aspects of diagnosis. The outreach team would make visits to particular 
villages, clinics and hospitals for case investigation, sensitization and training. To supplement 
my ethnography at KGH I went on five outreach trips and visited eight PHUs. After 
familiarising myself with the services in various chiefdoms through these trips, I concentrated 
on two PHUs in particular: one in Tongo fields (a mining town) and one in Dodo town (near 
my village research site). I stayed in each town for a week in total, spending time at the clinics 
discussing their work and Lassa fever with the staff. Another site I spent time in was Panguma 
hospital which is the nearest major hospital to my research village and the source of many 
referrals to KGH. I stayed there for a day or two on trips to and from the village, for a week in 
total. I was able to discuss Lassa fever with the long serving local staff there and the European 
doctor who was in charge of medical treatments at the hospital. At Panguma I conducted three 
interviews: one with the European doctor and two with senior nurses, one in charge of 
outpatients and the other in charge of the children’s ward. These trips were important in 
widening my gaze past Kenema, in particular to the hospitals which are in the middle of the 
so-named ‘hyper-endemic’ Lassa fever area; they opened my eyes to the concerns of the 
actors who were not at the ‘centre’ (i.e. at KGH) of the diagnostic system, in particular how 
their perceptions of risk and distance were important. 
 
The clinical setting posed considerable challenges for collecting data. It was both varied and 
expansive. It was near impossible to feel ‘on top of’ activities at KGH, let alone at other PHUs 
and hospitals. The flows of patients and staff were too many to follow. A few more months 
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spent at KGH and other clinical settings would undoubtedly have made this part of the 
research stronger. 
3.2.6 Community 
My community level data comes mainly from one village which I will refer to by the 
pseudonym ‘Tokenga’ (my strategy for anonymising people and places is described in section 
3.3). This was the only place where I spent distinct blocks of time. There I focused on Lassa 
fever in the village’s wider healthcare landscape in order to determine how Lassa fever 
narratives and diagnostic practices were part of them. As with the clinic, I decided that the 
limited time I had was best spent getting to know the therapeutic landscape of one village in 
as much detail as possible. This was as an alternative to the increased breadth (but limited 
depth) which data collection across a number of villages and urban settings would have 
offered. As I explain, when delving into subjects like witchcraft and deaths from Lassa, it was 
beneficial to have built up some degree of relationship between myself and research 
participants. I did however make efforts to visit other villages and interview Lassa patient’s 
from other areas to add some generalizability to my ‘village’ findings. Tokenga is located in 
the Mende region of Sierra Leone. Figure 3 provides a basic map of ethnic and language 
groupings in Sierra Leone. Mende, a tonal language, is spoken in Mende regions. Krio, an 
English-based Creole originating from the area on the map marked Creole, is now widely 
spoken throughout Sierra Leone. In this part of my research I have made use of 
anthropological and ethnographic literature on Mende social life as a way of making up for the 
limited time I had for my ethnography. In the laboratory and around the hospital I could at 
least talk relatively freely with people in English, but this was not the case in Tokenga. I 
needed this anthropological literature to quickly get to grips with the rules and principles of 
this social setting. 
 
I saved the community level part of my research for later on in my fieldwork, in March, so that 
I had sufficient time to learn Krio and some basic Mende. When identifying a village my main 
requirement was to find one with recent experience of Lassa fever, as documented in records 
at KGH. There were also practical considerations such as availability of water, accommodation 
and someone able to speak English and translate.  
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      Figure 3 Ethnic and linguistic regions in Sierra Leone (CIA, 1969) 
 
  
I set off for Dodo chiefdom for a preliminary scoping trip as the chiefdom had suffered a 
significant number Lassa fever cases from the year before and also some of the earliest ones 
for 2010. I had been to the chiefdom headquarters, Dodo Town, with the outreach team and 
had already met with the nurse there so it seemed a good place to begin. I met with the 
paramount chief (ndᴐlᴐ maha) and stayed with a family in Dodo Town for a week during 
which I visited surrounding villages, with advice and assistance from the nurse and an English 
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speaking teacher. Most of these villages were very small and had no water supply except 
streams and some were without even basic pit latrines. Although I was rarely sick, I thought it 
would be unwise to base myself in one of these villages as I had a limited amount of time and 
could not afford to lose some if I fell ill. There was one village which the nurse told me about 
where a young woman had recently died of Lassa. It also had a water supply, latrines and a 
teacher who could speak English. This may have meant the village’s overall health was 
marginally better; however in terms of Lassa fever I came to learn that, anecdotally, Tokenga 
was perhaps worse than others.21 As Tokenga was a three hour walk from Dodo Town 
(estimated to be 6 miles away) my plan was to go and stay at least one night to see how it was. 
I ended up staying for 4 weeks and made two subsequent trips of 10 days (May 2010 ) and 2 
weeks (April 2011) totalling just under 2 months. Though this is considerably less time to 
spend in the village than in traditional ethnographies it must be seen in the context of a multi-
sited approach. Figure 4 shows a map of the area, with Dodo Town and an approximate 
location for Tokenga marked on it. Panguma, which has a hospital, is also shown. The whole 
area is considered to be in the ‘Lassa belt’.      
 
    Figure 4 Satellite image of Panguma, Dodo Town and village research site  
 
 
                                               
21 In addition, a Tulane PhD student studying rodent ecology trapped rodents in the village prior to my 
visit. Seroprevalence of Lassa virus was found to be high (unpublished data) amongst the host species, 
Mastomys natalensis (see chapter four).  
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Gaining trust and access required effort. When I first arrived in Tokenga I met with the village 
chief (ta maha), and the section chief (pati maha22) to explain and get approval for my 
research. A village meeting was called where I was introduced to ‘everyone’ and I explained 
what I was doing there: that I wanted to learn about life in the village and hear about their 
experiences with health and Lassa fever. The reception I was given was extremely welcoming. 
Being a puumͻi (white person) and a woman on my own, I was never going to fade into the 
background. To settle in I joined in village activities whenever possible: helping to prepare 
food, visiting people’s compounds and talking, preparing palm oil, going to farms and 
exploring with the children who followed me everywhere. I had to overcome the special 
status I was afforded as a white ‘stranger’ which at first meant I was not involved in everyday 
life: everything was done for me, I was discouraged from doing anything remotely arduous 
such as fetching water or even helping to help cut ‘greens’ (for instance the cassava leaf used 
to make a sauce in cooking) in case I cut myself. When I first arrived I was housed in the ‘best’ 
house in the village, a new and unoccupied house built on the edge of the village which meant 
I remained largely separated off from the routines of community life. I did not have long in the 
village and it was important that I overcame such barriers quickly. Not wanting to appear 
ungrateful, I asked if I could stay somewhere more integrated into the village. It was an on-
going process for me to convey to people that I did want to be involved in village life and that, 
despite my white skin which people assumed meant I was weak, I was strong enough and 
willing to participate.  
 
I moved to the household of a married couple, Vandi and Aminatta (also pseudonyms), and 
their children. Vandi was a teacher at the small school in the village. He spoke and read good 
English and could assist me with Mende translation. He was interested in my research and, 
having studied an ethnography of a Mende village which I brought with me, he understood my 
interest in social life. I could converse easily with Aminatta as she spoke Krio as well as 
Mende. Vandi’s family were from Tokenga originally, whereas Aminatta had only come there 
when she married Vandi. Both helped me enormously by acting as guides to Tokenga’s social, 
cultural and political life. One limitation is that I was very much aligned to this family, at least 
initially. However, as I had less time than is usual to carry out an ethnography, I depended on 
key informants a great deal and embedding myself in a family was a way to do this quickly. 
                                               
22 Chiefdoms are divided into sections which contain a number of villages. After the Paramount chief 
the next level in the chieftaincy hierarchy is the section chief, followed by the village chief. Tokenga was 
a section headquarter village so it had both a section chief and a village chief living there.   
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Fortunately Vandi and Aminatta were forthcoming and perceptive with their explanations and 
introductions to aspects of Tokenga and health. 
 
Though my initial reception had been positive there were both high expectations and 
suspicions to navigate throughout my stay. The expectations ranged from funding, marrying 
or taking people to England,  to issues to do with my research for instance that I could get a 
PHU set up in the village or that my work would “stop the Lassa”. In terms of suspicion, 
women seemed to be more guarded towards me. For instance, on a women’s fishing outing (to 
which I had been invited) I was questioned by some women as to what I was doing there. 
There were also rumours amongst some of the older women that I was an investigator or a 
reporter; the photos which I took (or was often ordered to take) and the notes I made aroused 
their suspicion. On both these fronts there was little I could do except carry on and be careful 
about when and where I took notes or photos. I also spoke again to those present at a village 
meeting to reiterate my reasons for being there. I was lucky to have members of the 
community who would vouch for me. I think in general I was regarded as a novel curiosity. 
The rare times that other puublaa (white people, plural of puumͻi) came they were generally 
attached to non-governmental organisations (NGOs), turning up in a 4x4 and staying only few 
hours. The fact that I stayed with a family, walked hours to get there, and visited other villages 
seemed to please people; but while my efforts may have been appreciated I think it also meant 
that I was seen as a bit of an anomaly who did not fit any of the usual categories associated 
with strangers (i.e. NGO worker, Lebanese23 or increasingly, Chinese) which could have been a 
reason for some of the suspicion.  
 
Language was a limiting factor. I could not speak Mende well and although my Krio was 
passable it was not spoken by everyone in Tokenga. I had a Practical Introduction to Mende 
(Innes, 1971) and a Mende-English Dictionary (Innes, 1969) to assist me and so was able to 
relate to key words and concepts, such as kᴐlɛ (fever) and hale (medicine, secret society, and 
in a broad sense an object with power to achieve certain ends with supernatural means). Men 
seemed to speak Krio more than women, perhaps a result of having travelled out of the village 
more, so I was able to converse with them more naturally. There were also a handful of men 
who could speak English and seemed to enjoy having an opportunity to speak it with me. I 
was conscious not to spend too much time only with men, because (aside from the gossip it 
                                               
23 There is a relatively large Lebanese community in Sierra Leone who are very active in the business 
and commercial sectors.   
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would create) women’s views would be underrepresented in my research. Over time I 
developed good relationships with women, spending time with them in their gardens24, farms, 
and kitchens. My relationship with Aminatta was also very important; we struck up a good 
friendship and she provided me a woman’s perspective, took me under her wing and 
introduced me to other women which helped overcome some of the initial suspicion.  I found 
that by interviewing local health practitioners and heads of households (see below), many of 
whom were women, I got to know key female members of the community in the process. I 
spent more time with the younger generation of women, helping to look after children or 
being ridiculed for my lack of hair braiding skills.  
 
Given that Lassa fever starts with non-specific symptoms to understand how it fitted in to 
rural framings of disease and healthcare practices my ethnographic focus could not be Lassa 
on its own. I had to engage with the broader therapeutic landscape in Tokenga. However, 
health and sickness was not something easily observed. Although it was common to see 
aspects of medicinal practice, such as discarded packets of western medicine or amulets worn 
around children’s waists and necks, the patterns behind these visuals were less obvious. I 
conducted informal conversations with as many people as I could. I found that asking about 
the medicines was a good way in to understanding health, for example asking people to point 
out leaves and barks as we walked or to go through the western medicines (i.e. a drug 
inventory) sold on the petty trade stall in the village. People would also come to talk to me and 
show me their ailments as they knew I was interested, sometimes in the hope I would have 
medicine for them. In doing so I had to navigate other social codes: I took a while to learn 
what kinds of things I could discuss openly, initially I could be hesitant to ask questions, 
worried about being rude or insensitive when there was no need whereas at other times I was 
more direct than I should have been. My questions about common illnesses, discreet or not, 
did get people discussing local health matters with me and while not comprehensive enough 
to be a full survey, it helped illuminate how people talked about sickness, and how diseases 
were labelled and dealt with. As my relationships strengthened with particular people, I was 
able to ask about more sensitive issues, such as witchcraft or specific cases of Lassa in the 
village.   
 
                                               
24 ‘Gardens’ were often separate to a family’s main rice farm. They were primarily the domain of 
women.  
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I conducted a number of key informant interviews: first, I did interviews with the male and 
female heads of Tokenga’s five25 households. These focused on health and sickness in general, 
but I did ask specifically about Lassa too. My plan to interview men and women separately did 
not work out and often other family members would join. It was difficult to control the 
environment for all of these interviews. However, the household interviews were largely 
exploratory and were also designed as a way of introducing me to the different households, 
which they did very well. Once I had settled in I conducted interviews with the actors whom I 
had identified as being most involved in healthcare and other relevant aspects of society (n=6) 
these were: the visiting drug peddler, the unofficial ‘nurse/pharmaceutical medicine 
dispenser, two elderly female herbalists, the ‘witch doctor’26 and the Imam. Unfortunately this 
did not include the traditional birth attendants (TBAs) who were important given so many of 
the recent cases had been pregnant women. There were two TBAs in the village and though I 
was able to discuss Lassa fever and the recent cases with them briefly, I did not get to 
interview them fully. One TBA was away for a good deal of my stay and the other, the main 
TBA, was either very busy or ill when the time came to talk. As several of the arrangements I 
had made with her were broken I suspect she may have been unwilling to talk with me. As 
with all my interactions and interviews, there were social codes including secret societies and 
secret knowledge which I had to be sensitive to. The TBAs will also have been officials in the 
female secret society which may have had something to do with why I was not able to speak 
with the main TBA.27  
 
I was mostly very cautious, perhaps more than I needed to be. However, I did get it obviously 
wrong on one occasion, with the man known as the ‘witchdoctor’. I was on good terms with 
this man and many people had told me about his abilities; thus I thought I was on safe ground 
to ask fairly direct questions in an interview. My tactlessness was clearly not appreciated and 
he closed up on the subject entirely. Thus a limitation of this thesis is that much of the more 
                                               
25 As the chapter will explain, Mende villages are often organised around long-established settler 
households. A household would traditionally have farmed together and would have been large in 
number. This explains why Tokenga, a village of approximately 500 people, is described as having only 
five households. 
26 This is someone who can ‘fight witch’. Healing specialists are described in chapter four and five. 
27 In Sierra Leone, and much of West Africa, the initiation of adolescents into male and female sodalities 
is common. In the region where this fieldwork was conducted the male society was known as the Poro 
and the female society as the Sande. The initiations and knowledge obtained from it are to be kept 
secret from the uninitiated. The societies are hierarchical, and initiates are differentiated by further 
layers of society knowledge and skill.  Childbirth is a strictly Sande domain and traditional midwives 
are Sande officials (Ferme, 2001, MacCormack, 1984).  The societies shall be described in more detail in 
chapter five.     
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secretive aspects of Mende healing remain a mystery. Probing to this level of practice would 
have required a far more extensive ethnography than is possible in a multi-sited approach. 
 
I also did 6 patient history interviews of victims of Lassa fever in Tokenga: two with survivors 
still living in the village (both men in their 40s, one contracted Lassa fever in 1997 the other 
reported falling sick a few years after the war had ended, in approximately 2005); and four 
with the kin of villagers who had died. Three of these had been pregnant women (one in 2007 
and two in 2009) and the fourth was a man who fell sick at the end of the war (in 2002). 
Recall bias could be an issue for all of these interviews, particularly for the less recent cases. 
Interviews with kin provided rich information as they had been closely involved in the 
patient’s care. In fact their memories are likely to be more reliable and complete than the 
patients themselves who often report being unconscious or in very disturbed states. This was 
a common problem I encountered in the patient interviews described below.  
 
A potential limitation in this setting is that I relied heavily on a few people as ‘gatekeepers’. 
The family I stayed with in particular introduced me to many aspects of their therapeutic 
world. Inevitably this was the trade off with a relatively short period of ethnographic research 
in a village where I could not speak the main language: I had to rely on some key informants. I 
did ensure that these key informants were not all from the same family, and I built up 
relationships with people in other parts of the village and from other households. Based on 
this, I am confident that I accessed the key principles and actors of Tokenga’s therapeutic 
landscape, although I cannot claim to be able to describe all of Tokenga’s inhabitant’s 
perspectives fully by any means. 
3.2.7 The wider system  
In recognition that a lot of diagnostic work went on in other health settings or villages outside 
of Kenema, particularly in the ‘Lassa belt’ I went on the aforementioned outreach trips. In 
addition, during my stay in Tokenga I visited surrounding villages, although many of these 
were smaller and tended to use Tokenga’s informal health providers. There was also the time 
I spent in Tongo Fields which is a mining town with a notoriously high Lassa fever incidence, 
and Dodo town.  
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In urban settings it was much harder to get to grips with the less centralised and official 
aspects of the diagnostic system. In the towns of Bo and Kenema for instance there were 
countless other providers competing with the government’s provision, including: pharmacies, 
laboratories, Chinese health centres, NGO clinics or small private hospitals, as well as the 
more traditional healers or and ‘drug peddlers’ and ‘pepper doctors’.28  Inevitably I missed out 
on the dynamics of much of this. To make up for this and in an effort to describe health 
seeking behaviours more generally I conducted interviews with ex-Lassa fever patients. In 
these I explored their experiences and perspectives on Lassa fever including a detailed 
account of their symptom and treatment history. In total I interviewed 23 people: 21 
confirmed positive Lassa fever cases and 2 suspect cases which proved negative. Sampling 
was purposeful, interviewees were selected from ward and laboratory records of people 
tested for Lassa fever since 2006. My original selection criteria had been: cases from 2008 
onwards (to reduce recall bias), over 18 years old and I had aimed to include an even balance 
of male and female. With the 2008 cut off I found it difficult to track down enough patients. 
When recruiting interviewees ground to a halt at 16 interviews I extended the date of onset to 
2006.  Sadly, there is of course a ‘survivor bias’ too. Given that late presentation is associated 
with high fatality this may mean that the evidence I have represents people who sought care 
sooner. I stopped these interviews at 23 when the views and experiences I was hearing began 
to form a (broadly) coherent picture. These interviews drew on the perspectives of people 
living in a range of environments and I spent a good deal of time clinging on to the back of 
motorbikes while journeying around Kenema district’s mud tracks, villages and police 
checkpoints to reach them. As well as people from rural subsistence farming communities like 
Tokenga, these interviews included those living in urban centres like Kenema, ex-refugee 
camps, established mining communities such as Tongo Fields as well as smaller mining-heavy 
villages.   
 
Finally I conducted interviews with WHO officials (n=2, one in Freetown and one in Geneva) 
and a senior official (n=1) in the MOHS’s Directorate of Disease Prevention and Control. These 
contributed valuable alternative institutional perspectives on Lassa fever and the diagnostics. 
Although I was able to have informal discussions with people in the MOHS, ideally I would 
have conducted more interviews. Indeed I did have further interviews set up at the end of my 
last stint of fieldwork but they were cancelled and unfortunately I did not have time to 
                                               
28 Both pejorative terms used to describe untrained people who deal in and treat people with, primarily 
Western, medicine.  
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rearrange them. It is shame that I do not have more data on the official perspectives within 
Government or the WHO. Unfortunately there is considerable tension between the partners 
involved in the MRU-LFN and the WHO is an increasingly distant partner. Getting ‘on the 
record’ interviews, and drawing a line between personal and institutional politics proved 
tricky. As a result, to an extent, the data presented here is de-politicised because 
disagreements and different perspectives could not be freely or fully explored. Equally, there 
are many clinical settings which are not included in my data collection. Observation of 
practice in additional peripheral or non-Government providers of health services across 
Sierra Leone would undoubtedly have strengthened the work, but it would have involved 
many more months of fieldwork to do well. 
3.2.8 Data processing 
As I described in the section on data collection, when I was in the field I made jottings 
throughout the day which I then wrote up into more extended notes. I tried to do this on the 
same day for depth and accuracy. Sharing a house with Tulane researchers in Kenema was a 
rich source of data as they would continue analysing, interpreting and discussing the day’s 
events in the laboratory over dinner and into the night; finding time to get it all written up 
was a challenge. However in Tokenga, once the sun had gone down I had plenty of time and 
space to sit with a torch and write. I wrote these notes up by hand or electronically depending 
on where I was and whether power was available, which it often was not. I ended up with 8 
notebooks as well as folders of word processed notes. In addition, I had 50 interview write 
ups. Many interviews involved numerous people, were translated from Mende or conducted 
in Krio. Given the number of people and languages involved, these were difficult to transcribe 
word for word, but they were written up in as much detail as possible with extended passages 
and quotes. Table 1 summarises the interview data. On top of this were the documents and 
photos I had collected.  
 
As I moved from site to site throughout the day my original jottings and field notes featured a 
mix of the day’s events from across the settings. Even though I was not consciously starting to 
analyse, data processing started in the field; it was evident in decisions over which activities 
to follow and how what I chose to write about developed. Field notes should be descriptive 
rather than attempts at analysis but to separate the two is misleading as the process is more 
one of “analysis-in-description’ (Emerson et al., 1995). Initially I described everything, sights 
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and sounds as well as all activity, but subconsciously I became more selective as time went on 
and concentrated on themes I was finding interesting. I also began to re-organise my notes 
when I was in the field, so for the word processed field notes I was able to copy and paste 
them in to distinct files for each site: ‘LAB’, ‘CLINIC’ and ‘VILLAGE’. ‘RESEARCH’ was merged in 
to ‘LAB’ once back home. My hand written notes had to wait until I was back in the UK where I 
scanned them all and then cut and paste the various pages in to the distinct files. These were 
ordered chronologically. Throughout fieldwork and once back home I kept files for thoughts 
and analytical ideas as well as some miscellaneous notes which did not fit into the distinct site 
notes, for instance those covering outreach trips.  
 
Table 1 Interview summary 
Interview Category Total (no. electronically recorded) 
Lassa histories Tokenga 6 (6)  
Lassa histories other (positive)  21 (19) 
Lassa histories other (negative) 2 (1) 
Tokenga’s healing practitioners 6 (4) 
Tokenga household general health interview  5 (5) 
Tulane  4 (3) 
Clinical (Panguma) 3 (3) 
WHO/MOHS 3 (1) 
Total 50 (42) 
 
As I had this combination of typed, hand written and, later, scanned notes I decided not to use 
qualitative research software for my analysis. I had a lot of handwritten notes which I thought 
would take an unnecessarily long time to word process. Instead, I printed out all my scanned 
and typed field notes along with interview write ups and documents I had collected, and 
worked on coding them by hand. In coding I tried to pursue member’s categories and 
meanings (Emerson et al., 1995) particularly those concerning disease, fever, medicine, 
healthcare options, to see how these were used and mapped on to what people actually did in 
diagnostic activity.  
 
My aim was to identify framings, practices and narratives in each setting. Practices were 
relatively straightforward. There were codified procedures used in the laboratory and some 
explicit rules surrounding medicine use. Observations of people performing routines also 
revealed tacit knowledge and differences in stipulated rules and actual practice. Accounts of 
sickness also revealed broad approaches to therapeutic practice. In my coding of 
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observational data I also used artefact, technique and regime as labels to explore the use and 
practice of technology in a way which suited my conceptual framework. I also used Stirling’s 
dimensions of incertitude matrix (figure 1) which I presented in the previous chapter to 
review my data. To identify framings I concentrated on a simple formula of questions, probing 
the who, what, where, when and how’s contained in my data which helped to illuminate 
values, problems, boundaries, expectations and uncertainties in the way people described 
Lassa fever and health. For instance was Lassa fever an old or new disease? Who would it 
effect and why? Identifying narratives, and making links between framings and narratives, 
was more of a leap. Some aspects of narratives were easy, as there was fictional and non-
fictional popular literature which spelled out particular stories very clearly. Others I have to 
piece together: for instance, in the next chapter I identify a ‘global threat’ narrative about 
Lassa fever. As well as the horror stories in the press and various books, this came from 
documents such as the WHO’s International Health Regulations (IHR) and the Integrated 
Disease Surveillance and Response (IDSR) which was developed by the WHO and adapted by 
the MOHS in Sierra Leone. When reading the IHR the ‘who’ was clearly not confined to West 
Africans. The ‘what’ was a break down in social and economic order precipitated by disease 
outbreak, hence the ‘global threat’ narrative. Piecing these narratives together had to be done 
by thematically arranging framings used by particular actors into a coherent storyline. During 
this process I began writing extended analytical notes, exploring relationships within my data, 
which became the basis for chapters. Writing my empirical chapters was an important 
continuation of the analytical process; the process of analysis, for me, kept going up until the 
final drafts. The whole process involved induction and deduction, re-interpretations and new 
juxtapositions which made new aspects of data seem significant right until the end.   
3.3 Ethics 
This work was approved after going through University of Sussex’s ethics procedures. It was 
also approved by Sierra Leone’s Ethics and Scientific Review Committee. In all of my 
ethnographic site locations I sought, and gained, appropriate consent and approval: from KGH 
hospital administration, the Kenema District Medical Officer, Panguma hospital 
administration, Tulane University and the traditional authorities in Dodo Chiefdom and 
Tokenga village. As well as official approval I sought individual permission from the key 
health care workers I would be working with, in particular the doctor responsible for Lassa 
fever and the head nurse on the Lassa fever ward. All interviewees were provided with 
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written or verbal information on my research and I made it clear that participation was not 
obligatory. As such, I collected verbal ‘informed consent’ from all interviewees and 
institutions involved.   
 
In reality both the ethics reviews and the collection of ‘informed consent’ can only go so far in 
preparing for and dealing with the ethical issues which arise during fieldwork. Each site 
presented different challenges and I have indicated some of these issues in the preceding 
pages. Avoiding negative consequences of being involved in my research was paramount. I 
have outlined how my actions in the field dealt with this but once back in the UK and writing 
new challenges arose. The anonymity I had promised in interviews was difficult for some 
sources. The Lassa fever research world is very small and Kenema even smaller thus my 
reporting of activities there could be identifiable. This was more of a problem than in the 
village where people and places can be easily anonymised. However, the clinic and laboratory 
are also in a position to be more understanding of what being involved with my research 
could entail and this kind of implication. I did make my intentions to write up what I was 
seeing and being told clear at every step. With them ‘informed consent’ was more meaningful 
than it was in Tokenga and other communities. Also, some of the developments I discuss in 
this research have been the subject of published scientific papers by the researchers 
themselves already so my work does not pose any heightened risk of ‘exposure’ for them. 
 
With regards to anonymity, I have referred to well-known places or organisations, such as 
Kenema, Tulane or Panguma, by their real names as it would be confusing not to; I use a 
pseudonym, Tokenga, for my village site. I also use pseudonyms for people in the village (such 
as the family I stayed with or the people I interviewed) whose stories I tell in detail. None of 
these people indicated that they were concerned about their anonymity but I am working on 
the principle that it is best to be cautious. For interviews with patients, Tulane or clinical staff 
I distinguish them by category, for example: ‘Tulane laboratory scientist’. As discussed some 
of these categories may be revealing as the Lassa fever world is small.  All interviews are 
referenced by a footnote containing their pseudonym or category along with a place and date. 
Appendix 1 has a record of all the interviews including details of how they are referenced in 
the text.   
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The level of consent, motivation, expectation and effort that was involved or required of 
people when partaking in my research varied. What people would have to put in and what 
they might get out was always a fine balance. Although I had access to patient’s records, in an 
effort to satisfy the kind of privacy and ethics requirements in UK healthcare research I had 
enrolled members of the nursing staff and outreach team who already had contact with these 
patients to approach interviewees first, using my sampling criteria. However, sometimes I 
found patients to be under the impression that they were required to talk with me, so when 
explaining why I wanted to interview them, I made it very clear that they did not have to talk 
to me to avoid coercion. After interviewing patients, but without their prior knowledge, I 
offered them a small cash gift for their time because I was conscious that this research was 
not going to be directly beneficial to them but that, in very poor communities, even a small 
amount of extra cash would be. Elsewhere, in the end, I tried to simply treat everyone one 
with respect, and to be aware of what was expected or appropriate for the context. My 
worries about getting too close I realised were largely irrelevant. Of course I would get close 
to people and that was the point. I could not give people everything they may have hoped, or 
stopped Lassa, but I could be a respectful ‘stranger’ who would keep up connections forged in 
the field. In Tokenga I was able to assist with one of their aspirations. The community had 
been campaigning to get a nurse instated in their village but had been told that they first 
needed to build an appropriate building to house the nurse and the clinic. On my return trip in 
2011 I was able to give donations from family and friends to use for building this clinic.29   
 
Feedback to participants cannot be symmetrical. I have no current plans to return to Tokenga 
and the feasibility of sending a hard copy of my thesis to them is limited (many people are 
unable to read and there is no postal service in that area). I was able to relay my initial 
findings to villagers in Tokenga on the return trip I made in 2011 and little has changed since 
then. After examination, I will email copies to participants from Tulane, KGH and where 
possible other interviewees.   
                                               
29 The villagers had also been told that there was a freeze on opening new clinics in Kenema district 
because it had a higher number of clinics than other districts; they remained hopeful because they were 
told that a nurse could be officially registered in an existing clinic but in practice be based in their 
village – in a building they would have to provide independently. Although I was told the same story by 
a district official in Kenema, I was not convinced that a nurse would be sent. In that case, rather than 
having built a building for nothing it was suggested that the building could be used for the school which 
was in poor repair (and has since fallen down). It is my understanding that the building is currently 
being used as a school, but the campaign for a nurse is still on-going.   
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3.4 Conclusion 
In this chapter I have made the case that context specific processes are central to the use and 
impact of new and old diagnostics. To understand some of these context-specific processes I 
have conducted a multi-sited ethnographic study of Lassa fever diagnosis. I chose three sites, a 
village, KGH and the Lassa laboratory, to explore aspects and intersections within the 
diagnostic system. I have detailed how, with some limitations concerning time and language, I 
was able to collect interview and observational data from each of these settings. I also 
described how I have organised and analysed this data. In the next chapter I will present the 
framings and narratives about Lassa fever and diagnosis which I have identified and I will 
introduce the research sites in more detail.   
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4 System Context:  narratives of emergence and response 
I start this chapter with some background on Lassa fever in Sierra Leone. Although brief, this 
provides context to the policy narratives which have developed around the disease and which 
are the focus of this chapter.30 Three prominent narratives about Lassa fever can be identified. 
They each put a different slant on the virus’s emergence and control by framing the risks, 
origins and scope of the disease in different ways. As outlined in chapter two, by framing I 
refer to partial and differential interpretations of the world and its contents (Jasanoff, 2005, 
Schon and Rein, 1994). Diseases are understood as complex systems, involve interlocking 
social, technical, cultural, political, economic, ecological and biological dynamics, which can be 
framed differently (Leach et al., 2010). By narratives I refer to the piecing together of certain 
framings into persuasive, but ultimately unbalanced, stories (Roe, 1994, Wald, 2008) which 
find traction in particular institutions or communities. In the first narrative Lassa fever is 
articulated as a global threat which could escape traditional boundaries and wreak havoc 
internationally; in the second it is an endemic problem confined to a few countries in West 
Africa and linked to risky local practices; in the third it is a neglected disease, overlooked by 
global health actors. These narrative storylines have different beginnings but they converge 
towards the same ending: that the problems Lassa fever presents can be effectively addressed 
by science and technology. Once these narratives have been mapped out I describe how their 
convergence around the promise of science and technology has resulted in a push for 
improved diagnostics and standardised protocols for the surveillance, referral and treatment 
of Lassa fever. I then describe how this kind of approach is taking shape in Sierra Leone by 
examining formal protocols and policy documents. A version of the diagnostic system as it 
was planned and envisaged as working is outlined. However, I suggest that the reliance on 
diagnostics, protocols and algorithms reveals a narrow and optimistic view of disease control 
and, as later chapters in this thesis demonstrate, an idealised view of how such technologies 
work in practice. As an entry point for exploring these issues, I point to some aspects of Lassa 
fever which have been overlooked and which are not adequately represented in the 
formalised conceptualisations of the diagnostic system. These are the longer term dynamics of 
Lassa fever and Lassa fever as part of everyday practice. I then introduce the health care 
context in more detail and conclude this chapter by introducing the sites in which I have 
                                               
30 For an up to date comprehensive review see Bausch et al. (forthcoming, 2013) 
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chosen to explore these alternative framings and practices within the diagnostic system: a 
village, Kenema Government Hospital (KGH) and the Lassa laboratory. 
4.1 Disease dynamics    
The following background information is gleaned from scientific and policy literature and so it 
represents a particular, inherently biomedical, view of the disease. A quick foray into the 
scientific literature on Lassa fever shows that there are more questions than there are 
answers and that this sense of the unknown feeds into some of the narratives which are 
identified in this chapter. In later chapters the perspectives of those living and working close 
to the disease are explored as a means of adding to, and contextualising, this biomedical view.  
 
Lassa fever is a zoonotic31 disease caused by the Lassa virus, a member of the Arenaviridae 
family of viruses (Ogbu et al., 2007). It can cause a viral haemorrhagic fever in humans. Lassa 
fever was first identified in 1969 after missionary nurses working in the town of Lassa, 
Nigeria, became infected (Frame et al., 1970), although it is likely that the virus and disease 
had been around for some time before that (Monath, 1975). After the 1969 Nigerian outbreak, 
the reservoir host for Lassa virus was found to be the rodent Mastomys natalensis, identified 
during a subsequent outbreak in Tongo and Panguma (both are near my village research site), 
Sierra Leone, in 1972 (Monath et al., 1974). Exact transmission routes are unclear but 
evidence suggests the Lassa virus is transmitted from its rodent host to humans through 
contact with rodent bodily fluids, either through direct (e.g. from butchering of rodents) (Ter 
Meulen et al., 1996) or indirect (e.g. urine contaminated food or water) (Walker et al., 1975) 
pathways. The virus can then be passed from human to human by contact with infected bodily 
fluid (blood, vomit, urine, semen) making nosocomial outbreaks (e.g. in a health setting) 
common (Carey et al., 1972, Monath et al., 1973). There is some limited evidence of aerosol 
transmission, though it appears this is not a major transmission route (Borio et al., 2002, 
Carey et al., 1972, Stephenson et al., 1984). 
 
The effect of infection with Lassa virus appears to vary considerably in humans with some 
people experiencing mild or no symptoms while others experience severe and fatal effects 
including haemorrhaging, multi-organ failure and shock (Khan et al., 2008, McCormick et al., 
1987a). The reasons behind disparities in disease severity and the proportion of symptomatic 
                                               
31 Zoonotic disease are those which have an animal host from which it transfers to cause disease in 
humans. 
88 
 
to asymptomatic cases are not known; differences may be to do with dose of infection, co-
morbid conditions, genetics (Khan et al., 2008), misclassification or virulence of the virus 
strain (Bausch et al., forthcoming, 2014). Incubation period for Lassa fever is approximately 
10 days (but can range between 3 and 21 days) and in symptomatic clinical cases the disease 
is recorded as progressing as follows:  
 
- Early symptoms: gradual onset of intermittent fever, headache, anorexia, malaise and 
weakness. 
- Later symptoms: sore throat, retrosternal pain, tinnitus, conjunctival infection, nausea 
and vomiting, myalgia (muscle pain), lumbosacral pain (in lower spine), abdominal 
pain, tenderness, diarrhoea, occasionally a dry cough. In fair-skinned patients a 
reddish flat (maculopapular) rash is sometimes visible on the thorax, face and arms. 
- Severe late stage symptoms: after 4-7 days some patients suffer severe vascular 
instability which can manifest as edema (swelling) of the face and neck, bleeding, 
hypotension (low blood pressure), shock and proteinuria (an excess of serum 
proteins in the urine). Bleeding occurs in approximately 20% of clinical cases. 
Patients’ central nervous system can also be affected, resulting in disorientation, 
convulsions and coma. Figure 5 shows photographs of Lassa fever symptoms.  
- Death: death may occur 10-20 days after the onset of symptoms. Poor prognosis is 
associated with those severe symptoms listed above and also with high levels of 
virus. The case fatality rate for hospitalised cases ranges from 15% to 50% (figures 
from unpublished data from KGH, see Moses et al., 2012), 20% has been suggested as 
a good estimate for hospital cases, and under 5% for all infections including mild and 
asymptomatic ones. Pregnant women are especially vulnerable. Maternal and foetal 
mortality rate have been reported as approximately 90% in the third trimester 
(though this has not been a consistent finding).  
- Sensorineural (from the inner ear) deafness has been reported in survivors. This has 
been reported as affecting as many as 25% of patients, but this increasingly looks like 
an overestimate  
 
(For more details see Bausch et al., 2001, Bausch et al., forthcoming, 2014, Branco et al., 
2011a, Cummins, 1990, Frame et al., 1970, Khan et al., 2008, McCormick et al., 1987a, Price et 
al., 1988) 
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            Figure 5 Pictures of Lassa fever symptoms (from Khan et al., 2008) 
 
 
Treatment for symptomatic Lassa fever is with the broad spectrum anti-viral Ribavirin which 
is administered intravenously for 10 days. The effectiveness of Ribavirin is greater if 
administered early: it has been shown to decrease mortality (from 55 to 5%, though that is 
with dubious diagnostics) if begun in the first 6 days of illness (McCormick et al., 1986). This 
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makes early diagnosis critical, however due to the initial non-specificity of Lassa fever 
symptoms, this is often difficult to achieve. Ribavirin can have some unpleasant temporary 
side effects (such as nausea and vomiting), but they are not usually severe or long lasting. 
However, it can cause anaemia (Bausch et al., forthcoming, 2014, Khan et al., 2008) which 
although not normally serious, in the Sierra Leonean context is can be, as levels of anaemia 
are often already high and treatment is not as available as it is elsewhere. Ribavirin has also 
been demonstrated to cause foetal loss and malformation in laboratory animals which would 
usually rule it out as a treatment for pregnant women. However due to the high maternal and 
foetal mortality rates for pregnant women infected with Lassa fever the advice has been to 
treat anyway (Bausch et al., forthcoming, 2014). For these reasons, in addition to possible 
psychological trauma associated with isolating and treating patients for Lassa fever, decisions 
over administering Ribavirin can be complicated, especially when the diagnosis is not certain. 
 
There are four recognised strains of Lassa virus, three in Nigeria and one in Sierra Leone, 
Guinea and Liberia; on top of which there is considerable genetic heterogeneity within strains 
(Bowen et al., 2000). The burden and spread of Lassa fever in West Africa has long been a 
puzzle: the disease appears concentrated in Sierra Leone, Guinea, Liberia and Nigeria but not 
(or much less) in the countries surrounding and in between them. Estimated annual infections 
range from 100,000-300,000 with as many as 5,000 deaths (McCormick et al., 1987b) to as 
many as 3 million new infections a year, and 67,000 deaths (Richmond and Baglole, 2003). 
Fichet-Calvet and Rogers (2009) compiled evidence of  human and rodent Lassa fever 
between 1952 and 2007, combined it with climatological factors (rainfall, vegetation, 
temperature), to produce a risk map of Lassa distribution in West Africa. Their maps (one of 
which is shown in figure 6) suggest a much wider distribution of Lassa fever (up to 80% of 
Sierra Leone) than is commonly reported or recorded. There are doubts over the quality of 
the diagnostics, research methods or surveillance coverage, thus the picture of Lassa fever in 
West Africa remains unclear (Bausch et al., forthcoming, 2014). In 2011 Nigeria experienced 
what appeared to be a particularly extensive epidemic of Lassa fever: by the 6th July 2012, a 
total of 933 suspected Lassa fever cases were reported with 147 laboratory confirmed and 93 
deaths. Out of the 26 states in Nigeria, 23 reported cases, many for the first time (ProMED, 
2012, WHO, 2012b). How to interpret these developments cuts to the core of the above 
debates; questions have been raised about whether the observed epidemic in Nigeria is an 
expansion of Lassa fever or whether it is a sign that improved diagnostics are in place. It was 
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suggested at a workshop I attended that the cases in Nigeria could be an “epidemic of 
detection”.32 
 
         Figure 6 Risk map of Lassa fever (Fichet-Calvet and Rogers, 2009) 
 
 
Mastomys natalensis, is found throughout Sub-Saharan Africa but as yet Lassa virus has not 
been identified in Mastomys rodents found outside of West Africa (Ogbu et al., 2007). The 
reasons for this are unknown. The rodents are prolific breeders but it is unclear if the virus 
passes between them vertically or horizontally. M. natalensis has been described as ‘peri-
domestic’ (Moses et al., 2012). They are burrowing rodents and are found in close association 
with humans, often in homes and agriculturally cultivated fields close to rural villages. They 
have been trapped in high numbers (up to 50% relative to other species) in homes 
(McCormick et al., 1987b). Housing construction can influence abundance and dirt floors have 
been associated with higher M. natalensis presence (Bonner et al., 2007). It is likely that dirt 
floors provide opportunities for burrowing. The relationship(s) between LASV, rodent 
                                               
32 The workshop was for the Dynamic Drivers of Disease in Africa Consortium (DDDAC) and was held at 
the Institute of Development Studies in June 2012. Lassa fever is one of the consortium’s case studies. 
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populations, habitat, and biodiversity across village-farm-bush landscapes is an area of on-
going research (Moses et al., 2012). 
 
More cases of Lassa fever are reported in the dry season. Seasonal fluctuations may be due to 
the stability of the virus in different temperatures and humidity linked to rainfall, and ebbs 
and flows in infected rodent populations (Fichet-Calvet et al., 2007, Fichet-Calvet and Rogers, 
2009). Factors such as access to roads during the rains, agricultural duties and lack of funds in 
conjunction with harvesting patterns have been suggested (Bausch et al., forthcoming, 2014) 
but these are unexplored hypothesises. Moreover they relate to accessing care, not exposure. 
Consumption of rodents is suggested as a risk factor for infection (Ter Meulen et al., 1996). 
There has been almost no research looking at socio-economic or ecological trends which may 
drive exposure, for instance seasonal agricultural practices. There are important questions 
about changes to farming and grain storage practices in communities, perhaps linked to 
longer term shifts in social and agricultural traditions (some of which are described in chapter 
five). Other questions concern the impact of the civil war and socio-economic influences such 
as trends towards large scale agriculture or mining activity. 
 
As the above discussion makes clear, there are a lot of unanswered questions about Lassa 
fever. It is clearly endemic to some areas but what is the scale of the problem in West Africa? 
Does it pose expanded epidemic threats, and to whom? Are local cultural practices at the root 
of transmission or might longer term socioeconomic and environmental changes be driving it? 
Issues of diagnosis run through the entire disease system. By their design diagnostic 
technologies represent particular framings of Lassa fever but they can also become part of 
framings and narrative. This is exemplified in the recent article which asked whether Lassa 
was really an emerging disease or if it was a case of “emerging diagnoses” (Gire et al., 2012).  
4.2 Narratives of Lassa fever  
The three narratives described here present alternate views of Lassa fever’s emergence and 
approaches to its control. They are not, however, mutually exclusive, indeed they co-exist and 
overlap. At different times they are promoted by scientists, and organisations such as the 
Centers for Disease Control and Prevention (CDC) or the World Health Organisation (WHO). 
They are evident in scientific papers and policy documents produced by these organisations. 
For some of these narratives it is possible to make links between framings of the disease and 
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strategic attempts to level resources. However, these narratives are not confined to health and 
science policy circles, as I will try to indicate, they are also widespread in popular perceptions.  
4.2.1 An emerging global threat 
This narrative casts Lassa fever in a similar light to other much hyped VHFs like Marburg or 
Ebola despite some important differences between them. The story goes they have emerged 
recently and usually in Africa, but now have the potential to threaten large populations on a 
global scale. The risks of a newly emerged disease such as Lassa fever are increased by the 
trappings of modern life, with air travel and globalisation meaning we are increasingly 
connected. This narrative calls for responses to these increased threats which are based on 
extraordinary measures and rely on technologies to protect (usually rich and so previously 
well protected) populations. The global threat narrative is evident in the policy discourse of 
Northern Governments and International Organisations involved in the governance of global 
health. It is found in WHO policy documents such as the International Health Regulations 
(IHRs), in biosafety classifications, and in US biodefense funding priorities.  
 
An outbreak narrative (Wald, 2008) is pursued: at first mysterious infections beginning in 
distant lands but moving to Northern populations, making use of modern day transmission 
routes such as planes or deliberate acts of terrorism, to cause economic costs and break down 
in social order. This was basically the plot of the 2011 Hollywood film ‘Contagion’. Risks are 
framed as international, transcending normal geographical boundaries. They are also 
economic. The threats are great because there is no vaccine for Lassa fever, and treatment and 
diagnostics are not widespread and readily available. This perspective has been 
institutionalised by Lassa fever’s inclusion on the WHO list of ‘priority epidemic prone’ 
diseases which in certain circumstances merit notification under the IHRs (MOHS, 2008). The 
staff in Geneva who are responsible for overseeing the WHO’s work on Lassa fever are based 
in the Global Alert and Response (GAR) programme which is responsible for assisting member 
states to develop national capacity for epidemic preparedness. Epidemic preparedness 
involves implementing the IHRs, strengthening biosecurity and developing standardized 
responses to epidemic prone diseases. As well as carrying the weight of some of the more 
draconian aspects of the IHRs, Lassa fever is classified as a biosafety level 4 (BSL-4) pathogen. 
This requires samples containing the virus to be kept in high security environments to avoid 
any such outbreaks. Level 4, the highest biosafety level, “is used for the diagnosis of exotic 
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agents that pose a high risk of life-threatening disease, which may be transmitted by the 
aerosol route and for which there is no vaccine or therapy” (CDC, 2012c). After reviewing 
records of ‘imported cases’ (i.e. cases exported from West African endemic regions to 
anywhere else worldwide) a recent article noted “LASV is arguably the most prevalent 
Biosafety Level four agent and a prominent threat to human health worldwide” (Sogoba et al., 
2012, p43). 
 
Despite an initially relaxed approach to working with Lassa or similar pathogens when they 
were first discovered (Fuller, 1974), biosafety has become more of a concern. Although not 
legally binding, biosafety norms are now institutionally embedded and have significant impact 
on where, and by whom, Lassa fever can be handled. One side effect is that this makes 
research much harder to carry out in the places where the disease affects people the most. 
High containment facilities are few and far between in places like Sierra Leone. The framing of 
Lassa virus as a pathogen of international concern, necessitating high levels of control, opens 
up disjunctures between the local conditions of the disease and the global ‘potential’ ones. A 
further disjuncture can be seen in the ‘securitization’ (Elbe, 2010) of Lassa fever which 
reached a height after the 9/11 terrorist attacks in 2001. Lassa virus was assessed for its 
possible use as a bioterrorist agent (Borio et al., 2002) and is now categorised as a ‘Category A 
agent’. Category A is the highest risk level (of three) in the CDC’s classification of ‘select 
agents’ with potential use in bioterrorism on account of their ability to spread easily and to 
cause major public health impacts, including high mortality (CDC, 2012a).33 As such, Lassa 
virus has clearly been framed as a US national security threat which has opened up new, but 
limited in important respects, research funding possibilities which I explore in chapter 5. The 
hybrid global threat-security narrative has also been applied within Sierra Leone but referring 
to UN peacekeepers (Ter Meulen et al., 2001).  
 
With Lassa fever there seems also to be an accompanying sub-story of brave Westerners 
tackling dangerous diseases in exotic places, for instance one article described Tulane’s 
Kenema operations as a “U.S. anti-terror outpost” (Akam, 2011).  While this article was felt by 
some Tulane scientists to be inaccurate and unhelpful, other scientists involved in Lassa fever 
research over the years have played on this narrative themselves. Two early CDC researchers 
build the hype with their book “Level 4: virus hunters of the CDC” (McCormick et al., 1999). 
                                               
33 Other category A agents are: Anthrax, Botulism, Plague, Smallpox, Tularemia, Viral haemorrhagic 
fevers, which includes Lassa along with others like Ebola, Marburg and Machupo. 
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Another was a young North American doctor who came to work at the Kenema Lassa fever 
ward for a few months, writing a book with the excruciating title “The Lassa Ward: one man’s 
fight against one of the world’s deadliest diseases” (Donaldson, 2009). This is especially 
inappropriate as he had worked with Dr Aniru Conteh who, by all accounts would have been 
far more deserving of that title, having devoted 25 years of his life to caring for patients on the 
Lassa ward and who died in 2004 from Lassa fever after a needle-stick injury (Bausch et al., 
2004).  
 
Overall, the core dynamics in this global threat narrative are to do with flow of pathogens and 
interlocking modern conditions such as geopolitics, mobile people, and in the IHR the 
economic costs of disruption. The framing of Lassa virus as a highly infectious pathogen with 
an international reach invites responses based on high security, high containment and 
extraordinary policy interventions, all of which are based on the ability to detect the virus 
rapidly and accurately. In the following sections I show how this has meant that the 
development of biotechnology-based countermeasures has been prioritised. 
4.2.2 An endemic disease caused by risky local practices  
The second narrative emphasises the endemic West African aspects of the disease which 
contrasts with the global threat narrative. In this narrative Lassa fever is the result of a toxic 
mix of local traditions and the failure of development, the combination of which poses 
persistent threats to populations in an apparently miserable and disease ridden part of the 
world. As with the first narrative, transmission routes are important but in this telling the 
mechanics are local and related to certain ‘African’ conditions (i.e. overcrowding, poor 
hygiene at homes and hospitals) and cultural practices (i.e. traditional funerals, eating 
rodents), which are perceived to be the key drivers of disease. Agency and blame are 
attributed narrowly onto people’s behaviour as opposed to broader socio-economic dynamics. 
Consequently, prevention is focused on knowledge deficit and behaviour change models.   
 
The underlying framing of Lassa fever is of a disease with a local scope rather than an 
international one. It locates the risks factors associated with Lassa fever to be confined to 
practices and conditions in West Africa, or more specifically to the conventional endemic and 
‘hyper-endemic’ zones within Nigeria, Sierra Leone, Guinea and Liberia. The limited number 
of cases exported out of these regions (29 in total) is evidence of the localised nature of risk 
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(Sogoba et al., 2012). Within these endemic regions, there is expectation and acceptance of 
some degree of morbidity. The response is to build surveillance systems to monitor it. In 
Sierra Leone, the spatial variations in incidence which are underscored by notions of endemic 
and hyper-endemic areas have justified responsive surveillance activities in those areas. An 
‘outreach team’ operates out of KGH, responding to confirmed cases by tracing their contacts. 
These surveillance activities work by defining and then covering areas where it is usual to 
expect Lassa fever. Yet ideas of prevalence in these areas may be an artefact of the increased 
surveillance in those areas. Nevertheless, distinctions based on these divisions between 
normal and unusual have important consequences: the International Health Regulation’s 
‘decision instrument’ asks, for a subset of diseases including Lassa fever, whether a case or 
cluster of cases is “unusual or unexpected” (WHO, 2005). Clearly, there is a degree of 
tolerance of Lassa fever in this framing. The PHUs in Eastern Sierra Leone still have old health 
promotion posters (see figure 7), from when non-governmental organisations were involved 
in Lassa activities, advising of the best strategies to minimise the risk of infection.  
 
                 Figure 7 Lassa fever health promotion poster 
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The scientific literature has some possible explanations for the problem of Lassa in these 
regions. These are focused on exposure to the rodent host. However, scholars have pointed 
out the specific pathogen based transmission routes can easily acquire moral and cultural 
‘textures’ (Rosenberg, 2002, Treichler, 1999). In this way local traditions and cultures are 
often blamed. One paper identified the following practices as problematic in Nigeria: “rat meat 
as a source of protein”; “traditional autopsy”; “forceful ingestion of water used in bathing a 
dead husband, by a widow suspected to be involved in his death”; and “corrupt practices by 
staple food producers which involve drying garri (cassava flour) in the open air” 
(Inegbenebor et al., 2010 p54). 
 
In Sierra Leone there has been some sensationalisation of the consumption of rats. A cluster of 
cases in 2011 was rumoured (inaccurately) in the press as being linked to a woman running a 
“rat meat restaurant” (Bausch, 2010). Poor hygiene is blamed, for example Nigeria’s health 
minister was quoted as saying: “The spread of the recent scourge of Lassa fever in a number of 
communities in different parts of the country was as a result of poor personal hygiene” 
(Okafor, 2012). Even the breakdown of sanitation since colonialism has been blamed in the 
Nigerian press (Joseph, 2011). In the scientific literature ‘poor housing quality’, ‘rodent 
infestation’, ‘poor external hygiene’ (Bonner et al., 2007) and the sanitation of communities 
(Yalley-Ogunro et al., 1984) were assessed and found to be associated with rodent presence 
and of Lassa virus prevalence.  
 
Accordingly, understandings of Lassa susceptibility on the narrow terms of rat consumption 
or poor personal and community hygiene mean that accompanying health promotion 
activities are narrow. In a top-down approach to public health, both the CDC and WHO suggest 
rodent control as the main prevention method. From the WHO the message is: 
 
“Prevention of Lassa fever in the community centers on promoting good “community hygiene” to 
discourage rodents from entering homes. Effective measures include storing grain and other 
foodstuffs in rodent-proof containers, disposing of garbage far from the home, maintaining clean 
households and keeping cats. Because Mastomys are so abundant in endemic areas, it is not 
possible to completely eliminate them from the environment” (WHO, 2012a). 
 
Advice from the CDC is similar: 
 
“Putting food away in rodent-proof containers and keeping the home clean help to discourage 
rodents from entering homes. Using these rodents as a food source is not recommended. 
Trapping in and around homes can help reduce rodent populations. However, the wide 
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distribution of Mastomys in Africa makes complete control of this rodent reservoir impractical” 
(CDC, 2012b).  
 
The fact that both admit that complete rodent control is unfeasible is telling in itself (although 
figure 8 shows keeping a cat can be effective). The disease prevention recommendations 
effectively individualise the risk of infection and responsibility for avoiding Lassa fever. 
However, truly effective rodent control is likely to require a community effort, if some 
households do not implement rodent control, or the rubbish tip is not moved further from the 
houses, then rodents will continue to be attracted to a village. Furthermore, what these 
recommendations do not address is that there may be external factors influencing rodent 
populations nearby which communities cannot control such as commercial farming or 
diamond mining. Aside from behaviour change, the response strategy in this narrative hinges 
on local surveillance and prompt diagnosis. As before, this approach to disease control hinges 
on technology and protocols which can monitor, and hopefully contain, the disease in areas 
where it is expected. It also relies on an individual’s assumed agency to protect themselves 
and seek treatment appropriately if sick.     
 
        Figure 8 Cat eating a captured rodent, probably not M. natalensis 
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4.2.3 A neglected zoonotic disease ready for a scientific solution   
This last narrative about Lassa fever has emerged more recently. It blends a critical 
assessment of the global politics of disease, namely that diseases which affect poorer 
countries in the South are neglected as they do not affect populations in the North who 
control most resources, with the perception that if investments are made in particular 
technologies then such diseases can be quickly subjugated. As such it follows a logic which 
has proved successful in securing funding and action on neglected tropical diseases (NTD) 
elsewhere (Allen and Parker, 2011), although there are some key differences as I point out 
below.  
 
The story line in this narrative is that despite the hype that surrounds Lassa fever and other 
VHFs, Lassa fever has actually been the subject of little research, particularly in relation to 
treatment (Khan et al., 2008) and there have been almost no public health or prevention 
interventions. Indeed, it has been described as an “unheralded problem” (Birmingham and 
Kenyon, 2001) and the “poster child of neglected diseases” (Donaldson, 2009). The continued 
but overlooked scourge of Lassa fever is a popular theme in the press especially when an 
outbreak occurs. Within Sierra Leone, the blame is put at the Government’s feet. After the 
death of Dr Conteh one journalist wrote:  
 
“Would it not have been timely and appropriate for the Minister of Health for instance to cry out 
loud for the world to hear that heavily indebted poor country Sierra Leone also has Lassa Fever 
which is killing her children with reckless abandon? Would it not have been wise for some smart 
parliamentarians to capture the world's attention that while HIV/AIDS takes years to sentence 
somebody to death, the Lassa Fever virus is ruthlessly doing so in just few weeks? Or is it that 
Lassa fever does not matter? Or are we waiting for more people to die?” (Momodu, 2004, no 
page). 
 
This narrative finds evidence from the patchy history of Lassa fever operations in Sierra 
Leone. After the 1972 outbreaks in Sierra Leone, the CDC set up research stations in 
Segbwema, Kenema and Panguma (shown in figure 9). The main treatment program was 
based in Segbwema at the Nixon Memorial mission hospital (Bausch et al., 2004, McCormick 
et al., 1999). In 1991, due to the outbreak of war which spilled over the Liberian border not 
far from Segbwema, Lassa activities moved from Segbwema to Kenema where they remain, 
despite it being outside of the hyper-endemic ‘Lassa belt’. However, due to civil instability the 
CDC programme pulled out of Sierra Leone in 1993, and it was not until 1996, in the wake of 
a steep rise in Lassa cases, that the British aid organisation Merlin took the reins by providing 
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limited public health and treatment but not laboratory support (Khan et al., 2008). Merlin 
departed in 2004 and for a period there was no dedicated Lassa fever programme. This 
history is one of dependency on external actors who are liable to exit when priorities change, 
or when circumstance such as war make work too difficult 
 
    Figure 9 The hospital at Panguma  
 
 
As with other NTDs, this narrative has promoted technological solutions. But what is 
particular about Lassa fever is that the neglect is now being framed largely in terms of lack of 
research, and the discourse about poverty which has been persuasive elsewhere is less visible 
(Allen and Parker, 2011, Parker et al., 2008). Lack of basic research, due to long term 
programmes being stymied by war and instability, means that not enough progress has been 
made with diagnostics, drugs and vaccines (Khan et al., 2008). Here the three narratives 
converge around a scientific approach to disease control which hinges on establishing reliable 
diagnostics. In particular, the convergence with the global threat narrative means that 
resources can be made available to address the neglect. As I will now describe, the potential 
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biosecurity threat posed by Lassa fever has meant that particular actors have come to control 
the disease control agenda by being able to leverage resources most effectively.   
 
In 2004, heavy Lassa outbreaks drew renewed attention. With stability seemingly returned to 
Sierra Leone and Liberia, international partners came to together in recognition of the need 
to direct resources towards Lassa fever. The Mano River Union Lassa Fever Network (MRU-
LFN) was formed including Mano River Union (MRU) country governments34, WHO, Tulane 
University, the United Nations, the United States’ Office of Foreign Disaster Assistance 
(OFDA) and the US Army Medical Research Institute of Infectious Diseases (USAMRIID) 
(Khan et al., 2008). The WHO’s BioRisk Reduction for Dangerous Pathogens team, part of the 
Department of Epidemic and Pandemic Alert and Response coordinated the network and 
Tulane University were, and still are, the main implementing partner. The network was 
formed to enhance laboratory diagnostics and to develop national and regional disease 
control strategies, primarily for Lassa fever but also for other infectious diseases. Local 
disease burden was an important factor but as the list of stakeholders makes clear, the 
concern with Lassa fever was not simply about health in West Africa. The ‘global threat’ 
narrative and category A status gives it a leverage which other neglected diseases do not 
have. Yet those extra resources come on certain conditions. Techno-scientific approaches to 
disease control are favoured in biosecurity paradigms, where the need to develop ‘counter 
threats’ is paramount (Vogel, 2008b, Vogel, 2008a). The actors and funding sources, 
described more in chapter six, diagnose a lack of technology to be the problem and promote 
lab-based research to be the solution.  
 
Once narrowly problematised as a lack of effective biotechnology, what matters most within 
this narrative are the biomedical mechanisms that will become the target of the control 
efforts. Understanding these mechanisms provides the roadmap for reducing the risks posed 
by Lassa: either by stopping infections (e.g. vaccines) or limiting deaths from infections (e.g. 
rapid, reliable diagnostics that enable fast treatment). In the vacuum of technology there is 
also a vacuum of certainty. The subtext is that improved diagnostics will reduce this 
uncertainty and pave the way for science and wide ranging capacity building (Khan et al., 
2008). As chapter six shall explore, much of the work in the laboratory is influenced by these 
ideas, and the global threat narrative has proved very useful in terms of securing research 
                                               
34 Sierra Leone, Liberia and Guinea 
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funding for diagnostics. Significantly, some of the Tulane team reported that Lassa was 
actually seen as well funded and organisations which would usually fund neglected diseases 
were not interested. The problem, they suggested, was that the funding for Lassa fever only 
covered laboratory research which fitted with the security agendas of funders and nothing 
was being spent on wider health promotion. In that sense the socio-economic dynamics which 
mean West African populations are vulnerable to Lassa fever were still neglected.   
 
In summary, the three narratives about Lassa fever that I have identified above, converge into 
a narrative of diagnostic revolution like the one identified in chapter two. Lassa fever is 
presented as controllable through science. The narrative is one of moving from ignorance to 
risk. The first step in a scientific approach to controlling the disease is establishing diagnostics 
which will produce reliable knowledge and make treatment evidence based. Out of this will 
come wider capacity development, but what is meant by capacity remains vague. As following 
sections indicate, there has been some disagreement about how capacity can and should be 
developed. 
4.2.4 The Lassa fever diagnostic system: an official version 
Here I shall set out the diagnostic system as it is envisaged in the healthcare policy (and 
scientific) literature. As I describe this version of the system I highlight how certain dynamics 
within it have been framed, as a point of departure for subsequent chapters where I explore 
practice in different contexts within the system. Below, I trace how this formal depiction of 
the diagnostic system is part and parcel of the technological fix narratives in which 
diagnostics are envisaged as the cornerstone of rational health care, effective surveillance, 
national and international disease control, and, increasingly of wider capacity building 
projects. This version of the diagnostic system situates Lassa fever firmly in the grip of 
institutions of global health governance. The procedures and regulations described in the 
documents examined here represent an idealised version of how infectious disease control 
and surveillance should work. As later chapters show, they leave out much of the complexity 
of practice and experiential knowledge that a broader survey of the diagnostic system 
suggests is important.  
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The Sierra Leonean Ministry of Health and Sanitation (MOHS) adopted the WHO’s Integrated 
Disease Surveillance and Response35 (IDSR) which gives instructions on dealing with ‘Priority 
Diseases’ which includes Lassa fever. The June 2008 IDSR manual for Sierra Leone reads: 
 
“The general overall objective of the IDSR strategy is to provide a rational basis for decision-
making and implementing public health interventions that are efficacious in responding to 
priority communicable and non-communicable diseases”. (MOHS, 2008, p3)   
 
It goes on to explain that the International Health Regulations (IHR) are to be implemented 
through the IDSR, and explains their relevance to each other: 
 
“The successful implementation of the IHR requires the proper functioning of core surveillance, 
risk assessment and response capacities at country level. In Sierra Leone, IHR will be 
implemented within the context of the Integrated Disease Surveillance and Response (IDSR) 
strategy. Through IDSR Sierra Leone is developing capacities for surveillance, laboratory 
confirmation, notification and response to outbreak. This infrastructure could be applied for IHR 
implementation. On the other hand, the legal and policy backing of IHR and the additional 
resources that may be mobilized for supporting its implementation could be used to build 
national core capacities thus consolidating IDSR implementation”. (p4) 
 
This framework advises the promotion of simplified case definitions in communities and 
peripheral health units to assist in disease notification and referral. As such the case 
definitions are a critical first step in effective surveillance systems. Table 2 shows the 
simplified definitions for Lassa fever and viral haemorrhagic fevers (VHFs).  
 
Cases identified as suspect using the case definitions must then be confirmed by a laboratory 
test. The IDSR manual specifies that this can be with Polymerase Chain Reaction (PCR) or 
Enzyme Linked Immunosorbent Assay (ELISA)36, noting that it will “depend on standards 
established by the lassa lab (sic) in Kenema” (MOHS, 2008, p38). As I will describe in chapter 
five, the standard practice is that Lassa fever can be diagnosed by the detection of antibodies 
or antigen (Bausch et al., 2000) and the favoured technique in Kenema is an ELISA. Once 
confirmed, a number of actions should then follow: the case should be isolated according to 
infection control guidelines and treated with Ribavirin by staff using full personal protective  
                                               
35 IDSR was developed by WHO African region as a cross-cutting way of health system strengthening 
and global surveillance 
36 These are laboratory diagnostic techniques, details of which will be provided in chapter six.  
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equipment (PPE).37 Contacts should be traced and the health authorities notified.  Kenema 
Government Hospital, as the site of the Lassa laboratory and ward is at the centre of the 
formal diagnostic system: it is the only place in Sierra Leone (and many of the surrounding 
countries) where Lassa fever can be laboratory confirmed and treated with Ribavirin.  
 
Table 2 Case definitions for VHFs and Lassa fever used in the IDSR (MOHS, 2008)  
Simplified community 
definition for a VHF 
Any person who has an unexplained illness with fever and 
bleeding or who died after an unexplained severe illness with 
fever and bleeding (p28) 
Simplified clinical definition 
for reporting a VHF to 
district health authorities 
Any person with severe illness, fever and at least one of the 
following signs: bloody stools, vomiting blood, or unexplained 
bleeding from gums, nose, vagina, skin or eyes” (p26) 
Clinical case definition for 
Lassa fever 
Any person in or travelling from an endemic area for Lassa fever 
with fever >38°C less than 3 weeks duration not responding to at 
least 48 hours of appropriate anti-malarial and anti-biotic 
treatment, typically with chest pain, vomiting, sore throat, and 
muscle aches”“ (p179) 
 
There is a hierarchy of evidence and flow of information in this version of the system: disease 
reports and case definitions must be reported upwards and then confirmed by a laboratory, 
after which the diagnostic case is considered closed. This formulation of the diagnostic system 
puts the laboratory at the centre of disease control and healthcare. It paints a linear flow of 
people and information from communities up to regional hospitals, via the laboratory, and on 
to governments and WHO representatives. The model of Lassa fever is biomedical, in a 
particularly ideal type (Rosenberg, 2002) mode: the disease is characterised as identifiable on 
the basis of some key symptoms which become increasingly clear as the disease progresses. 
The problems with the system are framed as being to do with inadequate information systems 
and limited diagnostic capacity, as flagged up in the National Health Sector Strategic Plan 
2010-2015. The health strategy states the Government’s intention to improve these areas 
(amongst others), and in doing so to establish building blocks to the provision of ‘rational’ 
                                               
37 The WHO (2008) recommends that patients should be isolated (from at least a 15m distance) and all 
entrants to the isolation area should use PPE. Infection control precautions include: avoiding 
unprotected direct contact with blood and body fluids; perform hand hygiene before and after direct 
patient care and after removal of PPE; disposing of/de-contaminating PPE after contact; assign specific 
staff to patients and limit their other work and movements; limit used of needles; if needles are used 
they should never be reused or recapped; and make dedicated disposal boxes for ‘sharps’ such as 
needles and scalpels available at point of care. PPE for VHFs include: gloves (non-sterile examination 
gloves or surgical gloves); a gown to cover clothing and exposed skin (and a waterproof apron if gown 
is not impermeable); facial protection in form of a medical mask and eye protection (eye visor or 
goggles) or a face shield; and closed, resistant shoes (e.g. boots). These are from the WHO’s guidelines 
on the control of filovirus (Ebola, Marburg) haemorrhagic fever, but they are also recommended for 
Lassa fever.    
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healthcare (MOHS, 2009). In that vein, plans were made (supported by the CDC and WHO) for 
a National Reference Laboratory and a National Laboratory Strategic Plan and Policy were 
developed in 2010 (MOHS, 2010a, MOHS, 2010b). Likewise, for the international partners 
behind the MRU-LFN the shoring up of laboratory capacity was an obvious first step in 
improving surveillance and disease control:  
 
“The cornerstone of the MRU LFN is enhancement of laboratory capacity. The emphasis on the 
laboratory was a conscious decision taking into account the very non-specific clinical 
presentation of Lassa fever that continually undermines efforts to establish surveillance and 
control programs” (Khan et al., 2008).  
 
This call for enhanced laboratory capacity as a response to the non-specific nature of Lassa 
fever symptoms is evidence of the superior value attached to laboratory results by these 
institutions. It also gives a glimpse of tensions between ways of defining Lassa; in this example 
between clinical and laboratory definitions of the virus. It is expected that enhanced 
laboratory capacity would then provide the basis not only for better surveillance, but for 
wider capacity development in Sierra Leone and within global public health security (Khan et 
al., 2008). Figure 10 shows the Lassa Laboratory at KGH. Those in the WHO’s GAR 
programme, Geneva, have discussed plans to make the Lassa Laboratory a ‘centre of 
excellence’ to strengthen diagnostic capacity in the region and deal with disquiet that Lassa 
fever is getting disproportionate attention and resources.38 Taking these developments into 
account the diagnostic system, and the Mano River Union Lassa Fever Project, might be 
viewed as part of a broader project to shore up regional relationships which have historically 
been very difficult.  
 
In all of these formulations of the Lassa laboratory’s role, and its connections to wider 
capacity development, the ‘technological revolution’ narrative which I identified in chapter 
two can be detected. Developments in the laboratory are depicted as the driver of change. In 
this policy discourse, problems within the diagnostic system are framed in terms of technical 
issues (cold chain, sample storage, reagent supply, sensitivity) or the weakness of the health 
service (e.g. poor referral). There is also a hint that other disease control options are 
dismissed. As a senior researcher at one of the biotech firms involved in developing the 
diagnostics for Lassa put it in an interview: "You're never going to eradicate the virus," he 
said. "What we want to do for the next 10 years is just get into a system where we can 
                                               
38 WHO representative, Geneva, 14/12/2012 
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diagnose them quickly, treat them quickly and reduce the mortality rate" (Wallace, 2011). 
Such statements focus on medical countermeasures and play down the role of prevention 
activities unless they are based on vaccines. This approach contains assumptions about the 
controllability of Lassa fever through technology, where the presumed linearity of diagnostic 
processes is central to expectations of controllability.   
 
    Figure 10 The Lassa laboratory at KGH (from Khan et al., 2008) 
 
4.3 Alternative perspectives on Lassa fever  
By nature, framings and narratives put some factors sharply into focus at the expense of 
others. In all of the above conceptualisations there are some questions and alternative 
dynamics which receive less attention or which are concealed. A feature of the three policy 
narratives discussed earlier is a dependence on, and high expectations of, technology. In 
contrast, very little research has been conducted on the disease’s ecology or on simple 
community based preventions. Indeed this parallels much research on emerging viral diseases 
where efforts have focused on technology (diagnostics, surveillance, vaccines or treatments), 
and less on the underlying causes of this emergence (Farmer, 1999, Kuiken et al., 2003). For 
Lassa specifically it seems that there are at least two areas of research which need to be 
elaborated. First, the long term socio-ecological and political dynamics of the virus and 
second, its place as a longstanding and constant part of healthcare practice in Sierra Leone.  
4.3.1 Long-term dynamics of Lassa fever 
This is not the subject of this research but it should be mentioned briefly. Other than noting 
the war in Sierra Leone, broad societal stresses and changes receive scant attention in the 
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literature. Longer term shifts in agriculture, ecology, economics or technology are not 
explored in current research or policy debate. Even in articles which collect data from refugee 
camps, there is little mention of the social economic conditions and civil wars which may be 
driving those conditions, except to say that they make conditions for research unfavourable 
(Bonner et al., 2007).The focus on local practices or hygiene only highlights a limited range of 
potential risk factors and as such they should be viewed as partial stories. The “conflation of 
structural violence and cultural difference” or with problematic individuals, obscures 
underlying inequalities which drive disease susceptibility within and between communities 
(Farmer, 1999, p9). The Dynamic Drivers of Disease in Africa Consortium (DDDAC) is looking 
into aspects such as this in relation to Lassa fever.  Others are working on the genetic 
evolution of the virus and populations across West Africa to put ideas about its ‘emergence’ to 
the test (Gire et al., 2012).  
4.3.2 Lassa fever in practice  
There has been very little research, like that which proved so fruitful for Ebola (Hewlett and 
Hewlett, 2008), on local understandings and management of Lassa fever.39 Thus, a research 
agenda which addresses ‘Lassa fever in practice’ would fill a substantial gap. It would show 
how disease control approaches, and the policy narratives identified earlier which they are 
informed by, interact with longstanding healthcare practices. In practice Lassa fever is full of 
complexities and contradiction; this perspective echoes that of Kelly and Beisel (2011), whose 
descriptions of the multiple guises of malaria I described in chapter two. Their focus on the 
arduous, everyday ‘backstreet’ management of the disease is similar to what I have tried to 
achieve with Lassa fever. This is the Lassa fever which cannot be framed singularly because it 
is so diverse. This Lassa has multiple strains, various dosages, past infections, mild or severe 
symptoms and unknown prevalence and the point is to understand how that presents 
conundrums in everyday diagnosis and management. 
 
Thus the considerable gap in social research on Lassa fever is my starting point. Research 
focused on lay understandings of Lassa fever and practices surrounding its management. It 
also looked at the perspectives and work of health workers and laboratory technicians as they 
experience the disease on the ‘frontline’.  
 
                                               
39 Except a knowledge, attitudes and practice study by Merlin (Richmond and Baglole, 2003) 
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A ‘Lassa in practice’ perspective draws attention to divergences and clashes between the 
framings and narratives identified in this chapter, and others explored in the following ones. 
Evidence of conflicting framings of Lassa are visible in the instructions which govern the 
idealised official system. Under the IDSR framework Lassa fever is included as both a ‘priority’ 
and an ‘Epidemic Prone Disease’. Instructions for priority diseases state that “a single 
suspected case is a suspected outbreak” and must be reported immediately to district level. 
Yet elsewhere a measured judgement is advised. The ‘decision instrument’ I mentioned earlier 
separates expected disease incidents from ‘unusual’ ones (MOHS, 2008). As such it 
distinguished infections in people and places not normally vulnerable to Lassa fever. This 
tangled set of instructions demonstrates Bowker and Star’s point that classification systems 
are never coherent and in practice are always in need of tweaks to make them workable 
(Bowker and Star, 2000). Such tangles become very clear though, say, when a South African 
civil engineer dies from Lassa in a Northern province, or when a Swedish expat is suspected of 
contracting it, both of which happened in 2011. These cases both caused an unusual stir. The 
people who are infected and the places they were infected, made these cases more visible 
(and in terms of reporting, more significant). These are some of the tensions between the 
global epidemic threat and local endemic disease as they are represented in the diagnostic 
system.  
 
The diagnostic system in Sierra Leone cross-sects and includes a diverse range of settings, 
tools, regulations, countries, disciplines, communities and individuals. The system assembles: 
biosafety regulations; global surveillance networks; international organisations; 
governments; the international research and funding infrastructures; academic, private and 
military research institutions; official health practitioners; unofficial health providers; local 
communities and patients. Basic infrastructure, such as roads, cars, planes, the internet, even 
paper, are needed to transport the material and technological aspects of Lassa fever 
diagnostics within the system. The processes and equipment needed for laboratory tests 
includes: the collection of serum samples by health workers in Sierra Leone; diagnostic 
reagents which are grown and supplied by USAMRIID (and by Tulane’s consortium partners) 
and flown to Sierra Leone; solar powered freezers are supplied by the WHO so that reagents 
and samples can be stored appropriately; equipment to draw and store blood, including PPE 
for the laboratory and ward is sent in shipments to KGH by Tulane; denatured samples are 
sent back to the US for further analysis. In contrast to all of this timed and coordinated 
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organisation, Lassa virus presents itself unpredictably. Input of supplies and personnel can be 
managed to an extent but influx of people suffering from Lassa cannot and neither can the 
differential impacts it will have in some bodies as opposed to others.  
 
With all these actors, and in all these settings, the likelihood that the stakeholders want and 
expect different things from the system is high. This might be publishable research, a product 
to market, training for locals, simply to find out what is wrong with them and to survive it, or 
even to not get sick in the first place. Related to this is the possibility that all of these groups 
have their own understandings of health, their own norms, institutions and modes of 
authority, as well as power dynamics within and between them, which influence their actions. 
In these respects, different actors may frame the diagnostic system very differently. In formal 
versions of the system, the apparatus hinges on accurate, ideally laboratory confirmed, 
diagnosis: early identification, contract tracing, and appropriate disease control responses. As 
such, it represents and forms part of the general biomedical approach to epidemic disease 
control. But it remains to be seen whether all actors agree with those objectives, or their 
valuation of scientific knowledge systems, and whether the system ‘works’ in this manner. 
These aspects are the focus of the next three chapters; in order to render this doable I split the 
system up into distinct settings where I could explore the differential knowledge production 
contexts. However, this separation, as I also noted in chapter three, is not complete: processes 
run through them, flows of people and blood cross-cut them, and framings also travel between 
them.  
4.4 Health care dynamics in Sierra Leone 
Population health presents a huge challenge in Sierra Leone, and Lassa fever is only one of 
many problems. In 2008, when this research began, Sierra Leone was ranked bottom (177 of 
177) of the Human Development Index (UNDP, 2007). Average life expectancy was 41, infant 
mortality was 165 per 100,000 live births and the country also suffered some of the highest 
child and maternal mortality rates in the world. There were only 3 doctors per 100,000 
people (compared to 200-400 in more developed countries) and government spending on 
healthcare was the equivalent of 1.9% of GDP (UNDP, 2007). Thus, then and now, the 
healthcare system operates under extreme strain and with very low capacity.  
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That picture is further complicated by the range of formal and informal providers that provide 
healthcare alongside the state, including mission and NGO health services, traditional healers 
and drug peddlers. As with many low resource settings where formal health care is stretched 
(Peters and Bloom, 2012) informal providers flourish but are not well regulated by the 
government. Even in the formal sector there is great variation as a range of providers have 
different approaches to price and manner of payment; for instance the Médecins Sans 
Frontières (MSF) hospital in Bo is free, the mission hospital in Panguma charges a flat-rate fee 
(50,000 Leones, £9), while government health posts provide services on a ‘cost-recovery’ 
basis. In April 2010 the Government introduced the Free Health Care Initiative (FHCI) which 
provided free healthcare to children under five, pregnant women and nursing mothers. For 
these groups, the cost-recovery policy was removed and their healthcare was provided free of 
charge.40 Health centres overflowed initially and there has been a rise in those priority groups 
accessing services (Donnelly, 2011). For those not covered by the FHCI there are various 
vertical programmes, such as those for HIV, TB and also Lassa fever, where treatment is 
provided free. However, in most government health posts consultation and admission fees 
apply (in KGH it was upwards of 30,000 Leones, £5.40 in 2010, to be admitted to an inpatient 
ward). Any tests or treatments must be paid for by the patient. Extreme poverty means that 
the cost of government healthcare is extremely high and many are excluded as they are unable 
to afford even modest charges (MOHS, 2009). This is the backdrop for Lassa fever, a context 
crowded with many other diseases and programmes, and with very limited resources.     
 
In Sierra Leone’s tiered healthcare system, outlined in the previous chapter, ascending from 
Peripheral Health Units (PHUs), to District Hospitals onto Regional Hospitals, challenging 
cases are supposed to be referred from the PHUs upwards to the hospitals, however referral 
systems are not functional in some districts (MOHS, 2009). Much of the health expertise and 
facilities are concentrated in Freetown while there are few doctors ‘up-country’ in the 
‘provinces’.41  
                                               
40 The view of some NGO and development staff was that this was rushed through. Sierra Leonean 
healthcare workers I spoke with agreed with the policy in principle but worried about adequacy of 
provisions. There have been reports that some drugs have not been getting through.   
41 ‘Ghost’ workers on payroll is a particular issue in the health and education systems, particularly in 
rural areas; there are many ‘ghost’ staff on payrolls who are no longer/or never were working but 
whose salaries are still paid and collected and with the effect of preventing others from being 
employed. There are also many staff who provide services but who are not on the payroll. This has 
created bottlenecks as the Government will now only put ‘trained and qualified’ staff on payroll but it is 
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4.5 Sites in the diagnostic system 
Three sites were selected to explore framings and practices within the diagnostic system in 
Sierra Leone. Below I introduce each site as a preamble to the ethnographic descriptions of 
diagnosis in the next three chapters. I introduce these in the order they appear in the 
following chapters: the village of Tokenga located in the hyper-endemic zone, the laboratory 
at KGH, and the hospital wards at KGH. As I have argued that there is an upwards flow of 
information in the official version of the system from community to laboratory, this order may 
seem counterintuitive. I have two reasons for presenting the ethnography in this way. First, 
the flow of people and samples does not always follow that upwards flow. Indeed, blood 
samples can be sent directly from communities to the laboratory. Second, this order is 
intended to convey the brokerage role that the clinic plays both before and after a laboratory 
diagnosis. 
4.5.1 Community 
Tokenga is a Muslim42 village with an estimated population of 400,43 is found in Dodo 
chiefdom in Eastern Sierra Leone. Chiefdoms, of which there are 149 in Sierra Leone, are 
headed by a paramount chief, in Mende the ndᴐlᴐ maha. 44 Their territory is then divided into 
sections each with its own ‘section headquarter town’ and a ‘section chief’ (pati maha), who 
supports the paramount chief. Tokenga is the ‘section headquarter town’ of one of Dodo’s 
seven sections. Individual villages also have their own ‘village chief’ (ta maha), so both a 
section chief and a village chief reside in Tokenga: both are elderly men. The Mende do allow 
women to occupy the position (Hoffer, 1972). Chiefs are elected but only candidates from 
chiefly lineages are allowed to stand, although the notion of pre-colonial hereditary estates is 
questionable (Abraham 1978 and Barrows 1976 cited in Fanthorpe, 1998, p559). A chief’s 
responsibilities include settling disputes, presiding over the chiefdom courts and organising 
labour for various community enterprises. In doing so, they are supported by a ‘speaker’, 
‘headman’ and ‘women’s leader’ amongst others. Whereas once their role was to be a broker 
                                                                                                                                               
also these staff who are less willing to go to rural areas. As a result, rural areas have a low coverage and 
lots of untrained service provision.   
42 Muslim in a West African model, teachings of Islam overlay and interact with existing local traditions 
(which are also constantly changing). The result is one where Allah is worshiped alongside bush spirits 
and devils.  
43 This was the result of a census conducted by the head teacher of the school in 2009 
44 Chiefdoms were institutionalised by the British during colonialism, they did not exist before (Hoffer, 
1972)  
112 
 
between the British colonial administration and ‘provincial’45 populations, paramount chiefs 
are now the point of contact between the post-independence national government and their 
citizens. 
 
Sierra Leone has a parliamentary system and during my fieldwork Tokenga’s constituency 
was represented by a female member of parliament from the opposition Sierra Leone People’s 
Party (SLPP) party. Despite a post-war decentralisation effort from national government, 
which donors hoped would diminish chief’s power (Fanthorpe, 2006), the authority villagers 
encounter on a day to day level is that of the chiefs. In Tokenga, chiefdom elections had just 
been held and they were in the middle of a controversial election contest in a neighbouring 
village when I left. Even in matters where the chief may not have any influence, villagers will 
work through them to get to the relevant authorities. For instance, in Tokenga residents were 
lobbying to have a health clinic set up in the village; it was a ‘grassroots’ demand which 
required the attention, and resources, of central government officials. However, at every stage 
of organising and carrying out their campaign, for instance in sending a delegation to see the 
district medical officer in Kenema, the villagers would meet and consult with the town and 
section chief. 
 
Tokenga is 6 miles from Dodo Town, the chiefdom headquarter. Panguma, the headquarter 
town of neighbouring Lower Bambara chiefdom is 9 miles away, and is  better served for 
commercial, transport and health needs. The road to Tokenga is a dirt track, and is rough and 
hilly. During my visit, which was in the dry season, motorbikes would very occasionally ride it 
and once a truck arrived to collect a crop harvest, but otherwise journeys were made on foot. 
In the rains the mud and log bridges would be impassable for vehicles. There is a small 
primary school staffed by four teachers, only one of whom is on government payroll.46 If 
children are to continue schooling after primary level they would be sent to live elsewhere in 
order to attend secondary school.  
                                               
45 ‘Up country’ or outside of the British protectorate which consisted of Freetown peninsular 
46 The teachers (1 head teacher, 2 tutors, and 1 Islamic teacher) had tried numerous times to get on 
payroll which would mean they were official government employees and would receive a regular state 
salary. However, the current Government’s reform of payroll from public services like health and 
education is attempting to cleanse not only ‘ghost workers’ (who do not exist but whose salaries are 
picked up by someone), but also the ‘untrained and unqualified’ who currently occupy positions on the 
payroll. The teachers at Tokenga would fall into this latter category: despite the school being officially 
recognised no teachers had been sent to take up work there (filling rural positions is a common 
problem) and so the community requested some of their own people to fill the gap, but not being 
trained teachers these men have little chance of making it on to the payroll.   
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There is no government health clinic in Tokenga and so people travel to either Dodo or Guala 
(5.5 miles) where there are clinics. There is also a hospital in Panguma. There had once been 
maternal health nurse who visited Tokenga every few weeks, but that had ceased. Residents 
of the village are in the process of lobbying the district health officer for a Government nurse 
and clinic to be instated in the village. They had collected money between themselves to send 
delegates to Kenema to argue their case and, on my second trip, had also started construction 
on the clinic themselves. As far as I know, there is still no resident nurse. The nurse at Dodo 
clinic was described as frequently absent, or the clinic empty of medicine.  
 
Compounds consist of different kinds of housing structures. Mawɛɛ (household) heads 
traditionally built either ‘multiple houses’ or ‘big houses’ to house dependents (Leach, 1994). 
‘Multiple houses’ are divided into private rooms where individuals or couples (and their 
young children) will sleep. The ‘big houses’ are undivided shared sleeping quarters, usually 
for women, and as polygamy is common often for co-wives when it is not their turn spend the 
night with their husband. Tokenga has a number of large ‘multiple houses’, but it does not 
have any ‘big houses’, though it does also have  smaller individual houses built by men for 
themselves and their immediate family. Such ‘small houses’ are increasingly popular (Leach, 
1994). They are the newest structures in Tokenga, and there are more being built. Houses are 
built from a mud mix. At their most basic (and cheapest) this is packed into a wooden frame. 
Others are made from mud bricks which can be left bare, or if there are funds the bricks get 
covered with a plaster (figure 11 shows a plastered ‘big’ house, erosion is visible at ground 
level). Floors are mostly packed earth, though some are plastered. Roofs are thatched with 
palm or covered with corrugated iron. Houses with packed earth floors and no cement are 
more hospitable environments for burrowing rodents, including the M. natalensis.  
 
Tokenga is relatively well equipped, certainly more so than smaller villages, in that it had 
latrines, a water tank and pumps. It had retained more of the larger, older, plaster covered 
houses than many other villages. During the civil war the rebels had not entered the village, so 
these fine old buildings which had often been a target of the rebels elsewhere, are still 
standing; in other towns and villages in that area it is more common to see their burnt out 
remains. I was told the rebels had surrounded Tokenga but it had been protected by Kamajᴐ 
men. Kamajᴐ is the term for a male hunter who uses medicines. During the war many of them 
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acted as a civil defence force giving the word a new meaning47; they are now often referred to 
in an Anglicised way as Kamajors. In Tokenga, during the war the Kamajᴐ leader was the 
section chief’s son; the chief showed me photos of his son posing with bullets and guns and 
told me how he had died just before the war was over, of Lassa fever.    
 
    Figure 11 The water supply and houses in Tokenga 
 
 
Kitchens are separate buildings which are primarily used for storage as all cooking is done 
outside over a wood fire, though they are used for shelter during rain. Kitchens are generally 
on the periphery of the village, behind houses, and are always made of mud with thatched 
roofs, but with lockable doors to keep equipment and food safe. Figure 12 shows how kitchens 
and houses are arranged. Women cook, usually rice and a sauce of ‘greens’ such as cassava 
leaf or potato leaf. Left over rice is kept, usually in cooking pots or bowls with a plate balanced 
on top, to be eaten as kol ris (cold rice) the next morning. Stored food which rodents can gain 
access to is a possible transmission route for Lassa fever. The outreach team advise people to 
cover their food well to protect from Lassa fever. There is little food waste, but that and any 
                                               
47 As well as protecting communities there have also been accusations that they committed brutality 
too. Despite this, in Tokenga they are talked of positively. 
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other rubbish is put on a dump just on the edge of the village. Some villages have hygiene 
officers, but apparently not in Tokenga.  
 
    Figure 12 Houses (left) and kitchens (right) in Tokenga 
 
4.5.2 Laboratory 
The ‘Lassa Lab’ at KGH became operational in 2006 (with testing routine in 2008) as a result 
of the Mano River Union Lassa Fever Network which was formed in 2004. The “cornerstone” 
of the network was to improve laboratory capacity for diagnosis of Lassa fever (Khan et al., 
2008). Previously diagnostics had only been performed intermittently in Mano River Union 
(MRU) countries, or samples had to be sent to the US or Europe for testing which, with the 
increasingly strict regulatory environment for ‘Select Agents’ such as Lassa, meant they could 
take months to get a result rendering them of little use for clinical or case investigation 
purposes (Khan et al., 2008). The ‘Lassa lab’ is located within KGH hospital grounds, it shares 
a building with the KGH general laboratory which was built with support from Merlin, the 
United Nations Mission in Sierra Leone, OFDA, WHO, Tulane University, and the Sierra Leone 
Ministry of Health and Sanitation (Khan et al., 2008). The laboratory was built to operate at a 
BSL-3 level, though in practice it operates somewhere in between BSL 2 and BSL 3. Entrance 
to the laboratory is through a lockable door leading to small area for donning PPE: gowns, 
gloves, goggles, masks and wellington boots. There is a second door which leads to the main 
laboratory. Exit from the laboratory is via a different door, to an area where protective gear is 
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discarded or disinfected. In this way the flow of people through the laboratory is controlled, 
however not all staff and visitors to the laboratory follow these procedures to the letter. As 
the local electricity supply, known as ‘town power’, is not reliable (or even available at all 
during most of the dry season), electricity for the laboratory is supplied from a generator. 
Tulane and the WHO have installed solar panels to ensure that freezers maintain their 
temperature, 
 
At the time of fieldwork, the laboratory employed three permanent Sierra Leonean 
technicians who provided Lassa fever diagnosis using the ELISA technique which I explain in 
chapter five. The laboratory is regularly visited by Tulane University researchers and other 
affiliated researchers who are involved in developing new diagnostics for Lassa fever. The 
laboratory is seen as the engine of research, a building block which removed ‘bottlenecks’ and 
opened up new research avenues. Representatives of the MRU LFN described its potential 
thus:         
 
“The enhanced physical and organizational infrastructure provided by the MRU LFN and KGH 
Lassa Laboratory, and especially the implementation of real-time laboratory diagnostics, offer 
tremendous potential for research on LF (Lassa fever). Key areas of investigation include the 
development and testing of new diagnostic techniques (such as the aforementioned recombinant 
based assays); a more complete understanding of the clinical presentation, pathogenesis, 
correlates of immunity, and natural history of LASV (Lassa virus) transmission; and the 
development and testing of new treatments and vaccines”. (Khan et al., 2008, p109) 
 
As well as providing routine diagnostics the laboratory periodically hosts researchers from 
Tulane University and other institutions. In 2010 there were about a dozen research projects 
being run by Tulane University and collaborators through KGH. Two main projects were on-
going in the laboratory. The first was a project on the ‘Preclinical development of recombinant 
antigens for the diagnosis of Lassa fever’. This was a collaboration between Tulane University, 
Boston University, USAMRIID, and three biotech companies (Autoimmune Inc., Corgenix Inc., 
and Vybion Inc.). The second was investigating ‘Roles of protective or pathogenic B cell 
epitopes in human Lassa fever’ This was a collaboration between Tulane, Boston and Harvard 
Universities, USAMRIID, the Broad Institute, Scripps Institute, and Autoimmune Inc., Corgenix 
Inc., and Vybion Inc.. Both were funded by the National Institutes for Health (NIH) and led by 
senior laboratory scientists from Tulane University. Chapter five will describe progress made 
on the diagnostic grant.  
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4.5.3 Clinic 
The KGH hospital provides secondary care for the Kenema district. Inpatient care is offered in 
the male, female, maternity and children’s ward. There is also the ‘annex ward’ where patients 
can pay a higher admission fee for a private room or a room that is shared with fewer people. 
There are 4-5 doctors who cover these wards assisted by nurses and students. A converted 
shipping container houses the outpatient clinic which is simply known as ‘the container’. The 
hospital is supported by a blood bank and a general laboratory although the range of tests 
available is limited. There are also a handful of specialist clinics and wards such as the HIV 
clinic, TB clinic and, of course, there is the Lassa ward. The Lassa ward is looked after by the 
same doctor who is responsible for the male, female and annex ward. KGH is run as per the 
government health financing policies operating on a cost recovery basis, until the introduction 
of the Free Health Care Initiative in 2010 described earlier. Until that, and still for some 
people, nothing is free at the hospital; for example, as well as the admission fee patients have 
to bring their own bed sheets. Many purchase school exercise books as a cheaper alternative 
to the official patient charts. Some wards, such as the maternity ward, can be very busy but 
many others appeared frequently only half full, most probably because of cost. The 
environment is very basic, hot and dark. In 2011 the maternity ward burnt down, reportedly 
the result of faulty electrical wiring.  
 
Lassa fever presents a particular threat of nosocomial outbreaks and it has a long history of 
affecting health workers, including many at KGH. Nurses can remember outbreaks and 
colleagues who were affected. The provision of basic protective equipment such as gloves was 
not routine on KGH’s general wards, let alone anything like the PPE described in section 4.2.4. 
Confirmed cases of Lassa fever are treated in a separate isolation ward. I have already 
described the centralised diagnostic and treatment system but it should be pointed out that 
KGH is located outside of the traditionally hyper-endemic zone. It was not always this way, as 
well as the previous base in Segbwema some early outbreaks were dealt with on site. 
McCormick describes setting up isolation procedures at other hospitals in the ‘Lassa belt’ 
(McCormick et al., 1999), and it is conceivable that if proper PPE was provided this would be 
feasible again. However, as of now, everything is directed towards KGH, both resources and 
patients.  
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The ‘Lassa Ward’ is located on the grounds of KGH. It is shown in figure 13. It has 25 beds, 
divided between rooms which contain 1-3 beds each. The building was not originally designed 
to be an isolation ward and so it has been adapted; the red line which cuts the reception area 
in half should only be crossed by patients or those in full PPE and a disinfection station stands 
just behind it. PPE on the wards consists of a gown, wellington boots, gloves, goggles and a 
mask. New supplies of PPE arrived whilst I was there, but in the early stages some nurses had 
been making use of what looked like a ski-mask. The availability of PPE and adherence to 
isolation procedures can be a matter of life and death for healthcare workers in the region. 
Unfortunately many health workers have died after contracting Lassa fever from patients, 
including Dr Conteh. It is hard to recruit staff for the Lassa ward and the staff who do work 
there are particularly dedicated. A number of them have worked there for decades. I was told 
by nurses in other parts of the country that they had avoided working in the Eastern district 
just so they could avoid Lassa fever. The head nurse of the Lassa fever ward had herself been 
recruited after surviving Lassa. She and other nursing staff sometimes laughed that they were 
recruited because they were immune.  
 
    Figure 13 The entrance to the Lassa ward 
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The ward is extremely basic and dilapidated in parts. There is no reliable source of electricity, 
consequently it is dark and hot; I saw patients lying on the tiled floor in attempts to keep cool. 
Small scale repairs have been made recently; for instance the construction of a visitor’s 
reception area in the fenced off entrance area, and a replacement morgue which was built 
when the original one had become run down and, with tragic irony, so infested with rats that 
bodies could not be stored in there. There had been plans for a new ward (Khan et al., 2008). 
Foundations had even been laid but this had run out of funding and ground to a halt. It was a 
source of some tension between the WHO and Tulane, although I was informed new plans 
were being made, this time funded by the US Department of Defense.   
 
For now the old ward carries on with very limited medical equipment (Khan et al., 2008) and 
for drugs it suffers the same shortages and supply problems as the rest of Sierra Leone. 
Tulane University and the MRU-LFN do supply some supportive drugs and Ribavirin is offered 
free to patients after a donation by the Chinese government. The provision of free Ribavirin is 
critical as it would be far too expensive for most Sierra Leoneans to afford at approximately 
$1000USD per patient (Khan et al., 2008).   
4.6 Conclusion 
This chapter discussed three narratives about Lassa fever’s emergence and control which are 
evident in policy and popular discourses. The first narrative, about global threat, emphasised 
the need for disease identification and containment to stop the virus flowing across borders. 
The second concerned ideas of local endemicity and emphasised the need for local public 
health promotion and surveillance. The third described a neglected disease, which was in 
need of more technology and research. All three narratives converge on the promise of 
technology and greater investment in science. In an approach which exhibits signs of 
technology and science ‘silver bullet’ solutions, the establishment of diagnostics and 
surveillance is portrayed as the building blocks of effective disease control. The importance of 
these technologies cannot be denied, and they are certainly pivotal to dealing with the disease 
both locally and internationally. However, the troublesome feature of these narratives about 
the promise of science and technology for disease control is their tendency to overshadow, or 
even dismiss, alternative approaches and understandings of disease ecology and 
management. Moreover, I suggested they overlook the complexity of the disease and the 
process of diagnosis in the Sierra Leonean context. An illustration of this can be found in the 
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official version of the diagnostic system, as formulated in Government and WHO policy 
documents. This version of the diagnostic system frames Lassa fever and the process of 
diagnosis in an idealised way: case definitions are used to identify typical symptoms and the 
disease must be laboratory confirmed. Information flows upwards through healthcare tiers 
and patients and samples are centralised around the KGH. Two additional areas of research 
which were not adequately represented in these narratives, or in the idealised descriptions of 
the diagnostic system, were highlighted: the first acknowledged the longer term dynamics of 
Lassa fever and the second emphasised the everyday nature of Lassa fever in practice. The 
next three chapters aim to address the latter of those research deficits. By exploring Lassa 
fever in practice a more nuanced understanding of the role of new technologies for the 
diagnosis and control of Lassa fever is gained. 
 
Finally, at the end of this chapter I introduced the sites in which I examine Lassa fever in 
practice. As the previous chapter set out, the sites are settings where aspects, or framings, of 
Lassa fever are enacted. They are not the only places where diagnostic activity goes on; nor 
are they discrete places. They do not in themselves constitute the diagnostic system, rather 
they are locales where facets of the system interact. The following three chapters will examine 
the multiple processes, pathways, framings and enactments which make up the diagnostic 
system.   
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5 ‘We are just learning that name’: diagnosis in community 
settings  
Following on from the introduction to Tokenga in the previous chapter, I will now explore 
healthcare practice and Lassa diagnosis in the village as well as through the experiences of a 
group of ex-Lassa patients. In chapter two it was asserted that diverse framings and practices 
emerge out of social contexts, so instead of focusing on Lassa in isolation, here it is 
approached through the wider social and cultural framework of health and disease in a Mende 
village setting. The dominant narratives I identified in the previous chapter are largely 
unfamiliar here. On the world stage Lassa fever is a threat, an emerging or neglected disease 
whose presence in the region requires specialised healthcare measures. At the village level it 
is experienced alongside many other health problems, where what happens to someone 
infected with Lassa and how this is identified (or not) depends on established patterns of 
therapeutic practice, and how they relate to the social and material context of the village 
rather than the virus’s Category A or biosafety level 4 (BSL-4) status. But just as Lassa fever is 
the subject of nightmarish narratives on the global stage, the sudden and grisly end which it 
can cause has, at times, been associated with local stories of an equally alarming kind. People 
would often say they would rather have HIV than Lassa fever, as Lassa fever kills so quickly. 
Witchcraft too is implicated: I once heard Lassa fever referred to as a ‘witch fight’ with the 
injuries sustained in the fight manifesting themselves in the bleeding that is sometimes seen. 
More importantly, pregnant women, already vulnerable, are the subject of witchcraft 
rumours. Then there are stories of lethal injections administered at the hospital to people 
suffering the disease. I will come to all of these. Lastly, there are also respects in which village 
experiences of Lassa are influenced by those prominent international narratives, say by a visit 
from the outreach team; as a result new associations of Lassa are emerging in Tokenga as a 
range of outside meanings become associated with longstanding ideas of sickness and health. 
In this chapter I examine the negotiation of these framings and narratives, looking at how they 
intersect with the process and practice of disease recognition and healing.  
5.1 Social life and livelihoods  
Tokenga’s residents are subsistence farmers. A few families had larger plantations of cash 
crops like cocoa, oil palm and coffee, though a number of these larger plantations were not 
being harvested due to labour shortages. Others had smaller scale ventures growing crops 
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such as pineapples or even marijuana for sale. Rice is the staple food. People say if they have 
not eaten rice they have not eaten. It is a hugely significant part of social life and is often 
gifted. Not having rice, perhaps as a result of not being able to farm, is restrictive and a strain; 
people have to work hard to ‘buy’ or ‘find’ rice by other means. Households or individuals 
cultivate their own shifting areas of upland rice, or sometimes swamp rice. There are also 
some communal farm areas where ‘town rice’ is produced (which women are threshing in 
figure 14). Rice is supplemented by intercropping vegetables (i.e. maize, aubergine, chilli 
pepper) on designated farm areas, or with ‘greens’ (i.e. cassava leaf, potato leaf) grown in 
separate ‘gardens’, mostly by women. Livestock is limited in Sierra Leone particularly after 
the civil war. In Tokenga there were a few hens and goats but most meat was ‘bush meat’ 
which is hunted by men using dogs or traps (mani). This included cane rat (known in Krio as 
cottin grass); rodents (known as arata, and translated back to English as rats); and also 
monkey (referred to as baboon). Fish is widely eaten both dried and fresh. Fishing is done by 
women with nets in shallow waters, or by men with traps left on river beds.  
 
   Figure 14 Women threshing communal 'town rice' 
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At the village edge the buildings stop and the bush begins with only small footpaths leading off 
to farms or neighbouring villages. Older Mende villages, like Tokenga, tend to be composed of 
descent groups who trace their lineage to village founders. Descendants of these original 
settlers are usually the dominant landholders and chiefs are drawn from their lineages (Little, 
1967, Murphy and Bledsoe, 1987). There are five main descent groups in Tokenga and each 
claimed to occupy an area of the village. These sections contained one or more compounds for 
each lineage where people under a mawɛɛ (household) head lived, linked to them through 
kinship or patronage. The meaning of mawɛɛ has shifted as farming practices have changed; 
whereas once a mawɛɛ would have consisted of up to 50 people who farmed rice together 
(Little 1948), now it is commonly used to mean the smaller sub-units who farm together 
(Leach, 1994). Figure 15 shows one family’s farm, and farm hut (kpowa). To clear the farm in 
the picture after it had been burnt the family enlisted a group of adolescents and provided 
them a meal for their work. I was told by a member of the outreach team that the shift in 
farming as smaller units had particular relevance to Lassa fever. Where rice used to be stored 
in large rice barns (kpuwu) it was now common for these smaller family units to keep rice in 
their houses which attracts rodents. People do complain of rodents eating their rice both on 
the farm and in town. There is one arata, the one with the long mot (long mouth) who is said 
to be the ‘Lassa rat’. According to villagers this rodent smells bad and ‘loves rice’, which may 
be part of the reason why it has been (wrongly) designated the ‘Lassa rat’. By description, this 
rodent is more likely to be a shrew but it is relevant because it forms part of this community’s 
framings of Lassa fever and its transmission. 
 
As in much of Sierra Leone, the promise of finding diamonds provides a constant backdrop. 
Men in the village periodically go off for a few days or weeks to nearby villages thought to 
have diamonds, or to well-established mining towns like Tongo Fields which was a few hours 
walk. Much of this is done at their own expense, though occasionally they might receive 
sponsorship to dig, perhaps through a contact in the mining town Tongo or Kenema. For a 
contract they agree to give up most of the value of anything they find in return for a stipend. 
The constant presence of mining and its impact on the environment and social life has been 
noted elsewhere (Ferme, 2001, Leach, 1994, Richards, 1996). Tokenga is linked into Sierra 
Leone’s powerful informal sector, characterised by William Reno as the ‘shadow state’ (1995), 
as equally as any other village. 
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    Figure 15 Cleared and burnt upland farm, with farm hut 
 
 
Another much noted presence in Mende communities is that of the ‘secret societies’.48 Most 
rural adolescents will be initiated into either the local Pᴐᴐ (Poro, the male society) or Sande 
(Sande, female society). In the on-going Sande initiations during my visit, the initiates were 
segregated off into the Sande ‘society bush’, an area outside of the village in the forest. In these 
‘bush schools’ initiates undergo processes, training, and ordeals (controversially the 
clitoridectomy for girls) which turns them into gendered beings (Bledsoe, 1984). The bush 
schools of the secret societies have been described as being places of education, teaching 
young girls and boys essential life skills to be women or men (Little, 1967). This is certainly 
the ‘public face’ of the societies and their initiations. In a neighbouring village when the Sande 
initiates had completed their initiation and were ‘pulled’ from their ‘society bush’, they 
performed songs which they had learnt during initiation about, amongst other things, how to 
live in a polygamous marriage. The influence of secret societies in health domains will be 
described later in this chapter.  
 
The mosque in Tokenga is well attended. In addition to this there are a range of spirits and 
devils who inhabit the surrounding landscape. Others have described these matters in more 
detail (Ferme, 2001, Jȩdrej, 1974, Little, 1967), here I will outline only the main aspects. 
                                               
48 Links between secret societies, the ‘shadow state’ and Government officials should also be 
acknowledged  
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Secret societies have their own society devils and spirits. There are ancestral spirits who need 
to be respected but are generally kindly towards their descendants. Bush spirits inhabiting 
the surrounding areas can be mischievous and cause damage or accidents (Ferme, 2001, 
Leach, 1994). Another non-ancestral spirit, in Mende Jina and known as ‘Jins’ in English49, are 
described as having a human form, white skin and living near rivers. Jins can bring luck and 
wealth, but they are sometimes said to send sickness or madness.  
 
A hᴐna (witch spirit) is located in the belly of a hᴐnamᴐ (a witch). Witches are believed to 
have their own secret society; fellow witches can recognise one of their own but those who 
are not witches themselves cannot detect them. They are said to go about hᴐna hinda 
(witchcraft), or ‘witchcraft business’, at night. This includes eating children, poisoning victim’s 
food or shooting them with a ‘witch gun’. There are two kinds of ‘witch’: ‘born witch’ and 
‘bought witch’. Born witch is passed through ‘witch families’. One man estimated that witch 
families equalled non-witch families in number. Bought witch can be purchased from an 
appropriate medicine man (sometimes referred to as a witchdoctor though this is an 
anglicised term). Bought witch is stronger than born witch; bought witch is used to do good 
and to fight the bad ‘born witch’. Hᴐnamᴐ are likely to attack children or people who are 
successful. A particular kind of-post colonial discourse is evident when villagers attribute 
witchcraft to ‘African’ or ‘black’ desire to destroy each other because of their tendency for 
hatred and jealousy. The witchcraft in Tokenga is contrasted to the assumed witchcraft that 
puublaa (white people) have but which they use to do wonderful things such as invent 
mobile phones and planes. One of Tokenga’s neighbouring villages is said to have many 
witches. 
5.2 Impressions of ‘Lassa’ 
There are certainly hints in Tokenga of Lassa fever’s global and regional importance. There 
are not many diseases which cause so many visits from outsiders, including myself.  Only a 
few months before my first stint in Tokenga a local woman had fallen sick and died from 
Lassa. Following up this case, the outreach team had visited to do contact-tracing and health 
promotion as per protocol. Despite the sad occasion, the arrival of these ‘strangers’, along 
with a projector to show films was remembered with excitement. Perhaps because this visit 
was still fresh in people’s minds, at the time of my research the word ‘Lassa’ was recognisable 
                                               
49 Jins are mentioned in other Islamic areas so are likely to have been incorporated by the Mende 
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to almost everyone I spoke to; most people could list a few key symptoms and children took 
pride in reeling them off to me. Of course, there were those who were still unsure of how to 
recognise a case of Lassa or what should be done about one, but the dominant message 
contained in a phrase I heard repeatedly was clear: ‘that person should be taken straight to 
hospital’, and there should be no delay. Even the resident healers and imams agreed that there 
are no remedies to be found in traditional medicine and the only treatment for Lassa is 
biomedical, more specifically it should be administered only at a hospital. In terms of 
prevention, the village authorities had passed a new law that forbade the consumption of 
arata50, a strategy emphasised in the outreach team’s prevention efforts. This law stated that 
if anyone was found eating arata then they would be fined. On top of which, if that person 
subsequently fell sick they would not be taken to hospital.  
 
These statements should be considered against the backdrop of fevers in general. Fever is a 
common complaint in Mende villages. In Mende kᴐlε is used to mean fever and cold. A person 
would say they were attacked by kᴐlε to mean they “feel cold” or that they had a temperature, 
in Krio: de bodi wam (the body is warm). Kᴐlε was frequently accompanied by sweats or 
shivers. In Mende, kᴐlε is also used to mean deception (Innes, 1969), underlining the 
ambiguous nature of fever with its fluctuations from hot to cold. Ethnographic texts of the 
region emphasise the pervasiveness of ambiguity in social life (Bledsoe and Robey, 1986, 
Ferme, 2001) and it appears that the Mende experience of fevers is no different. People 
distinguish two types of fever: kᴐlε wee (small fever/cold) and kᴐlε wa (big fever/cold). The 
first, kᴐlε wee passes in a few hours, “kᴐlε wee attacks people, they tremble, their body gets 
warm, then later it goes away”.51 It ‘attacks’ people frequently I was told “every time you do 
hard work you will feel that one”.52 It is attributed to everyday causes such as hard work in 
the bush, eating kol ris. One man told me, “sometimes when you eat kol ris, kᴐlε wee will 
attack. You will tremble. You set fire to warm your body, but then you get hot and sweat”.53 In 
contrast kᴐlε wa was characterised by a more intense and longer lasting fever and was 
associated with other symptoms, “when that cold attacks the person and goes up into the 
head, they will see that persons mouth will be red and have some wounds, so straight off they 
                                               
50 Although Mastomys natalensis is actually a species of mouse it is usually referred to as a rat. Health 
promotion on Lassa in Sierra Leone warns people against eating rats in general.        
51 Female, Amara family, Tokenga, 13/03/2012 
52 Male, Sonnoh family, Tokenga, 12/03/2010 
53 Male, Turay family, Tokenga, 13/03/2010 
127 
 
will say that is kᴐlε wa”.54 I was frequently told that kᴐlε wa is Lassa: “kᴐlε wa used to kill 
people, (we) used to hear of it from Panguma. (we) heard of it from Panguma before it arrived 
here. Whenever people are attacked by such cold when they go to hospital they call it Lassa”.55  
 
A number of issues are raised above. The location of these fever categories in real experience 
is a critical part of exploring Lassa diagnosis; the classifications above appear straightforward 
but what do patient’s and community member’s accounts show? Fevers, big and small, are key 
to the general healthcare context in Tokenga and the processes by which Lassa is diagnosed, 
including the association between Lassa and kᴐlε wa. As experienced medical staff will testify, 
and chapter seven will demonstrate, Lassa is extremely hard to recognise based on symptoms 
alone; therefore what happens in village settings does not hinge on disease-specific 
knowledge of Lassa, but on wider concerns and approaches to health. In the village context 
the application of the label Lassa to someone’s symptoms is both the result of, and results in, 
varied treatment pathways which are rather different to the single pathway assumed in the 
formal framing of diagnosis which is represented above. The difficulty of recognising Lassa 
symptomatically means its response (or the lack of it) to treatments targeting other diseases 
becomes a critical element in the diagnostic process. Another part of the story is that the 
range of health interventions which get tried and tested as a Lassa diagnosis begins to take 
shape are negotiated using locally experienced categories; this opens the process up to the 
possibility of a range of different outcomes, many of which may not echo expert advice. There 
are also questions about how, in this process, a diagnosis of Lassa comes to be accepted as 
valid. 
 
One dimension of these locally experienced categories that is particularly relevant and 
potentially challenging is witchcraft; four out of the six cases of Lassa in the village were 
attributed at some point to me as having involved witchcraft. Some of these explanations were 
well developed and widely known. What is interesting is the way that these witchcraft stories 
overlap with local disease categories and the epidemiology of Lassa fever. The sudden death 
of someone powerful is cause for suspecting the involvement of a hᴐnamᴐ; this was the case 
with the chief’s son, the Kamajᴐ who was described as a war hero. Yet it is the particular 
vulnerability of pregnant women from Lassa fever which cross-sects these witchcraft beliefs 
so strikingly. There is a widely held belief that pregnant women who have difficulties or die in 
                                               
54 Male, Turay family, Tokenga, 13/03/2010 
55 Female, Amara family, Tokenga, 13/03/2012 
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pregnancy or childbirth are witches themselves.56 Three pregnant women have died of Lassa 
fever in Tokenga in almost as many years. Here, I explore how these explanations of disease 
causation and outcomes intersect with diagnostic practices, and in particular, how they 
challenge the validity of biomedical knowledge by dealing with the limitations of the 
government healthcare system. 
 
To recognise the plurality of experience and meaning so important in the diagnostic process, I 
will now set out the ‘therapeutic landscape’ (Leach et al 2008). In doing so I look not only at 
which treatments are available, but also how they are used, and how meanings are 
constructed in relation to experiences of them and the people associated with them. This 
acknowledges the defining influence such relationships have on healthcare practice. Through 
these practice-based categories I build up a picture of Lassa diagnosis, of how meanings 
surrounding Lassa are negotiated and how they might be changing. For all the talk of witches 
and Lassa fever there were people, in Tokenga and surrounding villages, who did not 
recognise the disease’s name, however these people would almost certainly know of kᴐlε. Did 
kᴐlε wa previously mean something broader, for example, and if so how has it narrowed to 
mean ‘only’ Lassa? Is Lassa integrated into normal routines or does it contrast to other 
healthcare practices?  Are there, or have there ever been, local methods of treatment and 
diagnosis for Lassa? None of these questions have been addressed before yet all of them are 
essential for understanding and improving Lassa fever diagnosis. 
5.3 Lassa within Tokenga’s Therapeutic Landscape 
Despite not having a government health clinic there is certainly no void of therapeutics or 
local technologies for diagnosis and treatment in Tokenga. As is common throughout low 
income countries (Peters and Bloom, 2012, Standing and Bloom, 2002) the informal sector is 
the source of much, if not most, of the treatments consumed; private suppliers of healing 
products and advice outweigh any formal government or accredited distribution. The 
relationship between new kinds of health technologies, such as ‘English medicine’ and old 
ones, such as ‘herbs’, is complex and residents described conflicted and uncertain 
relationships with aspects of both regimes.  
                                               
56 Similar ideas have been reported elsewhere (Ferme, 2001) and in relation to Lassa fever (Richmond 
and Baglole, 2003) 
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5.3.1 Mende hale and Pu hale 
The Mende word for medicine is hale. In Tokenga residents talk about two kinds of medicine: 
Mende hale (this covers traditional medicine, sometimes referred to as ‘native herbs’) and Pu 
hale (pu meaning white, indicating ‘white people’s medicine’, also known as English mersin in 
Krio; in practice this meant all ‘Western’ pharmaceuticals, which in reality were often Chinese, 
Nigerian or Indian made). Periodically external health workers for the Government or NGOs 
arrive to distribute vaccines or drugs as part of ‘priority disease’ programmes. But mostly pu 
hale is obtained informally. Individual tablets are sold alongside cigarettes on the village’s 
petty trade stall both priced at ‘2 for 2 block’, two cigarettes or two tablets for 200 Leones (the 
equivalent of £0.036 at 2010 exchange rates); a drug pedlar visits once a month with a 
suitcase of pharmaceuticals (but also some traditional medicine). Some residents have 
personal supplies, either bought outside of Tokenga, or sent from friends and relatives. There 
is one resident working with pu hale, a man called Mohammed who prior to marrying a local 
woman had worked in an urban pharmacy; though he has no formal training he has effectively 
become doctor to Tokenga and the surrounding villages. Mohammed makes house calls, 
supplies drugs, injections and, he told me, even fixing up and administering intravenous fluids. 
He is referred to as a nurse by residents.  
 
Mende hale includes tree barks, leaves, or any object which when processed – and used in the 
correct way – will have curative or protective powers. Importantly Mende hale is not used 
only for health matters, it is a broad category of medicines which can be used to assist in all 
sorts of practical or ritual tasks including hunting, farming, fishing as well as healing. As later 
sections will explore, the skills and knowledge needed to practice with Mende hale often 
comes with membership of a secret society or runs in families; in the domain of health there 
are some well-known remedies which can be prepared by anyone, but there are others which 
must be obtained from specialist halemᴐ. Tokenga has two halemᴐ, both elderly women, who 
are consulted for health concerns ranging from the minor to serious. Others who deploy 
specialist knowledge of Mende hale are the three traditional birth attendants (TBAs). The 
work of the TBAs in taking care of pregnant and nursing women is fundamentally tied to their 
position as Sande officials and their use of specific society hale (Ferme, 2001, MacCormack, 
1984). The TBAs also illustrate the way in which traditional and biomedical medicines are not 
rigidly separate: the TBAs have been trained by NGOs (and government) in elements of 
western medical midwifery as well as to ‘refer on’ to government health facilities (this is a 
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well-established strategy and has been documented previously in Sierra Leone for example in 
MacCormack, 1984).  
 
The blend of traditional and biomedical activities carried out by the TBAs suggests that 
although the distinction between pu hale and Mende hale is locally used, it is more nuanced 
than it first appears. As noted previously, African medical systems have been characterised as 
open and plural (Janzen, 1981, Reynolds Whyte, 1982). Furthermore, within those plural 
systems, pervasive dichotomies such as those between ‘public’ and ‘private’, ‘formal’ and 
‘informal’, or ‘traditional’ and ‘biomedical’ have been shown to be artificial (Cross and 
MacGregor, 2010, Leach et al., 2008, Standing and Bloom, 2002).   
 
Instead they are better understood as hybrid. However, hybrid should not be taken to mean 
that there are no differences in how therapeutics are used. In Tokenga, despite an often stated 
preference for pu hale it is clear that, as people negotiate their way through the multiple 
providers of healthcare, their choices are not simply determined by a play-off between 
biomedical and traditional options. Instead they make use of alternative categories which are 
more salient to their own experiences and which are rooted in broader social and historical 
concerns. As the following sections attempt to document, the categories mediating healthcare 
practice and the diagnosis of Lassa are more likely to revolve around: the way medicine is 
thought to work; forms of expertise; types of illness; and payment methods. Some are more 
relevant than others but it is through these elements that a diagnosis of Lassa develops, and 
thorough which it takes on meaning.  
5.3.2 How hale works: regimes of medicine use  
Although hale can be roughly translated as ‘medicine’, in its broadest terms it equates to 
‘power’. Thus, in Mende usage hale covers a much broader concept than the western 
biomedical notion of medicine. Mende understanding of hale encompasses powerful 
substances, chemical or supernatural, able to do both good and bad. As well as curative 
compounds hale can refer to objects or mixtures which have supernatural powers enabling 
them to achieve particular objectives, including the non-medical, for instance to detect lies or 
thieves (Little, 1948). Mende hale is distinctive, along with other West African regions (Leach 
et al., 2008), for having both protective and curative effects. Amulets are worn by children to 
ward off a range of things including thunder, witches, convulsions or malaria. The concept of 
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hale extends to the secret knowledge of the Sande and Poro societies, as the word hale also 
refers to the societies themselves: Sande hale for the Sande or polεi hale for the Poro (Jedrej, 
1976b).  
 
Yet although hale comes in many shapes and sizes and performs multiple roles with great 
effect, hale does not have innate power; it needs particular conditions or actions to make it 
work. It is owned and given by specific people for specific purposes. The social distinctions 
that hale represents either in its possession or use (in the form of knowledge or remedies), 
are critical not only to how it works but also to how society works: differentiation and 
distinctions in hale use echo distinctions in life. For instance gender crosscuts hale; activities 
such as palm climbing or hunting are gendered, men and women have differing roles and 
there are specific medicines to assist in these roles (Leach, 1994). Thus rules about medicines 
are also codes about gender and moral order, a point also illustrated by the secret societies 
control of hale and their maintenance of hierarchy.  
 
The conditions which must be ensured to bestow hale with its power are at the root of some 
striking features of medicinal socio-technical practice in Tokenga. On the one hand, numerous 
rules surround the use of Mende hale but on the other, the use of pu hale is characterised by 
an absence of rules. First, the controlled conditions which are so fundamental to the 
preparation of Mende hale also extends to how they are consumed and various restrictions 
are imposed. For instance a halemᴐ will pray on a medicine or ‘call the name’ of the person 
they are preparing medicine for, after which that medicine belongs only to that person and 
may do harm if used wrongly or by anyone else. There are distinct instructions about how to 
use Mende hale. Ropes made from special leaves twisted and tied around the waist is a 
common treatment, particularly for malaria, yet not anyone can do this. A halemᴐ is 
employed to make them and it will only work if tied on to the patient while they stand in a 
doorway. Another medicine for healing wounds cannot be passed from person to person but 
instead has to be placed on the ground before being picked up by another person. Other 
traditional remedies cannot be used with injections or pu hale. Even some of the self-
administered treatments have certain prescriptions. For example, putting babies to lie in the 
rice fan is a method of curing convulsions, but it will only work if the word for rice fan, fεlε in 
Mende, is not said aloud when preparing to treat the infant in this way. The socially embedded 
and prescriptive nature of Mende hale underlines how healing is not just a technical process 
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but a thoroughly social one. The efficacy of the medicine depends on the quality of social 
relations; the rules of its use, which determine its effectiveness, are to a large extent 
concerned with upholding the authority of healers and other moral codes. 
 
In contrast, Western medicines are sold without instructions and there is little guidance on 
administering them, except what people may know themselves, or what their (untrained) 
vendors may suggest. Old stocks of medicine from previous trips to health providers can also 
be re-used inappropriately, for instance the offer made by a grandmother of her typhoid 
medicine to treat the sore on her granddaughter’s foot. Sometimes pu hale is used in 
unconventional ways, as in the practice of sprinkling the contents on an antibiotic capsule on 
to wounds to heal and prevent infection. Yet, although there may be an absence of biomedical 
guidance this does not mean there is a blank slate; when people are left to self-medicate they 
will build their actions on other precedents. Bledsoe and Goubaud (1985) observed that 
Western pharmaceuticals are subject to “reinterpretation” in line with Mende concepts of 
hale; the transformation of pharmaceuticals, such as injections, as they are incorporated into 
established healthcare systems has been observed elsewhere (Geest et al., 1996, Reynolds 
Whyte, 1992) There are suggestions of this in Tokenga, for example the practice of taking 
paracetamol daily to protect from fevers and colds echoing the protective qualities of some 
Mende hale.  
 
It should be noted that not all Mende hale are subject to strict rules, and not all pu hale are 
unfamiliar. Indeed, there are traditional and biomedical medicines which are not subject to 
special controls, can be prepared independently and which villagers use regularly with equal 
familiarity. These are largely for those ‘everyday’ familiar diseases. Indeed it is these 
medicines that interviewees described using in their initial attempts to treat unknown cases 
of Lassa: ginger, pineapple skin tea, bitter leaves and bark, paracetamol. However aside from 
these common remedies, on the whole there are fewer restrictions governing the use of pu 
hale (at least that which is available in Tokenga), than on Mende hale.  
 
Healthcare systems and the use of medicine within them are co-produced with moral and 
social order, as such they are historically situated and path dependant (Bloom and Standing, 
2006, Janzen, 1981, Leach et al., 2008, Reynolds Whyte, 1982). In the Mende case, the rules 
and beliefs concerning how Mende hale works are embedded in wider configurations of a 
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social order based on secrecy and hierarchy.  Mende society is made up of people belonging or 
excluded from different societies57 and levels of hierarchy within these, each with their own 
areas of specialist knowledge, including health. There are both vertical (e.g. between all 
females in the Sande and between all males in the Poro) and horizontal (e.g. between senior 
society officials over younger initiates) manifestations of sodality and power (Bledsoe, 1984, 
Ferme, 1994, Hoffer, 1974). It is of particular relevance that hale also refers to secret societies 
(Sande hale and polεi hale), as it underlines how hale is not just a material remedy but also 
the hierarchical knowledge around which social relations are organised. In terms of health, 
the restricted possession of hale (as knowledge or as material medicines) is precisely what 
makes it so powerful (Bledsoe and Robey, 1986, Jedrej, 1976a). These are the historical and 
social foundations which Mende therapeutic practice is embedded in, and which create highly 
structured domains of wellbeing and access to healthcare. The situation is somewhat different 
for pu hale.  
 
Access to pu hale and biomedical treatment is, of course, restricted in important respects, 
both financially and through its own hierarchy of expertise, with community nurses at PHUs 
referring up to doctors at district hospitals. However, thinking of medicines as technology, it is 
significant that the production and use of Mende hale is set within locally meaningful 
‘techniques’ and ‘regimes’ (Hopkins, 2004). Conversely when pu hale is imported into the 
village by drug peddlers and the like, it is done so independently of the techniques and 
regimes which were designed to support its use. While some biomedical therapies are 
incorporated into existing Mende regimes, partly collapsing distinctions between traditional 
and Western, the limited technical know-how of pu hale within the biomedical regime has 
serious ramifications for drug resistance, where the informal and un-regulated supply of 
western medicine is so prevalent. The issue has additional relevance to processes of Lassa 
diagnosis because, as will be reiterated in chapter seven, clinical diagnosis depends on an 
accurate history of previous treatments and responses to them, and if drugs have not been 
taken properly this becomes difficult.  
5.3.3 Differential access to medicine and knowledge 
The proceeding discussion of hale is closely linked to the issue of power as practiced by 
certain people drawing on distinct claims to knowledge. Biomedical health systems can be 
                                               
57 Just as men and women have societies, so do witches and spirits 
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conceptualised as systems of organised access to expert knowledge (Bloom and Standing, 
2006), and the ability to make a diagnosis is one of the main reasons for consulting a specialist 
health worker. As the preceding discussion of hale has alluded to, access to expert healing 
knowledge is equally structured. In this section I outline the various domains of power, 
knowledge and practice and reveal how they assist in finding out what is the cause of a 
sickness. 
 
First there is Tokenga’s residents own expertise to consider. They have considerable 
experience in recognising and treating common ailments, from rashes and sores to malaria, 
they are able to recognise the symptoms and respond effectively in many cases. When a 
sickness cannot be dealt with independently at home, the choice of village based halemᴐ 
includes: the ‘drug peddlers’, herbalists, the TBAs, or the resident ‘nurse’. In all of Tokenga’s 
Lassa cases the advice of one of these people was sought initially; being located in the village 
they are an obvious first step when hospitals are so far away but the reasons one is chosen 
over another are more complex. The stated preference for pu hale is cross-cut by other 
considerations to do with payment, kinds of disease, as well as the regimes surrounding 
medicine use touched upon earlier. I found, in those who had knowledge of Lassa fever, a 
consensus view that there were no traditional remedies for Lassa fever and that going to the 
hospital was best. However, the difficulty in recognising Lassa means this can be largely 
irrelevant. 
 
The herbalists and the ‘nurse’ have few diagnostic tools in the biomedical sense. Instead they 
rely on their accumulated specialist knowledge of disease and symptoms. The herbalists see 
signs relating to treatment outcome as they prepare hale, such as the colour of medicinal 
leaves when they collect them or whether the ropes fray and break as they twist them for 
malaria. The resident ‘nurse’ relies on his experience in pharmacies and has a medical text 
book he consults about symptoms. Interestingly the herbalists’ signs concern prognosis rather 
than diagnosis indicating whether a patient will survive or die. The potential that sickness is 
due to supernatural causes calls for other forms of investigation, based the capacities of a 
limited number of people who have the powers to “see what is behind” a problem and then to 
deal with it appropriately.  
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When supernatural causes are suspected a ‘witch doctor’58, lookin gron59 or kamoh60 are 
amongst those who can confirm whether it is so and assist if it is. Certain kinds of sickness are 
more strongly associated with witchcraft or ‘bad medicine’. Sudden deaths and pregnancy 
have already been noted, but it can also be behind longstanding illnesses which are not cured 
by normal methods. For instance an elderly woman treated for months with pu hale and 
admitted to a hospital was eventually taken to a kamoh. A kamoh uses verses of the Quran to 
pursue outcomes as instructed by a client, this might include matters of love, work, school, 
telling the past or future, court cases, dealing with enemies, madness, or protection (Bledsoe 
and Robey, 1986). Because their privileged knowledge of Islamic texts is at the root of their 
abilities, the kamoh is regarded as good for dealing with devils and jins. In performing their 
work they may make a show of using Islamic writing; in Tokenga the kamoh wrote out a series 
of letters and symbols when I consulted him and made it clear his words of advice were based 
on messages derived from them. In general, they will not enter in to explanations in order to 
maintain secrecy and the respect which comes with it. Jins are said to have sodalities and the 
skill of the kamoh or moriman is to act as a broker  (Bledsoe and Robey, 1986). Likewise, 
witches are always explained as having ‘their own society’, and that a ‘witchdoctors’ ability to 
defeat witches comes from their knowledge of ‘witch business’. The kamoh in Tokenga, who 
was the Imam, said he could ‘try’ with witches but generally such things are left to 
witchdoctors. In Tokenga this is either the town chief who is a respected ‘witch doctor’, or a 
second man who visits Tokenga and has powers to ‘fight witch’ and ‘drive it away’. The 
involvement of witches can be detected in a number of ways: by soothsayers and 
witchdoctors but also in dreams or by certain people who are deemed to have the power to 
‘see things’, such as twins. The herbalists in Tokenga also claimed to be able to tell ‘straight 
away’ if a witch was behind an illness though they were not able to treat it.    
 
In terms of authority and belief in healing potential there are some interesting shifts taking 
place around hale. Before the war, Carol MacCormack  (1984) argued that the centralised, 
top-down, bureaucratic health system in Sierra Leone was dislocated from rural modes of 
authority. She pointed out that the limited manpower and resources which did reach those 
                                               
58 ‘Witch doctor’ is someone who was able to ‘fight witch’, a somewhat ambiguously acquired skill  
59 ‘lookin gron’ Krio for ‘looking ground’, someone who can see the past/future, similar to a soothsayer 
60 I use kamoh to mean someone who practices Islamic magic. Another Mende name for this was 
moriman. In Tokenga kamoh was interchangeable with moriman and soothsayer. This usage is slightly 
different from Bledsoe and Robey (1986, p223) who draw a distinction between a moriman as a 
practitioner of Islamic magic and a kamoh (also known as a karamoko) primarily as an Islamic teacher-
scholar.   
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areas was often alienated from recognisable forms of health care expertise and delivery, such 
as the TBAs who are also secret society officials, and so lacked legitimacy. During my 
fieldwork people frequently told me they preferred pu hale. The campaign by Tokenga’s 
resident’s to get a government clinic and nurse in the village was a good indicator of that 
preference, as well as some degree of approval for government healthcare. But the 
relationship with pu hale is complicated; villagers are aware and strongly disapprove of the 
counterfeit and expired drugs they are sold by pepper doctors (a negative term for drug 
peddlers or untrained providers). Equally they are not convinced by the integrity or quality of 
‘official’ healthcare where prices are high and where, it is said, the nurses ‘do not care’ for 
patients. The negotiation of medicine and treatment is also a negotiation of the people and the 
systems providing it. 
 
Some Tokenga residents expressed views which suggest MacCormack’s argument still holds: 
 
“He didn’t take the right medicine for that sickness, and even tests were delayed. The treatment 
should have been free, according to what we know. They didn’t ask for money, money was there, 
our brothers were there... the government hospital mostly are not busy for patients, this is the 
main problem, they do not care for patients”.61  
 
The pre-paid model that Sierra Leonean government hospitals work on is disapprovingly 
interpreted as hospital staff being more interested in money than treating patients. The lack 
of resources at these points of care leads to a further eroding of confidence. The nearest 
government clinic is often bypassed in favour of Panguma hospital because, residents told me, 
the nurse was often absent or had no medicines. The legitimacy of formal healthcare 
institutions is further undermined by incidents where holes in their claims to biomedical 
expertise are exposed. Lassa has a way of making the ‘experts’ appear incompetent, and 
stories like that of Mariama, who was misdiagnosed, are testament to this. This was what her 
husband recounted: 
 
“the doctors told us that they are trying. I asked them whether they would be able to cure my 
wife, and to know what really is affecting her. It is just at the later point that they told me it was 
Lassa, They didn’t mention about Lassa when we were there for all the 14 days, except on the 
15th day they reported that it was Lassa. We went to Kenema, we were there for only 4 days, then 
she died”.62  
 
                                               
61 Patient’s brother, Lassa history 2, Tokenga, 19/02/2010 
62 Husband of patient, Lassa history 3, Tokenga, 19/02/2010 
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Her husband described the hospital’s initial diagnosis of Typhoid as “their first sin”. 
Significantly, as I will come to, this is one of the cases which was widely reported as being 
witchcraft. Here the failure of biomedicine and common beliefs about pregnant women 
converge to challenge biomedical expertise and diagnosis, and keep alternative forms of 
authority alive.  
 
The awful story of one family from a village which experienced an outbreak of Lassa fever in 
2010 exemplifies the high costs of being on the very end of a poorly resourced health system 
where staff are not well trained. Four members of the same family contracted Lassa, and 
despite visits to the local government health centre, two children died before Lassa was 
queried, and a third child died later in Kenema, while their mother was left with severe 
deafness. When the first child got sick he was taken to the local clinic who said it was malaria. 
Medicines and injections were bought, but crucially the nurses did not transfer them on to a 
hospital until it was too late. As the boy’s father put it in Krio: “time don pass....no transfer 
we”63 (time passed…we were not transferred). The boy was not able to eat, stand, sleep, talk. 
His father told me that they did not make the trip to Panguma hospital because in his mind “he 
has died already”. The second child fell sick a couple of days later and they returned to the 
clinic. This time there was no medicine and so the father took the child to a clinic in a 
neighbouring village. Lassa fever was not mentioned at either clinic, and that child also died. 
On his return to his village the man found his wife and another child sick, at this point the 
nurses finally called Kenema. The failure to pick up these cases early enough led to a request 
by village residents that the nurses be removed and replaced, who were fed up with the lack 
of attention and care which left them so vulnerable. In this case their wish was granted, with 
some additional advocacy help from the Lassa outreach team, however the under-resourcing 
and lack of proper training in Sierra Leonean health settings means that non-specific diseases 
such as Lassa will continue to present problems for claims to legitimacy and expertise; in such 
circumstances, the dynamics of such relationships could be shaken up if diagnostic 
technologies, such as RDTs, were to be made available outside of KGH. 
 
Despite the tensions evident above, in cases of escalating severity a visit to a biomedical 
practitioner is usually regarded as the necessary next step for fever. But there are other 
factors at play in the decisions people make about where to go. It is striking that out of the 
                                               
63 Father of patients, Lassa history 8, Foindu, 12/05/2010 
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accounts of Lassa fever I collected from Kenema Town, one from a nurse at the hospital, the 
majority of them went initially to private hospitals and pharmacies rather than KGH. One 
exasperated nurse put it down to “personal relationships”. Established trust and connections 
are understandably likely to be a significant in decision-making: out of Tokenga’s six known 
Lassa cases, spanning a period from the civil war until 2010, five of them were treated by 
‘private’ pharmacists and ‘dispensers’; two of these saw no government representative and 
were never treated at Kenema. The first case fell sick during the civil war (1991-2002), he was 
treated for 3 days by a private pharmacist who gave him injections and tablets “but they never 
knew it was Lassa”.64 After two days his brother came and took him to Blama (a town near to 
Kenema) to a private dispenser “who had a relationship with my [his] brother”. This 
dispenser recognised the signs immediately: “straight away he said it is Lassa”.  He was 
treated by this man for a period of 40 days until he got better, though he did not recall with 
what as he had been too unwell to know what was happening. Though it was wartime and 
circumstances were strained, it is a striking example of Lassa being treated informally, 
especially given that the Lassa ward was so nearby. This case illustrates that there is a 
practice of treating Lassa informally, despite the attempts to centralise care in Kenema. While 
some private dispensers do refer suspect cases to hospitals, there are clearly those who 
actively discourage people and it is left to the outreach team to dissuade them from treating 
suspect Lassa patients, which would mean a loss of revenue for them.    
 
A second of Tokenga’s residents was actually on his way to Panguma hospital when he 
encountered a private dispenser in Dodo who recognised he had Lassa telling him “this is not 
just an ordinary cold, this is Lassa”.65  Both the sick man and the dispenser had heard of the 
lethal injection rumours and the dispenser advised him not to go to Kenema, telling him to go 
to Tongo where there were dispensers who could treat Lassa. He went straight to Tongo 
where another dispenser agreed it was Lassa because of his symptoms: sore throat, red eyes, 
and headaches. After at least a week of treatment and injections, at a cost of 40,000 Leones 
(£7.20 in 2010 exchange rates), he began to recover. It may be accepted that Lassa is not 
treatable with ‘herbs’, but there are apparently some informal providers of pu hale who will 
try to treat it. 
 
                                               
64 Lassa history 6, Tokenga, 11/03/2010 
65 Lassa history 1, Tokenga, 18/02/2010 
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The TBAs are a good example of how health systems and healing practices cross-sect patterns 
of authority in other social and cultural domains. They are also of particular relevance here as 
Tokenga has seen three pregnant women die from Lassa and all of them were seen by the 
TBAs initially. This indicates that there are certain domains of expertise whose linkages to 
official aspects of the Lassa diagnostic system are of considerable importance. The linkages 
are complex. On one level, they have long been cultivated: TBAs have been encouraged to 
‘refer on’ and feed into the government system for a long time (MacCormack, 1984). Some 
free health care has been provided to pregnant women historically too, but the dynamics 
changed entirely with the announcement of the Free Health Care Initiative in 2010. Even 
before that, I was told that pregnant women prefer to go straight to clinics if they are in the 
later stages of pregnancy. However, the walk from Tokenga to any of the nearest clinics was at 
least a few hours, able bodied; as such TBAs are an important source of general and 
emergency local care. A recent development is that TBAs have been banned from assisting in 
healthcare (Whitaker, 2012) making the links more precarious, though during my fieldwork 
they were still working and it is hard to imagine they would not continue to do so in the near 
future. The impact such developments have on how forms of expertise are accessed, and the 
consequences it has on therapeutic landscape and diagnosis have yet to become clear. 
 
In the next section I outline how concepts of kinds of disease are implicated in healthcare 
practice. Diseases are defined not down traditional or biomedical lines as much as by practical 
concerns. The disease categories are practice orientated and as such they cut across the 
relationships and social dimensions of healings described so far. After that I discuss the way 
therapeutic options are also influenced by money, or moni business as it is known in Krio.  
5.3.4 Kinds of disease 
Taken as a whole, healthcare and disease in Tokenga is multiple and complex. Here I build on 
well-established studies of African pluralistic treatment environments (Janzen, 1978, 
Reynolds Whyte, 1982) by focusing on an overlooked factor which is variation in disease 
categories (Leach et al., 2008). The reason for this is that the scope for understanding ‘natural’ 
diseases is huge. In Tokenga diseases present themselves in many shapes and sizes. Some 
have clear symptoms or causes while others remain mysterious. Some are serious, others are 
less so. They can have biomedical names and definitions or descriptions which depart 
significantly from Western medical principles. At no point does sorcery have to be involved in 
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causing or treating any of them. There are multiple other classifications which determine how 
people respond first. Explanations of disease involve shifts between kinds of sickness which 
reveals a fluid understanding of illnesses. I suggest that these fluid perspectives on disease are 
able to accommodate and deal with the inevitable ambiguity.  
 
Some diseases exist only as their symptoms, they include joijoi (hiccups), hewεi 
(convulsions), blaiblai (cracked heels) ngeloe (when a child cries like goat). These are 
maintained to be distinct diseases. Descriptions of them reveal understandings of disease 
which contrast to Western biomedical ones. For instance, joijoi is thought to be a serious 
disease; it can ‘come inside’ other diseases and last for up to a week, leaving a person unable 
to speak or breathe, even causing sudden death. Other diseases have well known causes 
attached to their symptoms such as kplee (worms), kraw kraw (heat rash) or bel wei 
(malaria). Biomedical disease labels are used, such as pneumonia, dysentery, or gonorrhoea. 
Some biomedical names have been incorporated into Mende: malari, typhoidi, even lassi. 
But not everyone is at ease with this biomedical language, replying that they ‘don’t know 
about that’ when asked. At times they seem to exist in little more than their abstract English 
name, as labels which are diagnosed and treated by unfamiliar people and in unfamiliar 
surroundings outside of the village. 
 
There are some distinctions between diseases which are known locally and are part of a 
longer history of health knowledge and those newer diseases which have been learnt about 
through new (biomedical) forms of healthcare. For a long time I was confused by talk of a 
dramatic sounding disease called ‘split head’ which seemed fairly common. I established that 
it affects mostly women and children and causes a dip in the middle of the skull from the front 
to the back of the head66. Even on fully developed adults this can feel soft and fleshy instead of 
hard like bone. I was assured that this is a Mende disease treatable only with Mende hale. 
Western medicines are not believed to be effective, it is not something they have the power to 
deal with. Indeed every Western doctor I asked working in Sierra Leone had never heard of 
such a disease. Sierra Leonean health workers knew what it was but said that there were no 
treatments for it, except the ‘native herbs’. I saw at least three cases during my fieldwork. It 
was also common to see evidence of it. To treat it a paste of herbs was applied to the soft 
                                               
66 Down the sagittal suture in between the two parietal bones, or the fontanels in children. 
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section of the skull and women who had been treated for it would have a characteristic bald 
patch down the middle of their heads.  
 
Lassa is the opposite to ‘split head’; as the villagers told me initially “[we] don’t have the 
medicine in Mende for that.”67, it is a biomedical disease label which needs biomedical care in 
a biomedical setting. Yet this framing and course of action depends on Lassa being identified 
early which does not happen. The cause of many illness episodes, including Lassa, remain 
unknown. As such the disease classification system which has most relevance and impact on 
people’s actions is the differentiation between an ordinary sick and hospital sick. Ordinary 
sicknesses can be treated with known remedies, traditional or biomedical, which do not 
require the patient to leave the village. Hospital sicknesses on the other hand need specialist 
attention which can only be found outside the village. Lassa is described as a ‘hospital sick’ 
because of its severity. All of Tokenga’s healthcare providers agreed that it cannot be treated 
in the village, with either pu-hale or Mende hale. In contrast kᴐlε wee is seen as an ‘ordinary 
sick’, for which sufferers described taking different concoctions of pills, herbs and just waiting 
it out. An ex-Lassa patient’s description of the beginning of his symptoms was typical:  “ah bin 
de feel say no more na ordinary cold, na mersin no more ah bin de drink, paracetamol” (I 
thought it was just an ordinary cold, I just took some medicine, paracetamol). 68 
 
The boundaries between a ‘hospital sick’ and a ‘ordinary sick’ are not drawn around 
particular diseases, symptoms, or causes, but on levels of seriousness. Boundaries are, and 
must be, flexible as an ‘ordinary sick’ can quickly shift to ‘hospital sick’; in rural contexts there 
is little alternative than a system based on waiting it out. As the accounts of Lassa in Tokenga 
make clear initially at least distinctions are not easily made: “We were thinking it was an 
ordinary cold or Malaria. This was our thinking, it’s malaria. Because [the cold] was frequent, 
it attacked him frequently”69. The mention of malaria is pertinent as it is another disease 
which crosses boundaries, chronic as it is in Sierra Leone it is usually a routine ‘ordinary sick’ 
but it can also flare up into a fatal episode of ‘hospital sick’.  
 
In addition to severity, there are other implicit dimensions to ‘hospital sicks’. Lassa was 
described to me as having a ‘big name’ or as one man put it “Dat sick, e nam big!” (that disease, 
                                               
67 Male, Sonnoh family, Tokenga, 12/03/2010 
68 Lassa history 9, Tongo, 24/04/2010 
69 Mother of patient, Lassa history 2, Tokenga, 19/02/2010 
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it has a big name). 70 This man described how he had been afraid when the doctor diagnosed 
Lassa: “wae de doctor don prove say na Lassa, mi heart be worry, mi heart e be poil” (When the 
doctor proved it was Lassa my heart was worried, it ‘spoiled’; meaning it was heavy).  Another 
expression in Mende was a hiegbɛ wa (a big disease), in Krio a ‘big sick’. As a renowned and 
fearful hiegbɛ wah, Lassa is an archetypal hospital sick. But with bigness and hospitals come 
implications: being away from work and farms, travelling long distances and, critically, paying 
potentially large sums of money. As such, routine life is severely disrupted, and can spiral out 
of control, once hospital care is sought. During a conversation with a man in another village he 
explained to me the fundamentals of treatment options for fever: “If you get money then if you 
have kᴐlε you will go (to the hospital), if not you don’t go anywhere”. The same man who 
referred to Lassa as a ‘big sick’ (above) emphasised that people only survive if they have 
money and family: “Wae dey no get moni, dey die” (when they do not have money they die). He 
added later, “dat sick, wae e move sombodi, if dey no get fambul, dey die. Becos, for carry n go 
any hospital, na big distance” (that disease, when it infects somebody, if they do not have 
family they will die because to take them to a hospital is a big distance). These are the social 
relations of sickness (Young, 1982). Lassa is not just experienced through these money and 
relationship dimensions, it is fundamentally diagnosed through them, perhaps constituted 
too: with money, and family, a sickness can make the transition to become a ‘hospital sick’. 
Without money, it is more difficult. I will be relating this to the mangle of practice in more 
detail later, but I want to emphasise how the dimensions of diagnosis covered here can be 
interpreted as being forms of resistance which are encountered as a diagnosis emerges. The 
way these resistances are responded to, be they fear of going to hospital or inability to get to 
the hospital, shapes how, and if, a diagnosis of Lassa fever emerges with some very different 
consequences. Negotiating the cost implications of sicknesses and of various treatment 
options is the theme of the next section. 
   
The transition from ‘ordinary sick’ to ‘hospital sick’ is a key step along the pathway towards 
the formal diagnostic system. However, when the label Lassa fever is applied to a ‘big sick’ it 
can, paradoxically, be a step in the wrong direction. In the lethal injection rumours the notion 
of a ‘hospital sick’ mutates in a way which has the potential to influence diagnostic pathways 
in a completely opposite way as the hospital becomes the one place to avoid. The rumour that 
Lassa patients are given lethal injections at Kenema was widespread. Ex-Lassa patients whom 
                                               
70 Lassa history 10, Tongo, 27/04/2010 
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I interviewed from areas across the Kenema district recalled they had been scared to go to 
Kenema because of it. In fact the Tokenga resident who decided not to go to Kenema hospital 
after the dispenser told him he likely had Lassa gave it as his primary reason:  
 
“People were dying whenever they took them to Kenema hospital. If they are having Lassa most 
of them will not survive. So really that was my fears!.....By then Lassa had broken out around 
here, so any patient which they discovered had Lassa they took to Kenema hospital, if they see 
that you are not going to survive they will inject you to die”.71  
 
There are signs that belief in the rumour is diminishing; in Tokenga people usually said it was 
something they used to believe and (as expected) surviving ex-Lassa patients could all 
confirm that was not true. However, one woman in Tokenga maintained that hospital staff still 
do it (in the case of HIV too) in order to minimise harm to others. The infected person is killed, 
she said, to “let it no scatter” (so it does not spread).  The supposed rationale therefore, is not 
evil health care workers but a fatalistic response to a situation where it is thought nothing can 
be done. Problematic beliefs such as these are most likely borne out of rumours (and 
experience) of high mortality rates combined with specialised and centralised treatment 
facilities which exclude those not with Lassa fever. Similar concerns about the distrust of 
health workers have been raised with Ebola (Hewlett and Hewlett, 2008).   
5.3.5 Payment methods 
There are practical matters about how treatments can be obtained and how much they cost. 
There are significant differences in the way these treatments are paid for. As I previously 
noted, the tablets sold at the petty trade stall are cheap and priced like cigarettes ‘2 for 2 
block’. The herbalists can be given ‘kola’72, perhaps 200 or 300 Leones, but sometimes food or 
other gifts. Mohammed, the informal village nurse, charged little or nothing for his services, 
only asking cost-recovery prices for any medicines he bought. If people did not have money he 
would accept rice. The visiting drug peddler’s business is based on monetary transactions 
which are mostly paid up front, though he allows some people to keep tabs with him. The key 
point here is that payments for the services of the ‘nurse’ and the herbalists (and to a lesser 
extent the drug peddler) are informal and can be paid after. Mustapha, the ‘nurse’, was 
                                               
71 Lassa history 1, Tokenga, 18/02/2010 
72 This is generally a small gift or amount of money. The expression comes from the giving of Kola nuts. 
Kola nuts are grown in Sierra Leone but are traded throughout Africa.  Within Sierra Leone they are 
used as offerings in key social occasions, including funerals and weddings. They break into two parts 
and so are often shared, which is part of their symbolic importance.    
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praised in particular by residents for the good he was doing for the community by providing 
nearly free-health care; one resident described him as “working for God”.  
 
This is in stark contrast to the government and mission hospitals or clinics where payment 
must come first. People’s disapproval is expressed in the Krio phrase ‘pas you pull moni’ (not 
unless you pay). Admission to the nearest hospital, Panguma, was 50,000 Leones (£9.00 in 
2010) which is a huge fee already but any treatment and procedures received would be 
charged on top of that. Operations could be hundreds of thousands of Leones, and if patients 
were referred on to hospitals such as KGH there would be a similar set of fees to pay again. 
Some suggested that in desperate times they may go to the hospital and see if someone there 
‘will help you’ by lowering a price. Otherwise it was agreed that without money there would 
be no point in going to the hospital. People tell stories of wounded or dying people being 
ignored for lack of money. This would not actually be true in the case for Lassa as it is one of 
the few diseases in Sierra Leone where treatment is free. However although some people 
were aware of this, it was not common knowledge. Furthermore, given that Lassa is usually 
not diagnosed until a trip to the hospital is made it remains the case that people with non-
specific febrile symptoms will perceive the monetary barriers as they would any other 
sickness.73 And the histories of Lassa in Tokenga reveal that substantial amounts of money get 
spent in hospitals before the free care is reached on the Lassa ward.  
 
The story of Kema the most recent case of Lassa from Tokenga demonstrates this all too well: 
Kema was 7 months pregnant, feeling feverish, with pain all over her body and especially in 
her sides. She was taken by her husband’s family to see Mohammed  and the TBAs who both 
treated and monitored her. Onlookers speculated she had a sickness called kotubee which 
causes pain in the sides and so she was given the traditional remedy for that. After two days 
her condition worsened and she was taken to the clinic at Dodo in a hammock. There, the 
nurse gave her “an IV” (intravenous therapy) and for a while she seemed better. She was able 
to stand up and wash. Her husband went back to Tokenga to fetch 50,000 (£9.00 in 2010) 
Leones to pay for the drip while his mother stayed with Kema. Overnight she went into labour 
but there were complications, she was unable to deliver and the child died. When Kema’s 
                                               
73 As the FHCI was only introduced in April 2010, after the bulk of my data collection, it remains to be 
seen how this will impact on health care seeking and Lassa diagnosis. Significantly, the months 
immediately after it was introduced the clinics and hospitals did see a noticeable increase in the 
number of women and children coming for care which should result in more Lassa fever diagnosis. 
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husband returned with the money in the morning he was told the news. At that point he 
remembers the nurse saying that she suspected Lassa: “she told us it is Lassa, she wore hand 
gloves”.74 An ambulance was called to take them to Kenema, where after paying 20,000 
Leones (£3.60 in 2010) for admission Kema was put on to the maternity ward. For a drip they 
had to pay another 15,000 Leones (£2.70 in 2010). During the night her condition worsened 
and the nurses told them to buy another injection. The doctor examined her the next morning 
and said he suspected Lassa. He asked them all to leave and arranged for her to be transferred 
to the Lassa ward. In all this time Kema had still not delivered her still born baby. Her 
relatives were told that the operation to remove the child would cost a further 200,000 
Leones. As they did not have that amount of money with them Kema’s husband had to travel 
back to Tokenga to ‘find’ it. Kema died while he was gone. The money, which he had 
succeeded in getting together, was used instead to pay for chemicals to spray and wash the 
body, and to buy a shroud for burial. During Kema’s ordeal her husband had had to travel 
back to Tokenga to ‘find money’ twice. Neither the distances or the sums are insignificant but 
both were futile. Kema’s husband reflected on his wife’s illness:  
 
“at Dodo health centre they did their best, they tried, it is only god that did not allow her to 
live....at Kenema they tried but their problem is unless you buy whatever they need for treatment, 
if you don’t buy it they will not treat….I came back for money.”75  
 
Though treatments at Dodo and Kenema have to be paid for, the nurse at Dodo, who was 
known to them, could be paid later. Whereas at Kenema, Kema’s husband said, “if you don’t 
pay money they won’t do anything”.  
 
Enlisting the help of a witchdoctor can rival hospitals in price. An initial consultation to a 
moriman, witchdoctor or kamoh could be as little as ‘2 block’ (200 Leones). However, receiving 
protection (often in the form of herbs and materials sewn into bundles to be worn or carried, 
usually in a concealed place) can cost as much as the hospital bills. The healers and 
witchdoctors do take on patients for long term treatment and usually the fee is paid as they go 
along or afterwards. In that way it is more flexible than a pre-paid hospital bill. One family had 
employed Tokenga’s kamoh to cure their grandmother who had been sick for a long time. He 
asked them for 300,000 (£54 in 2010) Leones and began treating her. The family had paid him 
200,000 (£36 in 2010) for the initial stages of her treatment when the lady died. Angered by 
                                               
74 Husband of patient, Lassa history 4, Tokenga, 09/03/2010 
75 Husband of patient, Lassa history 4, Tokenga, 09/03/2010 
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this, particularly because he had failed to warn them that she would die, the family had 
refused to pay the rest of the sum.  
 
Evidently, the different sources of care bring with them very different payment arrangements. 
Many of the informal healthcare workers, including private pharmacists, village dispensers or 
herbalists, can be paid informally, perhaps after the treatment, in instalments or by other 
means such as rice. These transactions serve to build up, and on, personal relationships and 
are often interpreted as the healer ‘caring’ and ‘trying’ for a patient which is looked on 
favourably; on the whole, these are the elements considered as lacking in the formal 
healthcare settings. In terms of Lassa the free treatment is welcomed once people arrive on 
the ward but it does little to affect the perceived monetary barriers, as many people either do 
not know about it, or more likely do not know they have Lassa. This leaves the pathway 
towards a diagnosis of Lassa in a hospital setting as riddled with risks and costs. As the case of 
Kema shows, it is possible to pay a huge amount and still lose everything. For some the risk is 
too much. As the father whose story I told previously, who lost three of his children to Lassa 
fever, explained in the barest sense: when the clinic staff finally referred his first son to 
Panguma hospital the boy had deteriorated to the point that he could no longer walk, sleep, 
eat or talk. Doubtful that he would even survive the journey to the hospital he refused to take 
him, reasoning that his son would die anyway and he would not pay money for him to die: “Ah 
say no, e don don, na die e dae die so, so ah no go pay no moni” (I said no, he is finished, it’s over, 
he has died already so I am not going to pay money).76 This underlines the point made earlier 
about big sicknesses; payment is a cruel mediator in the way ‘hospital sicks’ are, or can be, 
dealt with. Health and healing, with both Mende hale and pu hale is a social process; 
relationships, local categories and meanings are all important but frequently the final 
decisions are boiled down to access and finances. 
5.4 How Lassa emerges 
The activity to improve diagnostics being conducted in the Kenema lab is already having an 
effect, little by little; as diagnostics and surveillance improve village settings such as Tokenga 
are brought, unknowingly, into a global research machine. The trips to Kenema, ‘pulling’ of 
blood samples and visits from outreach and strange researchers like me are all impacting on 
how individual cases of Lassa fever come to be recognised.  
                                               
76 Lassa history 8, Foindu, 12/05/2010 
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5.4.1 The process of diagnosis 
The preceding pages have given an insight into aspects of therapeutic practice. I have tried to 
bring out the way they all have a part in shaping the Lassa diagnostic process. The process is 
not defined by testing instruments but instead it is a bricolage system which entails, to 
varying degrees: symptom recognition, the classification of severity, the use of different 
remedies, and visits to various authorities. The diagnostic label of Lassa is not usually applied 
until a trip to one of these authorities and usually to one located outside of the village. At most 
stages a diagnosis ‘relies’ on the failure of treatments as this provokes a trip to the next tier of 
healthcare. Most signs in this system point towards a hospital, for example there are not 
concerted attempts to treat it within village settings. Yet the process is still characterised by 
uncertainty combined with vulnerability because, on top of the risks that a trip to the hospital 
brings (whether it is fears of fatal injections, or cost), once there the uncertainty does not end. 
As the story of Mariama who spent 14 days in hospital before Lassa was queried shows, the 
stories of Lassa diagnosis are full of images of patients and their family being at the receiving 
end of clinical ambiguity. There is a sense among some families that it could have been 
avoided:  
 
“if they could have called or mentioned that is was Lassa maybe everybody would have been busy 
enough to contribute and to cure the man.....sometimes they [his relatives] called them [the 
doctors and nurses] to come to the bed but they never”77.  
 
Indeed sometimes the uncertainty appears to be increased by circumstances in health 
settings. Kema’s husband reported that the nurse at Dodo referred them to Kenema, wearing 
gloves and telling them it was Lassa. The apparent failure to communicate the message of 
Lassa fever is a story echoed by a doctor in chapter seven who describes his misgivings about 
the delay in the case definitions and the poor communication between tiers in the health care 
system. Kema was not transferred directly to the Lassa ward where she could have started 
treatment earlier.   
 
Until a patient’s blood sample gets to the Lassa laboratory in Kenema no reliable or formal 
diagnosis of Lassa is possible. Even so, it is sometimes tentatively applied before that point. 
This no-man’s-land of the illness/sickness experience is left largely to the peripheral and 
informal health care providers where there are contrasting approaches. Though there are 
                                               
77 Brother of patient, Lassa history 2, Tokenga, 19/02/2010 
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times when cases suspected of Lassa are referred to appropriate government clinics but there 
were also cases where patients were referred away from Kenema. Then there were the times 
where Lassa went undiagnosed in hospital for many days. Before a patient reaches Kenema, 
and more specifically the Lassa Ward, there are many opportunities for cases of Lassa to slip 
away from the more formal parts of the diagnostic system. Significantly it is not beliefs or 
practices surrounding traditional medicine which seem to cause the most disruption to the 
workings of the formal diagnostic system; instead disruption is more likely to be caused by 
avoidance and distrust of Government providers, in particular due to cost and rumours about 
lethal injections. 
 
Although the diagnostic system draws patients, and their blood, to a hospital, the test result 
which is so concrete for the scientists and doctors is open to different interpretations back in 
the village. Just because uncertainty is closed down in some people’s eyes, it may not be 
universal; ambiguity can be pervasive if there are other things which can be ‘behind’ a 
sickness. The application of a Lassa positive label to a patient by experts, thorough laboratory 
or clinic based knowledge production contexts, may encounter alternative explanations once 
away from those contexts, as appears to happen with witchcraft. This shifting and uncertain 
terrain is a feature of Mende social life, and is often cultivated. As Ferme (2001) has pointed 
out, there are a multitude of everyday ways in which Mende culture is ambiguous, and that 
much of the ambiguity is deliberate and actively maintained. There is a resistance to static 
definitions, or simple dichotomies, which Ferme highlights by pointing to the position of the 
mabole, a gender ambiguous female member of the male Poro society, whose gender shifts 
across contexts; or to the inclusion of the child born after a set of twins in the category of 
twins, and their links with the spirit world which blurs the lines between supernatural and 
natural. Family histories, and ties to land are also concealed in different ways, being re-
worked orally, which can obscure lineages of ‘stranger’, ‘founder’ ‘newcomer’ or ‘slave’ 
(Ferme, 2001) and can be used to political advantage (Murphy, 1980).  
 
These ethnographies which identify a ‘cultural idiom of ambiguity’ (Ferme, 2001, p8) point 
out that this unpredictability has long been a part of Mende life; the ‘sobels’ during the war 
(soldiers by day, rebels at night) and the sudden wealth of diamonds are just modern 
manifestations of it. What is more, on a daily level ‘practices of concealment’ (Ferme, 2001, 
p8) serve to manage unpredictability, instability, and ambiguity, and even to add to it. The 
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Mende world is one where meanings are actively contested and it is of particular relevance to 
consider how this may disrupt biomedical diagnosis, which seeks to identify a cause by 
closing down the possibility of alternative meanings. It presents a challenge to the authority of 
doctor, or biomedical care in general, and is a reminder of the importance of other sources of 
hale, and the people or rules which channel its power. The meaning of a test result finds itself 
open to alternative meanings when one considers the Mende logic of witchcraft. Biomedical 
diagnosis and its practice in healthcare settings which are frequently found wanting in their 
level of care and expertise, may simply be more modern manifestations of uncertainty and 
unpredictability to add to the list. 
 
As I have alluded to already, sickness in certain kinds of people is associated with being 
witches (pregnant women) or being targets of witches (children, successful people). Now I 
would like to turn to the ways those categories of vulnerable people cross-sect with Lassa 
fever, for which I draw on examples of actual cases in Tokenga. In doing so I return to the 
question I opened with about how local narratives surrounding Lassa, here witchcraft, impact 
on practices. What is clear from the accounts I was given, if they are to be trusted, is that there 
are not examples of people consulting witchdoctors or kamohs during the acute stages of 
sickness. This is important as at least two of the cases are widely linked to witchcraft, others 
occasionally, but those stories were less well developed. These accounts show that if front line 
everyday treatments in the village did not work, then biomedical treatment at a clinic, hospital 
or private dispenser was next. People’ health seeking practices tend to lead them out of the 
village where the name Lassa is applied but there is sometimes ambiguity about these labels 
once back in the village setting. Mambu, the Kamajᴐ son of the chief, was always said to have 
died of Lassa fever.  Some doubts were raised about what had made him sick. For instance, in 
relation to rodents his mother expressed her reservations: “that is what the medical people 
tell us, but by then he was not eating rats”.78 Privately, an alternative explanation was offered. 
Another Tokenga resident, Sao79, had had a dream in which he saw Mambu being beaten with 
sticks by a group of people. He told Mambu’s brother about this dream and the next day 
Mambu fell sick. The conclusion was that Mambu had been witched.  
 
The second witch related death was pregnant Mariama whose story I have already told part 
of. She was in Panguma hospital for 14 days before the doctor queried Lassa. Another part of 
                                               
78 Mother of patient, Lassa history 2, Tokenga, 19/02/2010 
79 Sao is a twin name. Twins have particular powers to ‘see things’ 
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her story, widely known in Tokenga, was this: the ‘Joboi’ devil80 had visited Tokenga during 
the day where it had danced and entertained. Afterwards all the women had beaten Joiboi to 
the ground and tried unsuccessfully to drag him from the village. This was all done in plain 
sight for all to see (and will have been performed by a masked dancer). However when the 
devil finally left the village it was said that pregnant Mariama had continued to torment the 
devil and ‘sat’ or ‘danced on the devil’s head’.81 This reported incident led people to the 
conclusion that her subsequent death was because she ‘had witch’ and had brought the 
misfortune on herself. According to Mende beliefs about pregnancy and witchcraft, if a female 
witch becomes pregnant then she must desist from all ‘witchcraft business’ for the duration of 
her pregnancy. If she does not, then she will bring harm either to herself or to her unborn 
child (or both). ‘Dancing on the devils head’ was interpreted as engaging in ‘witchcraft 
business’. A good friend of Mariama’s husband told me that when Mariama was taken to the 
hospital even though the doctors said it was Lassa, actually it was ‘witch’.   
 
These examples illustrate the instability resulting from a diagnostic category which is applied 
externally and then grafted on to local knowledge and experiences, where it can take on 
alternative meanings. A popular explanation is that if a witch is ‘behind’ a sickness it will 
either mean the hospital tests find nothing, or what they find will not be real. The witches play 
tricks on the doctors. It is important to note that these accusations of witchcraft do not appear 
to interfere with biomedical treatments or deter people from going to hospitals. In Mariama’s 
case it was an ‘after the event’ explanation, and with Mambu, though the dream was reported 
to his brother before he fell sick, he was still taken to hospital. Indeed, some of these 
explanations provide interpretations of disease events which bounce off biomedical ones as 
opposed to being entirely separate and ‘traditional’. The fact that Mariama’s husband did not 
contract Lassa despite its apparent contagiousness was offered as another sign that her 
sickness was caused by her witchcraft. This is the plural model of disease causation described 
elsewhere in which biomedical or natural causes can co-exist with non-natural ones (Janzen, 
1981, Reynolds Whyte, 1982). The day I left Tokenga I heard the following story which 
encapsulates this: a girl had woken up with a pain in her arm. She had had a dream in which 
she had been shot in the arm and so the consensus was that she had been shot with a witch 
gun. To deal with the ‘witch bullet’ she had been taken to a witchdoctor who removed it; to 
                                               
80 Joboi was a devil from the neighbouring village.  This village was said to have a lot of witches and 
strong spirits, Joboi was one of their most powerful devils. 
81 Versions of this story were told to me on three occasions by unrelated people.  
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deal with the pain she was taken to a clinic for painkillers. For health promotion and 
interventions to be successful the integration of biomedical and alternative beliefs about 
causation needs to be considered.  
 
I was initially troubled by the implications these stories had, as ‘to have witch’ is hereditary 
the surviving family of Mariama or the chief’s son would surely be cast in doubt too, but these 
paths did not seem to be pursued. It strikes me now that this is a continuation of the strategies 
of concealment and deliberate ambiguity which Ferme has shown are so pervasive and useful 
culturally. In terms of links between Lassa and witchcraft, pregnant women are more 
vulnerable to the stigma and ambiguity of what is believed (by others) to be causing their 
sickness. Even when a Lassa positive result can be received from the laboratory in Kenema, 
the diagnosis can still be questioned according to the cultural norm that things are not always 
as they seem. Improving the diagnostic tools which apply biomedical disease labels does little 
to suppress the instability and unpredictability of Mende life. The certainty that laboratory 
confirmation should bring is not recognised everywhere. This does not amount to reliable 
knowledge about disease causation in a village context.  
 
Given the central importance that getting to a hospital has for Lassa diagnosis, it would be 
incomplete to end this discussion without mentioning the wider social factors which facilitate, 
or hinder this journey. Young has defined sickness as the “process through which worrisome 
behavioural and biological signs, particularly ones originating in disease, are given socially 
recognizable meanings” (Young, 1982, p270). The process of getting to the hospital, or a clinic, 
or a private dispenser is encompassed in his use of ‘sickness’ and which I equate to the 
diagnostic system and navigation of therapeutic landscape. What I have shown is that it 
depends on more than just how symptoms present and are interpreted. All healthcare options 
are not equally possible. Depending on whom you are and where you are, the process is an 
unequal one characterised by the quality of your social relations.  
 
If you have a hiegbɛ wa then the trip to a hospital which would transform it into a ‘hospital 
sick’ is not a free move. First, there is the ‘money business’; as the saying goes ‘pass you pull 
moni’ (unless you give money): you must have money to go to a hospital. Second, to get to 
hospital also requires resources of a more social kind. People might need to be literally 
carried there. Sometimes these dependencies are made explicit, as in (the perhaps empty) 
152 
 
threat in Tokenga that if a person known to have eaten rats gets sick they will not be carried 
to hospital. The reality is that some people have more of these resources than others. This 
would apply to ‘finding’ or borrowing money to pay for emergency healthcare too. The phrase 
‘wealth in people’ (Bledsoe, 1980) has been used to describe the patron-client relations that 
pervade social and political life in the region. ‘Health in people’ could be a fitting adaptation to 
describe one of the key elements needed to attain some degree of security over wellbeing in 
rural villages. The same inequalities are present in death; on my last trip to Tokenga the 
chief’s son died. One the same day another woman also died but she was a ‘stranger’ and her 
death was barely noted, contrasting with the steady stream of guests arriving from as far as 
Kenema and Freetown to pay tribute to the dead man.  
 
The social relations of sickness were evident in similar ways for Lassa and influenced the 
experience of being diagnosed with Lassa and what Lassa comes to symbolise for them. The 
Lassa ward’s clinical staff play a pivotal role; some ex-patients speak of them as if family, they 
credit them with bringing them back from the brink of death and for their kindness during 
recovery. Also important is how they are treated by friends and family. Though the ward 
operates an isolation policy there are spaces for visitors, which is often so crowded with 
guests you could forget it was the dreaded Lassa ward; but the flip side to this was the 
patients who spoke of no visitors and of people ‘running from them’. Being avoided by 
companions was usually only mentioned after diagnosis, for a limited period during and after 
recovery, as fear of the name Lassa set in. A nurse, who contracted Lassa while working at 
KGH in 2008, cried as she remembered how people avoided her, refusing her food or any 
contact with her, she said, “that made the sick aggravated. Really, because there was nobody 
around me. The neighbours were there, but no assistance”.82 She said when she was in the 
hospital she had few visitors; when some friends from the hospital did come she was so glad 
and took it as a sign that she was going to survive. 
 
These issues are cross cut by the macro dynamics of the Sierra Leonean health system. The 
health service landscape is filled by different programmes and policies which give preference 
to particular groups (i.e. those covered by the FHCI) or particular diseases (i.e. HIV, TB, and 
also Lassa), for which treatment is provided free. In these it is inscribed that who you are 
makes a difference to the barriers you will encounter. However, even though Lassa treatment 
                                               
82 Lassa history 11, Kenema, 14/04/2012 
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is provided free, as most people are unaware they have Lassa until they go to a hospital, the 
economic barriers remain.   
5.4.2 “We are just learning that name” 
There are signs that the biomedical disease Lassa fever is converging with local framings of 
fever. The name Lassa is relatively new to Tokenga’s inhabitants. Time and again I was told 
that Lassa was something they were only hearing of recently: “I never knew of Lassa before...it 
is just recently now we are hearing about Lassa”.83 This does not mean that the sickness is 
new to them, some people described how they have suffered from it in the past but they have 
only just learnt the name Lassa: “People used to get this cold, then later people would talk 
about Lassa, normally they will not survive, only occasionally”.84 Another man told me: “it has 
killed people here, a lot. It is just now the people have discovered it is Lassa. Formally it 
attacked people here, they were just treating people with native medicine until that person 
either survives or dies”85. In this way, Lassa fever is framed as a longstanding sickness. It is 
increasingly associated with, and described as, kᴐlε wa. The merging of Lassa fever 
simultaneously presents Lassa as a disease which is not new while also narrowing down what 
kᴐlε wa signifies.  
 
During my fieldwork kᴐlε wa was frequently translated as Lassa, and Lassa as kᴐlε wa. It 
appeared that kᴐlε wa has become Lassa. One man summarised it thus: “formerly [we] did 
not know that name Lassa, [we] were just calling it kᴐlε wa. Just now [we] have known that 
kᴐlε wa is Lassa”86. However, another man ridiculed such statements, “people have been 
saying that kᴐlε wa is Lassa, but there are many others, we Mende just box them all together 
under kᴐlε wa”. When I asked whether other diseases with fever such as malaria, pneumonia, 
or typhoid could be kᴐlε wa the answer was mostly no. In practice when someone falls ill 
there is little way of distinguishing kinds of fevers based on symptoms alone. Though it is 
interesting if the significance of kᴐlε wa is changing from meaning something more general to 
something much more specific, in practice the same diagnostic processes apply. 
 
                                               
83 Mother of patient, Lassa history 2, Tokenga, 19/02/2010 
84 Male, Turay family, Tokenga, 13/03/2010 
85 Male, Sonnoh family, Tokenga, 12/03/2010 
86 Male, Sonnoh family, Tokenga, 12/03/2010 
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As this chapter has illustrated, diagnostic practices and processes are not disease specific but 
instead are related to more flexible notions of ‘hospital’ and ‘ordinary sicks’. In turn, the 
framing of Lassa as a ‘big fever’ means it is relatively open and inclusive so picks up all 
manner of non-specific fevers. It is in contrast to the pathogen specific diagnosis which brings 
the Lassa surveillance and outreach operation to the village. Arguably the link in Tokenga may 
have been strengthened by the outreach team’s recent visit, though it was not just in Tokenga 
that I was told kᴐlε wa meant Lassa, it is common in other villages too. Sensitisation to Lassa 
is not a new thing, the remnants of old Lassa fever awareness public health campaigns can be 
found in faded posters or on old t-shirts worn in villages across the region. Although 
awareness is still a long way off 100% it appears that, for many, kᴐlε wa and Lassa fever have 
come to mean a distinct disease, at least in Lassa heavy regions. 
 
There are two dominant issues emerging out of the Lassa sensitisation by outreach teams so 
far. The first is to do with hygiene and the second concerns the rodent hosts. Both topics are 
associated with stigma. This is not directly the result of the outreach team but of the health 
promotion efforts more widely, and historically. To begin, Lassa has become negatively 
associated with poor hygiene. People in Tokenga will criticise those in their own community 
for not being clean enough, comparing it to other villages which they said were cleaner and 
pointing to that as the reason for Lassa in Tokenga. It seems the outreach team’s advice about 
keeping the environment clean can be re-interpreted as a criticism of poor hygiene which 
labels certain towns, places and even people as dirty. One measure promoted by the outreach 
team to fight Lassa was to keep a cat. Once on a meeting with the paramount chief of Lower 
Bambara chiefdom (headquarter Panguma), I naively asked if he would be getting a cat to 
which he replied, stiffened and seemingly offended, that he did not need one because his 
house was clean.   
 
Knowledge of the Mastomys’ role as the reservoir for Lassa was patchy. Some would venture 
that arata were the source of Lassa but this is usually couched in uncertainty, for example I 
was told: “We don’t really know what causes it, it is just recently they are saying it is caused 
by rats”87. Dig deeper and people’s perspectives on the origins of Lassa are more complicated 
as the public health message meshes with local knowledge. People often focused the 
connection on the link between eating rats and getting Lassa which provoked some doubt: 
                                               
87 Male, Turay family, Tokenga, 13/03/2010 
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“the doctor used to come here and they advised people not to eat rats because they said the 
rat causes that. Those people who that cold attacked they are not eating this rat. Most of them, 
because I can’t talk for them all”.88  
 
The link with rodents is complicated by their dietary and social significance. Eating rodents is 
common in Sierra Leone. Though it is hard to collect data on this as most people say they no 
longer eat arata. When probed they would also tell me they tasted ‘sweet’. Some young boys 
said they didn’t believe it was the cause of Lassa fever because they had eaten arata and they 
did not get sick. This line of argument, whether rodents had or hadn’t been eaten and what the 
consequences were, shows an appreciation of biomedical causal explanations for Lassa fever 
infection. At the same time it also challenges them. Mostly, at least when talking to a white 
female researcher people would deny it and use it as an insult against others. After 
interviewing the family who had lost three children to Lassa fever their neighbour told me, 
disapprovingly, that he had seen the family eating rats.     
 
The stigma of eating rats is fed by the public health messages89 and subsequent laws against 
rat consumption. Those messages are in stark contrast to a ceremony called ‘feeding the palm’ 
which was to be performed in a nearby village. The ceremony is carried out exclusively by 
men with the intention of protecting the men who climb the tall ‘native’ palm trees to harvest 
their kernels for palm oil (as shown in figure 16). It takes place around March and April before 
the harvest. All the men who intend to climb for that year’s harvest are required to catch 
between 10-30 arata as a contribution. The preparations, involving catching, roasting and 
drying the rodents can start up to 2 months before the ceremony takes place. All kinds of 
arata are acceptable, except the ‘one with the long mouth’ (tuile90) which is said to have a bad 
smell and be the ‘Lassa rat’. The rodents are caught using a type of trap called torlei91 (see 
figure 17) which I was told is made especially for small rodents and ‘no other beef’ (no other 
meat). The trap is left overnight with bait to tempt the rodents. The men then cook rice and a 
stew with salt, hot pepper and the ubiquitous MSG laden ‘Maggi’ flavourings. An offering of 
this food is given to spirits in a ‘secret place’ and one man will climb a designated palm to 
                                               
88 Male, Amara family, Tokenga, 13/03/2012 
89 Apparently NGOs in the 1980s devised health promotion songs for Lassa fever 
90 My spelling 
91 My spelling 
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scatter food over the top saying “here is your own food, be generous with us, have a cold 
heart92”.  
 
                             Figure 16 A man climbing a palm tree to collect kernels for oil 
 
 
 
                                               
92 Cold heart is used to mean kind and peaceful, the opposite of a warm heart which means angry, fiery 
or vengeful.  
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The link between the palm and the ‘rat’ is that there is one ‘rat’ species in particular, known as 
segei93, who ‘loves the palm’ and is always found amongst the fronds at the top eating the 
palm kernels. By feeding the palm tree with rodents, the hope is that the segei will then stop 
feeding on the palm. During my first visit the men in this village had begun preparations for 
the ceremony and it was to be the first time they performed the ceremony for years, having 
stopped during the war. They were bringing it back because a number of men had fallen while 
cutting palm kernels. However, on this occasion the ceremony did not take place, On my 
second trip I was told that the election of a new village chief had disrupted their plans, so they 
had had to cancel it, but had eaten the rats anyway. In Tokenga, I was told the ceremony had 
not been performed since before the war. Their reason for stopping was that eating ‘rats’ was 
against the teachings of Islam.  
 
    Figure 17 Rodent trap, with mock 'rat' on right 
 
 
A final point about the convergence of local and scientific health messages is that the new 
biomedical explanations of kᴐlε wah and its transmission, accepted or not, are strongly 
couched as coming from outside sources. Usually this is described as from ‘the whites’, though 
sometimes ‘the doctors’: “I don’t really know where to get it but the white people are saying 
                                               
93 My spelling 
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from the river or rats. [but we] do not yet know how really it attacks”.94 Lassa is portrayed as 
something which they are told about, and as a topic about which they lack the expertise to 
‘really know ourselves’. There was considerable use of the phrase “we are told” accompanied 
by an apparent reluctance to question it: “I will not deny the doctor. I will not doubt what they 
say”.95 The disenfranchisement from medical knowledge about Lassa is striking, though 
perhaps less so considering the highly controlled and hierarchical system of specialist 
knowledge and power traditionally found in Mende communities. Medical knowledge 
surrounding Lassa may seem as off limits as certain aspects of secret societies. However 
although on one level there is acceptance of biomedical accounts, this chapter has also shown 
how, away from doctors, there is space for doubt and ambiguity where alternative 
explanations can flourish.   
5.4.3 Uncertainty after diagnosis  
The ambiguity experienced throughout the process of Lassa diagnosis is great and brings with 
it significant risks and vulnerability. I have discussed the uncertainties during the run up to a 
diagnosis and the ways these are negotiated, and also the subsequent underlying ambiguities 
over the ‘proof’ of a test result. There are further uncertainties which arise after a case of 
Lassa which are to some degree an outcome of the global research apparatus, which is driving 
the effort for improved diagnostics.  
 
The arrival of the team and their surveillance activities make a big impact. Some have their 
fears calmed. A woman who was caring for a patient before they went to hospital told me:  
 
“We were tested for Lassa, it proved negative. She ate food and gave me the balance, or drank 
water from the same cup, but my result was negative. I was worried that I could have it, because 
they said it was transferable, but they tested my blood and it proved negative. I was so 
worried”.96  
 
For others it raises new questions and uncertainties to confront. One man expressed how the 
ambiguity over how you get Lassa, and who has it, pervades all areas of social life: “Here we 
don’t know, we just live together, we don’t know who has Lassa. According to what you hear, 
you cannot eat with a Lassa person, but we eat together....we share jokes, this is what has 
                                               
94 Male, Sonnoh family, Tokenga, 12/03/2010 
95 Male, Turay family, Tokenga, 13/03/2010 
96 Carer of patient, Lassa history 4, Tokenga, 09/03/2010 
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given us doubt....we don’t know”.97 The plastic yellow tape which is attached to houses 
sampled for trapping and inspection by the outreach team is often left attached, a lingering 
reminder of these doubts and unanswered questions. 
 
It is interesting to consider this in the context of international biomedical research, where 
interpretations of research projects and institutions have been shown to be shaped by broad 
historical and social perspectives, for instance, of blood stealing white people (Fairhead et al., 
2006, Geissler and Pool, 2006). Although the injection rumours are clearly an example of 
distrust of both national and foreign providers of healthcare, the international research efforts 
surrounding it were less obviously negatively perceived. Partly this must be to do with limited 
awareness of the research machinery that patients and villages were now part of. However, in 
subtle ways they did see and feel its impacts. On both surveillance and research calls, the 
outreach and ecology team will take blood samples from case-contacts or from old follow up 
cases (for research purposes) as well as conducting overnight rodent trapping in selected 
houses. After such visits a number of Tokenga’s residents and ex-Lassa interviewees vocalised 
their ambivalence. One resident explained: 
 
“They only tested relatives that were around the people who passed away. According to our 
experience we are in the circle of Lassa (points around him) here, here, and here. But they only 
tested people in this area, where the last case was”98.  
 
The arrival of the team can be welcomed, but equally it can deepen uncertainty as to what is 
happening and why. The health promotion video and talks explain where Lassa comes from 
and what should be done to avoid it, but why some people get tested and others do not, or 
why some houses were selected for rat trapping and others aren’t, is less well communicated. 
A number of the ex-patients I interviewed enquired about follow up activities when the 
outreach team had come to take further samples from them. One man described: “dey cam 
investigate how de sick he don do well with me…. dey cam pull de blood back. Dem say dey de go 
test am but from dat time we no bin de yeri abot de results yet” (They came to investigate how I 
had recovered from the sickness, they took a blood sample. They said they would go and test 
it but from that time we haven’t heard about the results). He told me he wanted the results: 
“Ah wan get di information”. 99  
                                               
97 Brother of patient, Lassa history 5, Tokenga, 11/03/2010 
98 Brother, Lassa history 6, Tokenga, 11/03/2010 
99 Lassa history 9, Tongo, 24/04/2010 
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Many others asked me similar questions about if I knew why the team had come for follow up 
samples of their blood. They wanted to know if I knew what their results were and what it 
meant, could it mean that they could still have or catch Lassa? Lastly, some villagers in 
Tokenga are under the impression that they will be given the results of these tests, which is 
not the case. One of Tokenga’s residents, the headmaster at the neighbouring village’s school, 
informed me that the outreach team had come to catch rats on which they would perform 
tests to prove whether Lassa was in the village. He said for now they were still awaiting the 
results, but they would soon be returning with the results. His take on the outreach and 
surveillance activities shows how the rationale behind the case-contacting, trapping and 
sample collection are not differentiated at the village level. As a result, they can be the cause of 
concern as villagers are left in doubt and waiting for answers.100  
5.5 Conclusions  
The formal diagnostic system and the main institutional narratives which surround it are both 
conceptually and spatially distant from life in Tokenga and places like it. Aspects of them, such 
as the outreach team’s visit and the ‘pulling’ of blood, can nevertheless  be felt. The mangle of 
practice’s back and forth starts within the village’s therapeutic landscape. Routine healing 
approaches are twinned with routine symptoms: for small fevers there are ‘tabs’ of ‘panadol’ 
or bitter barks. This is familiar territory and usually ‘ordinary sicks’ and can be dealt with: it is 
a stable relationship. Uncertainty does creep in through and there are doubts about the 
quality of some medicines. The stability can be disrupted if the sickness proves not to be 
dampened by ordinary treatments. The virus exerts its agency and resistance is manifested as 
un-dampened fever or other unexplained pains and symptoms. In response, other therapeutic 
avenues are considered. For example a local healer may be sought, perhaps a practitioner 
of pu hale or Mende hale, or both. Kinds of sickness can mediate the decision, but most of all 
it depends on social relationships and money, as the categories of sickness themselves are 
generally flexible. Money and relationships become more important as symptoms get worse 
and can themselves count as resistances: ‘big sicks’ and ‘big fevers’ require big money and 
support to get to hospitals. At hospitals there is perceived to be less care and the risks and 
costs are higher, in such contexts, healing has to be negotiated differently. At various turns the 
sick, or their carers, can choose alternative routes, for example, by not going to hospital and 
                                               
100 The Tulane team considered it unethical to give results to villagers of invalidated diagnostics. 
However they were used for clinical and contact tracing purposes. 
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choosing a private dispenser. The diagnostic pathway for Lassa fever emerges in this mangle 
of practice. The name ‘Lassa’ has its own local associations which influence decisions: lethal 
injections and witchcraft are used to make sense of the progress and treatment of the disease. 
Overall, local framings of disease and Lassa fever, such as ‘big fevers’ and ‘hospital sicks’, 
reveal a fluid understanding of sickness and therapeutic practice. It is an approach which 
appears to acknowledge that certain aspects of health cannot be pinned down and as such it 
provides a way to live with uncertainty and the limited options available. 
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6 ‘An emerging paradigm’: diagnosis in the laboratory  
In contrast with the previous chapter, here I explore the framings, narratives and practices of 
Lassa fever diagnosis in the laboratory at Kenema Government Hospital (KGH).  As noted in 
chapter four, the ‘Lassa lab’ is indispensable in the formal diagnostic system and the 
foundation on which surveillance, response and capacity development efforts are built. The 
laboratory is the place where officially a case of Lassa fever is confirmed and as such is the 
link between proven and unproven, countable and not countable. Modified versions of the 
global threat and neglected disease narratives are most obvious in this setting, which is 
unsurprising as they both conclude with the assertion that more science and research is 
needed to address the problem of Lassa fever. This chapter describes how the resulting 
investments in diagnostics have influenced activities in the laboratory and the diagnostic 
system.  
 
In this chapter I will show that the developments in the laboratory are reshaping the 
knowledge base for Lassa fever not only in terms of what is known about the disease but also 
how it is known. There was an opinion among some laboratory researchers that the core body 
of knowledge about Lassa fever was based on unreliable clinical observations. As a senior 
laboratory scientist once put it to me, “doctors speak for what we know about Lassa”. 
However during the course of my fieldwork ‘the lab’ increasingly asserted its own claim of 
authority regarding Lassa. Laboratory scientists talk of the existing body of knowledge (i.e. 
information contained in scientific papers) as ‘dogma’. They view this canon of received 
wisdoms about the disease sceptically and see their work, sometimes zealously, as correcting 
it. An aspect of ‘dogma’ that I focus on in particular is the interpretation of Enzyme Linked 
Immunosorbent Assays (ELISAs) which test for Immunoglobulin M (IgM, an antibody). An 
article published in 2011 claimed that the “current diagnostic paradigm for acute LF (Lassa 
fever) should be reconsidered” (Branco et al., 2011b p1) in light of emerging knowledge about 
the disease gleaned from laboratory developments. It argued that the role of IgM needed to be 
redefined and specifically, that an IgM positive result in West African populations should not 
be considered a diagnostic marker. This chapter explains the conditions under which this 
revised view of Lassa fever diagnosis was achieved. The ‘emerging’ diagnostic paradigm 
should be seen as setting into motion a reframing of Lassa fever and a re-orientation of 
disease and diagnostic systems, which is part of a wider process which I am describing as 
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‘laboritization’ after Knorr Cetina (1999). I explore the dynamics and narratives of 
laboritization, looking to see how it is upheld in practice, but also where there are limits to it. 
6.1 Laboritization 
In Epistemic Cultures, Karin Knorr Cetina uses the term ‘laboritization’ to indicate the process 
by which a ‘field science’ becomes a ‘laboratory science’  (Knorr Cetina, 1999). Knorr Cetina 
argues that movement of objects into new environments in order to study them reconfigures 
them, and in the process, it also reconfigures the people studying them. In her words, they are 
‘enhanced’ (Knorr Cetina, 1999). I argue that Lassa fever diagnosis is undergoing its own 
process of ‘laboritization’: blood and other bodily fluids are taken out of their natural habitat, 
the patient’s body, and reconfigured by placing them in a laboratory and subjecting them to 
laboratory processes.101  
 
In Knorr Cetina’s original conceptualisation Laboritization is a social process through which 
both natural and social orders are renegotiated as a result of procedural and technical 
manipulations in the laboratory. The term is helpful because it conveys the sense in which the 
resulting transformations are the result of a very particular framing of Lassa fever, which is 
context specific: the ‘emerging diagnostic paradigm’ is a laboratory narrative and in many 
ways it is limited to laboratories. Thus, laboritization should be understood as a trajectory 
which is in keeping with the narratives surrounding Lassa fever which call for more control of 
the disease through improved and increased research on diagnostics (Gire et al., 2012, Khan 
et al., 2008). In these narratives, complete laboritization is a desired endpoint which will 
make diagnosis and health systems stronger and more scientific. 
 
The social dimensions of laboratories and laboritization must not be underestimated. Knorr 
Cetina’s term applies to the organisation and transformation of people in the laboratory as 
well as specimens. Laboratories have distinct social structures; they are spoken of as 
‘belonging’ to the senior scientist who is in charge of them. When Tulane were in Kenema they 
transported their hierarchy from the US to the Kenema laboratory. The hierarchy went from 
the senior researcher, through the doctoral students in order of experience and down to any 
assistants accompanying them. By and large, the senior members of the team directed the 
                                               
101 A potentially important dynamic in this process would be the influence of rapid diagnostic tests 
which imply the reverse by taking the laboratory back into the field. These tests are in development for 
Lassa fever but they were not being used widely during my fieldwork.  
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research activities which took place within the laboratory. The ‘Lassa lab’ was sometimes 
referred to as the ‘Tulane lab’ by people in Sierra Leone, a point bitterly contested by the 
WHO, who have also invested in it102. When the Tulane researchers were not in Kenema the 
hierarchy in the Kenema laboratory was notably less. There is a senior technician who is in 
charge of the two younger male technicians but activity in the laboratory is generally routine 
and by rota. The senior Lassa laboratory technician has worked on Lassa fever for years but, 
as the Lassa lab only became operational in 2006, the other two technicians are some of the 
newest members of the wider Lassa team. One of them runs his own small laboratory 
privately on the side and the second, who joined just when I arrived, had just finished college. 
He replaced a previous technician who had gone to Ghana for further training. He too was 
eager for training and accreditation opportunities. When Tulane are in Kenema there is a 
noticeable split between those involved in research (the US visitors) and those performing the 
clinical diagnostics (the Sierra Leonean technicians). These divisions have some bearing on 
how risks and uncertainties are experienced and dealt with as I will come to in later sections 
of this chapter. 
 
The point of a biosafety level 3 (BSL-3) laboratory, as the one in Kenema is supposed to be, is 
that it is distinct from the outside world. The ‘Lassa lab’ is located towards the back of the 
hospital grounds, at the bottom of an incline. The building houses the Lassa fever project 
office, the Lassa outreach and surveillance office, as well as the hospital’s general laboratory. 
The ecology team, who trap rodents on outreach and research trips, are located in an adjacent 
building. The staff of both the general and Lassa laboratories, who are mainly male, often sit 
under a mango tree near the building waiting for samples to come in or for procedures to run. 
Inside the Lassa laboratory the atmosphere is somewhat different. Lab coats, boots, goggles 
and facemasks are worn, and entrance and exit are through different doors. Boots must be 
bathed in disinfectant and gloves discarded upon exit. Inevitably, rules get relaxed the more 
time people spend in there. Masks come away from faces and people pop their heads round 
the doors to chat. Both the laboratory cleaner and the engineer routinely came into the 
laboratory wearing shorts and sandals. Relaxed the rules can be, the reasons for the 
precaution is never too far away: while visiting the Lassa ward one day I was surprised to 
hear the voice of that same cleaner from inside one of its rooms. He had come down with fever 
and had been admitted to the ward as a precaution. After spending a few days there it was 
                                               
102 WHO representative, Geneva, 14/12/2012 
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determined he did not have Lassa fever and he was discharged. Another time in the laboratory 
Tulane were running some tests on a sample which had already been confirmed positive. High 
levels of virus had been found in the sample and the patient had died a few days before. The 
senior technician warned everybody in the laboratory to “double glove” because the sample 
was “hot”. Both these incidents exposed the underlying threat which is easily normalised. 
They also expose the way human behaviour is supposed to be disciplined, part of 
laboritization, to limit such threats. As this chapter will show controlling both human and 
material agency is a difficult and often incomplete task.    
6.2 Narratives of Lassa fever diagnosis at work in laboritization  
Knorr-Cetina’s original use of laboritization was to highlight the transformation and 
manipulation of objects coming into the laboratory; in this chapter I set out how these 
processes have occurred for Lassa fever. I show how attempts have been made to make Lassa 
controllable and stable, to behave reliably enough to diagnose. Two sub-narratives have 
driven these efforts. They are recognisable as related to the narratives in chapter four which 
concluded technology was the pathway out of neglect. In the first, the global threat becomes a 
research and commercial opportunity. In the second, high quality diagnostics are needed to 
unravel the ‘dogma’ of Lassa research and pave the way for a new paradigm. Both sub-
narratives work with aspects of the framings introduced in chapter four. Essentially they view 
Lassa fever as an uncertain object but one which can be brought under control, a process in 
which improved diagnostics are a necessary and critical first step. Both of these framings have 
influenced the way diagnostics have been developed, by whom, for whom, and where and how 
they are used.  
6.2.1 The global threat becomes a research and commercial opportunity 
The implications of the global threat narrative are that it has enabled Lassa, and Lassa 
diagnostics, to become a viable commercial research opportunity. The ‘category A’ framing 
has brought in investment for Lassa but these resources have been won for reasons other 
than the local disease burden which, in practice, has resulted in tensions over conflicting 
agendas. This essentially vertical investment with its emphasis on product development (and 
silver bullet expectations) contrasts with the humanitarian operations of past and present 
NGOs. 
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The main manifestations of the global threat narrative, namely the BSL regulations and the 
category A status, impinge on work in the laboratory in different ways. The biosafety levels 
denote risk minimisation practices and are primarily concerned with protecting people 
handling pathogens in medical or scientific laboratories, while bioterrorism categories denote 
potential biological threats, and are largely concerned with protecting specific populations. 
The different rationales behind each classification means their impacts are distinctive. The 
BSL regulations have meant that providing diagnostics for both research and diagnosis has 
been challenging and has contributed to the air of uncertainty. I deal with these in the next 
section. For this first sub-narrative the Category A framing has had the most impact.   
 
The category A status looms large in the laboratory, indeed it is the reason the work is taking 
place in the first place. The first line of Tulane’s successfully funded bid to the United States’ 
National Institute of Health (NIH) to develop the recombinant ELISAs states that the project 
will develop “Diagnostics for Biodefense”. It continues later: 
 
“Because of its high case fatality rate, ability to spread easily by human-human contact, and 
potential for aerosol release, LASV (Lassa Virus) is classified as a Biosafety Level 4 and NIAID 
Biodefense category A agent. The potential use of LASV as a biological weapon directed against 
civilian or military targets necessitates development of “effective, rapid, highly sensitive, specific, 
easy to use, adaptable, and cost-effective medical diagnostics for public health laboratories, 
hospital-based clinical laboratories, and point-of-care use” to diagnose individuals exposed to 
and/or infected with LASV” (Garry, 2004 p64). 
 
In private researchers debate the category A classification: some do not think Lassa virus is 
likely to be used as a bioterrorist weapon or that it would make an effective weapon if it was 
used. It is regarded as excited exaggeration:  
 
“How likely is Lassa to become a disseminated biodefense agent? I don’t know, I think probably 
not very likely....There are people I have spoken to who really firmly believe that Lassa doesn’t 
even belong in the category A. It is just an issue of a little bit of sensationalism”.103  
 
You need not look far for examples of that sensationalism, the newspaper article which 
described the Kenema operations as a “U.S. anti-terror outpost” (Akam, 2011) is one. Yet, 
while at times the researchers try to distance themselves from such sensationalism, at others 
they are aware of its utility for funding and they actively evoke it. In the search for research 
                                               
103 Tulane laboratory scientist, Kenema, 02/03/2010 
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funding the categorisation of Lassa as a bioterrorist threat opens up new possibilities for 
research into Lassa:  
 
“If you fell into the category A, that’s where the big money was. Ok so if you wanted to do big 
money research you had to come up with some really good ideas, whether it was diagnostics, or 
vaccines or therapeutics......if you picked a category A agent your chances of being funded 
probably went up significantly. Kind of, sort of, in a way, why we’re in it, OK?”.104   
 
Researchers themselves claim to be more concerned about local disease burdens than 
hypothetical international ones and the diagnostics funding proposal goes on to state: “The 
impact of Lassa fever in endemic areas of West Africa is immense, and a safe and effective 
diagnostic would also provide a very significant public health benefit” (Garry, 2004 p64). The 
ordering of the paragraph makes it clear that, in regards to funding, the West African public 
health benefit is of secondary significance.105 This represents a ‘securitization’ of Lassa fever 
and the interventions to tackle it, a phenomenon which may increase resources but also tends 
to direct resources away from local priorities to international security ones (Elbe, 2006). 
Priorities are altered, and as biodefense eclipses local disease burdens new concerns and 
objectives enter the frame: counter-terrorism is one, but other security related opportunities 
open up. These include commercial ones: post 9/11 the US government formed the U.S. Africa 
Command (AFRICOM) and planned to station some, or all, of this new military outfit in 
Liberia, opening up a potential market for Lassa ‘products’:  
 
“so in a Lassa endemic area, what is that going to mean?...... Lassa fever is obviously going to be 
on the list of things to test, so having a quick rapid assay to test for Lassa fever, and a 
confirmatory assay, and the ability to treat this person is going to be important. So the United 
states government and NATO allies are going to be customers for these diagnostics at some 
point”.106 
 
Therefore, through securitization Lassa becomes both a security threat and a commercially 
viable research interest. This framing has brought in resources which arguably would not 
have been available otherwise, indeed for years Lassa received very little global attention or 
funding. However, for some, the way in which the money gained from Lassa’s securitization is 
being spent in Sierra Leone is a point of contention. An opinion expressed by WHO staff and 
Sierra Leonean officials was that operations at the Kenema laboratory have been proprietorial 
and to the benefit of US and Tulane’s interests above local ones. Sierra Leonean government 
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105 This should not be surprising given the funding stream is for biodefense. 
106 Tulane laboratory scientist, Kenema, 02/03/2010 
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officials point to the limited number of Sierra Leonean’s who have been trained compared to 
US citizens. There is a sentiment, albeit muted, that the capacity building could have been 
more wide ranging, and locally beneficial. Perpetuating these interpretations are the 
comparisons which are drawn between the program at Kenema and other NGOs and 
humanitarian organisations, past and present: the activities of ‘Tulane’ (as the most visible 
partner in the consortium) are compared to those of Merlin, the British aid organisation who 
were previously responsible for the Lassa ward, and of MSF who run a hospital not far from 
Kenema. ‘Tulane’ are usually judged to fall short when it comes to the trickle down of 
resources and operations outside of the laboratory.  
 
Any comparison should take into account the different remits of each organisation. There are 
institutional reasons for these differences as they are related to different framings of the Lassa 
disease system. Merlin is a provider of emergency health care and it was there in a 
humanitarian capacity, thus their focus was not on developing diagnostics but treating people. 
Tulane is not a humanitarian or aid organisation and the laboratory is their focus. These 
different objectives were not always acknowledged, the two were just measured against each 
other in terms of what could was seen to be provided. While there was some frustration 
amongst those in the research team who felt they were bringing in a great deal of extra 
resources to Kenema, and Sierra Leone, there was also recognition that there was more that 
could be done for disease control and capacity development both inside and outside of the 
laboratory. However with the terms set by research grants geared towards developing 
‘diagnostics for biodefense’ there was little room for manoeuvre. Small concessions were 
made as some research resources were freed up where possible, for instance improving the 
visitor’s area in the isolation ward or providing new equipment for the nurses. In general, 
there appeared to be a mismatch between what the research funds allowed Tulane to do 
through their grants and the expectations of different stakeholders: the lack of equipment in 
the ward, pay levels for the team, the level of training and development received in the 
laboratory, and the incorporation of Kenema’s facilities into national laboratory and health 
plans were all issues.  
6.2.2 High quality diagnostics to unravel the “Dogma” 
In this narrative the existing body of knowledge on Lassa, and past diagnostic techniques, are 
characterised as unreliable. Instead Lassa is constructed as a highly uncertain object and out 
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of this another narrative can flourish: the reduction of uncertainty as a result of the new 
diagnostics, made possible by improvements in ‘sensitivity’ and ‘specificity’.  
 
When I was spending time at the KGH laboratory Lassa was very much defined as being an 
unknown quantity. This framing rested on a characterisation of the existing knowledge base 
as unreliable. One mantra went: “throw out everything you think you know about Lassa”. 
Whether it was the (unreliable) methods or the (unreliable) diagnostics, a Tulane researcher 
put it succinctly: “they just don’t get the results we get” in reference to the years of published 
research on Lassa fever. The scepticism about the existing knowledge base was strong and 
vocal, and manifested in the use of the term “dogma” to describe the existing knowledge and 
what was perceived to be an unquestioning acceptance – and regurgitation - of unreliable 
results. They saw themselves as having to work against this “dogma” and they argued that 
instead of the assurances dogma would usually provide, actually there was considerable 
ignorance which would only be reduced by advances in diagnostics. This set of narratives, of 
blind faith and ignorance moving towards certainty, are interlocking; they rely on contrasts 
drawn between the “dogma” and the “emerging view” and between the “traditional assay” and 
the “recombinant assay”. Diagnostics were often referred to as “building blocks”, as the 
“obvious place to start”, reinforcing the idea that the existing knowledge was not reliable and 
did not amount to knowledge of real substance. 
 
The improvements in diagnostics are rooted in the mechanistic biomedical disease framing, 
specifically the principles of immunology, which have improved the sensitivity and specificity 
of the tests. The traditional assay is not trusted by the Tulane team because the inputs were 
considered to be of poor quality, even described as “junk”: “it’s the GIGO effect, right: Garbage 
in Garbage Out”107 was one researcher’s way of putting it. The objective was to get to a point 
where it was “Quality in, Quality Out”, for this the reagents and the samples needed 
considerable work, which I will soon describe. Framing the work in the laboratory is the idea 
of moving from ignorance to risk. Incertitude is expressed as the probability of classification 
errors expressed as improvements in assay sensitivity and specificity. As queried in chapter 
two, sensitivity and specificity are arguably only dealing with some aspects of uncertainty. 
 
                                               
107 Tulane laboratory scientist, Kenema, 02/03/2010 
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Validity and reliability are prominent themes in any diagnostic laboratory and a great deal of 
laboratory activity revolves around attempts to control or codify them; sensitivity and 
specificity are explicit attempts to deal with the risk and uncertainty of error. It is on the back 
of increased sensitivity and specificity that the scientists working in the Kenema laboratory 
believe that the new ‘recombinant assay’ they have developed provides a more reliable 
knowledge base than the ‘traditional assay’. With the new diagnostics not only is case 
identification more accurate, but as a result, a more robust disease profile is being built which 
departs significantly from the established ‘dogma’.108 
 
Traces of the BSL-4 classification are evident in the formulation of this narrative. As I noted 
earlier, it is a code of practice, not a legal regulation although it is often interpreted as such. It 
means that the live Lassa virus should not be handled in laboratories which do not have high 
containment facilities. In 2007 there were only 20 BSL-4 laboratories in the world (Gronvall et 
al., 2007) and when research on Lassa begun there were even fewer. None of these were, or 
are, in West Africa. BSL-4 Laboratories are hugely costly to maintain, and therefore research 
on Lassa fever was also extremely costly to do. This meant research could only be done by a 
select few players, notably the CDC and USAMRIID (US Army Medical Research Institute of 
Infectious Diseases), and there were significant bottlenecks in the process which was located 
so far from the areas of disease burden (Khan et al., 2008). A consequence was that 
diagnostics were not routinely available in Sierra Leone and other countries in the region 
which were most in need of them. This was not only to do with the absence of local 
laboratories equipped to diagnose Lassa, it was also due to bottlenecks in the manufacture of 
reagents for Lassa diagnosis in the US.  
 
Developing reagents for the traditional assay involved the use of live Lassa virus which, due to 
its biohazard classification had to be done in a BSL-4 level laboratory. These reagents were 
“incredibly cumbersome, difficult and expensive to produce”109 and after all the effort, yielded 
only very small amounts. Reagents had to be produced and shipped to Sierra Leone from the 
US military research centre, USAMRIID, which had BSL-4 facilities. This combination of factors 
meant that supply was limited and likely to run out. Also reagents had to be stored for long 
periods where they were liable to “go off”. Maintaining the laboratory’s service under these 
                                               
108 Despite all the talk of sensitivity, as the assays haven’t been fully validated yet there final sensitivity 
and specificity figures have not yet been calculated. 
109 Tulane laboratory scientist, Kenema, 02/03/2010 
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circumstances proved difficult. Indeed, in early 2010 the positive control that had been 
provided for the IgM ELISA stopped producing signal. As there was no more to replace it, it 
had to be substituted with real serum from previous positive cases, but this was also an 
unreliable supply, and there were extended periods when no IgM assays were performed. 
This all shapes the sense of urgency about improving the diagnostics.  
 
The supply and quality problems were another aspect of the uncertainty and strengthened the 
narrative of the benefits of new diagnostics. To a large extent they also shaped the innovation 
pathway as we shall see in the next section: to reduce dependence on the unreliable live-virus 
based diagnostics Tulane and their collaborators side stepped the BSL-4 issue by cloning the 
proteins in the Lassa virus. A researcher told me how this enabled them to remove the 
dangerous proteins which were responsible for infection, described as the “engine of the 
virus”110. From there they could use Polymerase Chain Reaction (PCR) techniques to select, or 
as he said “literally fishing out”, those that were of most relevance to diagnostics. This was the 
nucleoprotein and glycoprotein 1 and 2 in particular. The exclusion of the infectious proteins 
in the recombinant reagents meant that they can be handled in BSL-2 or 3 laboratories.    
6.3 Developing diagnostic and laboratory authority 
In the eyes of doctors, scientists, government and the WHO the laboratory is now the place 
where a diagnosis of Lassa is confirmed officially, following the upward flow of information in 
official versions of the diagnostic system. This was not always the way in Sierra Leone, indeed 
laboratory diagnostics for Lassa fever were not routinely available in the country until 2006 
when the Mano River Union Lassa Fever Network (MRU-LFN) and Tulane begun their work at 
KGH. Though the opinion that a case of Lassa fever should be confirmed by laboratory 
investigation may have been held in principle, in practice it was not possible; cases were 
diagnosed on clinical grounds (perhaps supported by some laboratory investigations into 
other clinical aspects of the disease) but unless samples were sent to overseas laboratories 
there was no confirmatory laboratory test on offer. The report of a WHO investigation after 
outbreaks in 2003, reaching further West than was usual, highlighted the need for enhanced 
laboratory capacity (WHO, 2003). The development and implementation of a routine test for 
Lassa fever is an important step because, as chapter four emphasised, this is central to the 
narratives of disease control which are based around identification, containment and 
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technological solutions. All of this relies on establishing that it is the Lassa virus which is 
making a particular patient sick. The laboratory, with its capabilities to isolate and identify 
viruses is the place where this can be done with most certainty, in a biomedical sense at least. 
There are implications. Cunningham (1992) has shown how the laboratory fundamentally 
altered definitions of disease and Rosenberg (2002) highlighted that institutionalisations of 
diagnosis tend to obscure the multi-dimensionality of disease. In the following sections I look 
at the way the laboratory defines Lassa fever. This will allow me to examine whether 
developments in laboratory diagnostics have caused other aspects of Lassa fever to be 
overlooked in diagnosis. 
 
Though there are various tests for Lassa fever they work on the same principle; due to the 
pathogenesis of LASV and the basics of immunology, either the virus itself or traces of it (i.e. 
antibodies, such as IgM) can be found in samples of bodily fluid. The confirmatory diagnostic 
for Lassa fever in Kenema is the ELISA. Indeed, for most of my fieldwork period this was the 
only test available for Lassa fever onsite.111  
 
Alternative methods to diagnose Lassa fever include virus isolation, PCR and Indirect 
Fluorescent-Antibody Test (IFA) (Bausch et al., 2000, Panning et al., 2010). ELISAs are 
favoured by Tulane scientists because they consider them to be a more appropriate procedure 
for routine diagnostics than the other techniques. Virus isolation or PCR require expensive 
and advanced equipment, a high degree of technical skill and, in the case of PCR, are easily 
contaminated (See Fair, 2007, Garry, 2004). Furthermore, with PCR, which works by matching 
strands of genetic material, there is an additional risk that it would not be able to detect the 
different strains of Lassa virus and it’s utility has been question elsewhere (Panning et al., 
2010). Therefore, though PCR and virus isolation are generally valued for their specificity, 
indeed virus isolation is considered to be the ‘gold standard’ for Lassa virus (Bausch et al., 
2000), in practical terms they were not considered appropriate. In some ways, PCR was too 
specific. In this instance, the ‘gold standard’ was not the “right tool for the job” (Casper and 
Clarke, 1998). The optimum test would be able to diagnose patients who had cleared the virus 
recently as well as patients who still had virus in their blood. As a simple technique which can 
                                               
111 Towards the end, a prototype rapid diagnostic test (RDT) was introduced but it was still in the early 
stages of validation and was only being used with any regularity in the lab to compare its results with 
the ELISA’s results. This rapid test, a ‘Lateral Flow’, was being developed as front line point-of care test 
only, positive cases on the lateral flow would need to be confirmed using the ELISA which will remain 
as the confirmatory assay.  
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be used to detect virus and antibodies the ELISA fitted the bill and was deemed to be the most 
clinically useful diagnostic test (Bausch et al., 2000, Garry, 2004). On measures of sensitivity 
and specificity the ELISA outperformed the other alternative, the IFA (Bausch et al., 2000). The 
choice of ELISA represents a technological choice, a trajectory. ‘Suitability of fit’ for the chosen 
diagnostic was determined by ideas about its future place and use within a wider diagnostic 
system. The wider system was characterised has having limited capacity and so a simple 
technique was favoured. Sick people within the system were characterised as having antigen 
or antibodies to Lassa virus and so a technique which could detect both was favoured. At this 
point then, both antigen and antibodies were considered diagnostically relevant.   
 
An ELISA is a kind of immunoassay. Immunoassays are tests which use antibodies as 
reagents112 (Crowther, 2000). Antibodies are used to test for a reaction (for a reaction would 
be expected if those antibodies were mixed with the other ingredients in the assay). Enzyme 
immunoassays work on the same principle but involve the addition of enzymes which are 
used to detect, by a change of colour, if a reaction has occurred (as shown in figure 18).113 
Analysis of the intensity of this change in colour, which is referred to as ‘signal’, allows for a 
quantifiable result which is one of the main benefits of an ELISA. Essentially then, an ELISA is 
a step-wise process which works on the basic principles of immunology, antigen and antibody 
binding. Different reagents are added in stages to be ‘captured’ or ‘separated’ during 
incubation or washing respectively. This makes the ELISA flexible as different reagents can be 
used to test for different things. 
  
There are three types of ELISA being developed for Lassa fever. One tests for the virus antigen 
proteins (AG). The two others test for antibodies to the virus: the first is for Immunoglobulin 
M (IgM) which is an early immune response and indicates a recent infection; the second is for 
Immunoglobulin G (IgG) which is a mature immune response and indicates a past infection. 
When fieldwork began the antigen-capture and IgM-capture ELISA were used for diagnosis 
and the IgG was used for surveillance (so was not a routine test). If the assay works well then 
the ‘signal’ which is observed should be the result of the specific Lassa virus and antibody 
proteins binding together.  For the ‘antigen capture’ the ELISA plate is coated with Lassa virus 
                                               
112 A reagent is a substance/compound added (to a testing system) to test for a reaction 
113 This is because when the enzymes are added they attach to the reactants (the ingredients which 
have reacted) and this can be seen when an appropriate substrate (a chemical compound which reacts 
with the enzyme and produces a change in colour) is added.  
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IgM which will capture Lassa virus AG if it is present in the test sample. For the ‘IgM capture’ 
the ELISA plate is coated with Lassa virus AG which will capture Lassa virus IgM if it is present 
in the test sample.  
 
   Figure 18 A used ELISA plate (dark yellow shows a reaction) 
 
 
A problem with the test is that non-Lassa proteins which are present in the sample and the 
reagent can also bind, which is called ‘non-specific binding’. Non-specific binding can also 
produce signal of varying strengths, this change in colour is often referred to as ‘background’ 
or ‘noise’. A certain amount of ‘background’ is expected and tolerated, but non-specific 
binding can produce signal strong enough to appear positive, which would be a false positive.  
 
The ‘traditional assay’ and Tulane’s new ‘recombinant assay’ work on the same basic 
principles; the ELISA ‘sandwich’ theory, outlined above. However, as figure 19 shows, there 
are differences. This table is taken from the diagnostics grant application. The prefix ‘anti’ is 
used as a short hand to indicate what the proteins in that reagent will bind to: ‘anti-human 
IgM’ is a reagent which will capture Lassa IgM (from a human).  There are more stages to the 
traditional assay and it takes longer (approximately 5 hours 15 minutes versus 1 hour 15 
minutes). These differences are significant because of the impact they have on the assay’s 
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clinical utility and its sensitivity and specificity. They have been achieved by adaptations to 
the assay’s ingredients and technique which I will describe below. It is on that basis that the 
Tulane scientists claim to have reshaped the ‘diagnostic paradigm’ (Branco et al., 2011b). 
Figure 20 is a photograph of a poster on the laboratory wall which shows the stages of 
traditional assay.  
 
        Figure 19 Comparison of 'Traditional' and 'Recombinant' IgM ELISA (Garry, 2004) 
 
               Figure 20 Visual representation of ELISA (IgM) protocol from the laboratory wall 
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6.4 The emergence of a new diagnostic paradigm in practice 
Returning to the theme of laboritization, I will now consider the way diagnosis of Lassa fever 
is practiced in the laboratory and trace any imprints of the sub-narratives just discussed on 
those practices. A paper published by members of the Tulane diagnostics team is a good place 
to start. It reads:  
 
“Analysis of humoral immune responses by antibody-capture ELISA and Lassa virus viremia by 
antigen-capture ELISA in suspected patients admitted to the Kenema Government Hospital Lassa 
Fever Ward in Sierra Leone over the past five years is reshaping our understanding of acute 
Lassa fever”  (Branco et al., 2011b, p1).  
 
It goes on to conclude:  
 
“we suggest that the traditional paradigm for diagnosis of acute Lassa fever in West Africa 
should be reconsidered and changed” (Branco et al., 2011b, p13).  
 
The article above marshals evidence from the laboratory to overhaul the existing approach to 
Lassa fever diagnosis, both in the laboratory and in clinical settings. The new approach they 
suggest is based on analysis of the new recombinant assays. In the following sections I 
describe the changes which took place in more detail and set out the terms on which this new 
paradigm is based. By looking at practice in detail it becomes evident that aspects of these 
statements conceal some remaining uncertainties and divergent opinions. With consideration 
of the wider diagnostic process in this thesis’ other empirical chapters, the way in which this 
enhanced and reshaped diagnostic paradigm is impacting on diagnostic processes and 
practices is questionable. Any major paradigm shift has to be worked out and negotiated in 
the context of established paradigms and practices. 
 
There are two areas in which the emerging view is strikingly different from the ‘dogma’ One 
concerns the interpretation of IgM serostatus and the second concerns the geographical 
spread of Lassa.  At the start of my fieldwork a positive IgM result was considered a 
‘laboratory confirmed’ case which had to be admitted to the Lassa ward; by the end of my 
fieldwork, patients testing positive for IgM were frequently kept on the general wards. In a 
short space of time, the relative importance of an IgM positive result was significantly 
reduced: “LASV specific IgM serostatus cannot be considered a diagnostic marker of acute 
disease in West Africans” (Branco et al., 2011b). This statement is made on the grounds that 
IgM appears to remain in patient serum longer than first appreciated. This led one senior 
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Tulane researcher to tell me “lots of the IgM we see are not new infections, they are sick with 
something else, they are dying of something else”. This new interpretation of IgM means many 
‘lab confirmed’ IgM positive cases were admitted to the ward, and treated, which he said, “was 
probably not the right thing to have done”.  
 
The new paradigm represents significant departures from the existing knowledge and 
practice of Lassa fever diagnosis. It is important to understand how such revisions could be 
suggested with the certainty they were. Much of this revolves around the reductions in 
uncertainty made possible by the new diagnostics. Much of the laboratory work involved in 
developing and using the diagnostics is about dealing with uncertainty: the recombinants 
altered the balance uncertainty in three ways: ingredients, technique and interpretation.  
6.4.1 Ingredients 
I noted earlier that much of the uncertainty surrounding Lassa, and the dogma, was to do with 
the ingredients used in the traditional assay. The traditional assay’s reagents are considered 
inferior because the way they are produced means they are impure and there is more chance 
of non-specific binding. Making the reagents requires growing more of the virus, which is 
done by infecting monkey cells in a laboratory and allowing the virus to replicate. The cells 
are from Green Monkey Kidney Cells, also known as Vero cells. The result is a sort of melting 
pot described by one scientist as containing “every protein in that cell which is tens of 
thousands if not hundreds of thousands” including the viral proteins in addition to the original 
cell proteins. To deal with this he said “they have got to figure out a way of actually pulling the 
specific Lassa proteins out of that gamish”.114 This process is very important because if any of 
the non-Lassa proteins get into the reagent they can cause cross-reactivity with non-Lassa 
proteins in the patient’s sample. The resulting reagents are called ‘Lassa virus slurry’ or ‘Lassa 
Vero slurry’. 
 
The purpose of the Lassa Vero slurry is that when added to the traditional ELISA, if there is 
Lassa specific IgM present in the test sample, it will bind to the Lassa virus in the slurry. 
However, if monkeys have been eaten or have simply had close contact with people (both of 
which can be true in Sierra Leone) then there is a chance they will have non-Lassa IgM in their 
blood which reacts to proteins in the Vero slurry. Such a reaction would have nothing to do 
                                               
114 Tulane laboratory scientist, Kenema, 02/03/2010. Gamish is a Yiddish word used to mean a mix or 
‘mis-mash’ 
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with Lassa virus and so would cause a false positive. For the laboratory it represents impurity; 
a complexity of the outside world which needs to be removed. In a setting like Sierra Leone 
where some of the common cell culture hosts are also food sources, it means that it is difficult 
to avoid running into chains of non-LASV specific reactions, like “anti-monkey, anti-virus, anti-
rat”.115  
 
Step three in figure 20 calls for ‘Lassa mock slurry’ or ‘Lassa Vero slurry’ to be added as part of 
the traditional IgM assay. This represents the extra stage (stage three) shown in the 
comparison between the traditional IgM assay and the recombinant assay in figure 19. This 
additional step is an attempt to deal with the cross-reactivity problems described above and is 
one of the reasons that the traditional assay takes longer. In addition to the Lassa Vero slurry, 
a mock slurry is also produced. This is the same as the Vero cell slurry but it has not had the 
Lassa virus grown in it, therefore it has all the proteins from the ‘gamish’ but no traces of 
Lassa virus. It acts as a control to counter the cross-reactions which may stem from “anti-
monkey, anti-virus, anti-rat” interactions. Thus in the traditional assay two samples are run: 
one with ‘mock slurry’ and one with ‘real’ Lassa Vero slurry. Once the assay is completed and 
optical density readings (measuring the intensity of colour change) have been obtained, the 
reading from the ‘mock slurry’ is subtracted from that of the ‘Lassa Vero slurry’. This is 
supposed to limit the influence of non-specific binding caused by proteins from the ‘gamish’ 
which have not been adequately removed from the ‘Lassa Vero slurry’. This step in analysis 
cannot remove the possibility of non-specific binding it is simply an attempt to control for the 
fact that it may occur. There is no clear way of knowing what is binding with what in both the 
mock and the Vero slurry assays, meaning results should still be interpreted with caution.  
 
The traditional assay’s laboritization processes are not sufficient to fully remove traces of 
varying food systems and immunity responses which interfere with its validity, such as if 
monkey are food sources. The result of this failure is a higher risk of false positives. As 
discussed the production of reagents for the traditional assay is also more expensive and 
dangerous because it involves working with a BSL-4 pathogen. Purer, cleaner and less 
dangerous reagents can be produced by re-engineering the virus to produce the ‘recombinant 
proteins’ to use as the reagents. In simple terms, this is done by cloning the viruses’ proteins 
and recombining them. Cloning the virus enables scientists to produce reagent in higher 
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quantities and free from the impurities of the gamish. Cloning also allows the researchers to 
manipulate the virus, to recombine it; the infectious ‘engine’ proteins are removed to side-
step the BSL-4 issue and specific proteins, or combination of proteins, are selected and are 
tested to see which are consistently useful in diagnosis, to be used as reagents in the final 
diagnostic kits. The resulting assay has more specificity because not only are non-Lassa 
proteins in the ‘gamish’ removed, but so are less relevant proteins in the virus. The assay 
achieves its specificity by narrowing the reactions down to specific parts of the virus; in the 
process the virus is spliced and recombined, and the result is increased certainty that a 
reaction is a valid one.  
 
Blood is another ingredient where assay validity can be affected. The process of extraction 
and storage of blood determines the quality of the sample and therefore the quality of the test 
result. This was not a weakness of the ‘traditional assay’ per se but work on the recombinants 
instigated work to improve the ‘cold chain’. By the time the recombinant assay was ready the 
‘cold chain’ was also stable enough to produce samples which could be described as “that nice 
little straw yellow serum”.116 The improvements made here did not involve the same level of 
re-engineering that developing the recombinant proteins did. However the changes made to 
the system of sample collection and storage altered the constitution of the sample in such a 
fundamental way that results from them were finally considered trustworthy. One researcher 
told me that the results obtained from samples collected before the cold chain was improved 
were judged not to be of publishable quality.  
 
Improving the cold chain required equipment and processes which reached far wider that just 
the laboratory, for instance the outreach team is also involved in collecting samples. Both the 
laboratory and the outreach team were given centrifuges in order to separate the serum from 
blood samples as soon as possible. Figure 21 shows a member of the outreach team using the 
centrifuge in the field. Samples were separated into smaller vials so they would not be 
subjected to being taken in and out of the freezer multiple times. Solar power had been 
installed to make power to the freezers more reliable. All of these changes were to streamline 
the transition of serum from the arm to the point that it was needed for testing, enabling the 
laboratory to “produce good samples” as one senior Tulane researcher put it. The impact of 
improving sample collection and storage illustrates Knorr Cetina’s point about the re-shaping 
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(and improvement) of objects as they are subjected to the ‘internal processing environments” 
of the laboratory (Knorr Cetina, 1999, p38). As such, the work of the diagnostic laboratory can 
be understood as producing as much as detecting.  
6.4.2 Technique 
As well as the innovations in ingredients the other key difference between the traditional and 
the recombinant assay was how they were performed. Time was dramatically reduced: the 
traditional assay used to take approximately five hours, with the ELISA plates needing to be 
coated overnight. Therefore in practice a diagnosis could take nearly 24 hours. The 
recombinant assay shortened the wait to just under two hours in total. The implications of 
this on patient survival are great because the earlier a diagnosis can be made the higher the 
chances that the treatment will be successful. Two hours as opposed to 24 hours could be 
critical.  
 
   Figure 21 A member of the outreach team using the centrifuge in the field 
 
 
A discussion of the research process which went into developing the diagnostics is 
enlightening here. In order for the diagnostic to be considered reliable, and in particular 
reliable enough for others to use, the technique had to be stabilised. Stability and 
standardisation is also important for the commercialisation of the assay and for approval by 
the Food and Drug Administration (FDA). The eventual method of performing the 
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recombinant assay was the result of tinkering with different parameters during field testing. 
This process is akin to the tuning which Pickering (1995) described in the mangle’s pursuit of 
stabilisation. The adjustments were aimed at settling on an optimum reaction process which 
encouraged specific binding and minimised ‘background’ binding which can make results 
hard to read. These included:  
 
- Plate washing cycles (minimising non-specific binding) 
- The addition of blocking solution (minimising non-specific binding) 
- Levels of enzyme in the substrate (can speed up or slow down a reaction) 
- Temperature of incubation (pace of reaction) 
- Movement i.e. vibrating plates or stationary (pace of reaction) 
- Time i.e. of blocking, reacting, incubation (levels of reaction) 
- Concentration of soap in plate wash (affecting levels of binding) 
 
The exploration of different combinations of these appeared unplanned. Many of the tweaks 
were based on trial and error or personal preference. When field tests were being run on the 
assays there was debate over how long they should be left to develop colour in the final stage. 
Tacit knowledge seemed to be important as researchers would judge by eye when to stop the 
reaction. Standing over the ELISA plates as the colour in the wells darkened, researchers 
would discuss when to add the stop solution to halt the reaction. Different team members had 
different preferences for the depth of colour in the positive samples and for tolerance of 
‘background’ colour. One of the more senior members of the team preferred to have a low 
background. When some of the other researchers were running tests in his absence, one 
decided to see what would happen if they left the reaction for longer than was usual. They 
joked that the senior colleague would ‘flip out’ when he saw them. 
 
Although the development stage may have looked haphazard, the data was always kept for 
analysis. The objective was to manufacture commercial diagnostic kits which would work 
anywhere in the world. As such the procedures would have to be as standardised as the 
hardware. When it came to introducing the new diagnostics into routine practice at KGH each 
step of the new assay was spelled out in revised Standard Operating Procedures (SOPs). In 
fact, new versions of SOPs would arrive with each Tulane research trip. All the equipment, the 
pipettes, ELISA plates, mixing plates are all standardised. The standardised equipment and 
techniques can be seen as the establishment of order to create scientific facts which STS 
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scholars have commented on (Cambrosio and Keating, 1995, Latour and Woolgar, 1979, 
O'Connell, 1993).  
 
The need to standardise the technique for performing the assay was highlighted by the 
problems other people had had in using the new recombinant assays in different settings. The 
team had given their reagents to teams in Nigeria and Gabon to trial. Results had not been 
consistent, causing some anxiety. Discussing this one night, one team member expressed his 
confusion: “We are the only ones who have run our assays and got them to work, it’s a bit of a 
worry”. He reasoned that this could be explained by failure to follow the given instructions 
properly but there were instances which could not be explained. Referring to previous team 
members who had tested early versions of the recombinant assays at KGH he remembered: “I 
don’t know what is going on. It was the same story here until recently. They used to come 
back really frustrated. All background. Then we would look at it and say there were positives”. 
Clearly there is resistance which needs to be accommodated but it is unclear where the 
resistance is coming from. It could be to do with the way the tests were performed, the 
environments they were performed in, or the tests themselves. 
 
Performing the assay successfully was a complicated affair even with the instructions. As a 
technique, there are many variables which can influence it. For a while the high background in 
samples processed in the Kenema laboratory were puzzling researchers. Background colour 
was higher than when the same tests were run in the US. It was initially explained to me as 
caused by a difference in the temperature between Sierra Leone and the site in the US. Later 
someone realised that the machine which washes the plates had not been cleaned properly 
which meant that the unbound reagents were not being washed away as effectively as they 
should have been. This could also cause high background. A clinician involved in the 
development of these new assays conceded that there is always an “inherent variability”117 to 
an ELISA test. The same clinician noted that he saw a lot of variation in the data coming out of 
the KGH laboratory. There could be any number of reasons: the temperature in the Kenema 
laboratory could fluctuate; the air-conditioning was not reliable and its use depended on the 
availability of ‘town power’118; electricity in general is not reliable and even the solar panels 
                                               
117 Tulane medical clinician, telephone interview, 27/07/2012 
118 Kenema’s electricity supply is known as ‘town power’ for at least 6 months of the year, during the 
dry season, it is patchy to non-existent. The laboratory has solar power for the freezers but air 
conditioning is rationed as that would come from the generator.  
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can occasionally become depleted; sometimes the sun pours into the window onto the 
laboratory workbench where plates were prepared. In sum, there are many potential sources 
of variability which can interfere with the smooth and standardised running of the assay. 
SOPs are an attempt to control for these kinds of events but they cannot rid all variability from 
the process. Finally despite training and the use of SOPs people cannot be homogenised. There 
are peculiarities to people and to moments in time and the simplest factors can make a 
difference. For instance, at what point the reagents are taken out of the fridge makes a 
difference to their temperature (and potentially the reaction) when they are added to the 
assay.  
 
The drive to see the product through to market was evident in many aspects of the work in 
the Kenema laboratory. In addition to the desired FDA approval, the success of the diagnostics 
were often discussed in terms of whether they could be mass produced, standardised and sold 
in kits which would work anywhere. As one senior Tulane researcher told me: 
 
“I hope with some of our partners in the private sector biotech companies, the goal, we may not 
get there right on time but we are not that far away, is to by the end of the year actually have a 
commercially available product where someone can say ok, for the first time in history, you can 
say ‘let me call up and order a Lassa kit,” from a company that has been produced and validated 
and you can use that anywhere in the world for your research or your public health or 
diagnosing patients of whatever”.119  
 
A major concern of the team was to develop tests which would work in laboratories with 
limited capacity. They have to be simple but reliable, considered as ‘appropriate’ in Mabey’s 
definition (Mabey et al., 2004). But how these products would be of benefit to Sierra Leone 
once they were no longer provided free during research was not clear. One suggestion was 
that arrangements could be made whereby they could be donated or sold cheaply to West 
African governments or aid organisations, compensated by more expensive prices from US 
based markets. 
6.4.3 (Re)Interpretation 
Interpreting the ELISA results is another area which underwent significant change. It is 
possible to make a guess at the results of an ELISA test by judging the colour the sample and 
reagent have turned in the plate wells with the naked eye. However, though this may be the 
end of the reaction, it is not the end of the diagnostic test. A binary result is the aim. The plate 
                                               
119 Tulane medical clinician, Kenema, 27/03/2010 
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is put through a light density reader which quantifies the density of light in each well, these 
readings can then be analysed.  
 
The way this subsequent analysis was done changed a number of times during my data 
collection period. Each time a new method was introduced it was supposed to be a more 
reliable way of interpreting the result. The changes provided some interesting examples of 
how uncertainty in interpretation was present, if not formally acknowledged and only really 
acknowledged once there was something better to replace it.    
 
Reading result by eye can be difficult, particularly if there is a lot of background noise, or weak 
signal. Allowing the test to develop longer will produce a higher signal on positives, but also a 
higher background. The tolerance level for these ‘optical densities’ differed between the team. 
It is the ratio of background noise to signal that matters, but can be hard to gauge. When the 
tests were in the early stages of field testing, this could be an uncertain and subjective 
decision: 
 
Researcher 1: “So you’ve got an overwhelming number of positives?” 
Researcher 2: “Depends on what you call positive” 
Researcher 1: 1“Well there are lots of very dark results” 
Researcher 2: “Very dark”, raises eyebrows. 
 
Later, Researcher 1 adds: “none of that means a damn thing until we know what’s 
negative.....and what is statistically different.....and then it’s the math talking, it’s not just you 
pushing the ruler back and forth”  
 
 
Working out the parameters of what is positive and what is negative went through different 
stages and became increasingly quantified. As the method changed, what made someone 
positive for Lassa fever also changed. Mol (1994) noted something similar in a study of 
anaemia where depending on the diagnostic method being used the object being defined 
changed. With the traditional assay the procedure had been to draw a bar graph in Microsoft 
Excel using the sample’s optical density values. If the column for the test sample looked about 
the same height as the positive then it was recorded as a positive. Figure 22 shows the bar 
charts I refer to on the computer screen. Differences in the scale on the vertical axis (used for 
the optical density reading) meant that there was variation in how big the differences looked 
and interpretation was not consistent across tests.  
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   Figure 22 Laboratory technician examining results, showing bar charts 
 
 
A test of statistical significance (an ANOVA) was introduced which provided an ‘improved’ 
way of distinguishing between the test sample and the positive and negative controls. The two 
younger Sierra Leonean clinicians were particularly enthusiastic about this new test. 
Frequently, the test proved a result to be different to what had been judged by eye. In one 
case, one of these technicians and a member of the clinical team who had seen the bar chart 
disagreed about how to interpret the levels in the IgM result. The technician went to run the 
statistical test on the results. It was negative as he had suspected. He was vindicated and so 
were the new statistical diagnostic techniques. In reference to this case he told me plainly: “if 
it is not positive, it’s not positive”. This was a huge change from only a few weeks earlier when 
there was no clear way to settle a disagreement like he and the nurse had had. Only a few 
months later the statistical test was discarded in favour of another method. Suddenly the 
statistics were the unreliable method and ‘cut offs’ were introduced. Cut offs were derived 
from the normal distribution of AG and IgM titres which were observed in a test population. 
From this distribution, the upper and lower cut off limits could be determined. The reading for 
a specific test had to fall between these two values to be considered positive. These values 
were determined by one of the institutions on the diagnostics grant. Before the cut offs were 
introduced positives and negatives were decided by looking at the difference between the 
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control sample and the test sample. The cut offs gave the test readings a meaning derived 
from a control population.  
 
Yet with each new improvement, the extent of what is not yet known becomes clearer. The 
issues of interpretation run deeper than which test, graph or cut off is used. In the words of a 
senior clinician at Tulane, a concept which is hard to grasp but immensely important is that 
“just because something isn’t negative it doesn’t mean it is positive”.120 The laboratory 
produces results of ‘positive’ ‘negative’ or ‘indeterminate’ which are based on numerical 
values produced by the ELISA. Working out the significance of those numerical values, and 
how they should be applied, is an extensive task. Quite aside from the issues of cross-
reactivity which I discussed earlier, infected individuals will naturally be found to have 
different levels of virus (or IgM) in their blood.121 Dose of infection can also make a difference. 
Plus these levels also change over the course of the illness as the virus and antibodies develop 
or reduce. To arrive at meaningful cut offs the distribution of AG or IgM titres can be plotted 
(as a bell-curves) for positive and negative samples within populations. For a well-researched 
and common disease this is relatively easy to do. But collecting adequate samples to 
comprehensively plot the bell-curves for Lassa fever can take years and was still on-going. 
Moreover, characterising positive samples is more difficult as there are fewer of them. Thus 
positive results come with more ambiguity hence the phrase, “just because it isn’t negative, it 
doesn’t mean it is positive”. At present, the cuts off should also be couched in considerable 
caution; in some ways, for the time being, the positive sample is unknowable. 
 
There are also concerns about finding and characterising an appropriate negative population 
to be used as the control. Whose blood is used is important because blood is not the same. The 
recombinant assays have been tested on samples coming through KGH but also on blood 
bought from a US blood bank and from Senegal. ‘African’ blood is talked of as being ‘sticky’. It 
is said to cross-react more and produce more background, though this was a matter for 
debate. Comparisons are of course relative, but the differences can be striking. The US blood 
bank controls had optical density readings so low that they made all Sierra Leonean samples 
which were tested against them look positive. At one stage the researchers had to take 
                                               
120 Tulane medical clinician, telephone interview, 27/07/2012 
121 Fascinatingly it has been observed with other viruses that people can seroconvert, meaning there is 
evidence of the virus in their blood, after having been around the virus or around people with the virus 
without having been infected themselves. I was told that sometimes laboratory workers test positive 
for viruses they work with without having contracted the disease.  
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samples from the Sierra Leonean Lassa team to act as the negative controls: “when using the 
American controls you will take everybody to be positive” laughed one Sierra Leonean 
laboratory technician. Trying to achieve stability across the board is difficult.  When working 
on an Sierra Leonean sample the advice was to use a Sierra Leonean sample, and when 
working on a US sample, a US sample should be found. A negative is not the same everywhere. 
 
A story recounted to me by one of Tulane’s clinicians, who support the doctors at KGH, 
highlights the importance of understanding these issues when interpreting laboratory results. 
For the purposes of this example we shall say the ‘cut off’ for a negative antigen sample is 
0.025.122 Anything below that figure is considered negative. A sample was received from a 
patient who felt generally well but their AG ELISA result, at 0.027, was just over the cut off. 
They were recorded as positive, put on the Lassa ward and commenced with Ribavirin. The 
doctor taking care of the patient at KGH became concerned when the antigen levels did not 
change significantly with treatment. He contacted the clinician at Tulane to discuss the case. 
The Tulane clinician suspected that the case was not really a positive: the titre levels were 
borderline and the patient’s symptoms were mild. Not knowing ‘the value of the test’ is a 
problem the world over he told me. In this instance the doctor at Kenema had made the 
common mistake of being “too heavily reliant on the test result in decision making”.123 The 
value of the test, he told me, is that it should assist in making treatment and diagnostic 
decisions but should not determine them. He and a second clinician emphasised that results 
should always be contextualised with clinical signs and with the time the test was taken. A 
laboratory test result represents only one aspect of disease however its partial nature is easily 
forgotten.    
 
There are times however, when those other aspects do find their way into the laboratory and 
in turn they can influence interpretation. The laboratory is not routinely informed of the 
clinical condition of the patients whose samples they are testing. However KGH is small and 
bits of information were passed between the laboratory and clinical teams, for instance if the 
patient had serious symptoms or where they were from. Even these small details can affect 
interpretation and given diagnosis. This was noticeable when test results are borderline. In 
such cases, standard procedure is to repeat the test but if this is not possible then the 
technicians are more willing to bend the rules. Laboratory staff spoke about how if a test was 
                                               
122 These figures are illustrative 
123 Tulane medical clinician, telephone interview, 27/07/2012 
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indeterminate or borderline and the sample was from somewhere further afield, then they 
would say the result was positive. This was a precaution because they know that a second 
sample would take longer to get. This can work the other way too. In another case the result of 
the statistical test indicated that a sample was negative. However the graph, which was still 
printed, showed the test sample to be a similar level to the positive control. The technician 
decided to say it was indeterminate because he knew the patient was in KGH and that a 
second sample could be taken easily.   
6.5 The value of a test: limits to laboritization?  
Great efforts were made in the laboratory to establish control and stability in Lassa 
diagnostics. There was a move from use of the live virus to the recombinant proteins. The cold 
chain was also tightened up as was the interpretation of the results. However, in all of this 
tuning and disciplined human action (Pickering, 1995) there are always limits to what can be 
controlled. I have highlighted some of these: people, temperature, techniques, knowledge 
about the distribution of the virus in a population. There are always ways for nature to get 
around the imposed order. One researcher exclaimed to her colleagues that the old samples 
they were working on had mould on them: she joked that they looked like beer and were 
making her thirsty. Even with solar powered freezers and a vastly improved cold chain, care 
still has to be taken with reagents and controls in storage as they begin to decay with daily 
usage. I was told how even the samples which had not been colonised by mould could not be 
entirely trusted. Changes in temperature as a result of breaks in cold chain can damage the 
proteins: “They go away, they fall apart, and you start to lose the ability to take any given 
sample, do an assay and then give the results any relevance”.124 Workaround strategies, such 
as dividing the samples into smaller vials (a process called alequoting) so they did not have to 
be removed from the freezer repeatedly, are employed to reduce this occurring. But it is a 
continual battle against material and non-human agency.  
 
There are some fundamental limits to the laboritization. Most dramatically there are limits to 
the value of a test. If there were reservations about the ‘dogma’ of Lassa, there is little visible 
reservation about the emerging view of Lassa, or at least not amongst the laboratory’s 
dominant voices. Though the more senior members of the Tulane team were brimming with 
confidence in the new diagnostics there were more cautious voices among the Sierra Leonean 
                                               
124 Tulane laboratory scientist, Kenema, 02/03/2010 
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staff and some of the doctoral students which suggested that the confidence was not shared 
by all. 
 
The reduced time and (reportedly) improved sensitivity was positively received but trust in 
the new tests was not instant. There were doubts about the sensitivity of the IgM test which 
seemed to be picking up more cases than usual. Before the ‘cut offs’ were introduced one 
technician confided in me that he thought it was picking up too many positives, or as he put it, 
it was “too sharp”. The dynamics in the laboratory mean that often these concerns were not 
fully expressed while Tulane researchers were there. After their departure I found one of the 
Sierra Leonean technicians performing his own validations. He was testing the new assay 
against the old assay on a panel of old samples from the freezer. There was clearly a desire to 
see for himself that the new assays were as good or better than what he was used to. He 
explained to me: “with these new tests we want to be sure there is no doubt, so when we say 
someone is negative then they really are negative”. A number of times the Sierra Leonean 
technicians emphasised that they were performing a different role to the researchers. Their 
job was to provide real-time diagnosis of patients they said, and so lives depended on the 
assays they ran. Understandably this carried an immediate sense of responsibility and I think 
it goes some way to explaining their caution in working with the new diagnostics. One of the 
technicians emphasised the obligation he felt to make sure that the new assays were reliable 
with the phrase, in Krio, “let we no lie”. Similarly, when the practice of keeping IgM patients on 
the general wards first started there was some unease about whether it was the right thing to 
be doing as it went against years of experience. A few staff members felt strongly that is was 
risky and the tests were not fully developed or validated.  
 
The unacknowledged uncertainties are encapsulated by the regulation vacuum. There is no 
FDA or WHO approved diagnostic test for Lassa fever. This means there is no clear bench 
mark which has to be obtained before the new diagnostics can be introduced. Although 
validation tests are being done back in the US, the recombinants were introduced into routine 
practice before they had been fully developed. The positive and negative samples had not 
been comprehensively characterised and sensitivity and specificity figures had not been 
settled. A revealing example of this tension could be found in the protocols for the new 
recombinant assays: they read “For research only, not for use as diagnostics’” though in 
practice they were being used as diagnostics.  
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This is not to say that there is a better alternative. Neither the traditional nor the recombinant 
assay had been validated and it is more than likely the recombinant assay is better. It is also a 
positive development that there are routine diagnostics at KGH at all. However, the likelihood 
is that these vacuums of certainty will continue with regard to diagnostics. One Tulane 
clinician admitted that “FDA approval is the holy grail of medical research” and the rigour 
required simply may not be possible for a remote West African disease.125 This is not unusual 
and others have indicated that it may well be representative of diagnostics in both developing 
and developed countries (Mabey et al., 2004). Still these uncertainties are little acknowledged. 
In practice much of the on-going uncertainty and ambiguity is ‘black-boxed’. The business of 
the clinical laboratory is to make a binary pronouncement on the presence of a pathogen. It is 
not usually in the business of admitting these lingering doubts. Yet, ‘positive’, ‘negative’, or at 
a push, ‘indeterminate’ does not reveal the full extent of uncertainty.  
 
There is a paradox. The position and utility of the laboratory depends on the assurance it 
provides: “the laboratory makes the tests, but equally the tests make the laboratory” 
(Cunningham, p218). A laboratory technician described their role as producing a diagnosis 
which is “really reliable”. This was as opposed to the doctors “who can try”, he said, to 
diagnose but who cannot accurately determine a Lassa diagnosis on clinical signs alone. 
Improvements in laboratory diagnostics have meant that the diagnosis of Lassa fever is done 
on increasingly narrow terms, on specific proteins within the Lassa virus. This narrowness is 
the source of the laboratory’s strength; it has improved sensitivity and specificity I was told. 
But there are further implications. As a classification tool changes, different elements of the 
classification system come more or less sharply into focus (Bowker and Star, 2000). With this 
in mind, it is striking how the laboratory offers very specific and in some sense restricted 
information, yet it does so with great authority. Only the identification of active virus (AG) or 
an immune response (IgM) counts and increasingly the immune response does not always 
count. The restricted nature of the information is also the source of its authority. Ian Hacking 
has written “The assay that is chosen, settled on, creates the criteria of identity for the 
substance of interest. It creates its own truth. It is self authenticating, for there is nothing else 
to authenticate it” (Hacking, 1988, p284). This does not mean that the disease is being 
invented. But it does mean that the terms under which it is investigated are critical and the 
                                               
125 Tulane medical clinician, telephone interview, 27/07/2012 
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picture that is presented is limited. Even the ‘gold standard’ which new diagnostics are 
measured against only becomes the ‘gold standard’ through the same processes of 
authentication. The process of ‘laboritization’ narrows a diagnosis of Lassa fever down to a 
blood sample which is further manipulated into specific proteins. A question that needs to be 
asked is while the viremia of Lassa fever is promoted into sharp focus what others aspects of 
the disease are obscured? 
  
As the diagnostics improve, confidence in them grows. But the story I recounted before of the 
very low-titre ‘positive’ case is a warning that this needs to proceed with care. Similar cases 
are described in the following chapter. In practice however, many of these uncertainties get 
forgotten as the laboratory churns out results; they are hard to process and they are often 
hard to do anything about. This is especially true when the pressure and risks involved in 
knowing that someone’s life may depend on the assay’s result are considered. But there has 
been some disagreement about the way they have been dealt with, or ignored, as in the case of 
the new interpretation of IgM. For example a recent publication asserted: 
 
“Recent studies in which IgM antibody responses are reported to not be consistent or helpful in 
the diagnosis of acute Lassa fever are based on a recombinant assay whose specificity has not 
been validated and contradict published data and years of field experience to the contrary” 
(Bausch et al., forthcoming, 2014). 
 
The issue of how to interpret IgM is clearly problematic and in the above quote it appears that 
what some have referred to as dogma is also being used to challenge the ‘emerging paradigm’. 
This is a far cry from the confident dismissal ‘they are sick with something else’. The 
implications of these debates will be continued in the next chapter. 
6.6 Conclusion   
This chapter traced how the narratives which present Lassa fever as a global threat and a 
worthy target for enhanced technology directly influence practice in the laboratory. Most 
notably the biodefense angle has provided funding for research. These narratives are 
modified in the laboratory setting: the biodefense global threat is not necessarily seen as 
being realistic but it represents a research and commercial opportunity for scientists. Indeed, 
in this Sierra Leonean setting the BSL norms are also not strictly adhered to. I borrowed 
Knorr Cetina’s term ‘laboritization’ to describe the transformation and manipulation of people 
and objects as they are processed by a laboratory. It is on the basis of these manipulations 
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that the enhanced authority of the laboratory and its diagnostics is claimed. But, I also 
suggested that laboritization has limits and that it represented a particular, narrowly defined, 
form of diagnosis. By concentrating on one aspect of Lassa disease, which increasingly is the 
presence of Lassa antigen, other aspects are lost: the roles of IgM and clinical symptoms have 
been downplayed and are the source of disagreements. The variability of ELISAs, the difficulty 
in characterising positive samples and the problems of applying a test result in clinical 
practice are all areas where laboritization is shown to be incomplete and where uncertainty 
and ambiguity are pervasive.   
 
Processes in the laboratory can be considered under the framework of the mangle of practice. 
Practice is based on goals such as improving sensitivity and specificity, producing a 
commercial product or circumventing BSL restrictions. Achieving these goals is done by 
building on existing technology such as recombinant proteins and ELISA assays. This 
repertoire of technology is part of the technological regime which encompasses BSL 
regulations, funding landscapes, international university and private research collaborations. 
Pickering highlighted the importance of tuning and stabilization in the mangle of practice and 
it is these processes which occupy the laboratory. The tests are being tuned to achieve a 
stabilization between material and human agency: through assay protocols the agency of the 
environment and technologies are brought under control. Human agency is simultaneously 
curtailed as the technicians are called upon to be increasingly disciplined. Material and human 
agency can threaten this stability. The blocked up plate washer which caused ‘high 
background’ colour in the ELISA’s results is a good example. This is what is sometimes called 
‘human error’: a failure to be disciplined enough and it allows the resistance of non-human 
agency to break through. Interestingly this was initially interpreted as the uncontrollability of 
the local conditions: Sierra Leone’s hot and humid environment which made the reactions 
faster. Another area of tuning was in the increasing use of statistical tests and cut offs to 
interpret the ELISA results which can be viewed as a human attempt to exert some order over 
the variability of the test and the populations it sampled. The next chapter will pick up on the 
challenges posed by limits to laboritization and it illustrates how the workings of the mangle 
of practice continue in the clinical setting.       
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7 ‘Classic Lassa’: diagnosis in a clinical setting 
In this chapter the practice of diagnosis in clinical settings takes centre stage. The chapter 
starts by examining case definitions for Lassa fever as an example of how the disease is 
framed in formal documents. The rest of the chapter is taken up with contextualising the way 
diagnosis actually happens in clinical settings. With back up from the laboratory, the case 
definitions are supposed to funnel people in or out of Lassa treatment. However, as I show 
processes around the hospital do not follow the neat pathways envisaged in the case 
definition forms or by the Integrated Disease Surveillance and Response (IDSR) guidelines. I 
describe the messier processes which come into play and I find that diagnostic, and treatment 
decisions are negotiated between a much wider set of concerns and voices. The data 
presented here is based primarily on events at Kenema Government Hospital (KGH) and so is 
rooted in the official diagnostic system. Observations made at KGH are complemented by 
those from peripheral health units (PHUs) and hospitals in the ‘Lassa Belt’. 
 
One day, during my walk to KGH, a man stopped me to ask where I was going. He said he 
wanted to come with me. Intrigued as to his response, I told him I was going to the ‘Lassa 
ward’ and asked if he still wanted to come. He pulled a shocked face and exclaimed: “No, I will 
not go to that place!”. The ward’s fame is far reaching but the place itself is full of 
contradictions. For all the alarm, including rumours of lethal injections in chapter five, the 
atmosphere around the Lassa ward is mostly calm, slow even. When ‘town power’ is on, 
nurses from the general wards may slip onto the isolation ward to charge their phones if they 
can avoid being told off for going behind the faded ‘do not cross’ line on the floor. The calm is 
pierced however when crowds gather after a death, or when the Lassa ambulance drives 
through the hospital gates and the people inside can be seen wearing face masks and other 
personal protective equipment (PPE). Seeing the ambulance drive along the main road in 
Kenema, masked faces inside, can be especially eerie. One nurse, working in the North of 
Sierra Leone told me that she had avoided working in East Sierra Leone because of Lassa 
fever. Nurses working at KGH were well aware of the risks they faced; they remembered 
colleagues who contracted Lassa at work and died, including Dr Conteh whose story is 
internationally known.   
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The framings and narratives which were described in chapter four cross-sect the clinical 
setting in various and conflicting ways. Clearly, Lassa fever stands out around KGH. An 
additional distinguishing feature is that treatment for Lassa fever is free. Lassa fever was 
grouped with a small minority of ‘exceptional’ diseases, such as HIV and TB, which also 
receive free treatment (at least until the Free Health Care Initiative (FHCI) was introduced in 
2010). It is not simply the vertical style programming (which is not so unique) and isolation 
that differentiates Lassa. So far these features are simply suggestive of the endemic local 
disease narrative where Lassa is marked out as serious but localised. The ‘exceptionalism’ of 
free treatment actually contradicts the neglected disease narrative, until one looks closer and 
finds that the Lassa ward had to use expired drugs for a substantial period until a second 
donation from the Chinese Government was forthcoming. For the even keener eye there are 
intriguing symbols of external interest which reflect the global threat narrative. There are 
signs around the hospital that report the US Department of Defense (DOD) as funding various 
Lassa projects: the satellite for internet signal is shown in figure 23 and the DOD is also 
funding a new ward. The dilapidation of the ward matches the dilapidation found throughout 
the hospital but in that respect this once neglected disease is emerging on both a local and 
global stage with investments in diagnostics, treatment and research.    
 
In the clinical setting Lassa has many unusual textures: high fatality, isolation, lethal injection 
mythology, free treatment, conspicuous outside interest and investment to name a few.  The 
bureaucracy and infrastructure of Lassa fever, including the ward buildings and the case 
definition and surveillance forms, suggest that Lassa fever can be dealt with separately. 
However as the following pages show, in practice, Lassa is not as separate from its typical 
clinical surroundings as is imagined.  
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                                   Figure 23 A satellite listing financial supporters 
 
 
7.1 Formal clinical diagnosis of Lassa fever  
It is well documented in the scientific literature that Lassa fever is hard to diagnose clinically 
due to the non-specific nature of its symptoms (Bausch et al., 2000, McCormick et al., 1987a, 
Monath and Casals, 1975). Thus, case definition forms are used to provide guidance for 
healthcare professionals in the region. Pinned to the walls of PHU’s, the official first tier of 
government health care who refer on to hospitals, are the simplified case definitions I 
introduced in chapter four (see Table 2):  
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“Any person in or travelling from an endemic area for Lassa fever (eastern Sierra Leone, Liberia, 
or southern Guinea) with fever >38ºC less than 3 weeks duration not responding to at least 48 
hours of appropriate anti-malarial and anti-biotic treatment, typically with chest pain, vomiting, 
sore throat, and muscle aches”.   
 
Figure 24 shows a case definition form developed for the surveillance of Lassa fever, Yellow 
fever and Dengue fever in Mano River Union countries. This is more detailed than the 
simplified case definitions. The expanded case definitions are used in hospitals or some PHUs 
in places with high Lassa incidence. An older Lassa-specific case definition which had been 
developed by Merlin, the aid organisation who had run the ward previously, is pinned to the 
wall in the Lassa ward. It is similar to the one shown here. Both forms work on the same 
principles of differential diagnosis reached from patient history and clinical presentation. 
Symptoms are grouped into major and minor signs. A fever (measured as over 38°C) is the 
first thing to be established in both forms. A differential diagnosis is built up including any 
patient with fever for under three weeks, and then excluding other fever-producing illnesses 
by non-response to treatment (i.e. malaria or typhoid). A final test of inclusion is done by 
checking that the patient has either two major, or one major and two minor signs of Lassa 
from the list.  
 
According to instructions on these case definition forms, once a suspect Lassa fever case is 
encountered by a healthcare worker the treatment pathway is clear. In Merlin’s older form, 
which predates the routine availability of laboratory diagnostics, the reader is advised to 
isolate the patient and commence full-barrier nursing while the Lassa ward is notified. At the 
time my fieldwork began the procedure was similar but with the additional step of collecting a 
blood sample for confirmation by the laboratory. Chapter five described some of the pathways 
a patient may take from home to a clinic or hospital. Sometimes the outreach team will also 
identify suspect cases in the community on their contact tracing trips. For suspect Lassa cases 
identified outside of KGH there is a dedicated ambulance to pick patients up and take them to 
the ward. Once diagnosed with Lassa (one assumes) there would be little room for 
manoeuvre: the protocol is isolation and treatment with Ribavirin for 14 days on the Lassa 
fever ward.  
 
There are signs in the ward to remind caregivers of isolation procedures (see figure 25). 
Isolation procedures were described in chapter four and include: washing hands, wearing 
protective clothing, disposing of needles, syringes and other waste appropriately, and lastly, 
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safe burial practices. Bowls of bleach diluted in water are placed behind the ‘do not cross’ line 
so that medical staff coming off the ward can disinfect themselves (see figure 26). A fence has 
been built to separate the ward entrance from the main part of the hospital and a small 
visitor’s reception area was built within the fence, with separate areas for visitors and 
patients.  
 
 Figure 24 Lassa fever case definition form 
 
Surveillance for Viral Hemorrhagic Fevers in the Mano River Union Countries 
Definition for a Suspected Case of Lassa, Yellow Fever, or Dengue Hemorrhagic Fever 
 
 Fever > 38oC for LESS than 3 weeks AND 
 ABSENCE of signs of LOCAL inflammation (i.e. the illness is systemic) AND  
 ABSENCE of a clinical response after 72 hours of anti-malarial treatment and/or a  broad-spectrum 
antibiotic AND 
 2 major signs OR 1 major sign AND 2 minor signs 
 
Major Signs 
 Abnormal bleeding (from the mouth, nose, rectum, and/or vagina) 
 Edema of the neck and/or face 
 Conjunctival or sub-conjunctival haemorrhage 
 Jaundice 
 Spontaneous abortion 
 Buzzing in the ears or acute deafness 
 Persistent hypotension 
 Confirmed contact with a patient suffering from Lassa fever 
 Elevated liver transaminases (SGOT/AST) 
 
Minor Signs 
 General malaise 
 Headache 
 Retrosternal pain 
 Muscle or joint pain 
 Vomiting 
 Cough 
 Sore throat 
 Abdominal pain 
 Diarrhoea 
 Proteinuria 
 Leucopenia < 4000/μL  
 
MRU LFN Workshop, Kenema, July 13, 2006 
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              Figure 25 Sign at the Lassa ward's entrance 
 
 
              Figure 26 Lassa ward entrance, with faded red 'Do not Cross' line on the floor 
 
199 
 
The form’s approach to diagnosis is linear: from patient history and clinical presentation it 
progressively builds a case for suspecting Lassa fever through stages of ‘counting in’. The 
‘rational’ provision of appropriate healthcare is built on that. The case definition sets out a 
number of requirements a patient’s illness must meet: time (length of fever), non-response to 
treatment and evidence of key Lassa symptoms. There are two assumptions here: first that 
the diagnostic and treatment process will progress in a linear fashion similar to that 
described; and second, that the disease will make itself known (albeit after an initial period of 
non-specificity) by manifesting itself into a collection of defining characteristics which can be 
ranked as major and minor symptoms. This version of Lassa fever and of treatment processes 
is based on an ‘ideal type’ disease-specific model of disease, as described by Rosenberg 
(2002). 
 
The patient’s trajectory is depicted as simple while the doctor’s decision making is rational, it 
implies an account similar to what Berg has described: “the healthcare worker being 
confronted with a patient’s problem, and deciding upon a specific intervention by means of a 
step by step, cognitive process” (Berg, 1997, p1082). In reality, when facing multiple 
uncertainties and ambiguity, decision making is not so simple. There are other concerns 
which the doctors and nursing staff face which affect their diagnostic and treatment decisions. 
With a disease like Lassa there are also important considerations to be made around risk: risk 
to the patient, risk to other patients and risk to themselves. The trajectory described by the 
form also takes it for granted that all the necessary information is available. In the form, the 
treatment process, the disease, and even the patient are purified versions of real life; it is the 
‘principles of medicine’ which Mol and Berg (1994) distinguished from the ‘practice of 
medicine’. The diagnostic process is more nuanced than categorising patients by ticking 
symptoms off a list.    
7.2 Diagnosing Lassa fever in practice  
Above I have outlined the case definition and protocol for diagnosing Lassa fever which can be 
described as the formal clinical framing of the disease and its diagnosis. I have suggested that 
it is a linear model of diagnosis, based on idealised notions of disease presentation, both in 
terms of a patients’ treatment seeking and care trajectory, and of the disease’s symptoms. The 
practice tells a different, more complex, story. A doctor working at a major hospital in the 
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Lassa belt, his hospital a major source of referrals to Kenema, summarises some of the 
difficulty in diagnosing Lassa:  
 
“we usually do our diagnostics on physical examination and history taking which is quite 
restricted...we probably miss quite a few cases…..we have this case now coming in with high 
fever, for about 2 days, and it could be anything, varying from malaria, up to typhoid, up to 
Lassa. You just have to wait till certain signs and symptoms evolve…but you know it’s not always 
a case of classic symptoms of red eyes and vomiting and so on”.126  
 
Things are rarely as simple as they first seem.  
7.2.1 Diagnostic pathways 
A patient’s journey, or diagnostic pathway, is mediated by many things: people, framings of 
disease, availability of treatment, money, local contexts and use of laboratory results. 
Diagnosis in the clinical setting emerges through interactions between these elements. The 
following sections detail the factors which were influential in this process. Clinical diagnostic 
pathways are extremely variable. Arriving at an official health post is neither the start nor the 
end of the story. People enter the hospital from the kind of settings outlined in chapter five for 
different reasons, and in different states: some are mildly sick visitors to the outpatient ward; 
others are comatose when admitted; they may have come straight from a village or have been 
transferred from another health provider. The more fortunate will have resources for 
treatment and be accompanied by friends and family who can provide health workers with a 
full overview of the patient’s symptoms and treatment history. Other arrive alone or semi-
unconscious on the back of a motorbike with a driver or companion who cannot supply the 
full illness history. Many never come to the hospital. Once at a health post a test for Lassa 
fever is just one of many treatment options. At KGH people are tested for Lassa fever for a 
range of reasons: some fit the case definition, others have a blood sample taken as part of 
contact tracing from known cases (and may not visit the hospital themselves initially); some 
people are referred from other health posts specifically for Lassa tests and treatment; a 
patient may ask to be tested specifically; increasingly, doctors order tests to ‘rule it out’ as a 
precaution without really suspecting Lassa.  
                                               
126 Clinician, Panguma, 22/02/2010 
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7.2.1.1 Getting a referral: querying Lassa 
Much depends on the manner in which a patient arrives at the hospital. There is often talk 
amongst the healthcare workers that patients are to blame for late referrals with severe 
disease as they stay in their villages too long, ‘taking herbs’ and ‘running from’ the hospital. 
Although delays certainly occur at this point, for reasons explored in chapter five interviews 
with ex-Lassa patients made it clear that it is also true that many patients do go to PHU’s or 
hospitals in good time, but can be held up there for days before Lassa is queried. For both 
patients and health workers spotting Lassa is difficult, even for those with a great deal of 
experience. Doctors, patients and ward records all offer examples of times when patients 
were treated for other sicknesses and Lassa is only picked up at the last minute. In chapter 
five I recounted a widowed husband’s story of being with his late wife at the hospital for 14 
days before Lassa was finally queried. Ward records show patients who are discharged having 
been treated for something else, supposedly on the mend, only to return when symptoms 
persist. Unfortunately many admissions to the Lassa ward, from both hospitals and 
communities, are recorded when late and severe symptoms have already started: coma, 
convulsions, bleeding.  
 
What are the complications which cause these delays? Why, with a case definition which 
clearly sets out the important signals and chronology, does Lassa get missed? One basic point 
to make is that for all the PHU and hospital staff who know the case definition and are familiar 
with Lassa there are many who are not so well acquainted with it. In areas where Lassa is 
common, where nurses may have come face to face with the disease or with the outreach 
team, nursing staff may be comfortable with the key signs. However, Lassa fever is not a 
standard part of national training for nurses in Sierra Leone and many are not familiar with 
the case definition. The Lassa fever outreach team have conducted training sessions in the 
past and they do ad hoc additional ones where possible, either on visits to villages or 
hospitals. Complete coverage is not possible and would likely be complicated by turnover and 
the numbers of healthcare workers at government posts who are not officially on payroll but 
who provide services to the community. One nurse, working in a Northern district, told me 
she had some lessons on Lassa fever years before but that she did not know it “deeply”. This 
situation is echoed across the regions of Sierra Leone where healthcare workers have heard of 
the disease but know little of its detail.  
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Even for well-trained experienced healthcare workers, who know the case definition, there 
can still be a delay: in regards to the non-specific symptoms, the doctor in Panguma noted that 
the case definition has a delay built in to it by advising clinicians to treat and observe non-
response. Although there is a rationale for this in terms of differential diagnosis, he felt there 
was a trade-off and in some cases waiting was inappropriate. At his hospital, based a good few 
hours from KGH over bad dirt roads, time was limited. In response to those conditions, he and 
his nurses told me that when they recognised patients with ‘classic signs’ they often decide 
not to wait but to send the patient straight away. Waiting to send a sample on the back of a 
motorbike and then waiting for the results, and only then calling the ambulance from Kenema 
to come and collect the patient risked too much of a delay.  
 
It terms of logistics and links between health care providers much depends on the outreach 
team who do far more than just contact tracing, sample collection and sensitization. The 
backbone of the outreach team is two Mende men, from Eastern Sierra Leone, who know the 
villages and healthcare workers in the region very well. One is married to the head nurse of 
Lassa ward and all of them have worked there for well over a decade. They are an essential 
link in the diagnostic system’s chain and often nurses ring their mobile numbers when they 
have suspect cases. Another surveillance and outreach officer who was officially senior to 
them, but who had come from Freetown, had noticeably less affinity with these rural areas 
and inhabitants. The outreach team would, in addition to their official duties, get involved 
with village health affairs. In Tokenga the outreach team advised the villagers in their 
campaign for a clinic and in at least two other villages they assisted in mediating in conflicts 
between nurses and the community. There is a dedicated ambulance for Lassa patients, 
provided for free, and many of its journeys are arranged by the outreach team. On occasion 
the outreach vehicle will be converted into an ambulance when urgent cases are found out in 
the field. The outreach team do their best to forge links between peripheral health posts and 
KGH, within a plural and at times fractured health system. And as chapter five demonstrated 
there are a number of other providers of therapeutic care who the sick can consult. 
 
What kind of healthcare provider a patient goes to see when they are ill depends on a number 
of factors. In chapter five I showed how people say they prefer Western medicine but they 
disapprove of, and dislike depending on, the drug peddlers who they are aware sell 
counterfeit or expired drugs. In rural villages people emphasised that they would like official 
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healthcare to be made more easily available to them. Yet, even in that favourable context the 
authority of staff sent to communities to run Government health clinics is not a given and 
must be earned. Nurses in government health posts need to work hard to establish 
relationships with the communities they serve which match the ties already established by 
existing embedded providers. A nurse in a well-established (and Lassa heavy) mining town 
told me that when she first arrived her clinic was empty as patients preferred to go to these 
existing providers. The quality of these other providers is varied, as is knowledge of Lassa. 
Nurses told me that they did receive referrals from informal providers, such as pharmacists, 
at times. However, nurses were also of the opinion that some informal providers kept treating 
patients as long as they could so that they would receive payment. In chapter five, Tokenga’s 
community members repeated the Lassa fever health promotion message to me and said that 
a Lassa victim should go straight to hospital, but they also reported instances where Lassa 
fever was treated independently of KGH. Chapter five showed that not only are these informal 
and village based providers diverse but so are people’s reasons for choosing them over a 
government hospital. Instead of being based on misunderstandings or ignorance of 
biomedicine, such choices are dependent on assessments of the social relations within health 
systems.      
7.2.1.2 Dysfunction in the system? 
The politics of village healthcare can affect diagnostic pathways. Conflict between nurses, who 
are often ‘strangers’, and village communities are not uncommon. Sometime these 
relationships can become dysfunctional; the headquarter village in Dodo chiefdom (Tokenga’s 
chiefdom) had a history of rejecting the community health officers, there were often disputes 
with the nurse who was well established there and at times she would refuse to work. The 
outreach team would sometimes be called to mediate on these occasions. I witnessed how 
Lassa fever care and prevention could become strategically enrolled in local politics: in one 
town which had a history of Lassa, the new Community Health Officer (CHO) made an attempt 
to gain some popularity by promising to supply a cat for every house in the town to improve 
rodent control if he was still there in six months (he was not). In another town the health 
prevention message of rubbish attracting rodents fed into complaints by some residents 
about other residents leaving their environments dirty and about the ineffective community 
sanitation officers. At one town meeting it was claimed that the sanitation officers only looked 
after the wealthy. Passing laws and imposing fines (for not cleaning, for eating rats or eating 
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cats) was a popular solution “whether he is the chief’s son or not!” shouted the man at that 
meeting.  
 
Disputes can disrupt the provision of care and with acute diseases like Lassa fever the costs of 
these can be high. One of the especially tragic stories I told in chapter five demonstrates this: 
recall the family who lost three children to Lassa fever and where the mother, who survived, 
was left with hearing problems. They lived in a mining village which had its own PHU with 
two registered nurses. One of these nurses had even had training on Lassa fever. But when the 
father had taken his son, who was sick with fever, to the clinic neither nurse had suggested 
anything other than malaria was wrong. The boy grew more seriously ill and died. When 
another of the man’s sons fell sick a few days later he returned to the clinic but again they 
noted nothing particularly suspicious. He described how the nurse used a ‘prova’127 to 
diagnose the boy with malaria and then prescribed anti-malarial drugs, which they did not 
have in stock. The man took his son to another clinic in a neighbouring village but the second 
boy died on the trip. When he returned he found that the children’s mother and another 
sibling had fallen sick. Finally, the nurses contacted the hospital in Kenema. The father 
explained that there was long-standing friction between the two nurses. He said the nurses 
were more involved in their own conflict than in taking action to care for patients or equip 
their clinic properly. It may be relevant that this was a mining village with a transient 
population where arguably community solidarity may have been more limited and less able to 
tackle on-going failures in basic healthcare provision. These events seemed to galvanise 
villagers to take action, backed up by the outreach team, they demanded that the two nurses 
be removed and replaced.  
 
Once at the hospital the uncertainty and diversity of pathways does not end. Extracting the 
full and necessary information to apply a case definition from patients is difficult, whether 
they are admitted straight to the isolation ward or to a general ward. When deliberating over 
whether to admit a new patient or clerking a new admission the nurses have to use whatever 
information they can. Scrutinizing the forms that are sent with patient, there are often gaps or 
inaccuracies. Illness and exposure histories are often not extensive, the case notification form 
may not be fully filled out, personal details of the patient are missing or conflicting in different 
forms. Patients turn up with referrals and no full treatment history, and they or their family 
                                               
127 A rapid diagnostic test 
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are often unable to give it. The outreach team also try to fit parts of the jigsaw together, 
visiting case contacts. Sometimes in these contexts the histories that are reported are 
suspected of not being accurate. Nurses can be very sceptical about the information given to 
them by patients:  
 
“they keep these patients until their condition is going bad….that is the general habit of our 
native people. They don’t seek the hospital advice as early as possible, they keep their children for 
a day, 2, 3, or 4 but when they come they never give the correct history. When we ask them how 
long has this child been sick they say just for 2 days, but if we go and ask another relative, or a 
neighbour, he or she will say that he has been sick for a week or two…..it is difficult to get the 
histories, they don’t give the actual history”.128  
 
Miss-communication or the total failure of information flow becomes lethal in the case of 
Lassa fever, and as one clinician commented to me, is almost made worse by one of the basic 
principles of the case definitions: clinically someone is to be suspected of Lassa once they 
have been treated, and found to be non-responsive, for anti-malarial and antibiotic drugs for a 
period of 72 hours. He told me that what can happen is that the 72 hour period will be 
observed after which the patient is referred to the next tier in the health service but although 
the patient may arrive there still in one piece unfortunately their treatment history may not. 
Thus, health workers at the next level start the process again, causing further delay.    
 
Many factors can get in the way of comprehensive treatment histories. As well as the 
problems with record keeping, patients may not have been told or remember what they have 
taken and nurses often distrust what is reported to them. In particular they assume that 
people do not report time and use of any alternative therapies accurately. I also observed 
what appeared to be an attempt to conceal a patient’s exposure history; it was actually a 
doctor who was disputing the dates a young girl had stayed in his household (in a Lassa 
endemic area). His account differed from what the outreach had been told by others and they 
guessed that he was trying to avoid the stigma of a Lassa infection being contracted under his 
roof.  In general, it is hard to tell what information is true and whether the nurses should be so 
dismissive of patient’s accounts, but what is clear is that doctors and nurses make decisions 
under considerable uncertainty.   
                                               
128 Paediatric nurse, Panguma, 22/02/2010 
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7.2.1.3 Building a solid case 
Returning to the case definition, the exclusion of the differential diseases is particularly 
troublesome, in part because ‘non-response’ is hard to judge when the quality of the 
treatment given is unclear and because many patients are co-infected making exclusion tricky. 
The intractable messiness of health and treatment is particularly apparent here. Despite the 
case definition requiring that patients have been treated with, and found not responsive to, 
antibiotics and anti-malarials there is a working assumption that this won’t have happened. At 
the Lassa ward they still treat most people for malaria on arrival (if drugs are available or 
purchased by the family), even when their records report that they have been treated for it – 
and as is required by the case definition. The assumption that malaria hasn’t been excluded is 
rooted in a number of factors: non-adherence to treatment, the possibility that drugs were 
counterfeit or expired, or miss-reporting and miss-management of cases. The Lassa nurses do 
not even trust the treatment history of cases referred from within KGH; only patients coming 
from the nearby MSF hospital were expected to have been treated appropriately for malaria. 
These factors seriously undermine the possibility of applying the case definition with any 
validity and in practice it means diagnosis takes a very different shape making it distinctly 
unpredictable and non-linear. When it was still routine practice to admit non-laboratory 
confirmed cases to the Lassa ward the steady stream of admissions who soon began to 
recover once they are commenced on anti-malarials is a reminder that that scepticism is 
justified.  
 
Another element affecting the capacity to establish a reliable diagnosis of Lassa and to exclude 
differential diseases is the financing of healthcare. The national (and international) funding of 
healthcare influences treatment seeking pathways because it determines the choices available 
to patients and clinicians. The assortment of payment policies and vertical programmes have 
a bearing on medical practice in a very real sense. Some diseases have free tests and 
treatment, most do not; and if a donor is not paying then it is left for the staff to do what they 
can with both the hospital and the patient’s scare resources.  
 
These negotiations not only account for particular decisions, they are also part of the 
knowledge base used to make decisions. Shadowing ward rounds with the doctor invariably 
meant trying to piece together what bits of treatment or tests a patient had had. ‘What about 
the labs?’ ‘What about the treatment?’ Time and time again when the doctors asked these 
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questions the nurses reported that they had not been done, usually on account of the patient’s 
inability to pay for them: ‘moni no dae’ (the money is not there).129 While the primary burden 
falls on the patient here, the doctor and supporting health staff are left with little to go on, 
investigations are confined to physical examination, diagnosis is symptomatic, prognosis 
involves waiting to see what happens and clinical decisions are made under considerable 
uncertainty. What was poignant was that often patients had made considerable efforts to get 
to a hospital, paying for transport and for hospital admission, but were left with no money for 
treatment. Getting to hospital entails significant cost alone; finding out what is making a 
person sick once they arrived there involves further financial strain which many patients (not 
covered by FHCI) cannot afford. Investigating a case, even to the minimal extent that the case 
definition requires, is often not possible. Fever, one of the most fundamental symptoms in the 
case definition is not always possible to measure in the manner that is called for: the Lassa 
ward, for example, did not have a thermometer130, and it is unlikely that many PHUs would 
have had one.  
 
In the place of so many unknowns other strategies for deciding how cases should be treated 
arise. For malaria, there is a strong tradition of presumptive diagnosis which was also 
recommended by the WHO for a long time (D'Acremont et al., 2009). I overheard the doctor 
telling his students to “assume, don’t even ask” about malaria. When I first sat in on outpatient 
consultations with a different doctor he asked me to write prescriptions for him as he 
dictated. I was having trouble keeping up at first with the lists of drugs for each patient. Here 
treatment was certainly the diagnosis, and when I asked him to slow down or repeat things he 
laughed and told me “you’ll get used to it”. Very quickly I did. 
 
In this section we have seen that clinical diagnosis in practice is much messier than the path 
set out in the case definition. Not only is it not linear, it can be chaotic and there is usually 
significant uncertainty. Furthermore we do not see the ‘hanging together’ that has been 
implicit in descriptions of diagnosis in higher income settings, supporting Street’s scepticism 
about its universality. In the Papua New Guinean clinical context Street describes a value 
being placed on uncertainty and sees nurses ‘working against’ those who try to seek closures. 
                                               
129 Laboratory tests for Lassa fever are free. Laboratory tests for other conditions are done by the 
general laboratory which charges on average between 3,000-50,000 Leones (£00.54p to £9.00) for 
analysis. Though some tests are as much as 150,000 Leones (£27.00).     
130 Tulane medical clinician, telephone interview, 27/07/2012 
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In KGH I did not see resistance to diagnostic closure, but there were some issues with the flow 
of information which at times meant things didn’t ‘hang’; in a healthcare context with multiple 
providers and only paper records, both forms and patients can get lost. Tracking a patient 
down within the hospital grounds can be difficult but outside, without full or permanent 
addresses, patients disappear. Efforts are made to keep any serious or probable looking cases 
in or near the hospital while test are being run, but some get away: there was a suspect case 
from the outpatients who was supposed to come back for monitoring, on hearing about them 
an experienced nurse laughed “you won’t see him now”, and they didn’t. Patients would 
sometimes resist to be admitted, or plead to be discharged. I never saw a patient refuse 
absolutely but I did hear of occasions; while I was there, there was a cluster of cases from the 
same household in Tongo (a mining area). There had already been three cases of Lassa linked 
to the house including one death. A fourth man fell ill after staying there, but despite vomiting 
blood he chose to return to his village instead of going to the Lassa ward, and his village is 
where he was reported to have died.131 
7.2.2 Classic Lassa? 
In addition to the variability of diagnostic pathways there is a fundamental problem of 
recognising Lassa fever. In terms of referral and treatment decisions, there are some 
symptoms on the case definition’s list which appear to have more currency than others in 
health workers decision making. ‘Classic symptoms’ or ‘classic signs’ as they are known by 
healthcare workers are: bleeding, red eyes, high fever, sore throat and a swollen face most 
typically, to that more mundane symptoms such as diarrhoea, side pain and vomiting are 
added. There is no comprehensive or definitive list, but the same symptoms are mentioned 
when nurses are guessing the status of someone awaiting a test, or deciding whether to refer, 
admit, or treat. 
 
As I have outlined fulfilling the requirements of the case identification form is not always 
possible and patients are often referred to the ward on symptoms alone – apparently often 
primarily on the basis of the ‘classic signs’. One nurse told me, “sore throat, fever and red eyes, 
we don’t waste time”132.  Another classic sign is bleeding, which is associated with the later 
stages of the disease. The same nurse explained of bleeding, “we don’t waste time with it at 
all….that is the final stage, whether we order the tests or not we just have to conclude that this 
                                               
131 Lassa history 12, Tongo, 26/04/2010 
132 Paediatric nurse, Panguma, 22/02/2010 
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is Lassa, we don’t even take the sample we just call for ambulance to take the patients”.133 
Here the health workers decisions are based on weighing up risks to themselves and to 
patients and classic signs are taken as a strong indication of risk. 
 
Symptoms like red eyes and bleeding in particular are reminders of Lassa’s alarming 
reputation and of the risks facing healthcare workers: “we are at a very great risk. Because 
when these people come with one or two signs of Lassa fever, we don’t know whether it is 
actual Lassa or not, so we just have to play with this patient”.134 Querying Lassa, starting 
isolation and referring that patient is a safer option for healthcare workers. Indeed such is the 
power of these signs that there are cases who are referred to the Lassa ward inappropriately, 
for instance at separate times: a man who was vomiting blood but had no other clinical signs; 
a girl with a bleeding nose; or another who had been referred by KGH to Freetown for an 
operation but was sent back when he was found to have some bleeding in his mouth. Such 
panic and risk aversion makes sense, when the classic signs reveal themselves the nurses 
have to protect themselves. This was brought home to me after a case was contracted on the 
grounds of a hospital in the Lassa belt. The outreach team conducted a training session with 
the student nurses there in which they advised them to use gloves and not to ‘play’ with 
suspect patients. However, in a shocking admission of the situation they faced, the matron 
stood up straight after and told them not to even ask for gloves because there weren’t any and 
that “only god can save you”. A final, equally unhelpful, piece of advice was simply that they 
should not let a patient be sick on them.   
 
Once at the ward there are similar judgments to be made about the numerous risks Lassa 
poses to patients and staff. As I touched upon in the preceding section, some patients are 
referred to the Lassa ward before their samples have been tested; some are referred on the 
back on a positive test result. Staff on the Lassa ward then need to decide whether to admit, 
treat or observe. Evidence of classic signs and severity of symptoms figure strongly in these 
decisions. At the start of my fieldwork it was common for suspect cases to be transferred to 
the isolation ward before the results were back; as the tests took longer there was a lengthier 
window of uncertainty during which the reasoning was that it was better not to delay or ‘play’ 
with Lassa. There was also the real possibility of traumatising a patient or doing them harm 
by starting treatment mistakenly, as one researcher put it, “you could argue if Lassa doesn’t 
                                               
133 Paediatric nurse, Panguma, 22/02/2010 
134 Paediatric nurse, Panguma, 22/02/2010 
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kill you then the treatment will”. While that may be over-stating the case, a course of Ribavirin 
is certainly not a treatment to be taken lightly and there were cases, which I will come to, 
which were treated erroneously causing serious side effects. Later on, as tests got quicker, 
admitting patients to the ward without test results became less frequent. 
 
On the admission forms there are two options to choose from if a patients sample has not yet 
been sent for testing: ‘suspect Lassa’ or ‘probable Lassa’. An old treatment algorithm of 
Merlin’s which was stuck to the wall defined ‘probable’ as cases which fulfilled all the case 
definition criteria (pre-laboratory tests) and hence should be treated, and patients not 
meeting all the case definition’s requirements were to be treated as suspect and monitored 
but not receive treatment initially. However, when I asked nurses how they defined the 
categories of ‘probable’ and ‘suspect’, specifically on what basis they allocated patients to each 
category, there was no clear consensus or unanimous method. One defined ‘probable’ as 
patients who were contacts of known cases. ‘Probable’ was widely used to mean that the 
patient was considered to have a higher probability of being sick with Lassa than a patient 
classed as ‘suspect’. But in general the terms which nurses used to divide patients up seemed 
flexible. The most important outcome of this classification was the decision about whether to 
treat with Ribavirin or not. Thus, in practice the classification of patients as ‘probable’ and 
‘suspect’ was largely the result of the nurses’ or doctor’s decision about whether a patient 
needed to be commenced on treatment.  
 
Rather than following a protocol or classification to the letter, the nurses appeared to make 
the decision based on their assessments of classic signs and the severity of symptoms. One 
brief exchange went: 
 
Nurse 1: “e don do de test?” (has he been tested?) 
Nurse 2: “No, but e get classic signs, we de commence Ribavirin” (no, but he has classic signs, we 
are starting Ribavirin)  
 
Severe symptoms (such as convulsions, coma) and classic signs were a strong incentive to 
start patients on treatment as early as possible. Nurses could make this decision without the 
doctor and frequently did. As soon as such cases arrived at the ward the nurses would start 
preparing the vials of Ribavirin for an initial dose. These practices incorporated an intimate 
knowledge of Lassa, an appreciation of a patient’s condition, likely stage of disease, a weighing 
up of the risks of waiting or starting treatment to a patient’s health and chances of survival. In 
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such instances these concerns override the formula set out by clinical protocols or case 
definitions. I once asked the doctor in charge about treatment protocols (other than the 
Merlin one from the wall), to which he replied there weren’t any “just what is in our heads”. 
Though this is not quite true (as there were treatment protocols for instance the dosage and 
length of treatment with Ribavirin, burial procedures, or discharge protocols), many of the 
clinical decisions were left up to individual’s judgements to which there could be considerable 
flexibility.  
 
Another area of clinical decision making concerns nurses practices of personal protection and 
risk aversion.  The safety concerns of the protocol are tangential to the practicalities of 
carrying out duties on the ward. If the ward is full and there are multiple patients requiring 
intravenous Ribavirin each at separate times the nurses would, by protocol, have to be in full 
PPE almost constantly. The inconvenience and discomfort of this was enormous in the humid 
heat and on a hot, badly ventilated ward. Nurses would sometimes emerge from patient’s 
rooms soaked with sweat. Relaxation of the safety rules are tolerated because they are a 
practically burdensome, a fact which is recognised by senior staff. There are resource 
limitations too, for instance the ‘appropriate disposal of needles’ requires ‘sharp boxes’ and an 
adequate supply of needles to ensure that nurses do not need to ‘re-cap’ them. Such resources 
are not always available, and given the heavy treatment schedule for Lassa patients, the 
nurses are required to re-cap and re-use needles (across one patient’s treatment period, not 
across patients) thus breaking a golden rule of hospital hygiene and safety. Alternative rules 
of thumb were explained to me. In practice some nurses would make assessments of the level 
of risk a patient presented and adjust their level of PPE according to that. One nurse told me 
that if a patient was bleeding, perhaps a miscarriage, or vomiting substantially he would dress 
in full protective gear but would not always ‘gown up’ if he considered a patient to be ‘stable’. 
For him, this level of risk was one he felt comfortable with and it was also something which he 
argued he should be able to have some degree of control over instead of simply following a 
protocol. It was for his own protection he reasoned.  
 
‘Classic Lassa’ is a framing of Lassa that comes out of the health care workers own experiences 
with Lassa, and of their knowledge of what Lassa looks and feels like in a patient. In contrast 
other nurses, who do not have experience with Lassa, can name a few symptoms but say they 
do not ‘really know’ Lassa. When confronted with a suspect case nurses’ knowledge is 
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combined with an appreciation of the treatment options and the risks that come with them, 
for instance; scaring the patient by admitting them to isolation, getting treatment started as 
early as possible to give the patient the best chance of survival, risking their own or other 
patients lives by not isolating or referring to Kenema. A lot rides on the ‘classic signs’, yet the 
quote I started with hinted at a problem: “it’s not always a case of classic symptoms”.  There is 
a deeper ambiguity; these classic signs and lists of major and minor signs are based on data 
collected about the symptoms observed in the clinic over a number of years. However those 
were also collected at a time when laboratory diagnostics were not reliable or routine, so 
what then, are the underlying clinical definitions of Lassa based on? A disjuncture is opening 
up between classificatory practices and the tacit and practical knowledge used in clinical 
decision making is caught somewhere in between. If it was ever certain, it seems more 
uncertain in some respects now. Here I will give some examples of the ways the classic signs 
may not be so clear-cut or reliable. 
 
To begin with although the ‘classic signs’ have a core group of symptoms some healthcare 
workers add their own. In Panguma, both of the Sierra Leonean nurses who I interviewed 
spoke of ‘black vomit’135 as a ‘symptom’ or warning sign of Lassa:  
 
“he (the previous doctor) chose this black fluid to be one of the symptoms of Lassa fever….. when 
the patient comes to hospital and we suspect them of having black fluid and at the same time 
running temperature, we just have to attribute it to be Lassa. .....the community people delay this 
patient in sending him to hospital”.136  
 
The nurses were unsure if it was from internal bleeding or use of herbal medicine, but when 
black vomit was observed it was a cue to suspect Lassa and was interpreted as a sign of 
delay.137 Black vomit is mentioned in some of the literature on Lassa fever (Ogbu et al., 2007) 
although not frequently. In Panguma however, it is appears to be a ‘classic sign’. Interestingly 
the senior doctor at this hospital, a European man, was confused as to the significance of 
‘black vomit’:  
 
“There is another thing which sometimes confuses me, and I have not really found out, what they 
mean with black vomit disease. If that is actually a thing which comes from the community 
which could fit in with either Lassa, but could also fit in with use of local drugs…..if I read my 
annual reports form the past there are people diagnosed with black vomit disease, which is not a 
clinical term. If you look into a clinical tropical book you would not find black vomit 
                                               
135 I have heard black vomit mentioned in regard to Yellow fever too.  
136 Paediatric nurse, Panguma, 22/02/2010  
137 Outpatient nurse, Panguma, 22/02/2010 
213 
 
disease….they use it and they are brought in that way, like a child is brought in with black vomit 
disease. It is not officially diagnosed on our clinical charts but they use that term, black vomit 
disease. That sometimes confuses me to what say what does it actually mean. Is it a community 
thing, or is it really something which is embedded in the clinical situation in Sierra Leone?”.138  
 
What ‘classic signs’ and ‘black vomit’ show is that even when formal case definitions exist, 
there will be alternative local working definitions, and local additions to the disease profile. 
These classification systems are part of the regime that laboratory diagnostics, old and new, 
are used within.  
 
For all the talk of classic signs, and dependence on them to make assessments, Lassa 
frequently proves itself to be unpredictable or at the least the laboratory results do not always 
concur. That Lassa fever’s clinical presentation is non-specific is well known. But the reliance 
on the classic signs and the notion that Lassa will emerge in this typical form is often 
undermined. Either the classic signs never appear or they are clearly evident but when the 
blood sample comes back it is negative for Lassa. As one doctor told me, there are always 
cases which take you by surprise. Most recently for him was the case of a pregnant woman 
who had given birth to a baby at five months who did not survive. The woman was 
despondent, unresponsive and he suspected stress from the trauma. She also had problems 
with a swollen abdomen. He and another doctor were treating her for days but had no real 
leads until she started bleeding from her IV site. They tested her for Lassa and it came back 
positive. He was still extremely surprised by this result, particularly due to the absence of 
fever. He asked me: “can you imagine? She was not hot at all”. In hindsight he felt he should 
have recognised her malaise as a symptom of Lassa yet there was very little else to go on until 
it was too late. Even without the ‘classic signs’ the case proved to be a fatal. Other times there 
are cases which have all the classic signs but which tests later show are not Lassa. Their 
symptoms may have looked so typical that they had already been admitted to the ward and 
commenced treatment. Mostly the patients are discharged from the ward but in some cases 
where the patient is clearly very sick, nurses confided that they have, on occasion, continued 
treatment, reasoning that it could be another VHF for which Ribavirin may be effective.  
 
One ‘sign’ which I haven’t mentioned but which is a cornerstone of Lassa’s framing in Sierra 
Leone, and could be said to be tacitly included the ‘classic signs’, is geography and exposure 
history determined by time spent in a Lassa endemic area. This has long been understood as 
                                               
138 Clinician, Panguma, 22/02/2010 
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the Eastern and Southern provinces of Sierra Leone. The Western area towards Freetown and 
the North of Sierra Leone have traditionally not been associated with Lassa fever. This was 
ingrained in popular culture as well as clinical practice. A few Freetown residents even told 
me they disliked, or even avoided, travel to the East. One man told me he always brought his 
own food with him. A nurse explained that although she trained in the East, the reason she 
had looked for work in Northern provinces was to avoid Lassa: “we thought it had a special 
area” she told me. Such ideas made their way into clinical practice; for instance the man I 
mentioned previously who was turned away from Freetown as he had been in Kenema and 
had some bleeding in his mouth.  
 
However, the strong association with Lassa and the Eastern Sierra Leone is beginning to 
unravel. In 2011 an outbreak in the Northern Province of Makeni was recorded. This caused a 
sensation as a South African national died and there were (inaccurate) reports in the press 
that a woman running a ‘rat meat restaurant’ had been the source. In an interview with a 
doctor who was involved in treating some of those affected in this outbreak, she 
acknowledged how she and her colleagues were slow to recognise Lassa as they associated it 
so strongly with the East of Sierra Leone. She added that when they began to send samples to 
Kenema they were not really suspecting to find Lassa, as well as the geographical issues the 
cases did not look classic “‘he was not bleeding…we didn’t recognise it as Lassa, he didn’t have 
the typical Lassa symptoms, but we checked it because we wanted to check it for the other 
things”139 (other viruses which they could test for at Kenema and which seemed more likely).  
 
Indeed, the supposed certainty with which diagnostic inferences have been made from a 
patient’s travel history (as having been in or not been in a Lassa endemic area) is based on 
severely limited knowledge about the spread of Lassa. As discussed in chapter 4 there are 
serious underlying doubts about the distribution and prevalence rates of Lassa fever in Sierra 
Leone and West Africa. These cases from the north seem to confirm that the association 
between place and diagnosis is unravelling or changing. The uncertainties about ecology, 
climate and prevalence which surround Lassa fever are, in this view, central to diagnostic 
practice. The questions over whether it is a forest zone disease or whether it is linked to 
rainfall and other climatological factors (see Fichet-Calvet and Rogers, 2009) map on to local 
understandings of prevalence, and thus regionally textured framings of Lassa, which challenge 
                                               
139 Lassa history 13, Makeni, 29/04/2011 (this interview was with a doctor who had been treating a 
Lassa patient and subsequently became infected) 
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the long-standing diagnostic inferences based on them. New research into these issues (See 
Gire et al., 2012, Moses et al., 2012) will undoubtedly bring further implications for diagnosis 
across the region. In the meantime in-country WHO officials discussed the need for 
broadening out surveillance in all of Sierra Leone’s regions, to “raise the suspicion index for 
Lassa” as one put it.140 However Ministry of Health and Sanitation officials admit that in a 
context of scarce resources, Lassa fever is not yet a national priority; though that may change 
if too many health workers, also considered as scarce resources, are lost.141    
7.2.3 Laboratory results in clinical practice 
Into this mix are thrown the laboratory tests, the subject of the previous chapter which I have 
alluded to at various points in this one so far. In general there is a synergy between the tests 
and the clinical signs. But as we have seen key treatment decisions are not always based on a 
test result, they are often made before and very occasionally in spite of one (i.e. the Lassa 
negative patients who are kept on Ribavirin or kept on the ward for observation). The KGH 
doctors have a healthy scepticism of laboratory results. One doctor took care to remind me 
that they “weren’t gospel”. Yet some were deemed more reliable than others. Lassa fever tests 
were respected on the whole, whereas tests for malaria and typhoid were not well trusted. 
The doctor emphasised that latter point to his students by waving a negative malaria result 
from in front of them while ordering a course of anti-malaria drugs for the patient: “are we to 
trust a mere bit of paper?” he said. The Lassa ELISA is not dismissed in this way and patients 
were admitted or discharged as a result. Much of the variation in diagnostics pathways I have 
described so far concerns what happens before a test. Now I want to turn to what happens 
after the result is received and what has changed with the new diagnostics. Although the 
result is trusted (though some doubts remain) it is not the definitive factor in treatment 
decisions. That, in principle, should come as no surprise to anyone who has had some 
involvement in diagnostics or medicine. Both Tulane clinicians emphasised that a test should 
not be used alone but rather in conjunction with other tools of investigation or methods of 
appraising symptoms. In practice, the way in which the meaning of a test result is negotiated 
for clinical decision making can be surprising; in the previous chapter I noted there had been 
some disagreement over the ‘new paradigm’ for interpreting IgM, here we see the clinical 
implications of those disagreements.  
 
                                               
140 WHO representative, Freetown, 29/04/2011 
141 Senior MOHS official, Disease Prevention and Control Directorate, Freetown, 28/04/2011    
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One change with major clinical implications is the reduction in the time it takes for a test 
result to come back. The result is that unless a suspect case looks particularly severe the 
decision to treat, and admit, is made after and on the basis of the test result. There are far 
fewer people who start treatment and are admitted mistakenly. There is another more 
complicated change in practice concerning the way IgM positive results are interpreted and 
dealt with. When I started fieldwork a positive result on the IgM or AG ELISA was considered 
a positive Lassa diagnosis. Such cases were admitted to the ward and the decision to start 
treatment was based on symptoms and clinical condition (as described above). Now IgM 
positives are frequently not considered a clinical diagnosis of Lassa fever. Many such patients 
are not admitted to the ward and, as a Tulane researcher explained to me, they now think they 
are “sick with something else”. As the last chapter demonstrated, if once the laboratory 
researchers complained that “doctors speak for what we know” about Lassa fever, the reverse 
now looks to be coming true. IgM patients were often kept on the general wards after their 
results came back. There appeared to be a growing sense that the IgM patients did not need 
any special attention and were considered stable. An IgM positive result was being described 
by more senior healthcare workers to the patients and nursing staff on these wards as 
meaning the patient had “conquered the Lassa”. In effect the developments in the laboratory, 
and the ‘emerging view’ that IgM stayed in a patient’s body for much longer than previously 
thought, was overturning the established diagnostic interpretation and the clinical routines 
which had been built on them. But as I noted in the previous chapter this is not without some 
contestation.  
 
More recently a clinician from Tulane explained how things were evolving with regards to IgM 
interpretation: the IgM could still have some diagnostic purpose in that it was “suggestive but 
doesn’t confirm” a recent Lassa infection, but for treatment decisions an IgM test “really isn’t 
clinically relevant” because an “IgM positive doesn’t mean a patient should be treated”.142 
What is important here is that there begins to be a separation between the purposes of 
diagnosis, say for research or surveillance, and clinical decision making. This is the same 
clinician who earlier emphasised the value of a test; that a test should assist, not determine, 
clinical judgement and decision making. Here, the interpretation of the test depends on its 
relevance and ability to inform the practical decision being made. IgM loses its clinical 
relevance, and diagnostic authority, because it cannot assist in making treatment decisions. 
                                               
142 Tulane medical clinician, telephone interview, 27/07/2012 
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The meaning and power of the test comes from what it can set into motion as a result. A 
positive IgM case is made in practice through treatment decisions not simply by the 
identification of IgM in the sample.    
 
Initially these deliberations and routines concerning IgM seemed in a state of flux; when I left 
Sierra Leone the fact that IgM patients were being kept on general wards was not widely 
shared, even amongst the team. As it became more commonplace (and public) there was some 
unease amongst a few staff members who were cautious about modifications to the 
established protocol which were understood as essential for minimising further infections. 
There was a feeling that the new criteria for diagnosis was not tried and tested.  
 
Earlier I mentioned bottlenecks in the flow of information and it was particularly apparent in 
these cases. The Lassa ELISA results are given to the doctor in charge of the Lassa ward and 
are not kept with the patient’s notes on the ward. In many cases the nursing staff were 
uninformed of the test results, including whether the patient being kept on their ward and 
cared for by they was an IgM positive. Even the other doctors were not always kept up to date 
with results, even from tests they had ordered; the doctor in charge of the maternity ward 
seemed to routinely have to chase up the results. Initially for these IgM cases he would push 
for positive patients to be transferred to the Lassa ward, arguing they were ‘Lassa patients’. 
However, when I returned in 2011 just under a year after my main fieldwork period, IgM 
patients were routinely kept on the wards: the doctor in charge of the Lassa ward and the 
maternity ward doctor now had a running joke about their struggles over transferring 
patients but in reality the practice that IgM patients often stayed on the general wards was 
well established. There was still some mystification about the results, with one nurse on the 
male ward telling me that “they do not tell us directly that this is a Lassa patient, they say he 
has the immune response”. She was unsure as to what exactly the results meant and asked 
me, “that IgM, what is it?” 
 
Another aspect of this is that patients are often not told of their Lassa results. There has 
always been a culture of shielding patients from Lassa fever before it was confirmed; it might 
be referred to as ‘Lassa fever’ or ‘the bleeding disease’. Not telling the patients was probably 
not such a departure from routine clinical practice as patients are not told a lot on the whole. 
Guided by an assumption that patients will panic or won’t understand, IgM cases are 
218 
 
sometimes only told indirectly or not at all: “they told me I have been exposed” was what one 
patient reported to me. I interviewed a woman who had tested positive for IgM and had been 
kept on the general ward. It became clear in the interview that she had never been told what 
sickness had made her ill and she asked me to come to the hospital with her to find out from 
her records. In light of the claims that improved diagnostic technologies will reduce 
uncertainty, examples such as this ask whose uncertainty is being reduced. She described 
never having been so sick before. I had seen her when she was on the general ward and she 
certainly seemed very ill. This raises some doubts about the assumption “that they are sick 
with something else”. Although the ‘emerging view’ from the laboratory was that these cases 
were not necessarily acute Lassa cases this had to be confirmed, because although it may not 
be Lassa, it was also possible that is was Lassa.  
 
It is also a reminder that laboratory diagnostics cannot hold all the information necessarily for 
patient care. Therefore, in addition to the re-interpretation of IgM there was a new emphasis 
on how ‘stable’ the patient was; this was a determining factor in whether a patient should be 
moved. Though in this assessment Lassa, as ever, proves itself to be unpredictable. The doctor 
in charge of the Lassa ward told me after his first six months in the job “if there is one thing I 
have learnt in these months it is that Lassa patients are unreliable! They can come in one day 
and be stable and the next day they are bleeding…they can explode!” He explained AG patients 
get put on Ribavirin even if they look stable or well, whereas they observe IgM positives, 
watching how the condition changes, adding that “sometimes they are worse than the antigen 
patients.” This means the new practice of keeping them on wards required considerable care 
and attention from all those looking after them. The head nurse on the Lassa ward actually 
seemed quite keen to admit IgM patients who looked sick: when an IgM case who she had 
pushed for the doctor to transfer took a turn for the worse she shot me a knowing look and 
said “see, she is being sick now”. 
 
This brings me back to the point made above about the bearing the test has on the practical 
decisions at hand. Here we see that many decisions made in clinical settings are based on 
fairly ambiguous assessments of condition, but also on much more social considerations of 
how nurses or patients may react and how important it is for them to know. In this ambiguous 
middle ground of classification, are the patients and their contacts for whom the 
consequences are very real. These new un-admitted IgM patients avoid the experiences that 
219 
 
come with being Lassa positive: they avoid the trauma or stigma of being on the isolation 
ward; alternatively, if they did have an acute case of Lassa, they could miss out on the 
experienced (and free) care which they would get if they had been admitted to the ward. 
When patients leave the Lassa ward they are given a list of rules, or as one ex-patient 
described them “laws”, to follow: precautions to take when eating, going to the toilet or having 
sex, which are aimed at reducing further infections as the virus has been isolated from urine, 
saliva and semen when it is no longer detected in blood. Given that such efforts are made to 
trace contacts of cases on the ward, in this grey area of acute or past infection, it is striking 
that some cases which could be acute do not have their contacts traced and are not told of the 
risks, including informing the people caring for them who could be at risk of nosocomial 
infection. The mangle of practice processes people with very different effects.  
 
Despite the case for the continued importance of clinical judgement and knowing the ‘value of 
a test’ there were other signs that laboratory results were perhaps overshadowing clinical 
observations. Thus to some extent clinical diagnostic procedure has become laboritized but 
the incomplete nature of laboritization is not always acknowledged. The interpretation of AG 
test results offers some examples. Antigen positive cases had always been taken seriously and 
it was one area where the ward’s nurses and established protocol reached consensus. There 
was certainly no covering up of AG positive cases. Clinical staff told me that AG cases were 
always treated, without fail. Such a statement should be considered in relation to the 
following: as is protocol, after a confirmed positive case which has been treated and admitted 
to the ward, anyone who may have been in contact with the patient is advised to look out for 
any Lassa like symptoms during the incubation period. On one such occasion, a health worker 
in a hospital which had recently dealt with a Lassa case had a mild fever. In an effort to be 
responsible, but not thinking it was really Lassa, the health worker reported their symptoms 
to KGH. By the time it had been arranged to take a blood sample the symptoms were nearly all 
cleared up and the staff taking the blood commented that ‘this couldn’t be a Lassa case’. 
However, the result came back Antigen positive. The health worker described their surprise 
and the following interaction occurred after a second test also proved positive:  
 
“They run my test back and they said you are Lassa positive still, you need to be admitted. Sure? I 
don’t want to be, I am feeling fine, no problem! No, you need to be admitted (they said), and you 
need to start treatment.....I didn’t want that but they convinced me anyway143”.  
 
                                               
143 Lassa history 13, Makeni, 29/04/2011 
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As the result has been Antigen positive the decisions was made to admit the patient to the 
ward and commence on Ribavirin; the patient had been resistant but submitted in the end. 
After a few days on treatment the patient was experiencing numbness and seizures as a result 
of an adverse reaction to the treatment. The side effects were far worse than the symptoms 
which had prompted the test and which had cleared up, she reported, five days before ever 
starting the treatment. In this instance the treatment decision was very much based on the 
laboratory results. They could also have been acting out of precaution due to a possible 
exposure to another case but this was done in the face of extremely mild, and increasingly 
absent, clinical symptoms. The patient later told me: “the protocol says, antigen positive, start 
treatment. And I want to tell you have a question mark about that”. Her case was unusual, but 
it revealed the inflexibility of the existing treatment protocol and the significance and alarm 
surrounding AG positive results.  
 
There is a mantra that AG positive cases do not survive and that they are worthy of alarm. It 
may be true as a general rule but it is not a failsafe one, and it is one which may need to be 
revised; particularly relevant is the possibility that as surveillance improves and laboratory 
testing becomes more routine it may be the case that more mild AG (and IgM) cases are 
detected. If that does happen then the clinical pathways and implications of an AG positive 
result need to be more diverse than simply treatment according to a protocol. 
7.2.4 Diagnostic interactions and decision making in clinical settings 
As I outlined in chapter two, diagnosis is much more than a moment or a test result. It is 
collaborative effort, where people’s focus is often on holding multiple care processes and 
concerns simultaneously, and not just identifying an underlying cause (Goodwin, 2010, 
Mesman, 2010). The preceding discussion has built on this view and portrayed Lassa 
diagnosis as better understood as an accumulation of moments along variable pathways. The 
diagnostic process encompasses a range of conditions, constraints and opportunities, 
throughout which a number of people play a part in decision making. In this section I focus on 
the discussions which healthcare workers have over particular cases in order to show how 
contingent a diagnosis can be. For outsiders it can seem shocking that a disease like Lassa 
fever, a biosafety level 4 (BSL-4) pathogen where isolation is advised, has any elasticity in 
diagnosis and treatment. Visitors to KGH were often surprised by the apparent flexibility. I 
have already touched on some of the dimensions which make a difference: the classic signs, 
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the uncertainty facing clinicians, a plural and at times fractured health care system as well as 
the variable presentation in patients. Here I give some examples of how these factors feed into 
particular treatment and diagnostic decisions.  
 
Dwelling on this issue of decision making and patient pathways it should be appreciated how 
many people are involved; there are many competing voices taking part in diagnostic and 
treatment decisions for Lassa fever at KGH. One case in point is this: a technician from the 
laboratory had come looking for the doctor to deliver some results. He stopped by the Lassa 
ward where some nursing staff are gathered talking with two members of the outreach team. 
One result was inconclusive on the IgM and he asked the others: “who is this Mohammed, 
where is he?” A couple of the outreach team recall the patient from the day before, “yes, he 
was sick”, but they do not know where he is now. Apparently he had been a contact of a recent 
case. They discuss the length of time since the onset of Mohammed’s symptoms and the 
technician suggests that the result could be indeterminate became the IgM was only just 
beginning to appear in the blood. He thinks that a second sample needs to be taken but first 
they have to locate the patient. One of them has a mobile number for him; they call him, and 
find that he was admitted to the general ward where he is receiving a blood transfusion. It is 
agreed with the laboratory technician that a nurse should go and assess him once the 
transfusion is complete. An hour or so later, the nurse, two members of the outreach team and 
I go to find him on the ward. The patient’s face is puffy but otherwise he does not have strong 
clinical signs. The nurse comments that he looks strong and that he does not really have the 
illness history, even though was a contact of a recent case. One of the outreach team protests 
“he was sick yesterday, bring him (to the ward), he is from the Lassa belt!” The nurse hesitates 
and says it is the doctor’s decision. We all go to the doctor who is seeing patients in the 
outpatient consultation area. The details of the case are reported to the doctor. They all agree 
a second sample is necessary but views differ on whether to move the patient to the ward in 
the meantime; the two outreach team members are pushing for that option, arguing he was a 
contact of a known case. The doctor asks about the tests and the patient’s condition. He checks 
the test was the ELISA and not the prototype rapid test which is being used alongside the 
ELISA in some cases. The nurse reports that he considers the patient to be stable and so for 
now the doctor decides the patient should remain where he is. This consultation with the 
doctor takes place in under three minutes and the doctor never actually examines the 
patients. 
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Another illustrative example also took place on the outpatient ward after the sister of a nurse 
at the hospital was found to be positive for IgM. The laboratory results are delivered to the 
Lassa ward while I am there and so I go with one of the nurses on shift to discuss the case with 
the doctor. The doctor queries TB because, he says, the patient has night sweats. He says that 
telling her she has Lassa may panic her and it could be that the fever is caused by TB; he 
reasons that starting treatment for Lassa could confuse matters, and make the TB harder to 
diagnose, if that were the case. The doctor calls the head nurse on the Lassa ward, who has 
seen the patient and talked with her sister, to ask her opinion. She is keen to admit but the 
doctor feels that the fever is not high enough, a guess in the absence of a thermometer. If it 
were Lassa making the patient sick, he says, then the symptoms would be more extreme; the 
signs are ‘not classical’. The nurse counters this and says the patient is sick, but she is just 
trying to be strong. She is persuasive and at first the doctor seems swayed towards a decision 
in the nurse’s direction. The doctor indicates they should start Ribavirin and see if there is a 
response, meanwhile they should take sputum to test for TB. He repeats that his main concern 
is working out what is causing the fever. However there is then a U-turn when the doctor 
looks again at the test results. The evidence of IgM he re-interprets as meaning the patient is 
on the mend, returning again to the uncertainty about what is causing the fever. In Krio, their 
interaction is as follows:  
 
Doctor: “e bin well by inself” (she has got/is getting better of her own accord) 
Nurse: “e bin strong for fight am” (she has been/is being strong to fight it (the Lassa)) 
Doctor: “let we give tests the benefit of the doubt”  
 
The doctor then asks the nurse again what she wants to do. She replies admit and start Lassa 
treatment, while they wait for a sputum result on the TB. However, the doctor disagrees and 
evoking the new interpretation of IgM results he says “let’s do it scientifically”: the patient 
should be admitted, temperature monitored but no Ribavirin for now. But he does want to 
order a sputum test and even to start TB treatment today to see if it reduces the fever. The 
head nurse says the patient may as well go home then, but the doctor and the other nurse say 
it is better to admit them to the ward so they can be monitored properly. Back on the ward the 
head nurse is explaining to me that IgM’s can still have problems when she gets a phone call 
from the doctor saying they should start the Ribavirin after all and hold back on the TB 
medicine. The reason he gives her is that Lassa fever can kill quickly whereas with TB they 
have more time.   
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As well as showing that decisions are made collectively, these examples provide an 
illustration of how a range of concerns cross-sect in clinical practice and diagnostic decisions: 
the problem of co-infections (in this case TB); the importance weigh up different evidence, 
how reliable is the history, what other signs are there, the ‘science’ of the test result; of great 
importance are basic clinical signs, if a patient’s ‘looks ill’, ‘stable’ or ‘strong’. In this the 
clinical priority is shown to be the basic status of a patients’ health, and how that intersects 
with ideas about other diseases, the expected presentation of Lassa, and the risks that are 
involved. In the Lassa fever ward records there are frequent annotations for ‘the doctor to 
please review’ which gives the impression that the doctor is making the decisions. It is true 
that the doctor has authority but nurses, and others, on the Lassa ward and team have great 
experience and work with considerable independence – they also fight as the above example 
shows, to put their view across. In essence, the diagnostic pathways and treatment decisions 
are established by a number of different voices, who have had different levels of contact with 
the patient. It can be done over the phone, with physical examinations, by looking at test 
results; what matters is the way all these aspects combine to make a credible case for Lassa 
fever in a patient.  
7.3 Conclusion 
Clinical settings are particularly interesting as they are the sites where multiple streams of 
people, knowledge and evidence intersect. Such convergences are central in the mangle of 
diagnostic practice. There is a tug-of-war in this setting between resistance and 
accommodation, ideals and messy realities. This is combined with a struggle for balance 
between the use of tools designed to be the mainstay of the official diagnostic system, such as 
the case definitions, referral procedures and laboratory results, and the unpredictable 
appearance of both patients and the virus in Sierra Leone’s clinical settings. When applying 
these tools health workers frequently find they do not fit. Either the virus or the patient does 
not present as they should: major symptoms are not detectable or the referral forms do not 
contain full treatment histories. In response to these uncertainties there are some practice-
based framings, rules of thumb, which health workers apply to deal with risks both to patients 
and themselves: ‘classic signs’ provide some tangible evidence to proceed on, though they 
may be unreliable. It is also a time of change in the clinic, some of the most well established 
framings including classic signs and the presence of IgM antibodies are becoming less 
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definitive, even misleading, as laboratory diagnostics are developed: the laboratory can now 
provide results faster and, on one level, test results are increasingly influential in treatment 
decisions. But although treatment decisions are often deferred until the laboratory results 
arrive, there are other ways in which those results are less decisive than they used to be. The 
contention around the significance of an IgM positive result has meant that treatment options 
are variable, perhaps more than before. Meanwhile Antigen positive laboratory results have 
had its significance affirmed. This affirmation has been in the face of cases (admittedly only a 
few) where antigen was found but the patient themselves was not visibly ‘ill’. Overall there is 
increasing diversity in the diagnostic pathways and the laboratory tests have not entirely 
conquered the clinical domain. The process of laboritization which was shown in the previous 
chapter to be incomplete even in laboratory settings is found to be even more limited in the 
clinical context.   
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8  Conclusion 
By now the idea of diagnosis as a singular or straightforward process should have been 
dispelled. Intuitively this may seem obvious; diagnosis can be tricky and it may take several 
attempts to get right. But when the ‘correct’ label is applied by the ‘correct’ technology there is 
an implicit assumption that the case is closed. So it is surprising that even for Lassa virus, a 
pathogen considered so dangerous that extraordinary biosafety and isolation procedures 
have been applied for its identification and management, neither diagnostic or treatment 
pathways are set in stone. What is more, ‘new and improved’ diagnostics do not appear to 
have curtailed this variability. Indeed, across village, laboratory and clinical settings, we have 
now seen that Lassa fever diagnosis is by no means the linear pathway undergoing 
‘laboritization’ that optimistic narratives of technological revolution presume. Instead, a 
different picture has emerged which portrays diagnosis as a series of negotiations between 
people, pathogens, instruments and contexts. What can now be said about diagnosis and new 
diagnostic technology and how has the conceptual framework introduced in chapter two 
helped to explain the dynamics of diagnosis?  
 
Chapter two argued that the emerging ‘sociology of diagnosis’ literature had not addressed 
key issues concerning innovations and expectations about diagnostics. I used science and 
technology studies to illuminate dimensions of technology, knowledge and practice which I 
highlighted as important but overlooked aspects of diagnosis. I proposed that diagnosis 
should be understood as a system which, on account of plural health systems, I defined 
broadly as including village healers as well as government and biomedical providers. This 
broad perspective on diagnosis called into question some of the literature which had been 
developed about diagnostic practice in European and American settings and which 
emphasised the ‘hanging together’ of assorted socio-technical assemblages in medicine (for 
example Mol, 2002). Therefore, Pickering’s notion of a ‘mangle of practice’ was employed as a 
means of characterising the patterns and processes of practice within the diagnostic system. 
The ‘mangle of practice’ concept was chosen because it is not overly prescriptive and so 
allowed for an examination of the diversity and unpredictability of diagnosis. I also explored 
framings and narratives of disease and diagnosis and, in doing so, a dominant narrative was 
identified which promotes the idea that new diagnostics are making diagnosis increasingly 
scientific. This narrative is based on a specific and mechanistic framing of disease, as 
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identified by Rosenberg (2002). It was suggested that framings and narratives of Lassa fever 
itself would be varied, and would thus influence approaches to diagnosis. Equipped with a 
framework which focused on framings, narratives and practice, this thesis addressed the 
following questions: 
 
How are developments in laboratory-based diagnostic technologies incorporated into the 
process and practice of Lassa fever diagnosis in Sierra Leone?  
 
- How is the diagnosis of Lassa fever framed and how do these framings relate to 
diverse narratives about the disease’s significance and control? 
- How is Lassa fever diagnosed in practice and how do different framings and practices 
intersect with each other? 
- How do new diagnostics influence the uncertainty surrounding diagnosis?  
 
In chapter three I set out the methodological underpinnings of this work. A multi-sited 
ethnography was chosen for exploring framings and practices within the diagnostic system 
because it combined a focus on context specific processes with an appreciation of the linkages 
between them. Inquiry into the diagnostic system was achieved with ethnographies in three 
sites: the village of Tokenga, the ‘Lassa lab’ and the wards of Kenema Government Hospital 
(KGH). Chapter four provided some context about Lassa fever and Sierra Leone’s healthcare 
context, and it outlined a version of the diagnostic system articulated by the WHO, Sierra 
Leone’s Ministry of Health and Sanitation (MOHS) and scientists. Their framing of the system 
prioritises laboratory and biomedical knowledge, which is reflected in its formal boundaries 
and centralisation around KGH. This conceptualisation of the system relates to a convergence 
between three overarching narratives about Lassa fever: Lassa as a global threat, Lassa as an 
endemic West African disease caused by problematic local practices, and Lassa as a neglected 
zoonotic disease is need of a scientific solution. All three arrive at similar solutions: more 
basic science and applied biotechnology is needed to control Lassa fever; establishing fast, 
scientific and accurate diagnostics is essential to surveillance as well as to effective disease 
control. Diagnostics are portrayed as the ‘building blocks’ of health system strengthening and 
wider capacity development. I concluded the chapter by introducing two underexplored areas 
of research which deserve attention: the longer term dynamics of Lassa fever; and Lassa fever 
as part of everyday life and practice. In chapters five, six and seven I focused on exploring the 
latter in the three sites mentioned above. Each site represents different settings in the 
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diagnostic system where aspects of the system interact. In each setting, relationships between 
framings, narratives and practices were examined, paying attention to the use of technology 
and the implications for uncertainty. Finally, at the end of each chapter, principles from the 
mangle of practice were used to draw out features of practice in each setting. In this 
conclusion I revisit and synthesise these.    
8.1 A mangle of practice: the diagnostic system 
The negotiated processes of diagnosis can be usefully characterised as a ‘mangle of practice’ 
which Pickering (1995) describes as an interlocking pattern of resistance and accommodation 
between human and non-human agency. For Pickering scientific knowledge, which must be 
understood as inseparable from the practice of science, emerges in this mangled way. By using 
the mangle of practice to describe diagnosis I am asserting that an individual diagnosis 
emerges in a similar fashion. Diagnostic pathways depend on the application of 
heterogeneous tools, routines and conceptualisations of disease; their application is 
structured by the interplay between the resistance and accommodation of diverse forms of 
agency which are encountered along the way, including that arising from negotiations 
between them. The emergence of a diagnosis is contingent on these interdependent, but 
variable, relationships, which means it is unpredictable.  
 
The attraction of Pickering’s mangle of practice is that it deals with the complexity of 
knowledge, practice and agency. Yet, apart from the pattern of resistance and accommodation, 
which Pickering insists repeats itself endlessly, the mangle of practice does this without 
imposing limits on what may or may not emerge. This is appropriate for a study exploring 
diagnosis in a context where its processes and practices were little studied. Significantly, it did 
not presume linearity or ‘hanging together’ which has characterised literature on diagnosis in 
high income settings. The mangle of practice does not, however, deal with the problem of 
subjectivity in relation to knowledge and practice in any extensive way. Pickering says human 
action is orientated by goals, and that models and theories based on previous experience are 
used to interpret resistance and to reach stabilisation, all of which implies a certain bounded 
subjectivity. But what about clashes between these goals or theories when many people are 
involved in reaching a diagnosis? I have modified the mangle of practice to account for the 
impact which such differences have on diagnostic interactions. By conceptualising the 
diagnostics system as a mangle of practice, but simultaneously dividing it into sites, I have 
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explored how different contexts, different framings and different practices intersect within the 
mangle.  
 
The modified version of the mangle of practice presented here means that there are some site 
specific aspects of the mangle of practice, and there are others which relate to interactions 
between them. I review these in turn now, beginning with those which are site specific.    
 
In Tokenga, diagnostic practices are based on categorisations of fever and on the social, 
political and financial relationships through which healing must be negotiated through. In 
Pickering’s terms, there is a stabilization between ‘ordinary sicks’ (including ‘small fevers’) 
and ordinary treatments. ‘Tablets’ and ‘herbs’ can be obtained easily within the village and are 
the first line of treatment. The persistence of symptoms presents the first sign of resistance 
which must be accommodated. When familiar treatments do not work there could be a 
number of reasons: poor quality drugs sold in the heat on petty trade stalls could be the 
explanation, but equally it may be that the complaint is not an ‘ordinary sick’. Already there 
are a number of possible strategies to deal with the apparent resistance: another tablet, some 
‘bitter barks’, or perhaps a visit to one of the local providers of hale (medicine). With 
persistence and increasing severity a fever can become a ‘big fever’ and an ‘ordinary sick’ can 
become a ‘hospital sick’. Resistance causes explanatory classifications to be modified which 
opens up new pathways for treatment. Although in some villages Lassa fever and ‘big fevers’ 
may increasingly be talked about as the same thing, the ‘big fever’ category is not disease 
specific. It is a practical classification, based on symptoms, which suggests a move to the next 
level of health care. But with that accommodation, other resistances emerge. The classification 
of a sickness as a ‘hospital sick’ does not necessarily result in a trip to a hospital. ‘Hospital 
sicks’ carry high risks and their realisation is beset with barriers. In order for a disease to 
become a ‘hospital sick’ both money and the assistance of kin is required to make the physical 
transition to a hospital. Furthermore, the implications of such a move are framed differently. 
Perceptions about the cost and quality of official healthcare are often negative which can be 
the reason alternative informal providers are sought. More dramatically, the rumours of fatal 
injections can be a motivation for people with suspected Lassa fever to go anywhere but KGH. 
In the response to the ultimate resistance, the failure of treatment and death, a final 
accommodation is sometimes applied in order to make sense of the events. The version of the 
truth offered by the laboratory diagnostic, known in Krio as the ‘prova’, is questioned: if 
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witchcraft is ‘behind’ a sickness then it can cause a laboratory test to show up positive to 
mislead doctors, in such cases the doctor’s medicines will do no good. Significantly, the 
application of witchcraft explanations to Lassa fever in Tokenga tended to occur after death 
and hospital treatment. Though the aetiology of a ‘hospital sick’ can include sorcery, this co-
exists with an understanding that symptoms need to be treated with biomedicine. 
 
In the laboratory the mangle of practice rests on achieving a stable relationship between the 
ingredients, technique and interpretation of the assay. In order for results to be considered 
reliable and valid there needs to be consistency in all three of these areas. This is done by 
building on and ‘tuning’ existing ELISA technology: recombinant proteins, improved sample 
storage and cold chain, revised protocols and standardised methods to interpret results. As 
part of this, great effort is made to ‘discipline’ human action so that it is able to overcome 
material agency. However both human and material agency can refuse to conform. Heat and 
humidity, blocked plate washers and forgotten timers can all contribute to the inherent 
variability of an ELISA. Other circumstantial considerations can also creep in and influence 
interpretation of results. For instance a technician’s interpretation of borderline results can 
be influenced by hearing about a particular patient’s symptoms, or of how far away the 
sample they are working on comes from. I used Knorr Cetina’s notion of ‘laboritization’ 
(1999) to characterise the manipulation of social and natural orders of objects in the 
laboratory. These manipulations are supposed to exclude the world outside of the laboratory 
to stop it interfering with the validity of its results. I suggested that laboritization had some 
limitations. The laboratory makes a diagnosis based on a narrowly defined, and self-
authenticated (Hacking, 1988), assay target. Indeed, increasing stabilisation in the laboratory 
was achieved by a narrowing down of the diagnostic criteria to certain aspects of Lassa fever: 
the detection of antigen proteins emerged as the key diagnostic indicator and the presence of 
immunoglobulin M (IgM) was afforded less significance. Yet the laboratory’s claims to 
diagnostic authority were shown to be limited by examples where a patient’s clinical 
symptoms contradicted test results. More intrinsic limitations were that the stabilisation of 
practice that enabled the laboratory to ‘produce’ good samples (and good results) concealed 
some areas of uncertainty. Notable examples are the ‘inherent variability’ of ELISAs and the 
problems of characterising the positive samples which give the test results relevance to the 
population it is being tested in. In these ways, the laboritization processes can be viewed as 
incomplete. The tick next to ‘positive’ or ‘negative’ serves to ‘black box’ some of these 
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uncertainties but it cannot eliminate them. In the clinical setting the narrowness of the 
laboratories diagnosis becomes a problem and, as I shall now review, the results must be re-
interpreted in conjunction with other signs and symptoms.    
 
In the clinical setting the patterns of resistance and accommodation are largely shaped by 
actors having to negotiate between the messy realities of Lassa fever and healthcare in Sierra 
Leone on the one hand, and the standardised tools used to diagnose the disease on the other. 
In contrast to the case definition forms which presume a linear approach to treatment and an 
‘ideal-typical’ (Rosenberg, 2002) presentation of Lassa fever, patient’s actual symptoms and 
referral pathways are consistently variable. To accommodate the misfit other principles are 
applied. Rules of thumb (Bowker and Star, 2000) about ‘classic signs’, and the risks which 
they pose, guide healthcare worker’s actions and decisions. Laboratory tests, which were not 
available when many of these practices developed, are now available in a matter of hours. To 
some extent, the new laboratory tests have reduced the importance of some of these informal 
practices: diagnostic and treatment decisions are usually deferred until ‘the labs’ have been 
completed. Yet, though the results are quicker and deemed to be more reliable there is a 
paradox in that they do not always convey clear treatment pathways. The interpretation of the 
IgM ELISA in particular is a matter for debate. Some members of the Tulane team have 
insisted that an IgM positive status is clinically irrelevant but for healthcare workers at KGH 
the IgM positive patients have become a tricky group to deal with.144 The present a number of 
questions: is Lassa fever making the patient sick or something else? Is the patient stable or 
should they go on to the Lassa ward? There is actually an expanded array of treatment options 
for these patients. There are also times when Antigen results do not fall in line with observed 
clinical symptoms triggering a similar set of questions. Such cases highlight the multi-
dimensional nature of disease presentation which improved laboratory tests cannot bypass 
and of which they only grasp one aspect. The interactions between the resistance presented 
by complex diseases, and the tools and treatments used to define and accommodate them, 
continue even after a laboratory result is received.  
 
The interactions between aspects of the mangle across these sites can now be considered. The 
emergence of a diagnosis involves the circulation of objects and concepts. By concepts I mean 
                                               
144 Personal communication with people working at the Lassa ward has confirmed that healthcare 
workers there still treat IgM results to be significant. Some IgM positive patients may be kept on 
general wards but others are admitted to the ward and treated with Ribavirin.   
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framings of Lassa fever, such as ‘big fever’ or ‘classic Lassa’ which are translated across sites. 
This is in addition to the more concrete passage of blood samples, pharmaceuticals, herbs, and 
ELISA reagents. The interfaces through which these things pass, be they artefacts, concepts or 
people, have multiple sides and meeting points. A doctor may encounter a patient when 
symptoms are just beginning or when the patient is already unconscious. The patient may 
provide a full treatment history or a patchy one. The laboratory may receive a sample straight 
from the KGH ward or one from near the Liberian border which has not been refrigerated. The 
information which accompanies some of these objects influences the way they are dealt with 
as they travel between settings. Consider the ‘hot’ sample in chapter six which caused the 
laboratory technicians to ‘double glove’. There are moments in these interactions where 
alternative pathways open up. Patient histories often reveal that they were tested, ‘diagnosed’ 
and treated for something else prior to Lassa fever. In a world of co-morbid infections it is 
easy to find evidence which supports alternative diagnostic pathways.  
 
Two points run through all of this. First, the practical circumstances as to how a patient or 
sample enters the diagnostic system are incredibly important. Quicker diagnostics can 
influence this but they cannot control it. Second, there are considerable differences in the way 
disease is defined and enacted at various stages in a diagnostic pathway. Again, a new 
diagnostic can provide an additional enactment of disease but it does not exclude the 
existence of others in the process. The process of diagnosis in the official system involves the 
transformation of ‘fever’ into ‘Lassa fever’ and then into ‘Lassa virus’. This transformation is 
‘confirmed’ by the laboratory which is unique in its ability to identify the “causative micro-
organism” (Cunningham, 1992 p224). But this transformation does not happen seamlessly.  
8.1.1 Framings within the mangle of practice 
Before sore throats, fevers and red eyes can become Lassa fever or Lassa virus they must go 
through a number of different guises. A feature of framings is that they are partial and contain 
fundamentally different perceptions of the risks and outcomes involved. Understanding how 
these relate to diagnostic practice and pathways is critical. By considering the role of framings 
in the mangle of practice the possibility that framings could be sources of resistance was 
raised. This possibility stems from their imposition of particular ways of seeing the case at 
hand which could obscure other aspects of the disease or pathways for dealing with it. As 
such, framings would then account for significant variation in diagnostic pathways.   
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Taking the interactions between parts of the mangle together, some patterns emerge about 
the way Lassa is framed:  classifications used in surveillance and written protocols frame 
Lassa as one continuous entity. Although defined in different ways by the case definitions and 
the laboratory tests, the implicit expectation is that the disease can be standardised and 
transferred between them. Coherence is assumed: the symptoms come first and are 
‘confirmed’ by the laboratory test. Just as Mol (2002) challenged this in regards to diagnosing 
atherosclerosis, here I have tried to emphasise that there is discontinuity between framings 
and enactments of Lassa even within the formal aspects of the system. The transition from 
fever to virus does not happen smoothly, the various enactments do not always ‘hang 
together’. In the process of diagnosis, diagnostic tools can contradict each other. Even in 
patients considered to have ‘classic signs’, the symptoms and test results do not agree 
surprisingly often. For a moment there are two pathways, two (or more) diagnostic 
possibilities, as two distinct realities are enacted. Occasions such as these serve to underscore 
the non-uniform, non-linear nature of diagnosis. This becomes more apparent outside of the 
clinical setting, when the name ‘Lassa’ can imply the archetypal ‘hospital sick’ which no-one 
but the doctor at KGH should attempt to treat, or it can mean that the doctors at KGH will give 
patients a lethal injection. 
 
One of Pickering’s aims with the mangle is to link the micro and macro of scientific practice. 
The interplay between these scales is clearly visible in the unfolding debate about how to 
characterise Lassa fever in West Africa and within Sierra Leone. The recent paper by Gire et al. 
(2012) on whether the expanding endemic areas of emerging infectious diseases, Lassa fever 
included, are the result of a real spread or simply better detection is an example. In this thesis 
I have highlighted some of the practical implications of such debates. Framings of Lassa 
fever’s regional prevalence influence diagnostic practices. The significance afforded to a 
history of travel within the ‘Lassa belt’ in forming a diagnostic profile is evidence of the 
importance of regional framings of prevalence within Sierra Leone. The distinction which is 
drawn between West Africans and non-West Africans when interpreting IgM results in the 
‘new diagnostic paradigm’ (Branco et al., 2011b) is evidence of these dynamics at an 
international level. This last example also reflects a shift in the rationale behind a diagnosis. It 
was claimed that IgM was no longer diagnostically relevant in West Africans because it could 
not be considered a marker of recent infection and so was not helpful in treatment decisions. 
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There the diagnostic classification was being made on the basis of its utility in assisting 
treatment decisions. For a while IgM patients were described as not having Lassa fever. But 
while IgM status may not prove an infection is recent it also does not prove that it is not. Thus, 
again, the new paradigm is only partial, and perhaps also somewhat rash.  
 
As noted by Bowker and Star (2000), there are both flexible and rigid classifications of Lassa 
fever in the diagnostic system. One of the more ridged framings of Lassa fever is that around 
Antigen positive cases.  Historically, these have been considered as non-debatable. The stakes 
were too high, “antigen patients do not survive’” said the nurse, they must be admitted and 
treated. Such eagerness to treat antigen cases is, of course, due in part to the severity of 
symptoms which ward staff have seen kill too many people ‘too quickly’ already. But, I 
suspect, it is also based on a long-established tacit separation between ‘hospital cases’ and the 
mild ‘in the community’ cases which go uncounted. With this in mind, cases at hospital and 
with positive results are assumed to be serious. Rightly so, no one would want to be accused 
of complacency. However, if surveillance expands and doctors continue to order tests as 
routine, there needs to be sufficient flexibility in both the Antigen and IgM treatment 
protocols to deal with atypical or mild cases. Once rapid diagnostic tests (RDTs) are in use this 
would become even more important. Protocols are needed to deal with mild and 
asymptomatic cases so that patients are not subjected to unpleasant, possibly harmful and 
traumatic treatments. As the patient who received treatment for mild symptoms after an 
antigen positive result put it, “have a question mark about that”145. The interpretation of 
laboratory results has gone through many stages to minimise error, that effort should be 
mirrored in the clinical setting to ensure that laboratory results are appropriately re-
contextualised with the patient’s condition. 
 
In contrast to the laboratory’s narrowly defined concepts of Lassa fever, other parts of the 
system depend on fluidity and breadth. In the village the effectiveness of disease 
categorisations such as big fever and small fever, and to an extent the classic signs in the 
clinical setting, depend on being somewhat vague. They allow for other considerations to be 
taken into account and respond to the ambiguous circumstances in many settings. The 
framings and enactments of disease as ‘small’, ‘ordinary’, ‘big’ or ‘hospital’ fit in with the 
narratives and categories which people use to negotiate the health landscape around them. As 
                                               
145 Lassa history 13, Makeni, 29/04/2011 
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has been shown elsewhere artificial distinctions between formal and informal, legitimate and 
illegitimate, or traditional versus biomedical (Cross and MacGregor, 2009, Leach et al., 2008) 
are not driving motivations. Rather, the therapeutic landscape is cross-cut with various forms 
of disease, medicine, and expert knowledge in which social relationships are pivotal to 
patterns of access. The reality is that the therapeutic landscape as experienced by people in 
the East of Sierra Leone is at odds with the official infrastructure for diagnosing and treating 
Lassa fever which is restricted to KGH. It is not surprising that patients with ‘big fevers’ can 
end up elsewhere. 
 
In a context where the superiority of formal or government health services is not always 
evidenced, it is not clear that a trip to the hospital will result in positive outcomes. For Kema’s 
husband every step towards the hospital was a step into terrain he could not afford; he 
returned to his village twice in an effort to ‘find’ money to pay for the escalating treatments 
she needed, but which in the end, did not save her. In contrast, the father who decided against 
taking his dying son to the hospital exercised the only control he had over the situation. His 
justification was that his son “has died already”146. From the perspective of doctors or 
surveillance officers this may seem like irresponsible, ignorant or non-compliant behaviour. 
An accusation is often that villagers ‘do not understand’. This thesis shows that they 
understand very well but that with understanding come implications which they assess with 
criteria which are relevant to their lives.      
8.1.2 Implications of the mangle 
Taking a ‘mangled perspective’ on diagnosis challenges the ‘underlying cause’ view of 
diagnosis. It does this without resorting to an argument which says that disease is entirely 
socially constructed, or by otherwise avoiding the study of diseases with identifiable 
pathologies. It shows that a number of underlying causes can emerge, their meanings and 
their identification the result of negotiations which makes versions of an underlying cause 
visible. The mangle of practice presents a view of diagnosis which is ‘de-centred’ and 
‘emergent’ (Pickering, 1995, 2008) which means that no one technique, place or person 
defines it, yet they all shape it; rather than being pre-determined a diagnosis unfolds across 
and through these different parts. This contributes two things: first, an understanding of 
diagnosis which takes practice and technology seriously and second, an understanding of 
                                               
146 Lassa history 8, Foindu, 12/05/2010 
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diagnosis which appreciates the uncertainty involved.  On the former, some studies of 
diagnosis which have tried to account for the role of technology have been overly 
deterministic. For instance, grand claims are made about the power of technology: the 
introduction of novel tools has enabled the creation of new diagnostic classes (Jutel, 2006); or 
technological developments in diagnostics have meant that diagnosis replaced prognosis in 
medical importance (Christakis, 1997). The mangle resists the draw of technological 
determinism and instead shows how these technologies are integrated ‘into the thick of’ 
agency (Pickering, 1995). On the latter, by combining the mangle of practice with framing, this 
thesis has been able to explain the tensions and differences in the process and practice of 
diagnosis in a way which does not assume these diverse parts ‘hang together’ as has been 
implicit elsewhere (see Mesman, 2010, Mol, 2002).The mangle of practice characterises the 
diagnostic system without implying coherence because it also emphasises the unpredictability 
and resistance of diagnosis. By introducing the notion of framing into the mangle of practice, it 
has been possible to see the extent to which a disease entity goes through many different 
forms as it is manipulated, judged, isolated, re-contextualised, guessed at, argued for, and 
standardised within the diagnostic system. This has also highlighted that stability in one 
setting does not equal stability in another. As such diverse framings and contexts are a source 
of unpredictability in the mangle of practice.   
8.2 Challenging narratives  
With the characteristics and implications of the mangle of diagnosis now outlined, in this 
section I will discuss how they relate to some of the policy narratives which commonly 
surround diagnosis and diagnostics. To do this, I have drawn out some of the assumptions 
which are implicit in those narratives of technological optimism and will discuss the key 
findings of this thesis in relation to each in turn.  
 
Diagnosis is a linear process 
The steps outlined in the Integrated Disease Surveillance and Response (IDSR) and case 
definitions for Lassa fever assume a number of sequential steps in one direction. They are 
based on the principle of a standardised disease entity which can be transferred along a linear 
pathway through the system. What this does not appreciate are the complex arrangements of 
social and technical dimensions which make up the process of diagnosis: social relations of 
sickness; the pervasive normality of fever in such contexts; the wide availability of pu hale 
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(white people’s or Western medicine) from different sources; the trial and ‘non-response’ of 
other medicines; conflicting evidence from co-morbid infections and other diagnostic tests; 
and haphazard referral patterns. More fundamentally there are differences in the way Lassa 
fever is framed and enacted which can signal alternative diagnostic pathways.  
 
The main diagnostic challenges facing resource poor settings relate to limited 
infrastructure and access 
In scientific and policy discourses the inadequacies of diagnosis in low resource settings are 
portrayed primarily in technical terms and relate to limitations in capacity and infrastructure. 
This is then paired with limitations in access, where barriers are understood as financial and 
geographical (see Burgess et al., 2006, Girosi et al., 2006, Pang and Peeling, 2007, Urdea et al., 
2006). Some authors have gone further and indicated that ‘context’ matters and that ‘one size 
fits’ all models may not be appropriate (Pang and Peeling, 2007). The contextual issues which 
have been briefly mentioned include decentralised and complex healthcare contexts, and 
multiple vertical and un-integrated programmes and providers (Bates and Maitland, 2006, 
Petti et al., 2006). Until now, these issues have not been explored empirically as new 
diagnostics have been introduced. 
 
This thesis has shown that the above considerations do not begin to explore the complexity of 
low resource health systems and the implications of new diagnostics within them. First, there 
appears to be a very narrow definition of access. People in Sierra Leone have access to a 
number of healthcare providers, what matters, is the way they choose between them. 
Strengthening laboratory and diagnostic systems means addressing why people choose not to 
use government services. Cost is important147 but opinions about the quality of care received 
in hospitals are relevant too. A stated preference for pu hale in hospitals is tempered by a 
dismissal of the way it is provided, demonstrated in the frequently repeated Krio phrase ‘pass 
you pull moni’ (not unless you pay). Fears about the risks that going to a hospital can bring, 
whether it is lethal injections, high prices, maltreatment, or time away from farms should be 
considered seriously in efforts to improve diagnostic systems. Second, laboratory knowledge 
is not valued equally by all. Elsewhere, distrust in laboratory quality has resulted in underuse 
(Polage et al., 2006). With Lassa fever, the laboratory is generally considered to be high 
                                               
147 It is telling that after the introduction of the FHCI ward records showed a rise in the number of 
patients from the target groups covered by the FHCI being tested and diagnosed with Lassa fever after 
the policy was introduced (Moses et al., 2012). 
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quality but even so there are competing sources of knowledge and claims to diagnostic 
authority in the diagnostic system. This includes secret societies, traditional healers, informal 
and formal providers of Western medicine. Informal sources of care, both traditional and 
biomedical will likely remain important parts of the diagnostic system. Since my fieldwork, it 
has been reported that traditional birth attendants (TBAs) have been banned in Sierra Leone 
(Whitaker, 2012). Even though pregnant women are now covered by the Free Health Care 
Initiative (FHCI), a policy which bans TBAs may be ineffective (or counterproductive) in 
settings where women are still hours from official healthcare. The fact that the TBAs authority 
is rooted in the Sande society is also likely to mean that any ban does not play out easily. In 
relation to other informal biomedical providers, such as pharmacists and ‘village doctors’, it 
has been suggested elsewhere that stretched governments need to find ways of using and 
regulating them more effectively (Peters and Bloom, 2012). Such providers are indeed part of 
the diagnostic system and their role within it must be considered.  
 
There is a need for better health education throughout the diagnostic system, including for 
healthcare workers and communities. Poorly designed health information has been shown to 
be a problem elsewhere (Allen and Parker, 2011, Parker et al., 2008) and potentially Lassa 
fever is no different. While the outreach team have impressive dedication, they use a 
sensitisation video which was made decades ago and is in English, a language most people in 
Sierra Leone cannot speak fluently. The message is simply ‘do not eat rats’ and ‘take fever 
cases to the hospital’. This information is simplistic and of little use to rural communities. In 
these communities there is a widespread misunderstanding about which arata (rat) carries 
Lassa fever and questions are raised about the role of eating arata in causing infection: people 
point to times when they or others have eaten rodents and not fallen ill, and also to times 
when somebody fell sick who had not eaten rodents.   
 
Finally, the developments which hold such promise also have problems of their own: experts 
have highlighted how the reality of many of these innovations in diagnostics, RDTs and 
laboratory based, is that they are often small scale, not properly validated, poorly regulated 
and lack quality control (Mabey et al., 2004, MacArthur, 2009, Peeling and Mabey, 2010). 
Again, with Lassa fever, similar patterns are evident. At various stages doubts have been cast 
about their validation from both within the Tulane team, the Sierra Leonean technicians, and 
the WHO.  And, as I will describe in the following sections, the new diagnostics present new 
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complexities and uncertainties which require overlooked capabilities to deal with. In that 
sense, the ‘technical’ difficulties are more complicated than they first appear and, more 
significantly, new innovations bring new challenges.  
 
Diagnostics are the ‘building blocks’ on which healthcare system strengthening and 
broader capacity development can be built 
In chapter four I described how establishing diagnostics in the laboratory at KGH has been 
presented as a first step which will pave the way for further research and capacity 
development (Khan et al., 2008). This is also underlying the WHO’s suggestion to make the 
‘Lassa lab’ a ‘centre of excellence’ for the region to improve surveillance. The practicalities of 
realising these promises have been, and will probably continue to be, complicated. Differences 
in opinion about who and what the capacity development is for has caused tensions between 
Tulane, the WHO and the Sierra Leonean government. Arguably a large part of this has been 
due to the ‘securitization’ (Elbe, 2010) of Lassa fever, which is related to the narrative, 
identified in chapter four, which paints Lassa fever as a ‘global threat’. In chapter one I asked 
to what extent biodefense and infectious disease control agendas converge, as had been 
tentatively suggested elsewhere (Mabey et al., 2004, Peeling and Mabey, 2010). The case of 
Lassa fever shows that the framing of diseases as security threats as opposed to public health 
problems has restricted the kind of activities which get funded. For Lassa fever, activities have 
been focused on basic research and technological ‘fixes’ which will be sold to the US military. 
The focus on basic research and medical interventions represents trends in health 
innovations more generally (Bloom, 2009). This, in turn, relates to an underlying problem 
with approaches to innovation. Innovation is often conceived in the narrowest terms to mean 
the invention of novel technologies. This is accompanied by the idea that these inventions can 
then be transferred to new settings where they diffuse (Bell, 2009). This overlooks the broad 
and heterogeneous innovation processes which occur as technologies (including 
organisational innovations) are adapted in different contexts. The result, Martin Bell argues, is 
that the narrow capabilities involved in production receive more attention than the wider 
‘complimentary capabilities’ (Bell, 2009, p47) such as those involved in the localised 
adaptations of technology. Elements of these dynamics can be observed in approaches to 
health system strengthening and can be found in the case of diagnostics for Lassa fever. 
Health system strengthening is a ‘catch all’ phrase which conceals the fact that in reality 
approaches are often disease specific (Marchal et al., 2009) and as such it also relates to the 
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debates about vertical and horizontal programming. The investment and treatment 
arrangements for Lassa fever are disease specific, vertically planned, highly centralised and 
highly technologically focused. Some of this is due to the need for isolation, but it also relates 
to the narratives of global threat explored above. As an example it serves to show the 
limitations of these approaches: the practice of Lassa fever diagnosis cannot be separated 
from other aspects of the healthcare system. The empirical chapters in this thesis have 
emphasised aspects of the therapeutic landscape which are pertinent to Lassa fever diagnosis, 
including: unorganised and informal healthcare, alternative forms of knowledge and 
authority, various framings of disease, limited training for nurses, poor health information 
about Lassa fever and issues of healthcare financing. Improving diagnosis means addressing 
the dynamics in these broader parts of the diagnostic system. As such this thesis repeats the 
need for broader approaches to health system strengthening (Travis et al., 2004) and to 
innovation (Bell, 2009).  
 
Finally, in chapter two I drew attention to the assumptions behind the ‘specific disease model’ 
(Rosenberg, 2002) of healthcare systems and questioned whether they would follow the same 
trajectories as they had in Europe and America. In light of the above discussion about context 
specific innovation processes, it is worth noting that diagnostics, like pharmaceuticals before 
them (Bledsoe and Goubaud, 1985), are adapted into Sierra Leone’s open plural medical 
systems. This follows patterns elsewhere in African settings (Reynolds Whyte, 1982, 1992). 
The co-existence of biomedical and ‘other’ disease causation beliefs is evidence that the co-
production of ‘specific diseases’ and healthcare systems do not follow the same lines.   
 
Improved diagnostics will reduce uncertainty  
In the laboratory much of the activity around improving the diagnostics is driven by a distrust 
of the Lassa fever ‘dogma’ and a prevailing sense of uncertainty about existing research on the 
disease. The new diagnostics are argued to be more specific and to have therefore reduced 
uncertainty. This represents a common theme in diagnostics. The uncertainties problematised 
and targeted in the laboratory relate primarily to sensitivity and specificity and to time. 
Results can now be received faster and the likelihood of false negatives or positives is 
reduced. Thus, in these two areas there have been real reductions in uncertainty. However, 
incomplete knowledge pervades many more aspects of diagnosis, and in some respects new 
diagnostics have increased uncertainty.  
240 
 
 
New ambiguities and uncertainties have opened up as new ‘diagnostic paradigms’ are 
integrated into existing practices. The debate about the interpretation of the IgM is one new 
area of doubt. What this reveals is a deeper ambiguity about disease classification. 
Commenting on new diagnostic tools for sleeping sickness (African trypanosomiasis), 
Deborggraeve and Büscher (2010, p437) ask “Does a positive molecular test result indicate a 
current infection in all cases and does every infection lead to disease? We do not yet have 
clear answers to these questions, and thus cannot consider molecular diagnostics as the 
golden bullet, as is often done”. There are similar questions concerning the significance of 
Lassa fever test results and their relationship to observed symptoms, for which there are no 
clear answers.  
 
There is also considerable intrinsic uncertainty which is not easily eliminated and is not 
always acknowledged. The process of laboritization is incomplete and the ELISA is ‘inherently 
variable’. This point is accentuated by the lack of conclusive validation and regulation for the 
new diagnostics and vocal disagreement about how to interpret some aspects of them. It may 
be that some of this uncertainty will be reduced over time, if full validation is achieved. 
However, doubts similar to these have been reported elsewhere and so may be typical of 
diagnostics in low resource settings (Mabey et al., 2004, MacArthur, 2009, Peeling and Mabey, 
2010). Furthermore, there is a more fundamental problem about the validity of using a test in 
a population where disease prevalence is unknown as discussed in chapter two. This thesis 
has demonstrated that knowledge about the prevalence of Lassa fever is severely limited. In 
addition, the incomplete characterisation of the distribution of positive samples in West 
African populations also calls into question the reliability of a positive result. In this sense the 
practice involved in developing (and using) the test is a kind of circular fumbling in the dark: 
validity of tests are confirmed against a gold standard but little is known about what the 
disease looks like in a given population. 
 
Finally, there is an issue about whose uncertainty is being reduced. At KGH and in follow up 
exercises in villages, both patients and communities were not told their results reliably. At 
times this was a deliberate strategy based on an assumption that the patients would panic and 
not understand. Although rumours about medical research are rooted in deeper asymmetrical 
relationships (Geissler and Pool, 2006) withholding information can only serve to create 
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space for suspicion by denying people full participation. Questions I was asked by patients 
and community members spoke to these concerns. Some were practical, such as is Lassa in 
our village? Whereas others hinted at deeper concerns, such as why did they ‘pull’ my blood 
and what are they doing with it? In addition, there are the people who test negative for Lassa 
fever whose uncertainty is not especially reduced. As Lassa fever diagnostics improve it 
serves to highlight that there are plenty more diseases out there which are equally unknown. 
 
As attention is focused on narrow conceptualisations of uncertainty and risk, such as 
sensitivity and specificity, the broader ambiguities and inherent uncertainty in diagnosis can 
be overlooked. Taking these into account, the claim that uncertainty has been reduced looks 
problematic. There is a further point about the importance of the social context in which 
claims about uncertainty can be made. In the Sierra Leonean context uncertainty is cultivated 
and is an important strategy for maintaining traditional forms of power and authority (Ferme, 
2001). Diagnostics do not reduce the ambiguity which pervades most aspects of Sierra 
Leonean life. In fact, in some ways, diagnostics simply fit into the established patterns of 
hierarchy and secret knowledge. Biomedicine, with or without enhanced diagnostics, is 
another area of knowledge which rural Sierra Leonean’s are excluded from and subjugated to. 
The concealment of results mentioned above is a perpetuation of this. Similar to what has 
been reported by Last (1981) in Nigeria, responses tend to vary from an apparent 
unquestioning acceptance to suspicion; yet, underpinning these reactions is the pervasive 
idea that meaning is not stable and things are often not what they seem.  
 
Diagnosis introduces order (out of messy symptoms) 
With the new uncertainties discussed above there is an argument that actually, rather than 
heralding order, there is increasing complexity and disorder. New diagnostics are not 
introduced on to a blank slate; rather they are introduced into a system brimming with 
distinct approaches to classifying Lassa. They cannot, therefore, be said to introduce order or 
knowledge where there was none. Instead, they should be seen as adding to, or modifying, 
some of the existing classification practices. Perhaps there has been a move to a more 
theoretically biomedical form of classification by which I mean that treatment decisions are 
usually deferred until the assays have looked for evidence of an immune response. However, 
across the board, the availability of faster and more sensitive ELISA tests has resulted not in 
more assured practices but rather in more debate and ambiguity over what to do and how to 
242 
 
interpret their results. The result has been that diagnostic pathways have become 
increasingly diverse. For example IgM positives can now be left on general wards or taken 
into isolation. An interesting way of thinking about the way laboratory diagnostics fit into the 
established diagnostic process is to consider their capacity to rule cases in or out. In the case 
of IgM it is no longer clear if a patient should be ‘ruled in’ or ‘ruled out’. And there have been a 
few cases where antigen positive results ‘ruled in’ patients who perhaps should not have 
been. As Tulane’s clinicians emphasises, laboratory diagnostics have to be used in conjunction 
with other signs and symptoms. In this light laboratory results begin to look more like a 
‘discursive resource’ (Willig, 2011) than a definitive diagnostic statement 
 
Laboratory diagnostics introduce reliable scientific knowledge where before there was 
ignorance or guesswork 
The ‘technological fix’ narrative, identified in chapter four, asserts the authority and ‘science’ 
of the new diagnostics. I have already discussed the implications of new diagnostics on 
uncertainty and order; here I make two further points about the notion of scientific diagnosis. 
First, claiming to be able to achieve a scientific diagnosis, as some have done (Miettinen, 
2001), is misleading. In the interpretation of test results, both inside and outside of the 
laboratory, a number of what might be called ‘social factors’ have been shown to be important. 
I have also shown that within the ‘reliable’ scientific approach to diagnostics in the laboratory 
there are a number of concealed ambiguities which arguably make the results less reliable 
than they first appear. The issue is not that science cannot be considered social in any way, or 
that if it is, it is somehow less valid. Indeed this thesis has shown that the assessment of wider 
signs and symptoms are needed to make the laboratory results more valid. However, 
expectations about new diagnostics and assessments of the current limitations in low 
resource settings appear to be based on knowledge deficit models: that without laboratory 
diagnostics there is only ignorance or unreliable guesswork. This thesis has shown that many 
different types of knowledge can be considered relevant and valid in the process of diagnosis. 
Furthermore, it does not always follow that increasing ‘scientific’ knowledge about a 
particular subject will reduce ignorance: as Einstein is reported to have said, “as our circle of 
knowledge expands, so does the circumference of darkness surrounding it”.148  With Lassa 
fever it is certainly the case that as diagnostics are developed, and more research is carried 
out, more questions arise.  
                                               
148 I am grateful to Andy Stirling for making me aware of this quote and its relevance here. I have not 
been able to find the original source.  
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A revolution? 
The preceding pages have highlighted the importance of being measured about technological 
progress. Predications of a revolution in the biotechnology industry have already been 
challenged (Hopkins et al., 2007, Nightingale and Martin, 2004). This thesis, and the 
discussion of innovation processes in the preceding pages, supports their arguments that 
innovation can lead to increased complexity which in turn needs new capabilities to deal with. 
As such innovations in diagnostics will not be a ‘silver bullet’ and technical and health system 
change will likely be more incremental than revolutionary. To deal with these new 
complexities the investment which is being put into diagnostics for Lassa fever in the 
laboratory would ideally be matched elsewhere. It should be directed not only into other 
laboratories in Sierra Leone and West Africa, but also at peripheral health settings and public 
health activities in local communities.  It should include consideration of the social, political 
and economic dynamics of therapeutic practice which this thesis has highlighted. However, 
while funding is attached to articulations of Lassa fever which emphasise ‘global threat’ 
narratives the scope for these broader activities may continue to be limited. It is possible that 
the Sierra Leonean Government, the WHO or other actors may find alternative pathways for 
action but, until they do so, the diagnostic revolution predicted by some may not happen as 
quickly or as full scale as might be hoped.  
8.3 Conclusions and future research  
Diagnostic technology is an area of health innovation which is increasingly attracting 
attention. So far, limited attention has been directed at these developments in critical 
anthropology or policy analysis, with the exception of some work on malaria rapid diagnostic 
tests (Chandler et al., 2008a, 2008b, 2012). The growing field of global health anthropology 
does not seem to have engaged with the subject yet (see Lock and Nguyen, 2010, Nichter, 
2008). And the implications for another growing, but vague, field of health systems 
strengthening (Marchal et al., 2009) needs also to be considered. Established debates about 
vertical and horizontal planning are also relevant. For its own part, this thesis has 
demonstrated that a combination of science and technology studies and medical anthropology 
can be usefully applied to highlight issues in this emerging field. This thesis has been able to 
show that, even at this early stage, some problematic narratives about diagnostic technology 
and its influence on low resource settings can be identified. Taking a practice-based 
244 
 
perspective has highlighted the complexity of ‘doing’ diagnosis in a range of contexts where 
multiple framings of disease are involved. Specifically, the ‘mangle of practice’ approach has 
highlighted the unpredictability and uncertainty of diagnostic processes.  
 
The limited previous attention to the perspectives of people living and working in endemic 
Lassa fever regions provides the basis for the empirical contribution made by this thesis. So 
too does the wide-ranging approach to diagnosis which has been taken here. Exploring 
framings and the practice of diagnosis in three different sites, a village, a laboratory and a 
hospital, has been an important initial step in highlighting the hidden perspectives of those 
who are most at risk from Lassa. While I did not find a culture of Lassa-specific community 
based diagnosis and healing, I was able to show how approaches to Lassa fever are embedded 
in local categories of disease and healing. More research on the local dynamics influencing 
health seeking is still needed. This is all the more urgent as Lassa fever is increasingly 
detected in areas previously considered as non-endemic. Across laboratory, clinical and 
community settings, contrasting and incomplete ways of knowing Lassa fever intersect with 
each other. A closer look at practice highlights that people have a complex, conflicted and 
contingent approaches to negotiating Lassa fever and therapeutic landscapes. Such nuances 
are lost in the more well-known framings and narratives about emerging or exploding 
epidemics, or unhygienic and uneducated communities.  
 
In relation to the overarching narratives of technological optimism and revolution a number 
of points can now be made. First, the challenges related to diagnosis in low resource 
healthcare settings are not simply a lack of knowledge or technology.  
They are systemic, broad and context-dependent. Second, approaches to innovation and 
health system development which assume universal ‘upward flows’ of information, and 
‘outward flows’ of capacity development from central and vertical programmes, do not 
capture the reality of innovation and healthcare. The diversity of people, tools and practices 
involved in diagnosis suggests that broader approaches to innovation and technical change 
are needed. A narrow focus on ‘hardware’ and infrastructure such as cold chains overlooks 
the importance of complementary innovation capabilities and complimentary approaches to 
disease control. As well as ‘centres of excellence’ what is needed are approaches which 
recognise the importance of appropriate health promotion in communities and training for 
healthcare workers. More than that, diagnostic processes must be seen as embedded in the 
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institutional delivery of healthcare. This means, for instance, that improving diagnosis 
involves getting to grips with unregulated and informal forms of healthcare which thrive. 
Lastly, no innovations in medical technologies can overcome the social and economic reasons 
behind particular communities’ vulnerabilities to Lassa fever and therefore these factors need 
equal attention.  
 
 
 
246 
 
9 References 
AKAM, S. 2011. U.S. anti-terror outpost tackles rat-borne virus [Online]. US Edition: Reuters. 
Available: http://www.reuters.com/article/2011/02/14/us-bioterror-africa-
idUSTRE71D49820110214 [Accessed 20/03/2012]. 
AKOBENG, A. K. 2007. Understanding diagnostic tests 1: sensitivity, specificity and predictive 
values. Acta paediatrica, 96, 338-341. 
ALLEN, T. & PARKER, M. 2011. The ‘Other Diseases’ of the Millennium Development Goals: 
rhetoric and reality of free drug distribution to cure the poor's parasites. Third world 
quarterly, 32, 91-117. 
ALTMAN, D. G. & BLAND, J. M. 1994a. Statistics Notes: Diagnostic tests 1: sensitivity and 
specificity. BMJ, 308, 1552. 
ALTMAN, D. G. & BLAND, J. M. 1994b. Statistics Notes: Diagnostic tests 2: predictive values. 
BMJ, 309, 102. 
ANDI. 2010. ANDI Mission and Vision [Online]. African Network for Drugs and Diagnostics 
Innovation. Available: http://www.andi-africa.org/index.php/vision-mission 
[Accessed 15th December 2012.] 
ANSPACH, R. R. 2011. Preface. In: MCGANN, P. & HUTSON, D. J. (eds.) Sociology of Diagnosis. 
Bingley, UK: Emerald Group Publishing. 
ARONOWITZ, R. 2008. Framing disease: An underappreciated mechanism for the social 
patterning of health. Social Science & Medicine, 67, 1-9. 
ATKINSON, P. & HAMMERSLEY, M. 1994. Ethnography and participant observation. In: 
DENZIN, N. K. & LINCOLN, Y. S. (eds.) Handbook of qualitative research. London: SAGE 
Pulblications. 
BAER, H. A., SINGER, M. & SUSSER, I. 2003. Medical anthropology and the world system, United 
States, Praeger Publishers. 
BALINT, M. 2000. The Doctor, His Patient and the Illness (Millennium reprint of second 
addition), London, Churchill Livingstone. 
BARAT, L., CHIPIPA, J., KOLCZAK, M. & SUKWA, T. 1999. Does the availability of blood slide 
microscopy for malaria at health centers improve the management of persons with 
fever in Zambia? The American journal of tropical medicine and hygiene, 60, 1024-
1030. 
247 
 
BARKER, K. K. 2011. Listening to Lyrica: contested illnesses and pharmaceutical determinism. 
Social Science and Medicine, 73, 833-842. 
BATES, I. & MAITLAND, K. 2006. Are laboratory services coming of age in sub-Saharan Africa? 
Clinical Infectious Diseases, 42, 383-384. 
BAUSCH, D. G. 2010. Lassa Fever - Sierra Leone (03): (Northern) [Online]. International Society 
for Infectious Diseases. Available: 
http://www.promedmail.org/direct.php?id=20101017.3770 [Accessed 24/09/2012.] 
BAUSCH, D. G., DEMBY, A. H., COULIBALY, M., KANU, J., GOBA, A., BAH, A., CONDÉ, N., 
WURTZEL, H. L., CAVALLARO, K. F. & LLOYD, E. 2001. Lassa fever in Guinea: I. 
Epidemiology of human disease and clinical observations. Vector Borne and Zoonotic 
Diseases, 1, 269-281. 
BAUSCH, D. G., MOSES, L. M., GOBA, A., GRANT, D. & KHAN, H. forthcoming, 2014. Lassa Virus 
Hemorrhagic Fever. In: SINGH, S. K. & RUZEK, D. (eds.) Viral Hemorrhagic Fevers. 
Taylor and Francis. 
BAUSCH, D. G., ROLLIN, P. E., DEMBY, A. H., COULIBALY, M., KANU, J., CONTEH, A. S., 
WAGONER, K. D., MCMULLAN, L. K., BOWEN, M. D., PETERS, C. J. & KSIAZEK, T. G. 
2000. Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked 
Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation. 
Journal of Clinical Microbiology, 38, 2670-2677. 
BAUSCH, D. G., SESAY, S. S. S. & OSHIN, B. 2004. On the front lines of Lassa fever. Emerging 
infectious diseases, 10, 1889. 
BELL, M. 2009. Innovation Capabilities and Directions of Development. STEPS Working Paper 
33. Brighton: STEPS Centre. 
BERG, M. 1996. Practices of reading and writing: the constitutive role of the patient record in 
medical work. Sociology of Health & Illness, 18, 499-524. 
BERG, M. 1997. Problems and promises of the protocol. Social Science & Medicine, 44, 1081-
1088. 
BERG, M. & MOL, A. 1998. Differences in medicine: unraveling practices, techniques, and bodies, 
Duke University Press. 
BERKELMAN, R., CASSELL, G., SPECTER, S., HAMBURG, M. & KLUGMAN, K. 2006. The “Achilles 
Heel” of Global Efforts to Combat Infectious Diseases. Clinical Infectious Diseases, 42, 
1503-1504. 
248 
 
BERKHOUT, F., SMITH, A. & STIRLING, A. 2004. Socio-technological regimes and transition 
contexts. In: ELZEN, B., GEELS, F. & GREEN, K. (eds.) System innovation and the 
transition to sustainability: theory, evidence and policy. Cheltenham: Edward Elgar. 
BIJKER, W. E. 1995. Of Bicycles, Bakelites, and Bulbs : Toward a Theory of Sociotechnical 
Change, London, MIT Press. 
BIRMINGHAM, K. & KENYON, G. 2001. Lassa fever is unheralded problem in West Africa. 
Nature Medicine, 7, 878-878. 
BIRX, D., DE SOUZA, M. & NKENGASONG, J. N. 2009. Laboratory Challenges in the Scaling Up of 
HIV, TB, and Malaria Programs. American Journal of Clinical Pathology, 131, 849-851. 
BLAXTER, M. 1978. Diagnosis as category and process: The case of alcoholism. Social Science & 
Medicine, 12, 9-17. 
BLEDSOE, C. 1984. The political use of Sande ideology and symbolism. American Ethnologist, 
11, 455-472. 
BLEDSOE, C. H. 1980. Women and marriage in Kpelle society, Stanford, California Stanford 
University Press. 
BLEDSOE, C. H. & GOUBAUD, M. F. 1985. The reinterpretation of western pharmaceuticals 
among the Mende of Sierra Leone. Social Science & Medicine, 21, 275-282. 
BLEDSOE, C. H. & ROBEY, K. M. 1986. Arabic literacy and secrecy among the Mende of Sierra 
Leone. Man, 202-226. 
BLOOM, G. 2009. Science and Technology for Health: Towards Universal Access in a Changing 
World STEPS Working Paper 28. Brighton: STEPS Centre. 
BLOOM, G. & STANDING, H. 2006. Future health systems: Why future? Why now? Social 
Science & Medicine, 66, 2067-2075. 
BLUME, S. S. 1992. Insight and industry: on the dynamics of technological change in medicine, 
The MIT Press. 
BONNER, P. C., SCHMIDT, W.-P., BELMAIN, S. R., OSHIN, B., BAGLOLE, D. & BORCHERT, M. 
2007. Poor Housing Quality Increases Risk of Rodent Infestation and Lassa Fever in 
Refugee Camps of Sierra Leone. The American journal of tropical medicine and hygiene, 
77, 169-175. 
BORIO, L., INGLESBY, T., PETERS, C., SCHMALJOHN, A. L., HUGHES, J. M., JAHRLING, P. B., 
KSIAZEK, T., JOHNSON, K. M., MEYERHOFF, A. & O'TOOLE, T. 2002. Hemorrhagic fever 
viruses as biological weapons. JAMA: the journal of the American Medical Association, 
287, 2391-2405. 
249 
 
BOURRET, P., KEATING, P. & CAMBROSIO, A. 2011. Regulating diagnosis in post-genomic 
medicine: Re-aligning clinical judgment? Social Science and Medicine, 73, 816-824. 
BOWEN, M. D., ROLLIN, P. E., KSIAZEK, T. G., HUSTAD, H. L., BAUSCH, D. G., DEMBY, A. H., 
BAJANI, M. D., PETERS, C. J. & NICHOL, S. T. 2000. Genetic diversity among Lassa virus 
strains. Journal of virology, 74, 6992-7004. 
BOWKER, G. C. & STAR, S. L. 2000. Sorting things out; classification and its consequences, 
Cambridge, Massachusetts; London, England, The MIT Press. 
BRANCO, L., BOISEN, M., ANDERSEN, K., GROVE, J., MOSES, L., MUNCY, I., HENDERSON, L., 
SCHIEFFELLIN, J., ROBINSON, J., BANGURA, J., GRANT, D., RAABE, V., FONNIE, M., 
SABETI, P. & GARRY, R. 2011a. Lassa hemorrhagic fever in a late term pregnancy from 
northern sierra leone with a positive maternal outcome: case report. Virology Journal, 
8, 404. 
BRANCO, L., GROVE, J., BOISEN, M., SHAFFER, J., GOBA, A., FULLAH, M., MOMOH, M., GRANT, D. 
& GARRY, R. 2011b. Emerging trends in Lassa fever: redefining the role of 
immunoglobulin M and inflammation in diagnosing acute infection. Virology Journal, 8, 
478. 
BRAUDE, H. 2009. Clinical intuition versus statistics: different modes of tacit knowledge in 
clinical epidemiology and evidence-based medicine. Theoretical Medicine and 
Bioethics, 30, 181-198. 
BROWN, P. 1990. The Name Game: Towards a Sociology of Diagnosis. The Journal of Mind and 
Behaviour, 11, 385 (139) -406 (160). 
BROWN, P. 1995. Naming and Framing: The Social Construction of Diagnosis and Illness. 
Journal of Health and Social Behavior, 35, 34-52. 
BROWN, P., LYSON, M. & JENKINS, T. 2011. From diagnosis to social diagnosis. Social Science 
and Medicine, 73, 939-943. 
BROWN, P., ZAVESTOSKI, S., MCCORMICK, S., LINDER, M., MANDELBAUM, J. & LUEBKE, T. 
2001. A Gulf of Difference: Disputes over Gulf War-Related Illnesses. Journal of Health 
and Social Behavior, 42, 235-257. 
BROWN, P., ZAVESTOSKI, S., MCCORMICK, S., MAYER, B., MORELLO-FROSCH, R. & GASIOR 
ALTMAN, R. 2004. Embodied health movements: new approaches to social 
movements in health. Sociology of Health & Illness, 26, 50-80. 
250 
 
BUKACHI, S., WANDIBBA, S. & NYAMONGO, I. 2009. The treatment pathways followed by 
cases of human African trypanosomiasis in western Kenya and eastern Uganda. Annals 
of tropical medicine and parasitology, 103, 211-220. 
BURGESS, D. C. H., WASSERMAN, J. & DAHL, C. A. 2006. Global health diagnostics. Nature, 444, 
1-2. 
BÜSCHER, M., GOODWIN, D. & MESMAN, J. (eds.) 2010. Ethnographies of diagnostic work: 
dimensions of transformative practice, Basingstoke: Palgrave Macmillan. 
CAMBROSIO, A. & KEATING, P. 1995. Exquisite specificity: The monoclonal antibody revolution, 
New York and London, Oxford University Press  
CAREY, D., KEMP, G., WHITE, H., PINNEO, L., ADDY, R., FOM, A., STROH, G., CASALS, J. & 
HENDERSON, B. 1972. Lassa fever epidemiological aspects of the 1970 epidemic, Jos, 
Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 66, 402-
408. 
CARTWRIGHT, N. 2011a. A philosopher's view of the long road from RCTs to effectiveness. 
The Lancet, 377, 1400-1401. 
CARTWRIGHT, N. 2011b. Predicting what will happen when we act. What counts for warrant? 
Preventive Medicine, 53, 221-224. 
CASPER, M. J. & CLARKE, A. E. 1998. Making the Pap Smear into the `Right Tool' for the Job. 
Social Studies of Science, 28, 255-290. 
CASSIDY, R. & LEACH, M. 2009. Science, Politics, and the Presidential Aids ‘Cure’. African 
Affairs, 108, 559-580. 
CDC. 2012a. Emergency Preparedness and Response - Bioterrorism Agents/Diseases [Online]. 
Centers for Disease Control and Prevention. Available: 
http://www.bt.cdc.gov/agent/agentlist-category.asp [Accessed 15th December 2012.] 
CDC. 2012b. Lassa Fever [Online]. US: Special Pathogens Branch; CDC. Available: 
http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lassaf.htm [Accessed 
24/09/2012]. 
CDC. 2012c. Special Pathogens Branch - Glossary of Terms [Online]. Centers for Disease Control 
and Prevention. Available: 
http://www.cdc.gov/ncidod/dvrd/spb/mnpages/glossary.htm#biosafety%20level 
[Accessed 19th March 2012.] 
251 
 
CHANDLER, C., JONES, C., BONIFACE, G., JUMA, K., REYBURN, H. & WHITTY, C. 2008a. 
Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A 
qualitative study. Malaria Journal, 7, 53. 
CHANDLER, C. I. R., CHONYA, S., BONIFACE, G., JUMA, K., REYBURN, H. & WHITTY, C. J. M. 
2008b. The importance of context in malaria diagnosis and treatment decisions - a 
quantitative analysis of observed clinical encounters in Tanzania. Tropical Medicine & 
International Health, 13, 1131-1142. 
CHANDLER, C. I. R., MANGHAM, L., NJEI, A. N., ACHONDUH, O., MBACHAM, W. F. & WISEMAN, 
V. 2012. ‘As a clinician, you are not managing lab results, you are managing the 
patient’: How the enactment of malaria at health facilities in Cameroon compares with 
new WHO guidelines for the use of malaria tests. Social Science & Medicine. 
CHRISTAKIS, N. A. 1997. The ellipsis of prognosis in modern medical thought. Social Science & 
Medicine, 44, 301-315. 
CIA. 1969. Sierra Leone - Ethnic Groups. U.S. Central Intelligence Agency. 
CONRAD, P. 1980. Deviance and medicalization: From badness to sickness, St Louis, The CV 
Mosby Company. 
CONRAD, P. & ANGELL, A. 2004. Homosexuality and remedicalization. Society, 41, 32-39. 
CROSS, J. & MACGREGOR, H. 2009. Who Are ‘Informal Health Providers’ and What Do They 
Do? Perspectives from Medical Anthropology. IDS Working Papers, 2009, 01-23. 
CROSS, J. & MACGREGOR, H. N. 2010. Knowledge, legitimacy and economic practice in 
informal markets for medicine: A critical review of research. Social Science & Medicine, 
71, 1593-1600. 
CROWTHER, J. R. 2000. The ELISA guidebook, Springer. 
CUMMINS, D. 1990. Lassa fever. Br J Hosp Med, 43, 186-8. 
CUNNINGHAM, A. 1992. Transforming plague: the laboratory and the identity of infectious 
disease. In: CUNNINGHAM, A. & WILLIAMS, P. (eds.) The Laboratory Revolution in 
Medicine. Cambridge: Cambridge University Press. 
CUNNINGHAM, A. & WILLIAMS, P. 1992. Introduction. In: CUNNINGHAM, A. & WILLIAMS, P. 
(eds.) The Laboratory Revolution in Medicine. Cambridge: Cambridge University Press. 
D'ACREMONT, V., LENGELER, C., MSHINDA, H., MTASIWA, D., TANNER, M. & GENTON, B. 
2009. Time to move from presumptive malaria treatment to laboratory-confirmed 
diagnosis and treatment in African children with fever. Plos Medicine, 6, e252. 
252 
 
DAAR, A. S., THORSTEINSDOTTIR, H., MARTIN, D. K., SMITH, A. C., NAST, S. & SINGER, P. A. 
2002. Top ten biotechnologies for improving health in developing countries. Nature 
Genetics, 32, 229-232. 
DALEY, T. C. 2004. From symptom recognition to diagnosis: children with autism in urban 
India. Social Science & Medicine, 58, 1323-1335. 
DEBORGGRAEVE, S. & BÜSCHER, P. 2010. Molecular diagnostics for sleeping sickness: what is 
the benefit for the patient? The Lancet Infectious Diseases, 10, 433-439. 
DENZIN, N. K. 1970. The research act: a theoretical introduction to sociological methods, Aldine 
Pub. Co. 
DONALDSON, R. 2009. The Lassa Ward: one man's fight against one of the world's deadliest 
diseases, London, Transworld Publishers. 
DONNELLY, J. 2011. How did Sierra Leone provide free health care? The Lancet, 377, 1393-
1396. 
DOSI, G. 1982. Technological Paradigms and Technological Trajectories: A suggested 
interpretation of the determinants and direction of technological change. Research 
Policy, 11, 147-162. 
EBELING, M. 2011. ‘Get with the Program!’: Pharmaceutical marketing, symptom checklists 
and self-diagnosis. Social Science and Medicine, 73, 825-832. 
EDDY, D. M. & CLANTON, C. H. 1982. The Art of Diagnosis. New England Journal of Medicine, 
306, 1263-1268. 
EDSTROM, J. 2010. Constructing AIDS: Contesting Perspectives on an Evolving Epidemic. In: 
DRY, S. & LEACH, M. (eds.) Epidemics: Science, Governance and Social Justice. London: 
Earthscan. 
ELBE, S. 2006. Should HIVAIDS Be Securitized? The Ethical Dilemmas of Linking HIVAIDS and 
Security. International Studies Quarterly, 50, 119-144. 
ELBE, S. 2010. Haggling over viruses: the downside risks of securitizing infectious disease. 
Health Policy and Planning, 25, 476-485. 
EMERSON, R. M., FRETZ, R. I. & SHAW, L. L. 1995. Writing ethnographic fieldnotes, Chicago and 
London, University of Chicago Press. 
EPSTEIN, S. 1996. Impure Science: AIDS, activism, and the politics of knowledge, Berkeley, 
London, University of California Press. 
EVANS-PRITCHARD, E. 1976. Witchcraft, oracles and magic among the Azande, Oxford, Oxford 
University Press. 
253 
 
FAIR, J. N. 2007. Development and characterization of recombinant Lassa virus proteins and 
monoclonal antibodies for diagnostic applications. Ph.D., Tulane University. 
FAIRHEAD, J., LEACH, M. & SMALL, M. 2006. Where techno-science meets poverty: medical 
research and the economy of blood in The Gambia, West Africa. Social science & 
medicine (1982), 63, 1109. 
FANTHORPE, R. 1998. Locating the politics of a Sierra Leonean chiefdom. Africa, 68, 558-584. 
FANTHORPE, R. 2006. On the limits of liberal peace: Chiefs and democratic decentralization in 
post-war Sierra Leone. African Affairs, 105, 27-49. 
FARMER, P. 1999. Infections and inequalities: the modern plagues, Berkeley, Los 
Angeles,London, University of California Press. 
FASSIN, D. & SCHNEIDER, H. 2003. The politics of AIDS in South Africa: beyond the 
controversies. BMJ, 326, 495-497. 
FERME, M. 1994. What ‘Alhaji Airplane’saw in Mecca, and what happened when he came 
home. In: STEWART, C. & SHAW, R. (eds.) Syncretism/Anti-Syncretism: The Politics of 
Religious Synthesis. London: Routledge. 
FERME, M. C. 2001. The Underneath of Things: violence, history, and the everyday in Sierra 
Leone, London, University of California Press. 
FICHET-CALVET, E., LECOMPTE, E., KOIVOGUI, L., SOROPOGUI, B., DORÉ, A., KOUROUMA, F., 
SYLLA, O., DAFFIS, S., KOULÉMOU, K. & MEULEN, J. T. 2007. Fluctuation of abundance 
and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector-
Borne and Zoonotic Diseases, 7, 119-128. 
FICHET-CALVET, E. & ROGERS, D. J. 2009. Risk maps of Lassa fever in West Africa. PLoS 
neglected tropical diseases, 3, e388. 
FIND. 2012. History [Online]. Foundation for Innovative New Diagnostics. Available: 
http://www.finddiagnostics.org/about/who_we_are/history/ [Accessed 15th 
December 2012.] 
FOUCAULT, M. 1973. The Birth of the Clinic: an archaeology of medical perception, London, 
Tavistock. 
FRAME, J. D., BALDWIN JR, J. M., GOCKE, D. J. & TROUP, J. M. 1970. Lassa fever, a new virus 
disease of man from West Africa. I. Clinical description and pathological findings. Am. J. 
Trop. Med. Hyg. , Vol.19, p670-676. 
FREIDSON, E. 1970. Profession of Medicine: A Study of the Sociology of Applied Knowledge, New 
York, USA, Dodd, Mead & Co. 
254 
 
FULLER, J. G. 1974. Fever! The Hunt for a New Killer Virus, New York, Reader's Digest Press. 
GARDNER, J., DEW, K., STUBBE, M., DOWELL, T. & MACDONALD, L. 2011. Patchwork 
diagnoses: The production of coherence, uncertainty, and manageable bodies. Social 
Science and Medicine, 73, 843-850. 
GARRY, R. 2004. Preclinical development of recombinant antigen Lassa fever diagnostics  - 
Technical Proposal. National Institutes of Health. 
GEELS, F. 2004. From sectoral systems of innovation to socio-technical systems: Insights 
about dynamics and change from sociology and institutional theory. Research Policy, 
33, 897-920. 
GEERTZ, C. 1973. Thick Description: toward an interpretive theory of culture. In: GEERTZ, C. 
(ed.) The interpretation of cultures: Selected essays. New York: Basic books. 
GEEST, S. V. D., WHYTE, S. R. & HARDON, A. 1996. The Anthropology of Pharmaceuticals: A 
Biographical Approach. Annual Review of Anthropology, 25, 153-178. 
GEISSLER, P. W. & POOL, R. 2006. Editorial: Popular concerns about medical research projects 
in sub-Saharan Africa – a critical voice in debates about medical research ethics. 
Tropical Medicine & International Health, 11, 975-982. 
GIRE, S. K., STREMLAU, M., ANDERSEN, K. G., SCHAFFNER, S. F., BJORNSON, Z., RUBINS, K., 
HENSLEY, L., MCCORMICK, J. B., LANDER, E. S. & GARRY, R. F. 2012. Emerging Disease 
or Diagnosis? Science, 338, 750-752. 
GIROSI, F., OLMSTED, S. S., KEELER, E., BURGESS, D. C. H., LIM, Y. W., ALEDORT, J. E., RAFAEL, 
M. E., RICCI, K. A., BOER, R., HILBORNE, L., DEROSE, K. P., SHEA, M. V., BEIGHLEY, C. M., 
DAHL, C. A. & WASSERMAN, J. 2006. Developing and interpreting models to improve 
diagnostics in developing countries. Nature, 444, 3-8. 
GLOBAL HEALTH DIAGNOSTICS FORUM 2006. The right tools can save lives. Nature, 444, 
681-681. 
GOLDACRE, B. 2006. Crystal Balls....and Positive Predictive Values [Online]. The Guardian. 
Available: http://www.badscience.net/2006/12/crystal-balls-and-positive-
predictive-values/ [Accessed 11/01/2013.] 
GOODWIN, D. 2010. Sensing the way: embodied dimensions in diagnostic work. In: BÜSCHER, 
M., GOODWIN, D. & MESMAN, J. (eds.) Ethnographies of diagnostic work: dimensions of 
transformative practice. Basingstoke: Palgrave Macmillan. 
255 
 
GRONVALL, G. K., FITZGERALD, J., CHAMBERLAIN, A., INGLESBY, T. V. & O'TOOLE, T. 2007. 
High-containment biodefense research laboratories: meeting report and center 
recommendations. Biosecurity and Bioterrorism, 5, 75-85. 
HACKING, I. 1983. Representing and intervening: introductory topics in the philosophy of 
natural science, Cambridge, Cambridge University Press. 
HACKING, I. 1988. The Participant Irrealist At Large in the Laboratory. The British Journal for 
the Philosophy of Science, 39, 277-294. 
HAMMERSLEY, M. 1990. Reading ethnographic research: A critical guide, London, Longman. 
HARAWAY, D. 1988. Situated knowledges: The science question in feminism and the privilege 
of partial perspective. Feminist studies, 575-599. 
HEDGECOE, A. M. 2002. Reinventing diabetes: classification, division and the geneticization of 
disease. New Genetics and Society, 21, 7-27. 
HENRY, S. 2006. Recognizing Racit Knowledge in Medical Epistemology. Theoretical Medicine 
and Bioethics, 27, 187-213. 
HEWLETT, B. S. & AMOLA, R. P. 2003. Cultural contexts of Ebola in northern Uganda. 
Emerging infectious diseases, 9, 1242. 
HEWLETT, B. S. & HEWLETT, B. L. 2008. Ebola, culture, and politics: the anthropology of an 
emerging disease, Wadsworth Pub Co. 
HOFFER, C. P. 1972. Mende and Sherbro Women in High Office. Canadian Journal of African 
Studies / Revue Canadienne des Études Africaines, 6, 151-164. 
HOFFER, C. P. 1974. Madam Yoko: ruler of the Kpa Mende confederacy. In: ROSALDO, M. Z. & 
LAMPHERE, L. (eds.) Woman, Culture, and Society. US: Stanford University Press. 
HOPKINS, M. 2004. Technique-Led Technological Change and The 'Hidden Research System': 
Genetic Testing in the NHS. University of Sussex  
HOPKINS, M. M. 2006. The hidden research system: the evolution of cytogenetic testing in the 
National Health Service. Science as Culture, 15, 253-276. 
HOPKINS, M. M., MARTIN, P. A., NIGHTINGALE, P., KRAFT, A. & MAHDI, S. 2007. The myth of 
the biotech revolution: An assessment of technological, clinical and organisational 
change. Research Policy, 36, 566-589. 
INEGBENEBOR, U., OKOSUN, J. & INEGBENEBOR, J. 2010. Prevention of Lassa fever in Nigeria. 
Transactions of the Royal Society of Tropical Medicine and Hygiene, 104, 51-54. 
INNES, G. 1969. A Mende-English dictionary, Cambridge, Cambridge University Press. 
256 
 
INNES, G. 1971. A practical introduction to Mende, London, School of Oriental and African 
Studies, University of London. 
JANZEN, J. M. 1978. The quest for therapy in lower Zaire, California; London, University of 
California Press. 
JANZEN, J. M. 1981. The need for a taxonomy of health in the study of African therapeutics. 
Social Science & Medicine. Part B: Medical Anthropology, 15, 185-194. 
JASANOFF, S. 2004. The idiom of co-production. In: JASANOFF, S. (ed.) States of knowledge: the 
co-production of science and the social order. London: Routledge. 
JASANOFF, S. 2005. Designs on nature: Science and democracy in Europe and the United States, 
New Jersey, Princeton University Press. 
JȨDREJ, M. 1974. An analytical note on the land and spirits of the Sewa Mende. Africa, 38-45. 
JEDREJ, M. C. 1976a. Medicine, fetish and secret society in a West African culture. Africa, 46, 
247-257. 
JEDREJ, M. C. 1976b. Structural Aspects of a West African Secret Society. Journal of 
Anthropological Research, 32, 234-245. 
JOHANNESSEN, H. 2006. Introduction: body and self in medical pluralism. In: JOHANNESSEN, 
H. & LÁZÁR, I. (eds.) Multiple medical realities: patients and healers in biomedical, 
alternative, and traditional medicine. United States Berghahn Books. 
JOSEPH, H. 2011. Colonial era sanitiary inspection kept Nigeria free from disease [Online]. 
Nigeria: The Daily Trust. Available: http://www.dailytrust.com.ng/index.php/other-
sections/environment/168274-colonial-era-sanitary-inspection-kept-nigeria-free-
from-diseases [Accessed 24/09/2012.] 
JUTEL, A. 2006. The emergence of overweight as a disease entity: Measuring up normality. 
Social Science & Medicine, 63, 2268-2276. 
JUTEL, A. 2009. Sociology of diagnosis: a preliminary review. Sociology of Health and Illness, 
31, 278-299. 
JUTEL, A. 2010. Framing disease: The example of female hypoactive sexual desire disorder. 
Social Science & Medicine, 70, 1084-1090. 
JUTEL, A. 2011a. CLASSIFICATION, DISEASE, AND DIAGNOSIS. Perspectives in Biology and 
Medicine, 54, 189-205. 
JUTEL, A. 2011b. Sociology of Diagnosis: A Preliminary Review. In: MCGANN, P. J. & HUTSON, 
D. J. (eds.) Sociology of Diagnosis. Bingley, UK: Emerald Group Publishing Limited. 
257 
 
JUTEL, A. & NETTLETON, S. 2011. Towards a sociology of diagnosis: Reflections and 
opportunities. Social Science and Medicine, 73, 793-800. 
JUTEL, A. G. 2011c. Putting a Name to It: Diagnosis in Contemporary Society, Johns Hopkins 
Univ Pr. 
KAMAT, V. R. 2006. “I thought it was only ordinary fever!” cultural knowledge and the 
micropolitics of therapy seeking for childhood febrile illness in Tanzania. Social 
Science & Medicine, 62, 2945-2959. 
KELLY, A. H. & BEISEL, U. 2011. Neglected malarias: The frontlines and back alleys of global 
health. BioSocieties, 6, 71-87. 
KHAN, S. H., GOBA, A., CHU, M., ROTH, C., HEALING, T., MARX, A., FAIR, J., GUTTIERI, M. C., 
FERRO, P. & IMES, T. 2008. New opportunities for field research on the pathogenesis 
and treatment of Lassa fever. Antiviral research, 78, 103-115. 
KLEINMAN, A. 1980. Patients and healers in the context of culture: An exploration of the 
borderland between anthropology, medicine, and psychiatry, University of California 
Press. 
KNORR CETINA, K. 1999. Epistemic cultures; how the sciences make knowledge, London, 
Harvard University Press. 
KUIKEN, T., FOUCHIER, R., RIMMELZWAAN, G. & OSTERHAUS, A. 2003. Emerging viral 
infections in a rapidly changing world. Current Opinion in Biotechnology, 14, 641-646. 
LAMUNU, M., LUTWAMA, J., KAMUGISHA, J., OPIO, A., NAMBOOZE, J., NDAYIMIRIJE, N. & 
OKWARE, S. 2004. Containing a haemorrhagic fever epidemic: the Ebola experience in 
Uganda (October 2000–January 2001). International Journal of Infectious Diseases, 8, 
27-37. 
LAST, M. 1981. The importance of knowing about not knowing. Social Science & Medicine. Part 
B: Medical Anthropology, 15, 387-392. 
LATOUR, B. 1987. Science in action: How to follow scientists and engineers through society, 
United States, Harvard University Press. 
LATOUR, B. & WOOLGAR, S. 1979. Laboratory Life: the social construction of scientific facts, 
Beverly Hills, Sage. 
LEACH, M. 1994. Rainforest relations: Gender and resource use among the Mende of Gola, Sierra 
Leone, Edinburgh, Edinburgh University Press. 
LEACH, M. 2008. Haemorrhagic fevers in Africa: Narratives, politics and pathways of disease 
and response. STEPS Working Paper 14, Brighton: STEPS Centre. 
258 
 
LEACH, M. & DRY, S. 2010. Epidemic Narratives. In: DRY, S. & LEACH, M. (eds.) Epidemics: 
Science, Governance and Social Justice. London: Earthscan. 
LEACH, M., SCOONES, I. & STIRLING, A. 2010a. Dynamic sustainabilities: technology, 
environment, social justice, Earthscan/James & James. 
LEACH, M., SCOONES, I. & STIRLING, A. 2010b. Governing epidemics in an age of complexity: 
Narratives, politics and pathways to sustainability. Global Environmental Change, 20, 
369-377. 
LEACH, M. A., FAIRHEAD, J. R. & MILLIMOUNO, D. 2008. New therapeutic landscapes in Africa: 
Parental categories and practices in seeking infant health in the Republic of Guinea. 
Social Science & Medicine, 66, 2157-2167. 
LITTLE, K. L. 1967. The Mende of Sierra Leone: A West African People in Transition, London, 
Routledge & K. Paul. 
LOCK, M. & NGUYEN, V. K. 2010. An anthropology of biomedicine, UK, Wiley-Blackwell. 
MABEY, D., PEELING, R. W., USTIANOWSKI, A. & PERKINS, M. D. 2004. Diagnostics for the 
developing world. Nature Reviews Microbiology, 2, 231-240. 
MACARTHUR, G. 2009. Global Health Diagnostics: research, development and regulation. 
Workshop Report. London: The Academy of Medical Sciences. 
MACCORMACK, C. P. 1984. Primary health care in Sierra Leone. Social Science & Medicine, 19, 
199-208. 
MALTERUD, K. 2001. The art and science of clinical knowledge: evidence beyond measures 
and numbers. The Lancet, 358, 397-400. 
MARCHAL, B., CAVALLI, A. & KEGELS, G. 2009. Global Health Actors Claim To Support Health 
System Strengthening—Is This Reality or Rhetoric? Plos Medicine, 6, e1000059. 
MARCUS, G. E. 1995. Ethnography in/of the world system: the emergence of multi-sited 
ethnography. Annual Review of Anthropology, 24, 95-117. 
MCCORMICK, J. B., FISHER-HOCH, S. & HORVITZ, L. A. 1999. Level 4: Virus hunters of the CDC, 
Barnes & Noble. 
MCCORMICK, J. B., KING, I. J., WEBB, P. A., JOHNSON, K. M., O'SULLIVAN, R., SMITH, E. S., 
TRIPPEL, S. & TONG, T. C. 1987a. A case-control study of the clinical diagnosis and 
course of Lassa fever. Journal of Infectious Diseases, 155, 445-455. 
MCCORMICK, J. B., KING, I. J., WEBB, P. A., SCRIBNER, C. L., CRAVEN, R. B., JOHNSON, K. M., 
ELLIOTT, L. H. & BELMONT-WILLIAMS, R. 1986. Lassa Fever. New England Journal of 
Medicine, 314, 20-26. 
259 
 
MCCORMICK, J. B., WEBB, P. A., KREBS, J. W., JOHNSON, K. M. & SMITH, E. S. 1987b. A 
Prospective Study of the Epidemiology and Ecology of Lassa Fever. The Journal of 
Infectious Diseases, Vol. 155, p437-444. 
MCGANN, P. & HUTSON, D. J. (eds.) 2011. Sociology of Diagnosis, Bingley, UK: Emerald Group 
Publishing. 
MESMAN, J. 2010. Diagnostic work in collaborative practices in neonatal care. In: BÜSCHER, 
M., GOODWIN, D. & MESMAN, J. (eds.) Ethnographies of diagnostic work: dimensions of 
transformative practice. Basingstoke: Palgrave Macmillan. 
MIETTINEN, O. S. 2001. The modern scientific physician: 3. Scientific diagnosis. CMAJ, 165, 
781-782. 
MILLER, F. A., AHERN, C., OGILVIE, J., GIACOMINI, M. & SCHWARTZ, L. 2005. Ruling in and 
ruling out: Implications of molecular genetic diagnoses for disease classification. Social 
Science &amp; Medicine, 61, 2536-2545. 
MITCHELL, J. P. 2007. Ethnography. In: OUTHWAITE, W. & TURNER, S. P. (eds.) The SAGE 
Handbook of Social Science Methodology. London: SAGE Publications. 
MOHS 2008. Technical Guidelines for Integrated Disease and Surveillance and Response in 
Sierra Leone. MINISTRY OF HEALTH AND SANITATION; DIRECTORATE OF DISEASE 
PREVENTION AND CONTROL. Freetown: Government of Sierra Leone. 
MOHS 2009. National Health Sector Strategic Plan 2010-2015. MINISTRY OF HEALTH AND 
SANITATION. Freetown, Sierra Leone: Government of Sierra Leone. 
MOHS 2010a. National Health Laboratory Strategic Plan 2011-2015. MINISTRY OF HEALTH 
AND SANITATION. Freetown, Sierra Leone: Government of Sierra Leone. 
MOHS 2010b. Sierra Leone National Laboratory Policy: delivering quality laboratory services.  
MINISTRY OF HEALTH AND SANITATION. Freetown, Sierra Leone: Government of 
Sierra Leone. 
MOL, A. 2002. The body multiple: Ontology in medical practice, Duke University Press Books. 
MOL, A. & BERG, M. 1994. Principles and practices of medicine. Culture, medicine and 
psychiatry, 18, 247-265. 
MOL, A. & BERG, M. 1998. Differences in medicine: an introduction. In: BERG, M. & MOL, A. 
(eds.) Differences in medicine: Unraveling practices, techniques, and bodies. Duke 
University Press. 
MOL, A. & ELSMAN, B. 1996. Detecting disease and designing treatment. Duplex and the 
diagnosis of diseased leg vessels. Sociology of Health & Illness, 18, 609-631. 
260 
 
MOMODU, S. 2004. Sierra Leone: Lassa Fever: Who is Next to Die? [Online]. Freetown: Concord 
Times. Available: http://allafrica.com/stories/200405190707.html [Accessed 
02/01/2013]. 
MONATH, T., MERTENS, P., PATTON, R., MOSER, C., BAUM, J., PINNEO, L., GARY, G. & KISSLING, 
R. 1973. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. The 
American journal of tropical medicine and hygiene, 22, 773-779. 
MONATH, T. P. 1975. Lassa fever: review of epidemiology and epizootiology. Bulletin of the 
World Health Organization, Vol. 52, p577-592. 
MONATH, T. P. & CASALS, J. 1975. DIAGNOSIS OF LASSA FEVER AND ISOLATION AND 
MANAGEMENT OF PATIENTS. Bulletin of the World Health Organization, 52, 707-715. 
MONATH, T. P., NEWHOUSE, V. F., KEMP, G. E., SETZER, H. W. & CACCIAPUOTI, A. 1974. Lassa 
Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone. 
Science, Vol. 185, p263-265. 
MOSES, L., KAMARA, A., GORGRA, A. & KOROMA, B. 2012. Lassa Fever Case Study: Situation 
Analysis. For the Dynamic Drivers of Disease in Africa Consortium. Institute of 
Development Studies, Brighton 
MURPHY, W. P. 1980. Secret knowledge as property and power in Kpelle society: Elders 
versus youth. Africa, 50, 193-207. 
MURPHY, W. P. 1990. Creating the Appearance of Consensus in Mende Political Discourse. 
American Anthropologist, 92, 24-41. 
MURPHY, W. P. & BLEDSOE, C. H. 1987. Kinship and territory in the history of a Kpelle 
chiefdom (Liberia). The African Frontier: the reproduction of traditional African 
societies, 123-147. 
NELSON, R. & WINTER, S. 1982. An Evolutionary Theory of Economic Change, Cambridge, 
Massachusetts, Belknap Press of Harvard University Press. 
NIAID. 2012. Biodefense and Emerging Infectious Diseases - NIAID Category A, B, and C Priority 
Pathogens [Online]. National Institute of Allergy and Infectious Diseases. Available: 
http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/cata.aspx 
[Accessed 15th December 2012]. 
NICHTER, M. 2008. Global health: Why cultural perceptions, social representations, and 
biopolitics matter, USA, University of Arizona Press. 
NIGHTINGALE, P. & MARTIN, P. 2004. The myth of the biotech revolution. Trends in 
Biotechnology, 22, 564-569. 
261 
 
NKENGASONG, J. N. 2009. Strengthening Laboratory Services and Systems in Resource-Poor 
Countries. American Journal of Clinical Pathology, 131, 774. 
NKENGASONG, J. N., NSUBUGA, P., NWANYANWU, O., GERSHY-DAMET, G. M., ROSCIGNO, G., 
BULTERYS, M., SCHOUB, B., DECOCK, K. M. & BIRX, D. 2010. Laboratory Systems and 
Services Are Critical in Global Health Time to End the Neglect? American Journal of 
Clinical Pathology, 134, 368-373. 
O'CONNELL, J. 1993. Metrology: The creation of universality by the circulation of particulars. 
Social Studies of Science, 23, 129-173. 
OGBU, O., AJULUCHUKWU, E. & UNEKE, C. 2007. Lassa fever in West African sub-region: an 
overview. Journal of vector borne diseases, 44, 1. 
OKAFOR, J. D. 2012. Lassa Fever "result" of poor hygiene [Online]. Nigeria: The Daily Trust. 
Available: http://dailytrust.com.ng/index.php/news/165670-lassa-fever-result-of-
poor-hygiene?device=xhtml [Accessed 14/12/12.] 
OLMSTED, S. S., MOORE, M., MEILI, R. C., DUBER, H. C., WASSERMAN, J., SAMA, P., MUNDELL, B. 
& HILBORNE, L. H. 2010. Strengthening Laboratory Systems in Resource-Limited 
Settings. American Journal of Clinical Pathology, 134, 374-380. 
OLSON, R. E. 2011. Managing hope, denial or temporal anomie? Informal cancer carers’ 
accounts of spouses’ cancer diagnoses. Social Science and Medicine, 73, 904-911. 
ONG, A. & COLLIER, S. J. (eds.) 2005. Global assemblages: technology, politics, and ethics as 
anthropological problems, Malden, USA; Oxford, UK: Blackwell Publishing Ltd. 
PANG, T. & PEELING, R. W. 2007. Diagnostic tests for infectious diseases in the developing 
world: two sides of the coin. Transactions of the Royal Society of Tropical Medicine and 
Hygiene, 101, 856-857. 
PANNING, M., EMMERICH, P., ÖLSCHLÄGER, S., BOJENKO, S., KOIVOGUI, L., MARX, A., LUGALA, 
P. C., GÜNTHER, S., BAUSCH, D. G. & DROSTEN, C. 2010. Laboratory diagnosis of Lassa 
fever, Liberia. Emerging infectious diseases, 16, 1041. 
PARKER, M., ALLEN, T. & HASTINGS, J. 2008. Resisting control of neglected tropical diseases: 
dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in 
north-west Uganda. Journal of Biosocial Science, 40, 161. 
PARKER, M. & HARPER, I. 2006. The Anthropology of Public Health. Journal of Biosocial 
Science, 38, 1-5. 
PARSONS, T. 1951. The Social System, London, Routledge & Kegan Paul Ltd. 
262 
 
PEELING, R. & MABEY, D. 2010. Point-of-care tests for diagnosing infections in the developing 
world. Clinical Microbiology and Infection, 16, 1062-1069. 
PEELING, R. W. & NWAKA, S. 2011. Drugs and Diagnostic Innovations to Improve Global 
Health. Infectious disease clinics of North America, 25, 693-705. 
PETERS, D. H. & BLOOM, G. 2012. Developing world: Bring order to unregulated health 
markets. Nature, 487, 163-165. 
PETTI, C. A., POLAGE, C. R., QUINN, T. C., RONALD, A. R. & SANDE, M. A. 2006. Laboratory 
medicine in Africa: A barrier to effective health care. Clinical Infectious Diseases, 42, 
377-382. 
PICKERING, A. 1992. From Science as Knowledge to Science as Practice. In: PICKERING, A. 
(ed.) Science as practice and culture. Chicago: University of Chicago Press. 
PICKERING, A. 1993. The Mangle of Practice: Agency and Emergence in the Sociology of 
Science. The American Journal of Sociology, 99, 559-589. 
PICKERING, A. 1995. The mangle of practice: Time, agency, and science, University of Chicago 
Press. 
PICKERING, A. 2008. New Ontologies. In: PICKERING, A. & GUZIK, K. (eds.) The mangle in 
practice: science, society, and becoming. Durham and London: Duke University Press  
PINCH, T. J. & BIJKER, W. E. 1984. The social construction of facts and artifacts - or how the 
sociology of science and the sociology of technology might benefit each other. Social 
Studies of Science, 14, 399-441. 
PLEBANI, M. 2006. Errors in clinical laboratories or errors in laboratory medicine? Clinical 
Chemical Laboratory Medicine, 44, 750-759. 
POLAGE, C. R., BEDU-ADDO, G., OWUSU-OFORI, A., FRIMPONG, E., LLOYD, W., ZURCHER, E., 
HALE, D. & PETTI, C. A. 2006. Laboratory use in Ghana: physician perception and 
practice. The American journal of tropical medicine and hygiene, 75, 526-531. 
POSTE, G. 2001. Molecular diagnostics: a powerful new component of the healthcare value 
chain. Expert Review of Molecular Diagnostics, 1, 1-5. 
PRICE, M. E., FISHER-HOCH, S. P., CRAVEN, R. B. & MCCORMICK, J. B. 1988. A prospective study 
of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ: 
British Medical Journal, 297, 584. 
PROMED. 2012. PRO/AH/EDR> Lassa Fever - Nigeria (08): Update [Online]. International 
Society for Infectious Diseases. Available: 
263 
 
http://www.promedmail.org/direct.php?id=20120714.1201872 [Accessed 
02/01/2013.] 
RAFAEL, M. E., TAYLOR, T., MAGILL, A., LIM, Y. W., GIROSI, F. & ALLAN, R. 2006. Reducing the 
burden of childhood malaria in Africa: the role of improved. Nature, 444, 39-48. 
RAPP, R. 1999. Testing women, testing the fetus: the social impact of amniocentesis in America, 
New York, Routledge. 
REIN, M. & SCHÖN, D. 1996. Frame-critical policy analysis and frame-reflective policy practice. 
Knowledge, Technology & Policy, 9, 85-104. 
RENO, W. 1995. Corruption and State Politics in Sierra Leone, Cambridge, Cambridge 
University Press. 
REYNOLDS WHYTE, S. 1982. Penicillin, battery acid and sacrifice: Cures and causes in Nyole 
medicine. Social Science &amp; Medicine, 16, 2055-2064. 
REYNOLDS WHYTE, S. 1992. Pharmaceuticals as folk medicine: transformations in the social 
relations of health care in Uganda. Culture, medicine and psychiatry, 16, 163-186. 
RICHARDS, P. 1996. Fighting for the rain forest: war, youth and resources in Sierra Leone, 
London, International African Institute. 
RICHMOND, J. K. & BAGLOLE, D. J. 2003. Lassa fever: epidemiology, clinical features, and social 
consequences. BMJ, 327, 1271-1275. 
RITCHIE, J. 2003. The Applications of Qualitative Methods to Social Research. In: RITCHIE, J. & 
LEWIS, J. (eds.) Qualitative research practice: A guide for social science students and 
researchers. London; California: Sage Publications Limited. 
ROE, E. 1994. Narrative policy analysis: Theory and practice, USA, Duke University Press. 
ROSENBERG, C. E. 1989. Disease in history: frames and framers. The Milbank Quarterly, 1-15. 
ROSENBERG, C. E. 1992. Introduction: Framing Disease: Illness, Society and History. In: 
ROSENBERG, C. E. & GOLDEN, J. (eds.) Framing Disease: Studies in Cultural History. 
New Brunswick: Rutgers University Press. 
ROSENBERG, C. E. 2002. The Tyranny of Diagnosis: Specific Entities and Individual 
Experience. The Milbank Quarterly, 80, 237. 
ROSENSTEIN, B. J. 2002. Cystic fibrosis diagnosis: new dilemmas for an old disorder. Pediatric 
pulmonology, 33, 83-84. 
RUBIN, H. J. & RUBIN, I. S. 2005. Qualitative Interviewing: The Art of Hearing Data, London, 
SAGE Publications. 
264 
 
SAIJO, M., NIIKURA, M., IKEGAMI, T., KURANE, I., KURATA, T. & MORIKAWA, S. 2006. 
Laboratory Diagnostic Systems for Ebola and Marburg Hemorrhagic Fevers Developed 
with Recombinant Proteins. Clinical and Vaccine Immunology, 13, 444-451. 
SALTER, C. I., HOWE, A., MCDAID, L., BLACKLOCK, J., LENAGHAN, E. & SHEPSTONE, L. 2011. 
Risk, significance and biomedicalisation of a new population: Older women’s 
experience of osteoporosis screening. Social Science and Medicine, 73, 808-815. 
SCHAEPE, K. S. 2011. Bad news and first impressions: Patient and family caregiver accounts of 
learning the cancer diagnosis. Social Science and Medicine, 73, 912-921. 
SCHEPER-HUGHES, N. & LOCK, M. M. 1987. The Mindful Body: A Prolegomenon to Future 
Work in Medical Anthropology. Medical Anthropology Quarterly, 1, 6-41. 
SCHON, D. & REIN, M. 1994. Frame reflection: toward the resolution of intractable policy 
conflicts, New York, Basic Books. 
SCHUBERT, C. 2011. Making sure. A comparative micro-analysis of diagnostic instruments in 
medical practice. Social Science and Medicine, 73, 851-857. 
SCOTT, W. J. 1990. PTSD in DSM-III: A case in the politics of diagnosis and disease. Soc. Probs., 
37, 294. 
SOGOBA, N., FELDMANN, H. & SAFRONETZ, D. 2012. Lassa Fever in West Africa: Evidence for 
an Expanded Region of Endemicity. Zoonoses and Public Health, 59, 43-47. 
SSL 2006. Final Results: 2004 Population and Housing Census. Statistics Sierra Leone (SSL). 
Government of Sierra Leone. 
SSL & ICF MACRO 2009. Sierra Leone Demographic and Health Survey 2008. Statistics Sierra 
Leone (SSL) and ICF Macro. Calverton Maryland, USA:. 
STAKE, R. E. 1994. Case Studies. In: DENZIN, N. K. & LINCOLN, Y. S. (eds.) Handbook of 
Qualitative Research London: Sage  
STANDING, H. & BLOOM, G. 2002. Beyond public and private? Unorganised markets in health 
care delivery. 'Making Services Work for Poor People' World Development Report 
(WDR) 2003/04 Workshop. Oxford. 
STAR, S. L. & GRIESEMER, J. R. 1989. Institutional Ecology, `Translations' and Boundary 
Objects: Amateurs and Professionals in Berkeley's Museum of Vertebrate Zoology, 
1907-39. Social Studies of Science, 19, 387-420. 
STARBUCK, W. H. 2006. The production of knowledge: The challenge of social science research, 
Oxford, Oxford University Press. 
265 
 
STEPHENSON, E. H., LARSON, E. W. & DOMINIK, J. W. 1984. Effect of environmental factors on 
aerosol‐induced lassa virus infection. Journal of medical virology, 14, 295-303. 
STIRLING, A. 2007. Risk, precaution and science: towards a more constructive policy debate. 
EMBO reports, 8, 309-315. 
STREET, A. 2011. Artefacts of not-knowing: The medical record, the diagnosis and the 
production of uncertainty in Papua New Guinean biomedicine. Social Studies of 
Science, 41, 815-834. 
TER MEULEN, J., LENZ, O., KOIVOGUI, L., MAGASSOUBA, N. F., KAUSHIK, S. K., LEWIS, R. & 
ALDIS, W. 2001. Short communication: Lassa fever in Sierra Leone: UN peacekeepers 
are at risk. Tropical Medicine & International Health, 6, 83-84. 
TER MEULEN, J., LUKASHEVICH, I., SIDIBE, K., INAPOGUI, A., MARX, M., DORLEMANN, A., 
YANSANE, K., KOULEMOU, J., CHANG-CLAUDE, J. & SCHMITZ, H. 1996. Hunting of 
peridomestic rodents and consumption of their meat as possible risk factors for 
rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med 
Hyg, Vol. 55, p661-666. 
TIMMERMANS, S. & BERG, M. 2003. The practice of medical technology. Sociology of Health & 
Illness, 25, 97-114. 
TRAVIS, P., BENNETT, S., HAINES, A., PANG, T., BHUTTA, Z., HYDER, A. A., PIELEMEIER, N. R., 
MILLS, A. & EVANS, T. 2004. Overcoming health-systems constraints to achieve the 
Millennium Development Goals. The Lancet, 364, 900-906. 
TREICHLER, P. A. 1999. How to have theory in an epidemic: Cultural chronicles of AIDS, Duke 
University Press Books. 
TRUNDLE, C. 2011. Biopolitical endpoints: Diagnosing a deserving British nuclear test 
veteran. Social Science and Medicine, 73, 882-888. 
UN 2004. Map of Sierra Leone. Department for Peacekeeping Operations Cartographic Section, 
United Nations. 
UNDP 2007. Human Development Report 2007/8. Fighting climate change: human solidarity 
in a divided world. Human Development Reports. New York: United Nations 
Development Programme, United Nations. 
UNDP 2009. Human Development Report 2009. Overcoming barriers: Human mobility and 
development. Human Development Reports. New York: United Nations Development 
Programme, United Nations. 
266 
 
URDEA, M., PENNY, L. A., OLMSTED, S. S., GIOVANNI, M. Y., KASPAR, P., SHEPHERD, A., 
WILSON, P., DAHL, C. A., BUCHSBAUM, S., MOELLER, G. & HAY BURGESS, D. C. 2006. 
Requirements for high impact diagnostics in the developing world. Nature. 
VOGEL, K. M. 2008a. Biodefense: considering the sociotechnical dimension. In: LAKOFF, A. & 
COLLIER, S. (eds.) Biosecurity interventions: global health and security in question. New 
York: Columbia University Press. 
VOGEL, K. M. 2008b. Framing biosecurity: An alternative to the biotech revolution model? 
Science and Public Policy, 35, 45-54. 
WALD, P. 2008. Contagious: Cultures, carriers, and the outbreak narrative, Duke University 
Press Books. 
WALKER, D. H., WULFF, H., LANGE, J. V. & MURPHY, F. A. 1975. Comparative pathology of 
Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bulletin of the 
World Health Organization, Vol. 52, p423-34. 
WALLACE, A. 2011. Broomfield's Coregenix involved in medical efforts related to Lassa fever, 
Ebola [Online]. US: Daily Camera. Available: 
http://www.dailycamera.com/business/ci_17601956 [Accessed 02/01/2013.] 
WHITAKER, K. 2012. Is Sierra Leone right to ban tradtional birth attendants? [Online]. UK: The 
Guardian. Available: http://www.guardian.co.uk/global-development/poverty-
matters/2012/jan/17/traditional-birth-attendants-sierra-leone [Accessed 
03/01/2013.] 
WHO 2003. Lassa Fever and Communicable Disease Surveillance and Control in Sierra Leone: 
Report and Recommendations of WHO/UNHCR mission to Sierra Leone (extract of full 
mission report). World Health Organisation. 
WHO 2005. International Health Regulations (2005), second edition, Geneva, World Health 
Organization. 
WHO 2008. Interim Infection Control Recommendations for Care of Patients with Suspected 
or Confirmed Filovirus (Ebola, Marburg) Hemorrahagic Fever. Geneva: World Health 
Organisation. 
WHO. 2012a. Lassa fever factsheet [Online]. Geneva: Global Alert and Response; World Health 
Organisation. Available: http://www.who.int/mediacentre/factsheets/fs179/en/  
[Accessed 24/09/2012.] 
267 
 
WHO. 2012b. Lassa Fever in Nigeria [Online]. Global Alert and Response, World Health 
Organisation. Available: http://www.who.int/csr/don/2012_04_04/en/index.html 
[Accessed 24/09/2012.] 
WHO & CDC 2010. Technical Guidelines for Integrated Disease Surveillance and Response in 
the African Region. Brazzaville, Republic of Congo and Atlanta, USA: World Health 
Organization and Centers for Disease Control and Prevention. 
WILLIAMS, S. J. & CALNAN, M. 1996. The 'limits' of medicalization?: Modern medicine and the 
lay populace in 'late' modernity. Social Science & Medicine, 42, 1609-1620. 
WILLIG, C. 2011. Cancer diagnosis as discursive capture: Phenomenological repercussions of 
being positioned within dominant constructions of cancer. Social Science and Medicine, 
73, 897-903. 
YALLEY-OGUNRO, J., FRAME, J. & HANSON, A. 1984. Endemic Lassa fever in Liberia. VI. Village 
serological surveys for evidence of Lassa virus activity in Lofa County, Liberia. 
Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 764-770. 
YOUNG, A. 1982. The anthropologies of illness and sickness. Annual Review of Anthropology, 
257-285. 
ZUNG, W. W. K. 1973. From Art to Science: The Diagnosis and Treatment of Depression. Arch 
Gen Psychiatry, 29, 328-337. 
 
 
259 
 
Appendix 1: Interview details 
Interview Category Total149 Date Location Description Name 
Pseudonym150 
Interview reference (for in-
text citation) 
Tokenga’s151 health 
and healing 
practitioners 
6  
 
17/03/2010 Tokenga ‘Witchdoctor’, Male N/A N/A 
16/03/2010 Tokenga Imam, Male N/A Imam, Tokenga, 17/03/2010 
09/03/2010 Tokenga  Informal nurse, Male Mohammed Informal nurse, Tokenga, 
09/03/2010 
16/03/2010 Tokenga Visiting drug peddler, Male N/A Drug peddler, Tokenga, 
16/03/2010 
20/02/2010 Tokenga Resident herbalist, female N/A Herbalist 1, Tokenga, 
20/02/2010 
20/02/2010 Tokenga Resident herbalist, female N/A Herbalist 2, Tokenga, 
20/02/2010 
Tokenga household 
interviews 
5 13/03/2010 Tokenga Senior male and female members 
of household 
Musa family Musa family, Tokenga, 
13/03/2010 
12/03/2010 Tokenga Senior male and female members 
of household 
Sannoh family Sonnoh family, Tokenga, 
12/03/2010 
13/03/2010 Tokenga Senior male and female members 
of household 
Samai family Samai family, Tokenga, 
13/03/2010 
13/03/2010 Tokenga Senior male and female members 
of household 
Amara family Amara family, Tokenga, 
13/03/2012 
13/03/2010 Tokenga Senior male and female members 
of household 
Turay family Turay family, Tokenga, 
13/03/2010 
Lassa histories 
Tokenga 
6  18/02/2010 Tokenga Interview with Lassa survivor, 
teacher, male 
Sheku Lassa history 1, Tokenga, 
18/02/2010 
                                               
149 Interviews not recorded are in italics 
150 Names of interviewees and any patients they refer have been changed in the text 
151 The name of the research village has been changed  
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19/02/2010 Tokenga Interview with mother and 
brother of deceased Lassa case, 
dead man was a Kamajᴐ 
Deceased name 
was Mambu 
Lassa history 2, Tokenga, 
19/02/2010 
19/02/2010 Tokenga Interview with husband of 
deceased Lassa case 
Deceased name 
was Mariama 
Lassa history 3, Tokenga, 
19/02/2010 
09/03/2010 Tokenga Interview with husband and 
mother in law of deceased Lassa 
case 
Deceased name 
was Kema 
Lassa history 4, Tokenga, 
09/03/2010 
11/03/2010 Tokenga Interview with husband and 
brother of deceased Lassa case 
Deceased name 
was Jina 
Lassa history 5, Tokenga, 
11/03/2010 
11/03/2010 Tokenga Interview with Lassa survivor, 
farmer, male (and brother) 
Bockari Lassa history 6, Tokenga, 
11/03/2010 
Lassa histories other 
(positive)  
21  10/04/2010 Kenema Interview with Lassa survivor, 
trader, female 
Adama Lassa history 7, Kenema, 
10/04/2010 
13/05/2010 Foindu Interview with husband and wife, 
lost 3 children, wife survived 
N/A Lassa history 8, Foindu, 
12/05/2010 
24/04/2010 Tongo Interview with Lassa survivor, 
student, male 
N/A Lassa history 9, Tongo, 
24/04/2010 
27/04/2010 Tongo Interview with Lassa survivor, 
famer, male 
N/A Lassa history 10, Tongo, 
27/04/2010 
14/04/2010 Kenema Interview with Lassa survivor, 
nurse, female 
N/A Lassa history 11, Kenema, 
14/04/2012 
26/04/2010 Tongo Interview with Lassa survivor, 
diamond miner, male 
N/A Lassa history 12, Tongo, 
26/04/2010 
29/04/2011 Makeni Interview with Lassa survivor, 
European clinician, female 
N/A Lassa history 13, Makeni, 
29/04/2011 
13/04/2010 Foindu Interview with Lassa survivor, 
female 
N/A N/A 
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13/04/2010 Foindu Interview with Lassa survivor 
(female) and her father, farmers 
N/A N/A 
07/05/2010 Kenema Interview with Lassa survivor, 
student, female 
N/A N/A 
08/07/2010 Kenema Interview with Lassa survivor, 
housewife 
N/A N/A 
12/04/2010 Kenema Interview with Lassa survivor, 
student, female 
N/A N/A 
09/05/2010 Kenema Interview with Lassa survivor, 
trader, female 
N/A N/A 
13/04/2010 Kenema Interview with Lassa survivor, 
farmer, male 
N/A N/A 
20/04/2010 Kenema Interview with Lassa survivor, 
business man, male 
N/A N/A 
19/04/2010 Kenema Interview with Lassa survivor, no 
work, male 
N/A N/A 
17/04/2010 Kenema Interview with Lassa survivor, 
student, male 
N/A N/A 
11/05/2010 Largo Interview with Lassa survivor, 
farmer, female 
N/A N/A 
28/04/2010 Tongo Interview with Lassa survivor, 
housewife, female 
N/A N/A 
29/04/2010 Tongo Interview with Lassa survivor, 
mining business, male 
N/A N/A 
27/04/2010 Tongo Interview with Lassa survivor, 
housewife, female 
N/A N/A 
Lassa histories 
(negative) 
2  22/04/2010 Kenema Interview with Lassa negative 
patient from Lassa ward, 
Canadian business man 
N/A N/A 
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13/05/2010 Kenema Interview with Lassa negative 
patient from Lassa ward, 
housewife, female 
N/A N/A 
Tulane  4 02/03/2010 Kenema Doctoral student – laboratory 
specialist, male 
N/A Tulane laboratory scientist, 
Kenema, 02/03/2010 
11/04/2010 Kenema Doctoral student – rodent ecology 
specialist, female 
N/A Tulane rodent ecologist, Kenema   
27/07/2012 Skype Tulane researcher, medical 
clinician, male 
N/A Tulane medical clinician, 
telephone interview, 27/07/2012 
27/03/2010 Kenema Tulane Clinician, male N/A Tulane medical clinician, 
Kenema, 27/03/2010 
Clinical (Panguma) 3 22/02/2010 Panguma Interview with clinician at 
Panguma, male 
N/A Clinician, Panguma, 22/02/2010 
22/02/2010 Panguma Interview with paediatric nurse 
at Panguma, male 
N/A Paediatric nurse, Panguma, 
22/02/2010 
22/02/2010 Panguma Interview with outpatient nurse 
at Panguma, male 
N/A Outpatient nurse, Panguma, 
22/02/2010 
WHO/MOHS 3 14/12/2012 Geneva WHO, Lassa fever coordinator, 
Global Alert and Response, female 
N/A WHO representative, Geneva, 
14/12/2012 
29/04/2011 Freetown WHO, Freetown, male N/A WHO representative, Freetown, 
29/04/2011 
28/04/2011 Freetown Director of disease prevention 
and control, male 
N/A Senior MOHS official, Disease 
Prevention and Control 
Directorate, Freetown, 
28/04/2011    
Total 50      
 
